Wikidata:WikiProject Source MetaData/Wikidata lists/Items about HTLV-1

From Wikidata
Jump to navigation Jump to search

This list is periodically updated by a bot. Manual changes to the list will be removed on the next update!

WDQS | PetScan | TABernacle | Find images Recent changes | Query: SELECT ?item WHERE { { ?item wdt:P921 wd:Q1280388 . } }


scholarly article[edit]

Article
Alteration of blood-brain barrier integrity by retroviral infection
The HTLV-1 Tax interactome
Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis
HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter
Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses
STLV-1-infected Japanese macaque as a model of HTLV-1 infection
HTLV-1 Tax-associated hTid-1, a human DnaJ protein, is a repressor of Ikappa B kinase beta subunit
The HTLV-1 Tax protein inhibits formation of stress granules by interacting with histone deacetylase 6
Interaction of human T-cell lymphotropic virus type I Rex protein with Dicer suppresses RNAi silencing
The bZIP transcription factor ATFx binds human T-cell leukemia virus type 1 (HTLV-1) Tax and represses HTLV-1 long terminal repeat-mediated transcription
HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression
APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1
Functional interaction of the HTLV-1 transactivator Tax with activating transcription factor-4 (ATF4)
The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the PDZ domain of cellular proteins
Altered expression of a novel cellular gene as a consequence of integration of human T cell lymphotropic virus type 1
Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2
Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding
Multiple cDNA clones encoding nuclear proteins that bind to the tax-dependent enhancer of HTLV-1: all contain a leucine zipper structure and basic amino acid domain
Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha
Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34
HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications
Selective expression of a protein-tyrosine kinase, p56lyn, in hematopoietic cells and association with production of human T-cell lymphotropic virus type I
The imprint of the Slave Trade in an African American population: mitochondrial DNA, Y chromosome and HTLV-1 analysis in the Noir Marron of French Guiana
Thioredoxin-binding protein-2 (TBP-2/VDUP1/TXNIP) regulates T-cell sensitivity to glucocorticoid during HTLV-I-induced transformation
Physical and functional interaction between the human T-cell lymphotropic virus type 1 Tax1 protein and the CCAAT binding protein NF-Y
Involvement of transcription factor YB-1 in human T-cell lymphotropic virus type I basal gene expression
Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2
Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite th
HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding
Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort study
Critical role of hnRNP A1 in HTLV-1 replication in human transformed T lymphocytes
HTLV-1 p30II: selective repressor of gene expression
Specific TATAA and bZIP requirements suggest that HTLV-I Tax has transcriptional activity subsequent to the assembly of an initiation complex
Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers
Retrovirology highlights a quarter century of HTLV-I research
The discovery of the first human retrovirus: HTLV-1 and HTLV-2
Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease
Altered expression of inflammatory cytokines in primary osteoarthritis by human T lymphotropic virus type I retrovirus infection: a cross-sectional study
Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL)
Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes
The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix
Quantification of HTLV-I proviral load in experimentally infected rabbits
APOBEC3G & HTLV-1: inhibition without deamination
Ku protein as a potential human T-cell leukemia virus type 1 (HTLV-1) Tax target in clastogenic chromosomal instability of mammalian cells
SUV39H1 interacts with HTLV-1 Tax and abrogates Tax transactivation of HTLV-1 LTR.
A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes
Quantification of the virus-host interaction in human T lymphotropic virus I infection.
Postrenal Transplant Human T-Cell Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis: A Case Report and Review of the Literature
Transcriptional and Epigenetic Regulatory Mechanisms Affecting HTLV-1 Provirus
HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZ
Hepatitis C virus/human T lymphotropic virus 1/2 co-infection: Regional burden and virological outcomes in people who inject drugs
Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission
Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis
Mother-to-Child Transmission of HTLV-1 Epidemiological Aspects, Mechanisms and Determinants of Mother-to-Child Transmission
Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV Infections
The Role of HBZ in HTLV-1-Induced Oncogenesis
HTLV-1, Immune Response and Autoimmunity
Seroprevalence of HTLV-1 and HTLV-2 amongst mothers and children in Malawi within the context of a systematic review and meta-analysis of HTLV seroprevalence in Africa
Molecular Studies of HTLV-1 Replication: An Update
Roles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related Diseases
From Immunodeficiency to Humanization: The Contribution of Mouse Models to Explore HTLV-1 Leukemogenesis
HTLV-1 ORF-I Encoded Proteins and the Regulation of Host Immune Response: Viral Induced Dysregulation of Intracellular Signaling
How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?
The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis
HTLV-1 pathogenesis mediated by HTLV-1 bZIP factor
Blood-brain barrier and retroviral infections
New insights into HTLV-1 particle structure, assembly, and Gag-Gag interactions in living cells
The need to accessorize: molecular roles of HTLV-1 p30 and HTLV-2 p28 accessory proteins in the viral life cycle
Physiotherapy for human T-lymphotropic virus 1-associated myelopathy: review of the literature and future perspectives
HTLV-1/-2 and HIV-1 co-infections: retroviral interference on host immune status
Origin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the Americas
Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research
Immunopathogenesis and neurological manifestations associated to HTLV-1 infection
Cell death of salivary gland epithelial cells and involvement of HTLV-I in Sjögren's syndrome
Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography
Sequence-specific 1H, 13C and 15N chemical shift assignment and secondary structure of the HTLV-I capsid protein
Anchoring an extended HTLV-1 Rex peptide within an RNA major groove containing junctional base triples
Crystal Structures of Inhibitor Complexes of Human T-Cell Leukemia Virus (HTLV-1) Protease
Structural basis for HTLV-1 protease inhibition by the HIV-1 protease inhibitor indinavir
Privileged Structures Meet Human T-Cell Leukemia Virus-1 (HTLV-1): C2-Symmetric 3,4-Disubstituted Pyrrolidines as Nonpeptidic HTLV-1 Protease Inhibitors
Iatrogenic Transmission of Human T Cell Lymphotropic Virus Type 1 and Hepatitis C Virus through Parenteral Treatment and Chemoprophylaxis of Sleeping Sickness in Colonial Equatorial Africa
HTLV-1 Rex Tunes the Cellular Environment Favorable for Viral Replication
Family Aggregation of Human T-Lymphotropic Virus 1-Associated Diseases: A Systematic Review
HTLV-1 bZIP factor impedes the menin tumor suppressor and upregulates JunD-mediated transcription of the hTERT gene
Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1
HTLV-1-associated myelopathy/tropical spastic paraparesis with pseudohypoparathyroidism
Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site
Activation of IKKalpha and IKKbeta through their fusion with HTLV-I tax protein
The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV
Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells
Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica
IRF-4 activities in HTLV-I-induced T cell leukemogenesis
Human T-cell lymphotropic virus type I Tax activates lung resistance-related protein expression in leukemic clones established from an adult T-cell leukemia patient
Telomerase: a crucial player in HTLV-I-induced human T-cell leukemia
Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation
Human T lymphotropic virus type-1-associated myelopathy manifesting shortly after living-donor renal transplantation
A human T-cell lymphotropic virus type 1 enhancer of Myc transforming potential stabilizes Myc-TIP60 transcriptional interactions
The origin of HIV-1 isolate HTLV-IIIB
Modulation of Tax and PKA-mediated expression of HTLV-I promoter via cAMP response element binding and modulator proteins CREB and CREM
Expression of CCR9 in HTLV-1+ T cells and ATL cells expressing Tax
Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus
Licensure of screening tests for antibody to human T-lymphotropic virus type I
HLA class I and class II of the Nivkhi, an indigenous population carrying HTLV-I in Sakhalin, Far Eastern Russia
Mapping of the intermolecular association of human T cell leukaemia/lymphotropic virus type I p12I and the vacuolar H+-ATPase 16 kDa subunit protein
Setting the stage for transformation: HTLV-1 Tax inhibition of p53 function
Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1
HTLV-1 Tax-induced NFkappaB activation is independent of Lys-63-linked-type polyubiquitination
The gene encoding the Act-2 cytokine. Genomic structure, HTLV-I/Tax responsiveness of 5' upstream sequences, and chromosomal localization
Human interleukin-9: genomic sequence, chromosomal location, and sequences essential for its expression in human T-cell leukemia virus (HTLV)-I-transformed human T cells
Differential activation of viral and cellular promoters by human T-cell lymphotropic virus-1 tax and cAMP-responsive element modulator isoforms
Effect of retinoic acid on the replication of human immunodeficiency virus in HTLV-I-positive MT-4 cells
Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides
Antigenic cross-reactivity between human T lymphotropic virus type I (HTLV-I) and retinal antigens recognized by T cells
Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis
Epidemiological analysis of HTLV-1 and HTLV-2 infection among different population in Central China
CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis
HTLV-1 Tax-mediated inhibition of FOXO3a activity is critical for the persistence of terminally differentiated CD4+ T cells
HTLV-1 Tax Functions as a Ubiquitin E3 Ligase for Direct IKK Activation via Synthesis of Mixed-Linkage Polyubiquitin Chains
Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule
Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy
Human T-lymphotropic virus type 1 in coastal natives of British Columbia: phylogenetic affinities and possible origins
Treatment of HTLV-I-Associated Myelopathy / Tropical Spastic Paraparesis: Towards Rational Targeted Therapy
Human T Cell Lymphotropic Virus Type I Tax Activates IL-15Rα Gene Expression Through an NF-κB Site
[Prevalence of human T-lymphotropic virus, Type 1 and 2 in blood donors and patients with sexually transmissible diseases in Surinam]
High seroprevalence of human T-cell lymphotropic virus type 1 in blood donors in Guyana and molecular and phylogenetic analysis of new strains in the Guyana shelf (Guyana, Suriname, and French Guiana)
[Progressive myelopathy caused by human T-cell lymphotropic virus type I (HTLV-I) in 3 patients in The Netherlands]
Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay
Interaction between the SH3 domain of Src family kinases and the proline-rich motif of HTLV-1 p13: a novel mechanism underlying delivery of Src family kinases to mitochondria.
Genetic markers on the HTLV-1 p12I protein sequences from Brazilian HAM/TSP patients and asymptomatic HTLV-1 carrier isolates.
In vitro and in vivo functional analysis of human T cell lymphotropic virus type 1 pX open reading frames I and II.
Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes.
Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression
Reducing the global burden of HTLV-1 infection: An agenda for research and action.
Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I).
Global epidemic of human T-cell lymphotrophic virus type-I (HTLV-I): an update.
Molecular mechanisms affecting HTLV type 1-dependent fusion at the cell membrane: implications for inhibiting viral transmission.
HIV and HTLV-I infections in the Americas: a regional perspective.
A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.
Interaction of HTLV-1 Tax protein with calreticulin: implications for Tax nuclear export and secretion.
Contribution of Galvanic Vestibular Stimulation for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
Human T-cell lymphotrophic virus type-I (HTLV-I) retrovirus and human disease.
A public HTLV-1 molecular epidemiology database for sequence management and data mining.
Complex cell cycle abnormalities caused by human T-lymphotropic virus type 1 Tax.
Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).
[Human T-cell lymphotropic virus type 1(HTLV-1)-associated myelopathy].
Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Molecular epidemiology of simian T-lymphotropic virus (STLV) in wild-caught monkeys and apes from Cameroon: a new STLV-1, related to human T-lymphotropic virus subtype F, in a Cercocebus agilis.
Transmission of human T-cell lymphotropic virus type 1 tax to rabbits by tax-only-positive human cells.
New approach for generation of neutralizing antibody against human T-cell leukaemia virus type-I (HTLV-I) using phage clones.
Tax oncoprotein of HTLV-1 binds to the human homologue of Drosophila discs large tumor suppressor protein, hDLG, and perturbs its function in cell growth control.
Inferences about the global scenario of human T-cell lymphotropic virus type 1 infection using data mining of viral sequences.
Seroprevalence of human T-lymphotropic virus type 1 in Papua New Guinea and Irian Jaya measured using different western blot criteria.
Is human T cell lymphotropic type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) syndrome a neglected disease?
Human T lymphotropic virus I in Indonesia. Very low seroprevalence in the Jakarta area: antibodies in healthy blood donors and in various nonhematological diseases.
The human T-cell leukemia virus type I (HTLV-I) X region encoded protein p13(II) interacts with cellular proteins.
High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease
Physiological functions of the ascending spinal tracts in HTLV-I-associated myelopathy (HAM).
Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein
[A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].
Progressive spastic myelopathy in a patient co-infected with HIV-1 and HTLV-II: autoantibodies to the human homologue of rig in blood and cerebrospinal fluid.
Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis.
HTLV-I-associated peripheral neuropathy with smoldering-type adult T-cell leukemia.
Monoclonally integrated HTLV type 1 in epithelial cancers from rabbits infected with an HTLV type 1 molecular clone.
Indocyanine green angiography in patients with human T cell-lymphotropic virus type 1 uveitis.
Differential role of PKC-induced c-Jun in HTLV-1 LTR activation by 12-O-tetradecanoylphorbol-13-acetate in different human T-cell lines.
Chronic rhinitis in HTLV-1 carriers: a histopathologic study.
HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity.
Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data.
Epitope analysis of the cerebrospinal fluid IgG in HTLV-I associated myelopathy patients using phage display method.
Lack of evidence to support the association of a single IL28B genotype SNP rs12979860 with the HTLV-1 clinical outcomes and proviral load.
HTLV-I Tax induces and associates with Crk-associated substrate lymphocyte type (Cas-L).
Repression of DNA repair mechanisms in IRF-4-expressing and HTLV-I-infected T lymphocytes.
HTLV-1 specific CD8+ T cell function augmented by blockade of 2B4/CD48 interaction in HTLV-1 infection
Regulation of human T-lymphotropic virus type I latency and reactivation by HBZ and Rex.
IL-2 independent transformation of a unique human T cell line, TY8-3, and its subclones by HTLV-I and -II.
Immune response against the exp-1 protein of Plasmodium falciparum results in antibodies that cross-react with human T-cell lymphotropic virus type 1 proteins.
Nucleocytoplasmic transport of HTLV-1 RNA is regulated by two independent LTR encoded nuclear retention elements.
Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C.
Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells.
High variability of HTLV-I in a remote population of Gabon as compared to that of a similar population of French Guiana.
A pilot study of HTLV-I infection in high-risk individuals & their family members from India.
Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2
Seven years of recurrent severe strongyloidiasis in an HTLV-I-infected man who developed adult T-cell leukaemia.
Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.
Expression of human T-cell lymphotropic virus type-1 gene products in the short-term cultured skin tissues of an adult T-cell leukemia/lymphoma patient with cutaneous manifestations.
Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results
Intrahost variations in the envelope receptor-binding domain (RBD) of HTLV-1 and STLV-1 primary isolates.
Determination of a unique and immunodominant epitope of human T cell lymphotropic virus type I.
Detection of HTLV-I and -II in Scottish blood donor samples and archive donations.
The cause of urinary symptoms among Human T Lymphotropic Virus Type I (HLTV-I) infected patients: a cross sectional study.
Highly enhanced expression of CD70 on human T-lymphotropic virus type 1-carrying T-cell lines and adult T-cell leukemia cells.
HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP
Is it necessary to test patients with immune thrombocytopenic purpura (ITP) for seropositivity to HTLV-1?
Poor response to prednisolone of idiopathic thrombocytopenia with human T-lymphotropic virus type I infection.
Current concepts regarding the HTLV-1 receptor complex.
[HTLV-I clinical pathological spectrum]
The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis
Denileukin diftitox and hyper-CVAD in the treatment of human T-cell lymphotropic virus 1-associated acute T-cell leukemia/lymphoma.
Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2.
Human T-lymphotropic virus type I infection and idiopathic thrombocytopnic purpura.
Post-translational glycosylation of target proteins implicate molecular mimicry in the pathogenesis of HTLV-1 associated neurological disease.
Human T-cell lymphotropic virus type I associated adult T-cell leukaemia/lymphoma in Taiwan Chinese.
Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread.
HTLV-1-associated adult T cell leukemia is highly susceptible to Navitoclax due to enhanced Bax expression.
[Acute myelogenous leukemia accompanied by HTLV-I associated myelopathy (HAM) caused by blood transfusion]
Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphoma.
Hepatitis C virus and human T-cell lymphotropic virus type 1 co-infection: impact on liver disease, virological markers, and neurological outcomes.
Evaluation of the INNO-LIA HTLV I/II assay for confirmation of human T-cell leukemia virus-reactive sera in blood bank donations
[Seropositivity for human T-lymphotropic virus types I and II among donors at the Municipal Blood Bank of Caracas and associated risk factors].
Human T-lymphotropic virus type I/II infections in volunteer blood donors from Northern and Western Greece: increased prevalence in one blood bank unit.
Human T-Cell Lymphotropic Virus Types 1 and 2 Seropositivity among Blood Donors at Mbarara Regional Blood Bank, South Western Uganda.
Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.
Genome wide analysis of human genes transcriptionally and post-transcriptionally regulated by the HTLV-I protein p30.
NRP/Optineurin Cooperates with TAX1BP1 to potentiate the activation of NF-kappaB by human T-lymphotropic virus type 1 tax protein.
[Peripheral T cell lymphoma (immunoblastic type, HTLV-1 negative) associated with aganglionosis of the intestine]
High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis.
Comparative study of CSF neurofilaments in HTLV-1-associated myelopathy/tropical spastic paraparesis and other neurological disorders.
Functional interaction of HTLV-1 tax protein with the POZ domain of the transcriptional repressor BCL6.
Prevalence of antibody to human T-lymphotropic virus type-1 (HLTV-1) in Australian aborigines, and detection in Indonesian sera.
Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?
Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors
The simian origins of the pathogenic human T-cell lymphotropic virus type I.
Human T-lymphotropic virus type I (HTLV-I) and tropical spastic paraparesis or HTLV-I-associated myelopathy in Hawaii.
Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier.
Effect of human T-cell lymphotrophic virus type 1 (HTLV-1) in seropositive infertile women on intracytoplasmic sperm injection (ICSI) outcome
Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features
Treatment of patients with polyarthritis and anti-HTLV-I antibodies with interferon-alpha.
Polymerase chain reaction fails to incriminate exogenous retroviruses HTLV-I and HIV-1 in rheumatological diseases although a minority of sera cross react with retroviral antigens.
HTLV-I associated arthritis: characteristics of an HTLV-I virus infected T cell line from synovial fluid.
Familial clusters of HTLV-1-associated myelopathy/tropical spastic paraparesis.
High prevalence of arthropathy in HTLV-I carriers on a Japanese island.
Tropical spastic paraparesis and human T-cell lymphotropic virus type 1.
A cluster of HTLV-1 associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution.
Human T cell lymphotropic virus type 1- associated infective dermatitis in KwaZulu Natal, South Africa
Chronic polyradiculoneuropathy associated with human T-cell lymphotropic virus type I infection.
Pathogenesis and treatment of HTLV-I associated myelopathy.
Multiple sclerosis, tropical spastic paraparesis and HTLV-1 infection in Afro-Caribbean patients in the United Kingdom.
Characterization of simian T-cell leukemia virus type 1 in naturally infected Japanese macaques as a model of HTLV-1 infection.
MRI-pathological correlate of brain lesions in a necropsy case of HTLV-I associated myelopathy
Multiple sclerosis, tropical spastic paraparesis and HTLV-I infection
Evaluation of antibody frequency against HBV, HCV and HTLV-1
Crusted scabies in association with human T-cell lymphotropic virus 1.
Distinct p300-responsive mechanisms promote caspase-dependent apoptosis by human T-cell lymphotropic virus type 1 Tax protein.
Human T-lymphotropic virus types I and II.
Human T-lymphotropic virus type I seroprevalence among Japanese Americans.
Prevalence of HTLV types I and II among drug users in King County, Washington.
Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity.
A seroepidemiologic survey of human T-cell lymphotropic virus type I in two Hawaiian hematologic-oncologic practices.
HTLV-I-associated diseases
Infection with the human T-lymphotropic virus type I. A review for clinicians.
What does seropositivity for HTLV-I mean?
Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a nonendemic area.
Initiation of translation by non-AUG codons in human T-cell lymphotropic virus type I mRNA encoding both Rex and Tax regulatory proteins.
Lupus nephritis class I accompanied by tubulointerstitial nephritis with marked T-lymphocyte infiltration in an HTLV-1 positive patient
Cyclosporine-induced immune suppression alters establishment of HTLV-1 infection in a rabbit model.
Development of HTLV-I associated myelopathy (HAM) in a seroconverted patient for antibody to HTLV-I.
Central motor and sensory conduction in adrenoleukomyeloneuropathy, cerebrotendinous xanthomatosis, HTLV-1-associated myelopathy and tabes dorsalis.
Multimodality evoked potentials in HTLV-I associated myelopathy.
Magnetic resonance imaging in an HTLV-I antibody positive patient with tropical spastic paraparesis.
The dynamics of HTLV-I and the CTL response.
Marked suppression of T cells by a benzothiophene derivative in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.
Retinal vasculitis in human T-lymphotropic virus type I associated myelopathy.
HTLV-I infection in human disease.
Retinal vasculitis in a mother and her son with human T-lymphotropic virus type 1 associated myelopathy.
Immunogenetics and the Pathological Mechanisms of Human T-Cell Leukemia VirusType 1- (HTLV-1-)Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.
Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I.
Human T-lymphotropic virus type I infection.
Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in 10 Chilean seronegative patients with tropical spastic paraparesis or HTLV-I-associated myelopathy.
Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.
Duodenal obstruction caused by Strongyloides stercoralis enteritis in an HTLV-1-infected host.
Human T Lymphotropic virus-1 associated gastrointestinal histoplasmosis in Peru.
Regulation of NF-kappaB by the HTLV-1 Tax protein.
HLA class I binding of HBZ determines outcome in HTLV-1 infection.
Comorbidity between HTLV-1-associated adult T-cell lymphoma/leukemia and verrucous carcinoma: a case report.
In vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine
HTLV-I Tax directly binds the Cdc20-associated anaphase-promoting complex and activates it ahead of schedule.
On the etiology of tropical spastic paraparesis and human T-cell lymphotropic virus-I-associated myelopathy.
Undifferentiated Pleomorphic Sarcoma and the Importance of Considering the Oncogenic and Immune-Suppressant Role of the Human T-Cell Lymphotropic Virus Type 1: A Case Report.
Chronic dacryosialadenitis in HTLV I associated myelopathy.
HTLV 1 associated myelopathy and adult T cell leukaemia-lymphoma in the same patient: report of a case.
Arsenic trioxide induces down-regulation of gp46 via protein oxidation: proteomics analysis of oxidative modified proteins in As2O3-treated HTLV-1-infected cells.
Primary gastric T-cell lymphoma accompanied by HTLV-I, HBV and H. pylori infection.
HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1)
HTLV-I Tax-dependent and -independent events associated with immortalization of human primary T lymphocytes.
Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo
Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis.
Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease.
Screening of blood donations for HTLV-I/II.
An exposed KID-like domain in human T-cell lymphotropic virus type 1 Tax is responsible for the recruitment of coactivators CBP/p300
Soluble IL-2 receptor and beta-2 microglobulin as possible serologic markers of neurologic disease in HTLV-1 infection.
The HTLV-1 tax protein cooperates with phosphorylated CREB, TORC2 and p300 to activate CRE-dependent cyclin D1 transcription
Quantification of HTLV-1 clonality and TCR diversity.
Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.
HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro.
Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice
The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma.
Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells.
Human T-lymphotropic virus type 2 (HTLV-2) provirus in circulating cells of the monocyte/macrophage lineage in patients dually infected with human immunodeficiency virus type 1 and HTLV-2 and having predominantly sensory polyneuropathy
Cloning and expression of a human T-lymphotropic virus type 1 protein with reverse transcriptase activity
Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain.
Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
Syncytium-inhibiting monoclonal antibodies produced against human T-cell lymphotropic virus type 1-infected cells recognize class II major histocompatibility complex molecules and block by protein crowding.
Simian T-cell lymphotropic virus type 1 from Mandrillus sphinx as a simian counterpart of human T-cell lymphotropic virus type 1 subtype D.
Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.
HTLV-1 Tax deregulates autophagy by recruiting autophagic molecules into lipid raft microdomains.
Persistent activation of NF-kappaB by the tax transforming protein of HTLV-1: hijacking cellular IkappaB kinases.
Characterization and sequencing of prototypic human T-lymphotropic virus type 1 (HTLV-1) from an HTLV-1/2 seroindeterminate patient.
HTLV-1 is lower in blood donors in West Midlands than South Thames.
Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.
Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2.
Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in human and other primate cell lines
Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax.
A lysine-to-arginine change found in natural alleles of the human T-cell lymphotropic/leukemia virus type 1 p12(I) protein greatly influences its stability.
Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy
Human T-lymphotropic virus type 1 transcription and chromatin-remodeling complexes.
Early spatial and temporal events of human T-lymphotropic virus type 1 spread following blood-borne transmission in a rabbit model of infection.
Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters.
Evaluation of Sensitivity and Specificity Performance of Elecsys HTLV-I/II Assay in a Multicenter Study in Europe and Japan
Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission.
Prevalence of erectile dysfunction in HTLV-1-infected patients and its association with overactive bladder
Comparison of immunoperoxidase staining with indirect immunofluorescence, ELISA, and Western blotting assays for detecting anti-HTLV-I antibodies in systemic lupus erythematosus.
Human T-cell leukemia virus type 1 (HTLV-1) infection of mice: proliferation of cell clones with integrated HTLV-1 provirus in lymphoid organs
Comparison of a human T-cell lymphotropic virus type I strain from cerebrospinal fluid of a Jamaican patient with tropical spastic paraparesis with a prototype human T-cell lymphotropic virus type I.
Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300.
HTLV-1-induced leukotriene B4 secretion by T cells promotes T cell recruitment and virus propagation
HTLV-I/II associated disease in England and Wales, 1993-7: retrospective review of serology requests.
Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin.
Human T cell lymphotropic virus type I genomic expression and impact on intracellular signaling pathways during neurodegenerative disease and leukemia.
Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors
Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM/TSP patients and identification of viral mutations
Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2
Human T-cell lymphotropic virus-I in Latin America.
HTLV-I Tax and cell cycle progression.
The presence of ancient human T-cell lymphotropic virus type I provirus DNA in an Andean mummy.
Genetic characterization of human T-cell lymphotropic virus type 1 in Mozambique: transcontinental lineages drive the HTLV-1 endemic.
The 5' untranslated region of the human T-cell lymphotropic virus type 1 mRNA enables cap-independent translation initiation
Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients.
NF-κB hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZ.
HTLV-1 and HIV infections of the central nervous system in tropical areas
Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells
Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II sensitizes Jurkat T cells to Ras-mediated apoptosis
DC-SIGN (CD209) gene promoter polymorphisms in a Brazilian population and their association with human T-cell lymphotropic virus type 1 infection.
Tax1 induction of the HTLV-I 21 bp enhancer requires cooperation between two cellular DNA-binding proteins.
The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1
Human T-lymphotropic virus type I provirus and T-cell prolymphocytic leukemia.
Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea
Transcription factor AP-2 activates gene expression of HTLV-I.
HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells.
HTLV-1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells.
HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.
Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunity.
Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-kappaB pathway and is dependent on p53 phosphorylation.
Opposing effects of a tyrosine-based sorting motif and a PDZ-binding motif regulate human T-lymphotropic virus type 1 envelope trafficking.
Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis
Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.
The immune response to HTLV-I.
Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.
HIV-1, HBV, HCV, HTLV, HPV-16/18, and Treponema pallidum infections in a sample of Brazilian men who have sex with men
HTLV-I transmission from mother to child.
Human T-cell lymphotropic virus type 1 tax among American blood donors
[HTLV-I and leukemogenesis].
Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage.
HTLV-1 propels thymic human T cell development in "human immune system" Rag2⁻/⁻ gamma c⁻/⁻ mice.
Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression.
HTLV-1 infections
Synergistic activation of the HTLV1 LTR Ets-responsive region by transcription factors Ets1 and Sp1.
Epidemiology and immunovirology of human T-cell leukemia/lymphoma virus type I-associated adult T-cell leukemia and chronic myelopathies as seen in France.
Northern African strains of human T-lymphotropic virus type 1 arose from a recombination event.
HTLV-I-associated myelopathy.
Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein
Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein.
Mechanisms of NF-kappaB activation by the HTLV type 1 tax protein.
Activation of I-kappaB kinase by the HTLV type 1 Tax protein: mechanistic insights into the adaptor function of IKKgamma.
Insights into the molecular mechanism of p53 inhibition by HTLV type 1 Tax.
How does interleukin 15 contribute to the pathogenesis of HTLV type 1-associated myelopathy/tropical spastic paraparesis?
HTLV type 1 infection in squirrel monkeys (Saimiri sciureus): a promising animal model for HTLV type 1 human infection.
The p13II protein of HTLV type 1: comparison with mitochondrial proteins coded by other human viruses.
HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.
Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriers
Differential roles of Annexin A1 (ANXA1/lipocortin-1/lipomodulin) and thioredoxin binding protein-2 (TBP-2/VDUP1/TXNIP) in glucocorticoid signaling of HTLV-I-transformed T cells.
HTLV-1 and HIV-2 infection are associated with increased mortality in a rural West African community.
Effect of lamivudine on transmission of human T-cell lymphotropic virus type 1 to adult peripheral blood mononuclear cells in vitro
Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain
Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34+) cells: modulation of p21cip1/waf1 and p27kip1 expression.
Rex-dependent nucleolar accumulation of HTLV-I mRNAs.
Prevalence of HTLV-1/2 in pregnant women living in the metropolitan area of Rio de Janeiro.
HTLV-1 p13, a small protein with a busy agenda.
Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.
Is human T-cell lymphotropic virus type I really silent?
Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy.
Immunopathogenesis of HIV and HTLV-1 infection: mechanisms for lymphomagenesis.
HTLV-I associated leukemia/lymphoma: epidemiology, biology, and treatment.
Divergent Subcellular Locations of HTLV-I Tax and Int-6: A Contrast between in vitro Protein-Protein Binding and Intracellular Protein Colocalization.
Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton.
Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.
Mother-to-Child Transmission of Human T-Cell Lymphotropic Viruses-1/2: What We Know, and What Are the Gaps in Understanding and Preventing This Route of Infection.
Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometry.
Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production
Kinetic characterization of newly discovered inhibitors of various constructs of human T-cell leukemia virus-1 (HTLV-1) protease and their effect on HTLV-1-infected cells.
Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy.
IL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers.
Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors.
Association between maternal antibodies to the external envelope glycoprotein and vertical transmission of human T-lymphotropic virus type I. Maternal anti-env antibodies correlate with protection in non-breast-fed children.
Interferon beta-1a treatment in HTLV-1-associated myelopathy/tropical spastic paraparesis: a case report.
Prevalence of human T-cell lymphotropic virus type 1 infection in hospitalized patients with tuberculosis.
High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1.
Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations.
Indications for the presence of antibodies cross-reactive with HTLV-I/II, but not HIV, in patients with myelodysplastic syndrome.
Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.
Immunopathogenesis of human T cell lymphotropic virus type I-associated myelopathy.
HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells
Comparative mutational analysis of cis-acting RNA signals for translational frameshifting in HIV-1 and HTLV-2.
Prevalence of antibody to human T-cell lymphotropic virus type I/II in people of Caribbean origin in Toronto
HTLV-I negative tropical spastic paraparesis: a scientific challenge.
Immune activation induces immortalization of HTLV-1 LTR-Tax transgenic CD4+ T cells
Synergistic inhibition of HTLV-1-infected cell proliferation by combination of cepharanthine and a tetramethylnaphthalene derivative.
Spontaneous remission and relapse in adult T cell lymphoma/leukaemia associated with HTLV-I.
Lack of antibody to HTLV-I and HIV in patients with multiple sclerosis from France and French West Indies.
Binding of human prothymosin alpha to the leucine-motif/activation domains of HTLV-I Rex and HIV-1 Rev.
Complete genome sequence of Central Africa human T-cell lymphotropic virus subtype 1b.
Distribution of Two Subgroups of Human T-Lymphotropic Virus Type 1 (HTLV-1) in Endemic Japan.
Molecular epidemiology of endemic human T-lymphotropic virus type 1 in a rural community in Guinea-Bissau.
Living invisible: HTLV-1-infected persons and the lack of care in public health.
HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.
HTLV-1 tax-induced rapid senescence is driven by the transcriptional activity of NF-κB and depends on chronically activated IKKα and p65/RelA.
The high-affinity Sp1 binding site in the HTLV-1 promoter contributes to Tax-independent basal expression
Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12(I).
Human T-lymphotropic virus type 1 oncoprotein tax promotes S-phase entry but blocks mitosis.
A case of post-transplant adult T-cell leukemia/lymphoma presenting myelopathy similar to but distinct from human T-cell leukemia virus type I (HTLV- I)-associated myelopathy.
Localization and sub-cellular shuttling of HTLV-1 tax with the miRNA machinery.
A chimeric human T-cell lymphotropic virus type 1 with the envelope glycoprotein of Moloney murine leukemia virus is infectious for murine cells.
HTLV-1 structural proteins.
Expression and functional properties of proteins encoded in the x-II ORF of HTLV-I.
Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells.
Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background.
Similar regulation of cell surface human T-cell leukemia virus type 1 (HTLV-1) surface binding proteins in cells highly and poorly transduced by HTLV-1-pseudotyped virions
Enhanced activation of tax-dependent transcription of human T-cell leukemia virus type I (HTLV-I) long terminal repeat by TORC3.
Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy
HIV-1 and HTLV-I in sexually transmitted disease clinics in the Dominican Republic.
Cloning of a cDNA encoding a DNA-binding protein TAXREB302 that is specific for the tax-responsive enhancer of HTLV-I.
Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein.
The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties.
HTLV-I tax increases genetic instability by inducing DNA double strand breaks during DNA replication and switching repair to NHEJ.
Influence of HTLV-1 on the clinical, microbiologic and immunologic presentation of tuberculosis.
HTLV-1 tax stabilizes MCL-1 via TRAF6-dependent K63-linked polyubiquitination to promote cell survival and transformation
Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals.
Current views in HTLV-I-associated adult T-cell leukemia/lymphoma.
Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand.
A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II.
Howard Temin memorial lectureship. Molecular biology of HTLV-1: deregulation of host cell gene expression and cell cycle.
HTLV-I Tax is a zinc-binding protein: role of zinc in Tax structure and function.
Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding.
Common origin of human T-lymphotropic virus type-I from Iran, Kuwait, Israel, and La Réunion Island.
Phylogenetic analysis of simian T-lymphotropic virus Type I (STLV-I) in common chimpanzees (Pan troglodytes): evidence for interspecies transmission of the virus between chimpanzees and humans in Central Africa.
History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2.
Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis.
Molecular mechanisms of cellular transformation by HTLV-1 Tax.
Animal Models Utilized in HTLV-1 Research
Co-dependence of HTLV-1 p12 and p8 functions in virus persistence
Ocular manifestations and pathology of adult T-cell leukemia/lymphoma associated with human T-lymphotropic virus type 1.
Racial and other characteristics of human T cell leukemia/lymphoma (HTLV-I) and AIDS (HTLV-III) in Trinidad
Cell cycle dysregulation by HTLV-I: role of the tax oncoprotein.
Transcriptional activity of HTLV-I Tax influences the expression of marker genes associated with cellular transformation.
HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.
Chronic inflammatory demyelinating polyneuropathy in a patient infected with human T lymphotropic virus type I
Arsenic trioxide induces apoptosis in HTLV-I infected T-cell lines and fresh adult T-cell leukemia cells through CD95 or tumor necrosis factor alpha receptor independent caspase activation.
Leukotrienes are upregulated and associated with human T-lymphotropic virus type 1 (HTLV-1)-associated neuroinflammatory disease
Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection.
Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.
Functional similarity of HIV-I rev and HTLV-I rex proteins: identification of a new nucleolar-targeting signal in rev protein.
Infection of human T lymphotropic virus-I-specific immune T cell clones by human T lymphotropic virus-I.
Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence.
Long-term serological outcome of infants who received frozen-thawed milk from human T-lymphotropic virus type-I positive mothers.
Prevalence of antibodies interactive with HTLV-I antigens in selected Solomon Islands populations.
Adult T-cell leukemia/lymphoma associated with human T-lymphotropic virus type I (HTLV-I) infection--North Carolina.
The CD3 versus CD7 plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-I
Antibodies reacting with human T-lymphotropic retrovirus (HTLV-I) or related antigens in lymphomatous and healthy hamadryas baboons.
Evaluation of HTLV-1 activity in HAM/TSP patients using proviral load and Tax mRNA expression after In Vitro lymphocyte activation.
HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo.
Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal.
Activation of WIP1 phosphatase by HTLV-1 Tax mitigates the cellular response to DNA damage
Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications.
The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.
PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients.
HTLV-I antisense transcripts initiating in the 3'LTR are alternatively spliced and polyadenylated.
Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens.
Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity.
Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival.
Human T-lymphotropic virus 1: recent knowledge about an ancient infection.
HTLV-I Tax self-association in optimal trans-activation function.
HTLV-1-mediated immunopathological CNS disease.
Tax interacts with P-TEFb in a novel manner to stimulate human T-lymphotropic virus type 1 transcription.
Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo
Seroprevalence of antibodies to HTLV-I in patients with chronic neurological disorders other than tropical spastic paraparesis.
Human T cell leukemia virus type 1 (HTLV-1) and oncogene or oncomiR addiction?
High affinity interleukin 2 receptors in HTLV-1-infected T cells can mediate signals for gene expression.
The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones
Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.
Induction of lactoferrin gene expression in myeloid or mammary gland cells by human T-cell leukemia virus type 1 (HTLV-1) tax: implications for milk-borne transmission of HTLV-1.
Kefir induces cell-cycle arrest and apoptosis in HTLV-1-negative malignant T-lymphocytes
Primary gastric T-cell lymphoma without human T-lymphotropic virus type 1: report of a case.
Functional activity of monocytes and macrophages in HTLV-1 infected subjects.
Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease.
Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: inverse correlation with HTLV-1-specific cellular immune response
In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome.
Strategies for diagnosis of HTLV-I and -II.
A Caucasian Australian presenting with human T-lymphotropic virus type I associated myelopathy: a case report
Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
Clinical manifestations in individuals with recent diagnosis of HTLV type I infection.
Severe graves ophthalmopathy accompanied by HTLV-1-associated uveitis (HAU) and anti-neutrophil cytoplasmic antibody-related vasculitis: a case report and a review of the literature of HAU with Graves disease.
Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression.
Redox events in HTLV-1 Tax-induced apoptotic T-cell death.
Disseminated Strongyloides stercoralis infection in HTLV-1-associated adult T-cell leukemia/lymphoma.
Role of post-translational modifications of HTLV-1 Tax in NF-κB activation.
Immunological profile of HTLV-1-infected patients associated with infectious or autoimmune dermatological disorders
Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial
Therapeutic benefits of an oral vitamin B1 derivative for human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemia
Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions.
Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP).
Identification of TL-Om1, an adult T-cell leukemia (ATL) cell line, as reference material for quantitative PCR for human T-lymphotropic virus 1.
Separate cellular localizations of human T-lymphotropic virus 1 (HTLV-1) Env and glucose transporter type 1 (GLUT1) are required for HTLV-1 Env-mediated fusion and infection.
Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease.
Human T lymphotropic virus type-I and adult T-cell leukemia in Japan.
Human T cell lymphotropic viruses (HTLV-I/II) in South America: should it be a public health concern?
HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression.
Seroprevalence of human T-cell lymphoma/leukemia virus type-1 (HTLV-1) antibodies among blood donors at Enugu, Nigeria.
Human T-cell lymphotropic virus type 1 subtype C molecular variants among indigenous australians: new insights into the molecular epidemiology of HTLV-1 in Australo-Melanesia.
Human T-cell lymphotropic virus type 1 exposures following blood-borne virus incidents in central Australia, 2002-2012.
Quantitative studies of the effect of HTLV-I Tax protein on CREB protein--DNA binding
Human T-cell lymphotropic virus type 1-associated adult T-cell leukemia/lymphoma in the Inuit people of Nunavut.
Activation of HTLV-I long terminal repeat by apoptosis inducing agents: mechanism and implications for HTLV-I pathogenicity (review).
Reduction of human T-cell leukemia virus type 1 (HTLV-1) proviral loads in rats orally infected with HTLV-1 by reimmunization with HTLV-1-infected cells.
Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.
Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran.
Human T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA repair.
The HTLV-1 Tax oncoprotein represses Ku80 gene expression.
Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo.
Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial.
Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.
Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous australians: results of a case-control study.
Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag
Kaposi's sarcoma-associated herpesvirus vFLIP and human T cell lymphotropic virus type 1 Tax oncogenic proteins activate IkappaB kinase subunit gamma by different mechanisms independent of the physiological cytokine-induced pathways
Primary gastric T-cell lymphoma not associated with human T-lymphotropic virus type I: a case report and review of the literature.
pecific nutrient combination effects on tax, NF- κB and MMP-9 in human T-cell lymphotropic virus -1 positive malignant T-lymphocytes.
Muscle wasting induced by HTLV-1 tax-1 protein: an in vitro and in vivo study.
Coactivator-associated arginine methyltransferase 1 enhances transcriptional activity of the human T-cell lymphotropic virus type 1 long terminal repeat through direct interaction with Tax.
Gem-induced cytoskeleton remodeling increases cellular migration of HTLV-1-infected cells, formation of infected-to-target T-cell conjugates and viral transmission.
HTLV-1 Tax oncoprotein inhibits the estrogen-induced-ER α-Mediated BRCA1 expression by interaction with CBP/p300 cofactors.
Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Human T-cell lymphotropic virus type I and neurological diseases.
HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.
Effects of nucleoside-based antiretroviral chemotherapy on human T cell leukaemia/lymphotropic virus type 1 (HTLV-1) infection in vitro.
miR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection.
TCF1 and LEF1 act as T-cell intrinsic HTLV-1 antagonists by targeting Tax.
Molecular characterization of human T-cell lymphotropic virus type 1 full and partial genomes by Illumina massively parallel sequencing technology
Understanding HTLV-I protease.
Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.
A primate T-lymphotropic virus, PTLV-L, different from human T-lymphotropic viruses types I and II, in a wild-caught baboon (Papio hamadryas).
Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki
HTLV-1 and its neurological complications.
Detection of HTLV-I in clinical specimens.
Evaluation of the microbicidal activity and cytokines/chemokines profile released by neutrophils from HTLV-1-infected individuals
Human T-lymphotropic virus type 1 oncoprotein tax promotes unscheduled degradation of Pds1p/securin and Clb2p/cyclin B1 and causes chromosomal instability.
Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles.
Screening for prolonged incubation of HTLV-I infection in British and Jamaican relatives of British patients with tropical spastic paraparesis.
Two cases of uveitis with tubulointerstitial nephritis in HTLV-1 carriers.
HTLV-I infection in Britain.
Prevalence of antibodies to human T-lymphotropic viruses types I and II among healthy blood donors.
HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator.
Human T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signaling.
Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades.
Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB
Multiple primer pairs for the detection of HTLV-I by PCR.
Immune recognition of human T-cell leukemia virus type-I (HTLV-I) by MHC-restricted cytotoxic T lymphocytes.
Infection with human T-lymphotropic virus types I and II results in alterations of cellular receptors, including the up-modulation of T-cell counterreceptors CD40, CD54, and CD80 (B7-1).
Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infections
Neuropathology of HIV-1 and HTLV-1 infection.
HTLV-1 and neurological disease.
HTLV-I in neurological diseases.
Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.
Move or die: the fate of the Tax oncoprotein of HTLV-1.
Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.
Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence.
Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.
The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns
Direct inhibition of RNAse T2 expression by the HTLV-1 viral protein Tax.
HTLV-1 and innate immunity.
Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replication.
Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease.
Efficacy of novel histone deacetylase inhibitor, AR42, in a mouse model of, human T-lymphotropic virus type 1 adult T cell lymphoma.
Molecular insights of protein contour recognition with ligand pharmacophoric sites through combinatorial library design and MD simulation in validating HTLV-1 PR inhibitors.
Seroprevalence of human T-cell lymphotropic viruses types 1 and 2 antibodies in hepatitis C virus-positive patients: manitoba, Canada, 2012-2014
Identification and characterization of HTLV-1 HBZ post-translational modifications.
Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis.
Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation.
Human T lymphotropic virus type-I (HTLV-I) immortalizes human T cells in vitro--its implication in the pathogenesis of adult T cell leukemia (ATL).
High prevalence of HTLV-1 infection among Japanese immigrants in non-endemic area of Brazil.
Post-transplantation HTLV-1 myelopathy in three recipients from a single donor.
Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls
Oncogenic human T-cell lymphotropic virus type 1 tax suppression of primary innate immune signaling pathways.
Inhibition of geranylgeranyl transferase-I decreases cell viability of HTLV-1-transformed cells.
Hospital admissions for human T-cell lymphotropic virus type-1 (HTLV-1) associated diseases in Dominica.
Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I).
Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers
High prevalence of Sjögren's syndrome in patients with HTLV-I associated myelopathy.
HTLV-I associated Sjögren's syndrome is aetiologically distinct from anti-centromere antibodies positive Sjögren's syndrome.
Human T lymphotrophic virus-I (HTLV-I) infection in patients with unclassifiable dermatitis in central Kerala, south India: a preliminary study.
Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I
Ocular manifestations of human T-cell lymphotropic virus type 1 infection.
Molecular analysis of a deletion mutant provirus of type I human T-cell lymphotropic virus: evidence for a doubly spliced x-lor mRNA.
Close association between interleukin 2 receptor mRNA expression and human T cell leukemia/lymphoma virus type I viral RNA expression in short-term cultured leukemic cells from adult T cell leukemia patients.
Short Communication: Current Prevalence and Risk Factors Associated with Human T Lymphotropic Virus Type 1 and Human T Lymphotropic Virus Type 2 Infections Among HIV/AIDS Patients in São Paulo, Brazil
The immune control and cell-to-cell spread of human T-lymphotropic virus type 1.
Human T-cell Lymphotropic Virus types I and II (HTLV-I/II) in French Guiana: clinical and molecular epidemiology.
An Evaluation of the Spontaneous Proliferation of Peripheral Blood Mononuclear Cells in HTLV-1-Infected Individuals Using Flow Cytometry
Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.
Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control.
Adult T-cell leukemia/lymphoma not associated with human T-cell leukemia virus type I
High prevalence of serum antibody against human T cell leukemia virus type I (HTLV-I) among the Bismam Asmat population (Indonesian New Guinea).
Possible etiologies for tropical spastic paraparesis and human T lymphotropic virus I-associated myelopathy.
Emodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1
HTLV-I induced extranodal lymphomas.
Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells.
Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription.
Phylogenetic and similarity analysis of HTLV-1 isolates from HIV-coinfected patients from the south and southeast regions of Brazil.
Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals
HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines.
Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry
High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease.
HTLV-1-associated adult T cell leukemia lymphoma presenting as granulomatous pneumocystis jiroveci pneumonia (PJP) and hypercalcemia
Recurrent Facial Erythema with Cytotoxic T Cell Infiltration as a Possible Reactive Eruption in a Human T-Cell Lymphotropic Virus Type 1 Carrier.
Seroepidemiology of HTLV-I/II in Argentina: an overview.
Saudi National Guard donor screening for human T cell lymphotropic virus I/II: time to use molecular biology techniques.
STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I-Transformed and ATL Cells.
HTLV-1 Tax Stimulates Ubiquitin E3 Ligase, Ring Finger Protein 8, to Assemble Lysine 63-Linked Polyubiquitin Chains for TAK1 and IKK Activation.
The Sumo-targeted ubiquitin ligase RNF4 regulates the localization and function of the HTLV-1 oncoprotein Tax.
Interferon-γ Promotes Inflammation and Development of T-Cell Lymphoma in HTLV-1 bZIP Factor Transgenic Mice.
Rapamycin-induced inhibition of HTLV-I LTR activity is rescued by c-Myb.
Helminthic infection and the risk of neurologic disease progression in HTLV-1
Ras signaling contributes to survival of human T-cell leukemia/lymphoma virus type 1 (HTLV-1) Tax-positive T-cells.
Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells
No evidence of HTLV-I proviral integration in lymphoproliferative disorders associated with cutaneous T-cell lymphoma
Detection of HTLV-1 by polymerase chain reaction in situ hybridization in adult T-cell leukemia/lymphoma
HTLV-1 and associated adult T-cell leukemia/lymphoma.
Stimulation of alpha 1 (I) procollagen gene expression in NIH-3T3 cells by the human T cell leukemia virus type 1 (HTLV-1) Tax gene.
How the DNA damage response determines the fate of HTLV-1 Tax-expressing cells.
Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin, galectin-3
In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection
Correlation between LTR point mutations and proviral load levels among human T cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriers
Identification of novel monocistronic HTLV-1 mRNAs encoding functional Rex isoforms.
Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease.
Detection of HTLV-I proviral sequences in CD30-positive large cell cutaneous T-cell lymphomas.
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL
Immunological risks of adult T-cell leukemia at primary HTLV-I infection.
Myelopathy associated with human T cell lymphotropic virus type 1 in a white European native to England.
Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion.
RNA helicase A interacts with divergent lymphotropic retroviruses and promotes translation of human T-cell leukemia virus type 1
Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren's syndrome.
Distinct regions in human T-cell lymphotropic virus type I tax mediate interactions with activator protein CREB and basal transcription factors.
Humoral hypercalcemia of malignancy: severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression.
Interference with immune function by HTLV-1.
Transactivation of the human T-cell lymphotropic virus type 1 Tax1-responsive 21-base-pair repeats requires Holo-TFIID and TFIIA
HTLV-1 Tax mutants that do not induce G1 arrest are disabled in activating the anaphase promoting complex.
Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction
Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.
In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations.
Mixed connective tissue disease with interstitial pneumonia in HTLV-1 carrier: case report and review of the literature.
Time course and cytokine dependence of human T-cell lymphotropic virus type 1 T-lymphocyte transformation as revealed by a microtiter infectivity assay.
Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1.
Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat.
Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion
PCR-in situ hybridization detection of human T-cell lymphotropic virus type 1 (HTLV-1) tax proviral DNA in peripheral blood lymphocytes of patients with HTLV-1-associated neurologic disease.
Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides.
Human T-cell lymphotropic virus type 1 Tax mediates enhanced transcription in CD4+ T lymphocytes
Human T-cell lymphotropic virus type 1 Tax1 activation of NF-kappa B: involvement of the protein kinase C pathway
Repression of the NF1 gene by Tax may expain the development of neurofibromas in human T-lymphotropic virus type 1 transgenic mice.
A Transgenic Drosophila melanogaster Model To Study Human T-Lymphotropic Virus Oncoprotein Tax-1-Driven Transformation In Vivo.
The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface
Costimulation of cytokine gene expression in T cells by the human T leukemia/lymphotropic virus type 1 trans activator Tax.
Human T lymphotropic virus type 1 regulatory and accessory gene transcript expression and export are not rex dependent.
The tumor suppressor gene WWOX links the canonical and noncanonical NF-κB pathways in HTLV-I Tax-mediated tumorigenesis
Interaction of the human T-lymphotropic virus type 1 Tax dimer with CREB and the viral 21-base-pair repeat.
Imbalanced expression of glutamate-glutamine cycle enzymes induced by human T-cell lymphotropic virus type 1 Tax protein in cultivated astrocytes
The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex
The cellular stress response enhances human T-cell lymphotropic virus type 1 basal gene expression through the core promoter region of the long terminal repeat.
Human T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation mediated by vascular cell adhesion molecule-1: evidence for involvement of cell adhesion molecules in HTLV-1 biology.
Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in Pygmies.
Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection.
Mechanisms of HTLV-1 transformation.
Immunopathogensis of HTLV-I associated neurologic disease: molecular, histopathologic, and immunologic approaches.
HTLV envelopes and their receptor GLUT1, the ubiquitous glucose transporter: a new vision on HTLV infection?
HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica
Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide.
Induction of tumor necrosis factor alpha in human neuronal cells by extracellular human T-cell lymphotropic virus type 1 Tax.
Regulation of HTLV-1 Gag budding by Vps4A, Vps4B, and AIP1/Alix
The Smac mimetic RMT5265.2HCL induces apoptosis in EBV and HTLV-I associated lymphoma cells by inhibiting XIAP and promoting the mitochondrial release of cytochrome C and Smac.
Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element.
Coinfection with HTLV-I and HIV: increase in HTLV-I-related outcomes but not accelerated HIV disease progression?
Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain.
Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival.
A decade with HTLV-I/HTLV-II: lesions in viral leukemogenesis.
Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site.
Lymphotoxin cDNA clones from a HTLV-I-carrying T cell line HUT-102.
Deregulated expression of CD40 ligand in HTLV-I infection: distinct mechanisms of downregulation in HTLV-I-transformed cell lines and ATL patients.
A Canadian immigrant with coinfection of Strongyloides stercoralis and human T-lymphotropic virus 1.
Barefoot Plantar Pressure Indicates Progressive Neurological Damage in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection.
Prevalence of Human T-Lymphotropic Virus Types I and II in Patients With Hematological Disorders in Isfahan, Iran.
The HTLV-I Tax oncoprotein: hyper-tasking at the molecular level.
Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases.
Human T-cell leukemia virus type 1 (HTLV-1) latency: death signaling awakens the sleeping retrovirus.
Neurological Manifestations in Human T-Cell Lymphotropic Virus Type 1 (HTLV-1)-Infected Individuals Without HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Longitudinal Cohort Study.
Frequency of adult T-cell leukaemia/lymphoma and HTLV-I in Ibadan, Nigeria.
Are increased Foxp3+ regulatory T cells responsible for immunosuppression during HTLV-1 infection? Case reports and review of the literature.
Origin of human T-lymphotropic virus type 1 in rural Côte d'Ivoire.
Selection of HTLV-I positive clones is prevented by prostaglandin A in infected cord blood cultures
Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo.
Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy.
Negative regulation of the SH2-homology containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoprotein
Immunocytochemical demonstration of PTHrP protein in neoplastic tissue of HTLV-1 positive human adult T cell leukaemia/lymphoma: implications for the mechanism of hypercalcaemia.
CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis.
Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells.
Human T Lypmphotrophic Virus (HTLV1) Related Diseases.
Epidemiology of HTLV-1 in Neyshabour, Northeast of Iran
Khorasan Disease: Prevalence of HTLV-I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) In West Azarbaijan from 2004 to 2007.
Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cells
Seroepidemiology of human T-cell lymphotropic virus type-I in blood donors of Northeastern Iran, Sabzevar
Cellular Factors Involved in HTLV-1 Entry and Pathogenicit
Adult T-Cell Leukemia/Lymphoma in a Caucasian Patient After Sexual Transmission of Human T-Cell Lymphotropic Virus Type 1.
Common γ-chain blocking peptide reduces in vitro immune activation markers in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Assessing Walking Ability in People with HTLV-1-Associated Myelopathy Using the 10 Meter Timed Walk and the 6 Minute Walk Test
The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1.
Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Improvement of HIV-1 and Human T Cell Lymphotropic Virus Type 1 Replication-Dependent Vectors via Optimization of Reporter Gene Reconstitution and Modification with Intronic Short Hairpin RNA
Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300.
The autophagy molecule Beclin 1 maintains persistent activity of NF-κB and Stat3 in HTLV-1-transformed T lymphocytes.
Progressive loss of CD3 expression after HTLV-I infection results from chromatin remodeling affecting all the CD3 genes and persists despite early viral genes silencing.
Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein.
Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR.
Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.
Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study.
Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway.
The HTLV-1-encoded protein HBZ directly inhibits the acetyl transferase activity of p300/CBP.
In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infection
HTLV-1 uveitis.
HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals.
Evidence of Brain Inflammation in Patients with Human T-Lymphotropic Virus Type 1-Associated Myelopathy (HAM): A Pilot, Multimodal Imaging Study Using 11C-PBR28 PET, MR T1-Weighted, and Diffusion-Weighted Imaging.
Hepatitis C virus infection and spontaneous clearance in HTLV-1 and HIV co-infected patients in Salvador, Bahia, Brazil.
Tuberculosis incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.
GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: possible activation of beta-1,4-N-acetylgalactosaminyltransferase gene by p40tax.
Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.
Major depression and generalized anxiety disorder among human T-lymphotropic virus types I- and II-infected former blood donors.
Human T-cell leukemia virus type 1 (HTLV-1) bZIP factor requires cellular transcription factor JunD to upregulate HTLV-1 antisense transcription from the 3' long terminal repeat.
The human T-lymphotropic virus type 1 tax protein inhibits nonsense-mediated mRNA decay by interacting with INT6/EIF3E and UPF1.
HAM/TSP-derived HTLV-1-infected T cell lines promote morphological and functional changes in human astrocytes cell lines: possible role in the enhanced T cells recruitment into Central Nervous System
Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tr
The Tax-Inducible Actin-Bundling Protein Fascin Is Crucial for Release and Cell-to-Cell Transmission of Human T-Cell Leukemia Virus Type 1 (HTLV-1).
Reexamination of human T cell lymphotropic virus (HTLV-I/II) prevalence.
Structure, regulation and oncogenic mechanisms of HTLV-I and HTLV-II.
What we are learning on HTLV-1 pathogenesis from animal models.
Cell-mediated immune response to human T-lymphotropic virus type I.
Mechanisms of persistent NF-kappaB activation by HTLV-I tax.
Radiation therapy for the management of patients with HTLV-1-associated adult T-cell leukemia/lymphoma.
A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats.
Development of lupus nephritis in a patient with human T-cell lymphotropic virus type I-associated myelopathy.
HTLV-1 bZIP Factor Enhances T-Cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors
A Novel Human T-lymphotropic Virus Type 1c Molecular Variant in an Indigenous Individual from New Caledonia, Melanesia.
Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during 2007-2009
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
HTLV-1 Tax Induces Formation of the Active Macromolecular IKK Complex by Generating Lys63- and Met1-Linked Hybrid Polyubiquitin Chains.
Transcriptional and post-transcriptional gene regulation of HTLV-1.
Activation of NF-kappaB by HTLV-I and implications for cell transformation.
Deregulation of cell-signaling pathways in HTLV-1 infection.
Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response.
Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.
HTLV-1 tropism and envelope receptor.
Cellular immune response to HTLV-1.
Global epidemiology of HTLV-I infection and associated diseases.
The peripheral nervous system complications of HTLV-1 myelopathy (HAM/TSP) syndromes.
Multidisciplinary insight into clonal expansion of HTLV-1-infected cells in adult T-cell leukemia via modeling by deterministic finite automata coupled with high-throughput sequencing
HTLV-1 drives vigorous clonal expansion of infected CD8(+) T cells in natural infection.
HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil
The prevalence of HTLV-1 and its Co-Infection with HCV, HBV and HIV in Hemophilic patients
Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy.
Genomes of evolutionarily divergent members of the human T-cell leukemia virus family (HTLV-I and HTLV-II) are highly conserved, especially in pX.
Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection
HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene
Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia
Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients
FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency
HTLV-1 Tax nucleocytoplasmic shuttling, interaction with the secretory pathway, extracellular signaling, and implications for neurologic disease.
Adult T-cell leukemia/lymphoma in a Peruvian hospital in human T-lymphotropic virus type 1 (HTLV-1) positive patients.
Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28: insights into difference in pathobiology of human retroviruses.
The human T-cell leukemia virus type 1 (HTLV-1): new insights into the clinical aspects and molecular pathogenesis of adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM).
Reporter Systems to Study HTLV-1 Transmission.
HTLV-1 induced molecular mimicry in neurological disease.
Low Proviral Load is Associated with Indeterminate Western Blot Patterns in Human T-Cell Lymphotropic Virus Type 1 Infected Individuals: Could Punctual Mutations be Related?
Human T-Lymphotropic Virus Type I (HTLV-1) Infection among Iranian Blood Donors: First Case-Control Study on the Risk Factors
Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil
Silent dissemination of HTLV-1 in an endemic area of Argentina. Epidemiological and molecular evidence of intrafamilial transmission
MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications.
Pathways of cell-cell transmission of HTLV-1
Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia.
Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells.
HTLV-1-infected T cells contain a single integrated provirus in natural infection
PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells.
Opportunistic Infections in Patients with HTLV-1 Infection.
Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers.
High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
Selection of rabbit CD4- CD8- T cell receptor-gamma/delta cells by in vitro transformation with human T lymphotropic virus-I.
Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Persistence of human T cell lymphotropic virus type 1 (HTLV-1) sequences in peripheral blood mononuclear cells from patients with mycosis fungoides.
LTR point mutations in the Tax-responsive elements of HTLV-1 isolates from HIV/HTLV-1-coinfected patients.
Molecular Detection and Clinical Implications of HTLV-1 Infections among Antiretroviral Therapy-Naïve HIV-1-Infected Individuals in Abuja, Nigeria.
Resistance to fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy
HTLV-I-associated myelopathy/tropical spastic paraparesis: semiautomatic quantification of spinal cord atrophy from 3-dimensional MR images.
Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies i
Epidemiological Aspects and World Distribution of HTLV-1 Infection.
Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-1
Sporadic cases of carriers of human T-lymphotropic virus type 1 in Southeast Asia.
[Seroepidemiologic data on viral infections (HTLV-I and LAV/HTLV-III) in the Caribbean region and intertropical Africa]
HTLV-1: A Significant Retrovirus
Molecular cloning and complete nucleotide sequence of an adult T cell leukaemia virus/human T cell leukaemia virus type I (ATLV/HTLV-I) isolate of Caribbean origin: relationship to other members of the ATLV/HTLV-I subgroup.
Adult T-cell leukemia associated with HTLV-I and simultaneous infection by human immunodeficiency virus type 2 and human herpesvirus 6 in an African woman: a clinical, virologic, and familial serologic study.
[Chronic T-lymphocyte lymphatic leukemia. Clinico-pathologic assessment and new epidemiologic data related to cases correlated with HTLV-I in Italy]
Cotranscriptional Chromatin Remodeling by Small RNA Species: An HTLV-1 Perspective
Tax gene characterization of human T-lymphotropic virus type 1 strains from Brazilian HIV-coinfected patients.
Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau.
The discovery of HTLV-1, the first pathogenic human retrovirus.
The Prevalence of Human T-Cell lymphotropic Virus Type 1 in Pregnant Women and Their Newborns
Diffuse large B-cell lymphoma in human T-lymphotropic virus type 1 carriers.
Inhibition of methyltransferases results in induction of g2/m checkpoint and programmed cell death in human T-lymphotropic virus type 1-transformed cells.
Activation of a novel KpnI transcript by downstream integration of a human T-lymphotropic virus type I provirus.
[Informing the HTLV-I positive blood donor: summary of epidemiologic data and recommended attitude]
[Vertical transmission of HTLV-1 in Peru]
Leukoencephalopathy in HTLV-I-associated myelopathy: MRI and EEG data.
ADF, a growth-promoting factor derived from adult T cell leukemia and homologous to thioredoxin: involvement in lymphocyte immortalization by HTLV-I and EBV.
Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients
Ubiquitination of HTLV-I Tax in response to DNA damage regulates nuclear complex formation and nuclear export.
Advances in HTLV-1 peptide vaccines and therapeutics.
HTLV-1 and -2 infections among 10 indigenous groups in the Peruvian Amazon
HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy
Depression of early phase of HTLV-I infection in vitro mediated by human beta-interferon
Complex role of microRNAs in HTLV-1 infections.
Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation.
The importance of ubiquitination and sumoylation on the transforming activity of HTLV Tax-1 and Tax-2.
Interplay between the HTLV-2 Tax and APH-2 proteins in the regulation of the AP-1 pathway.
Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis
Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients
Seroepidemiology of HTLV-I in relation to that of HIV-1 in the Gauteng region, South Africa, using dried blood spots on filter papers.
A serosurvey for HTLV-I among high-risk populations and normal adults in Egypt.
Antenatal survey for the seroprevalence of HTLV-1 infections in the West Midlands, England.
PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival.
HTLV-I Tax-Mediated Inactivation of Cell Cycle Checkpoints and DNA Repair Pathways Contribute to Cellular Transformation: "A Random Mutagenesis Model"
Inhibitory activity in saliva of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro: evaluation of saliva as an alternative source of transmission
Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and -2 assay. HTLV-1 and HTLV-2 Spanish Study Group
WIP1 deficiency inhibits HTLV-1 Tax oncogenesis: novel therapeutic prospects for treatment of ATL?
Geographical clustering of human T-cell lymphotropic virus type 1 infection in Honduras.
Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins
Ubiquitination and sumoylation of the HTLV-2 Tax-2B protein regulate its NF-κB activity: a comparative study with the HTLV-1 Tax-1 protein.
XBP-1, a novel human T-lymphotropic virus type 1 (HTLV-1) tax binding protein, activates HTLV-1 basal and tax-activated transcription.
Pulmonary CT findings in 320 carriers of human T-lymphotropic virus type 1.
Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells.
Human T-cell lymphotropic virus type I and II in transfusion medicine.
Association of Sicca Syndrome with Proviral Load and Proinflammatory Cytokines in HTLV-1 Infection.
Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA
Characterization of the nuclear export signal of human T-cell lymphotropic virus type 1 Rex reveals that nuclear export is mediated by position-variable hydrophobic interactions.
Backbone (15)N relaxation analysis of the N-terminal domain of the HTLV-I capsid protein and comparison with the capsid protein of HIV-1
Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.
Relationship Among Strongyloides stercoralis Infection, Human T-Cell Lymphotropic Virus Type 1 Infection, and Cancer: A 24-Year Cohort Inpatient Study in Okinawa, Japan
Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia.
PA28γ is a novel corepressor of HTLV-1 replication and controls viral latency.
Utility of HTLV proviral load quantification in diagnosis of HTLV-1-associated myelopathy requires international standardization.
Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells.
Identification of human T-cell lymphotropic virus type I 21-base-pair repeat-specific and glial cell-specific DNA-protein complexes
Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells.
Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission
Transcription of the human T-cell lymphotropic virus type I promoter by an alpha-amanitin-resistant polymerase.
Isolation of a novel simian T-cell lymphotropic virus from Pan paniscus that is distantly related to the human T-cell leukemia/lymphotropic virus types I and II.
Isolation of a human T-lymphotropic virus type I strain from Australian aboriginals.
Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from melanesia: genetic and phylogenetic relationship to HTLV-I strains from other geographical regions.
In vitro selection of DNA elements highly responsive to the human T-cell lymphotropic virus type I transcriptional activator, Tax.
A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I.
Sequences downstream of the RNA initiation site regulate human T-cell lymphotropic virus type I basal gene expression
Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals
Transactivation of the P2 promoter of parathyroid hormone-related protein by human T-cell lymphotropic virus type I Tax1: evidence for the involvement of transcription factor Ets1.
Transcriptional activation of the human T-lymphotropic virus type I long terminal repeat by functional interaction of Tax1 and Ets1.
The HTLV-1 neurological complex.
The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase.
The cellular proto-oncogene product Myb acts as transcriptional activator of the long terminal repeat of human T-lymphotropic virus type I.
Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism
HTLV-1 Tax and adult T-cell leukemia.
Evidence for anti-Plasmodium falciparum antibodies that cross-react with human T-lymphotropic virus type I proteins in a population in Irian Jaya, Indonesia.
Immunologic cross-reactivity between structural proteins of human T-cell lymphotropic virus type I and the blood stage of Plasmodium falciparum.
Hematological manifestations of human T lymphotropic virus type 1 infection: a possible association with autoimmune myelofibrosis.
Mapping of a human T-lymphotropic virus type I gag protein epitope that cross-reacts with anti-Plasmodium falciparum antibodies.
Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy.
Characterization of immunodominant epitopes of gag and pol gene-encoded proteins of human T-cell lymphotropic virus type I.
Manifestations of the human T-cell lymphotropic virus type I infection in childhood and adolescence.
Phenotypic progression of a rat lymphoid cell line immortalized by human T-lymphotropic virus type I to induce lymphoma/leukemia-like disease in rats.
Phylogeography of Human T-lymphotropic Virus Type 1 (HTLV-1) Lineages Endemic to Japan
The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments.
Human T-cell leukemia virus (HTLV) type II Rex protein binds specifically to RNA sequences of the HTLV long terminal repeat but poorly to the human immunodeficiency virus type 1 Rev-responsive element.
Transdominant human T-cell lymphotropic virus type I TAX1 mutant that fails to localize to the nucleus.
Effects of Physiotherapy in the Treatment of Neurogenic Bladder in Patients Infected With Human T-Lymphotropic Virus 1
Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals.
HUMAN T-LYMPHOTROPIC VIRUS 1 (HTLV-1) AND HUMAN T-LYMPHOTROPIC VIRUS 2 (HTLV-2): GEOGRAPHICAL RESEARCH TRENDS AND COLLABORATION NETWORKS (1989-2012)
Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I.
Absence of human T-cell lymphotropic virus type I and human foamy virus in thymoma.
Expression of HTLV-I Env and Tax recombinant peptides in yeast: identification of immunogenic domains.
Lymphocyte-facilitated infection of epithelia by human T-cell lymphotropic virus type I.
Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins.
The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome.
HTLV-I Infection: virus structure, immune response to the virus and genetic association studies in HTLV-I-infected individuals.
Immediate effects of reversible HTLV-1 tax function: T-cell activation and apoptosis.
The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells.
The coactivators CBP/p300 and the histone chaperone NAP1 promote transcription-independent nucleosome eviction at the HTLV-1 promoter
Expression of parathyroid hormone-related protein during immortalization of human peripheral blood mononuclear cells by HTLV-1: implications for transformation.
trans activation of nerve growth factor in transgenic mice containing the human T-cell lymphotropic virus type I tax gene
Long Terminal Repeat Circular DNA as Markers of Active Viral Replication of Human T Lymphotropic Virus-1 in Vivo.
Overexpression of transforming growth factor-beta in transgenic mice carrying the human T-cell lymphotropic virus type I tax gene
Detection of human T lymphotropic virus type I tax gene in salivary gland epithelium from two patients with Sjögren's syndrome.
HTLV-1-like particles and HTLV-1-related DNA sequences in an unambiguous case of Sèzary syndrome.
Quantifying HTLV-I dynamics.
Neurological symptoms and signs in HTLV-1 patients with overactive bladder syndrome
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.
Seroepidemiology of human T-cell lymphotropic virus type-1 (HTLV1) in Mashhad.
Re-mapping the molecular features of the human immunodeficiency virus type 1 and human T-cell lymphotropic virus type 1 Brazilian sequences using a bioinformatics unit established in Salvador, Bahia, Brazil, to give support to the viral epidemiology
trans activation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene.
Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization.
Sequence-specific interaction of the Ets1 protein with the long terminal repeat of the human T-lymphotropic virus type I.
Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates.
Inhibition of cell-to-cell transmission of human T-cell lymphotropic virus type 1 in vitro by carbohydrate-binding agents.
[Tropical spastic paraparesis due to HTLV-I. 4 case reports and literature review]
Severe Diarrhea Due To Cystoisospora belli Infection in an HTLV-1 Woman.
Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice.
Transactivation of the proenkephalin gene promoter by the Tax1 protein of human T-cell lymphotropic virus type I
Urinary and sexual manifestations of patients infected by HTLV-I.
HTLV-1 and HIV-1 co-infection: A case report and review of the literature.
Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II
Absolute quantification of HTLV-1 basic leucine zipper factor (HBZ) protein and its plasma antibody in HTLV-1 infected individuals with different clinical status.
The Influence of Coinfection on Mood States in HTLV-1-Infected Patients.
Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis
Pre-morbid human T-lymphotropic virus type I proviral load, rather than percentage of abnormal lymphocytes, is associated with an increased risk of aggressive adult T-cell leukemia/lymphoma
Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease
Phylogenetic relationships of HTLV-I/STLV-I in the world.
Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies.
Purification and characterization of the external envelope glycoprotein from two human immunodeficiency virus type 1 variants, HTLV-IIIB and HTLV-IIIRF
Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I.
HTLV-1 infection and the viral etiology of multiple sclerosis.
Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells
Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.
Spontaneous lymphocyte proliferation in human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infection: T-cell subset responses and their relationships to the presence of provirus and viral antigen production
Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers.
Human T cell lymphotropic virus type 2a strains among HIV type 1-coinfected patients from Brazil have originated mostly from Brazilian Amerindians.
Implication of the HTLV-I bZIP factor gene in the leukemogenesis of adult T-cell leukemia.
HTLV-1 infection: the clinical spectrum widens
HTLV-I infection and neurological disease in Rio de Janeiro
Activation and detection of HTLV-I Tax-specific CTLs by epitope expressing single-chain trimers of MHC class I in a rat model
Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Initial management of an outbreak of the HTLV-1 virus in Nunavut, Canada.
Infective Dermatitis in an Adult Patient With HTLV-1.
Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM)
Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy.
Identification of TBK1 and IKKε, the non-canonical IκB kinases, as crucial pro-survival factors in HTLV-1-transformed T lymphocytes.
Long-term remission of primary gastric T cell lymphoma associated with human T lymphotropic virus type 1: a report of two cases and review of the literature.
HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis.
Human T-cell lymphotropic virus type I and adult T-cell leukemia/lymphoma outside Japan and the Caribbean Basin.
Human T-cell lymphotropic virus, type 1 (HTLV-1)-associated myelopathy: MR findings.
Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
Human T-cell lymphotropic virus type 1 nucleocapsid protein-induced structural changes in transactivation response DNA hairpin measured by single-molecule fluorescence resonance energy transfer.
Clinical manifestations associated with HTLV type I infection: a cross-sectional study
Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.
The state of the art in the pathogenesis of ATL and new potential targets associated with HTLV-1 and ATL.
High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response.
How HTLV-1 may subvert miRNAs for persistence and transformation.
Molecular aspects of HTLV-I infection and adult T-cell leukaemia/lymphoma.
HTLV-1 Tax oncoprotein subverts the cellular DNA damage response via binding to DNA-dependent protein kinase
Reciprocal functional pseudotyping of HIV-1 and HTLV-1 viral genomes by the heterologous counterpart envelope proteins.
Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cells.
Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.
MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes.
Acetylation at lysine 346 controls the transforming activity of the HTLV-1 Tax oncoprotein in the Rat-1 fibroblast model
Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group.
Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.
Functional comparison of antisense proteins of HTLV-1 and HTLV-2 in viral pathogenesis
HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.
Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion
The impact of human T-cell lymphotropic virus I infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus.
Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections.
Comparison of six commercial human T-cell lymphotropic virus type I (HTLV-I) enzyme immunoassay kits for detection of antibody to HTLV-I and -II.
Serologic confirmation of simian T-lymphotropic virus type I infection by using immunoassays developed for human T-lymphotropic virus antibody detection.
Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol.
Effect of treatment of Strongyloides infection on HTLV-1 expression in a patient with adult T-cell leukemia
Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.
In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Human T lymphotropic virus type 1 SU residue 195 plays a role in determining the preferential CD4+ T cell immortalization/transformation tropism
HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4(+) T cells.
Immunoelectron microscopy for rapid diagnosis of varicella-zoster virus in a complicated case of human T-cell lymphotropic virus type 1 infection
Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II
Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction.
No evidence of HTLV-I infection in French patients with multiple sclerosis using the polymerase chain reaction.
HTLV-1 associated T cell lymphoma in South East Asia: case report and family study.
HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking.
Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1.
Human T lymphotropic virus type 1 accessory protein p12I modulates calcium-mediated cellular gene expression and enhances p300 expression in T lymphocytes.
Human T-Lymphotropic Virus (HTLV) Type I in vivo Integration in Oral Keratinocytes
Cholesterol dependence of HTLV-I infection.
Predictive factors of HTLV1-HIV coinfections in French Guiana
Human T-Lymphotropic Virus Type 1-Induced Overexpression of Activated Leukocyte Cell Adhesion Molecule (ALCAM) Facilitates Trafficking of Infected Lymphocytes through the Blood-Brain Barrier.
Cervical shedding of human T cell lymphotropic virus type I is associated with cervicitis
Induction of p21(CIP1/WAF1) expression by human T-lymphotropic virus type 1 Tax requires transcriptional activation and mRNA stabilization
Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays
Quantitative assessment of subclinical spasticity in human T-cell lymphotropic virus type I infection.
Human T cell lymphotropic virus type 1 infection and early neurologic development: a pilot study of 48 children
Immunodetection of human T-cell lymphotropic virus type I core protein in biological samples by using a monoclonal antibody immunoassay.
Cell-Free versus Cell-to-Cell Infection by Human Immunodeficiency Virus Type 1 and Human T-Lymphotropic Virus Type 1: Exploring the Link among Viral Source, Viral Trafficking, and Viral Replication.
Memory lineage relationships in HTLV-1-specific CD8+ cytotoxic T cells.
The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.
High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in peru.
Quantitative estimation by a standardized enzyme-linked immunosorbent assay of human T-cell lymphotropic virus type I antibodies in adult T-cell leukemia and acquired immune deficiency syndrome.
Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia.
HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165
Telomere Length, Proviral Load and Neurologic Impairment in HTLV-1 and HTLV-2-Infected Subjects
Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I.
Human T lymphotropic virus types 1 and 2: a point of view
Prevalence of human T-cell lymphotropic virus types 1 and 2 in blood donors of the Caruaru Blood Center (Hemope).
Human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis: viral load and muscle tone are correlated.
Association between ABO and Rhesus blood group systems among confirmed human T lymphotropic virus type 1-infected patients in Northeast Iran.
Evaluation of a solid-phase immunoassay for the simultaneous detection of antibodies to human immunodeficiency virus type 1 and human T-cell lymphotropic virus type I.
The clinical significance of HTLV-I and HTLV-II infection in the AIDS epidemic.
Evaluation of a recombinant human T-cell lymphotropic virus type I (HTLV-I) p21E antibody detection enzyme immunoassay as a supplementary test in HTLV-I/II antibody testing algorithms.
Pentoxifylline down modulate in vitro T cell responses and attenuate pathology in Leishmania and HTLV-I infections.
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.
Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica.
Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals.
Improvement of simultaneous detection of antibodies to Gag and envelope antigens of human T-lymphotropic virus type I by western immunoblot assay
The epidemiology of HTLV-I infection.
Variant human T-cell lymphotropic virus type 1c and adult T-cell leukemia, Australia.
EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier
Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes.
HTLV-1 infection in blood donors from the Western Brazilian Amazon region: seroprevalence and molecular study of viral isolates.
Analysis of the Prevalence of HTLV-1 Proviral DNA in Cervical Smears and Carcinomas from HIV Positive and Negative Kenyan Women.
High prevalence of skin disorders among HTLV-1 infected individuals independent of clinical status.
Seroprevalence of antibodies to HTLV-I in patients with ocular disorders.
Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety.
HTLV-I neurotropism. In vitro studies.
Clinical features of HTLV-I associated uveitis.
Familial clustering of human T lymphotropic virus type 1 uveitis.
Human T lymphotropic virus type 1 uveitis
Human T lymphotropic virus type 1 uveitis after Graves' disease
Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study
HTLV-I associated uveitis in central Japan.
Differential effects of HTLV-1 Tax oncoprotein on the different estrogen-induced-ER α-mediated transcriptional activities.
The HBZ gene, a key player in HTLV-1 pathogenesis.
Meningitis associated with strongyloidiasis in an area endemic for strongyloidiasis and human T-lymphotropic virus-1: a single-center experience in Japan between 1990 and 2010.
HTLV-I associated uveitis revisited: characteristic grey-white, granular deposits on retinal vessels
The 14th International Conference on Human Retrovirology: HTLV and related retroviruses (July 1-4, 2009; Salvador, Brazil)
Immune Compromise in HIV-1/HTLV-1 Coinfection With Paradoxical Resolution of CD4 Lymphocytosis During Antiretroviral Therapy: A Case Report.
Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease.
HSP90 protects the human T-cell leukemia virus type 1 (HTLV-1) tax oncoprotein from proteasomal degradation to support NF-κB activation and HTLV-1 replication
Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy.
Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel
The neurology of HTLV-1 infection.
Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders.
Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor κB (NF-κB) signaling
Early neurologic abnormalities associated with human T-cell lymphotropic virus type 1 infection in a cohort of Peruvian children
SEROPREVALENCE OF HTLV IN A POPULATION OF HIV1-INFECTED PATIENTS IN MIDWESTERN BRAZIL.
Upregulation of HTLV-1 and HTLV-2 expression by HIV-1 in vitro.
WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells.
Characterization of a variant of human T-lymphotropic virus type I isolated from a healthy member of a remote, recently contacted group in Papua New Guinea
The immune control of HTLV-1 infection: selection forces and dynamics.
Control of cell death pathways by HTLV-1 proteins.
Deregulation of calcium fluxes in HTLV-I infected CD4-positive T-cells plays a major role in malignant transformation.
Clonal expansion of HTLV-1 infected cells depends on the CD4 versus CD8 phenotype.
Protein-protein interactions and gene expression regulation in HTLV-1 infected cells.
DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells.
Drug targets in human T-lymphotropic virus type 1 (HTLV-1) infection.
Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease.
Mechanisms of HTLV-1 persistence and transformation.
C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity.
HTLV-1 and neurological conditions: when to suspect and when to order a diagnostic test for HTLV-1 infection?
HTLV-1 bZIP factor supports proliferation of adult T cell leukemia cells through suppression of C/EBPα signaling
"HTLV-I Infection" Twenty-Year Research in Neurology Department of Mashhad University of Medical Sciences.
A Systematic Review for Estimation of HTLV-I Infection in the Blood Donors of Iran
Association Between HTLV-I Infection with Chronic Lupoid Leishmaniasis.
Designing a Human T-Lymphotropic Virus Type 1 (HTLV-I) Diagnostic Model using the Complete Blood Count.
Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers.
Evaluation of HTLV-I and HCV Prevalence in Non-Hodgkin's Lymphoma.
Is there any Association Between Human Lymphotropic Virus Type I (HTLV-I) Infection and Systemic Lupus Erythematosus? An Original Research and Literature Review.
Association of IL-10 Gene Polymorphisms and Human T Lymphotropic Virus Type I-Associated Myelopathy/tropical Spastic Paraparesis in North-East of Iran (Mashhad).
Human T Lymphotropic Virus Type I (HTLV-I) is a Risk Factor for Coronary Artery Disease
Human T-lymphotropic Virus Type I (HTLV-I) Proviral Load and Clinical Features in Iranian HAM/TSP Patients: Comparison of HTLV-I Proviral Load in HAM/TSP Patients.
Cutaneous Manifestations in HTLV-I Positive Blood Donors.
Population-based Seroprevalence of HTLV-I Infection in Golestan Province, South East of Caspian Sea, Iran.
Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL).
Outcome of Intravenous Immunoglobulin-Transmitted HTLV-I, Hepatitis B, Hepatitis C, and HIV infections.
Pulmonary complications in human T-cell lymphotropic virus type 1 carriers with Sjögren's syndrome, three case reports and literature review.
Proviral loads and clonal expansion of HTLV-1-infected cells following vertical transmission: a 10-year follow-up of children in Jamaica.
Seroepidemiology of HTLV-1 and HTLV-2 Infection in Neyshabur City, North-Eastern Iran, during 2010-2014.
Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population.
Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study.
The leukemogenic activity of TaxHTLV-1 during human alphabeta T cell development.
Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 tax oncoproteins modulate cell cycle progression and apoptosis.
Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.
Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain.
The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements
Comparison of seropositivity of human T lymphotropic virus type 1 in mycosis fungoides patients and normal volunteers: a case-control study and review of literature.
HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
Human T-cell growth factor (interleukin 2) and gamma-interferon genes: expression in human T-lymphotropic virus type III- and type I-infected cells
Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia.
The Rex regulatory protein of human T-cell lymphotropic virus type I binds specifically to its target site within the viral RNA
Infection of human endothelial cells by human T-lymphotropic virus type I.
CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.
Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands.
Sero-Prevalence of Bloodborne Tumor Viruses (HCV, HBV, HTLV-I and KSHV Infections) and Related Risk Factors among Prisoners in Razavi Khorasan Province, Iran, in 2008.
Multiple sclerosis or HTLV-I myelitis?
Relative frequency of Human T-cell Lymphotropic Virus I/II in HIV/AIDS patients.
Establishing phenotypic features associated with morbidity in human T-cell lymphotropic virus type 1 infection.
The HTLV-1 Tax protein: revealing mechanisms of transcriptional activation through histone acetylation and nucleosome disassembly.
Assessment of HTLV-I proviral load, HIV viral load and CD4 T cell count in infected subjects; with an emphasis on viral replication in co-infection.
Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran
Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs.
Seroprevalence of HTLV-1/2 among blood donors in the state of Maranhão, Brazil.
The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown.
A Fashi Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated Neuroinflammation
NF-κB inhibition facilitates the establishment of cell lines that chronically produce human T-lymphotropic virus type 1 viral particles
Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report.
Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia
Interaction of the human T-cell lymphotrophic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer
Abundant expression of HMGB1 in human T-cell lymphotropic virus type I-infected T-cell lines and high plasma levels of HMGB1 in patients with adult T-cell leukemia.
Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis.
Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Brain Metabolism Changes in Patients Infected with HTLV-1
Recurrent Spontaneous Rupture of the Urinary Bladder in a Patient With Human T-lymphotropic Virus Type 1-Associated Myelopathy: A Case Report and Literature Review.
Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV-I).
Standardisation of Western blotting to detect HTLV-1 antibodies synthesised in the central nervous system of HAM/TSP patients
Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites.
HTLV-1 in pregnant women from the Southern Bahia, Brazil: a neglected condition despite the high prevalence.
Molecular approach to human leukemia: isolation and characterization of the first human retrovirus HTLV-1 and its impact on tumorigenesis in adult T-cell leukemia.
Effects of human T-cell leukemia virus type 1 (HTLV-1) p13 on mitochondrial K+ permeability: A new member of the viroporin family?
Combined cytolytic effects of a vaccinia virus encoding a single chain trimer of MHC-I with a Tax-epitope and Tax-specific CTLs on HTLV-I-infected cells in a rat model.
Immunocytochemical localization of the endogenous neuroexcitotoxin quinolinate in human peripheral blood monocytes/macrophages and the effect of human T-cell lymphotropic virus type I infection.
Clinical trials for human T-cell lymphotropic virus type I-associated peripheral T-cell lymphoma in Japan.
CD4+ T cell subsets and Tax expression in HTLV-1 associated diseases.
Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.
Prevalence and genetic characterisation of HTLV-1 and 2 dual infections in patients with pulmonary tuberculosis in Central-West Brazil.
Adult T-cell leukemia/lymphoma and HTLV-1.
Neuroimmunity of HTLV-I Infection.
HTLV-1 and the host immune system: how the virus disrupts immune regulation, leading to HTLV-1 associated diseases.
Molecular and cellular events at the onset of the lymphoproliferative process induced by HTLV-I (human T-cell leukemia virus, type I).
HTLV-1 Tax: Linking transformation, DNA damage and apoptotic T-cell death.
HTLV-1 bZIP factor gene: Its roles in HTLV-1 pathogenesis.
Role of microRNAs in HTLV-1 infection and transformation.
[Human T cell lymphotropic virus (HTLV-1): when to suspect infection?].
Human T-cell lymphotropic virus type I sequences detected by nested polymerase chain reactions are not associated with multiple sclerosis.
Cutaneous manifestations associated with HTLV-1 infection.
HTLV-1 and adult T-cell leukemia: insights into viral transformation of cells 30 years after virus discovery.
Ethnoepidemiology of HTLV-1 related diseases: ethnic determinants of HTLV-1 susceptibility and its worldwide dispersal.
Endocrine and metabolic disorders in HTLV-1 infected patients.
Interaction between the HTLV-1 envelope and cellular proteins: impact on virus infection and restriction.
Surveys of HIV-1, HTLV-I, and other sexually transmitted diseases in female sex workers in Taipei City, Taiwan, from 1993 to 1996.
Human T cell lymphotropic virus type I infection among female sex workers in Peru.
Development of a monoclonal antibody-based p24 capsid antigen detection assay for HTLV-I, HTLV-II, and STLV-I infection.
Adult T cell leukemia/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1.
Incidence of antibodies against human immunodeficiency virus, human T-cell lymphotropic virus type 1, hepatitis B virus, hemorrhagic fever with renal syndrome virus and Chlamydia in Tonga and western Samoa.
Human lymphotropic viruses associated with lymphoid malignancy: Epstein-Barr and HTLV-1.
Infection with Chlamydia sp and HTLV-I in a patient mimicking infective endocarditis.
Human T-lymphotropic virus 1 (HTLV-1) infection--dermatological implications.
Prospects for the management of human T-cell lymphotropic virus type 1-associated myelopathy.
Tropical spastic paraparesis and HTLV-I myelopathy: clinical features and pathogenesis.
Leukemia's viral link: What role does a viral gene play in HTLV-1 infection's progression to T cell leukemia?
HTLV-I.
Neurological disorders associated with HTLV-1.
An HTLV-I transgenic mouse model: role of the tax gene in pathogenesis in multiple organ systems.
Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis.
Molecular mechanisms of HTLV-1 infection and pathogenesis.
Current status of HTLV-1 infection.
Human T-cell lymphotropic virus-type I.
Intracellular localization and cellular factors interaction of HTLV-1 and HTLV-2 Tax proteins: similarities and functional differences.
Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.
Cell surface markers in HTLV-1 pathogenesis.
Research and discovery of the first human cancer virus, HTLV-1.
Transforming properties of the HTLV-I tax gene.
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP): still an obscure disease.
The microRNA regulatory network in normal- and HTLV-1-transformed T cells.
Dynamic roles for NF-κB in HTLV-I and HIV-1 retroviral pathogenesis.
Human T lymphotropic virus type I neurotropism.
CT scans of the chest in carriers of human T-cell lymphotropic virus type 1: presence of interstitial pneumonia.
Mechanisms of human T-lymphotropic virus type 1 transmission and disease.
HTLV-1 infection: what determines the risk of inflammatory disease?
HTLV-1 Rex: the courier of viral messages making use of the host vehicle.
Animal models on HTLV-1 and related viruses: what did we learn?
HTLV-1-associated infective dermatitis: updates on the pathogenesis.
HTLV-1: persistence and pathogenesis.
Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis
Mother-to-child transmission of human T-cell lymphotropic virus type 1.
Development of peripheral T-cell lymphoma not otherwise specified in an HTLV-1 carrier.
Human T-lymphotropic virus type 1 non-structural proteins: Requirements for latent infection.
Biology and treatment of HTLV-1 associated T-cell lymphomas.
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators.
HTLV-1 and leukemogenesis: virus-cell interactions in the development of adult T-cell leukemia.
Prevention of human T-cell lymphotropic virus type 1 infection and adult T-cell leukemia/lymphoma.
Fine tuning of the temporal expression of HTLV-1 and HTLV-2.
Human T-cell leukemia virus type 1: replication, proliferation and propagation by Tax and HTLV-1 bZIP factor.
Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection.
Infective dermatitis associated with HTLV-1 mimics common eczemas in children and may be a prelude to severe systemic diseases.
Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
Prevalence of human T-lymphotropic virus type 1 infection among blood donors in mainland China: a meta-analysis.
Neurologic disease due to HTLV-1 infection.
Sexual transmission of human T-cell lymphotropic virus type 1.
HTLV-1 and HTLV-2: highly similar viruses with distinct oncogenic properties.
Donor-transmitted HTLV-1-associated myelopathy in a kidney transplant recipient--case report and literature review.
HIV-2 and HTLV-1 infections in Spain, a non-endemic region.
HTLV-1 Tax: centrosome amplification and cancer.
Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma.
Inflammatory manifestations of HTLV-1 and their therapeutic options.
Regulation of HTLV-1 tax stability, cellular trafficking and NF-κB activation by the ubiquitin-proteasome pathway.
Human T-lymphotropic virus-1 serology in the Northern Territory: 2008-2011.
Primary central nervous system lymphoma in Miyazaki, southwestern Japan, a human T-lymphotropic virus Type-1 (HTLV-1)-endemic area: clinicopathological review of 31 cases.
Identification of the Tax interaction region of serum response factor that mediates the aberrant induction of immediate early genes through CArG boxes by HTLV-I Tax.
IL-2 withdrawal induces HTLV-1 expression through p38 activation in ATL cell lines.
Constitutive association of MyD88 to IRAK in HTLV-I-transformed T cells.
Infection of synoviocytes with HTLV-I induces telomerase activity.
Expression of the Gfi-1 gene in HTLV-1-transformed T cells.
Characterization of a glial cell-specific DNA-protein complex formed with the human T cell lymphotropic virus type I (HTLV-I) enhancer.
Proteolytic processing of the human T-cell lymphotropic virus 1 reverse transcriptase: identification of the N-terminal cleavage site by mass spectrometry.
A cellular protein which is coprecipitated with HTLV-I rex protein in the presence of the target mRNA.
Gene expression array of HTLV type 1-infected T cells: Up-regulation of transcription factors and cell cycle genes.
Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway.
HTLV-1 bZIP factor suppresses apoptosis by attenuating the function of FoxO3a and altering its localization.
Involvement of HTLV-I Tax and CREB in aneuploidy: a bioinformatics approach
Transcriptional activation of JC virus by human T-lymphotropic virus type I Tax protein in human neuronal cell lines.
HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization.
The lymphotoxin promoter is stimulated by HTLV-I tax activation of NF-kappa B in human T-cell lines.
Interaction of HTLV-1 Tax1 with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes.
IL-2- and STAT5-regulated cytokine gene expression in cells expressing the Tax protein of HTLV-1.
HTLV-1 Tax has distinct but overlapping domains for transcriptional activation and for enhancer specificity.
HTLV-1 envelope sequences from Brazil, the Caribbean, and Romania: clustering of sequences according to geographic origin and variability in an antibody epitope.
Four regulatory elements in the human c-fos promoter mediate transactivation by HTLV-1 Tax protein.
Induction of the HTLV-I LTR by Jun occurs through the Tax-responsive 21-bp elements.
The HTLV-I Rex response element mediates a novel form of mRNA polyadenylation.
Identification of a functional serum response element in the HTLV-I LTR.
Association of a particular amino acid sequence of the HLA-DR beta 1 chain with HTLV-I-associated myelopathy.
Tax-independent binding of multiple cellular factors to Tax-response element DNA of HTLV-I.
Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain.
HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene.
Integration of HTLV-1 provirus into mouse transforming growth factor-alpha gene.
A nuclear factor is required for transactivation of HTLV-I gene expression.
AP-1 derived from mature monocytes and astrocytes preferentially interacts with the HTLV-I promoter central 21 bp repeat.
Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer.
Human T cell lymphotropic virus 1 manipulates interferon regulatory signals by controlling the TAK1-IRF3 and IRF4 pathways.
Distinct nuclear body components, PML and SMRT, regulate the trans-acting function of HTLV-1 Tax oncoprotein.
HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4.
cAMP-response element-binding protein induces directed DNA bending of the HTLV-I 21-base pair repeat.
HTLV-1-associated cutaneous disease: a clinicopathological and molecular study of patients from the U.K.
[Cutaneous manifestations of the leukemia-lymphoma of HTLV 1: apropos of 1 case]
[HTLV-1 infection in time and space]
[Coexistence of mass hysteria, konzo and HTLV-1 virus in the Democratic Republic of the Congo]
[Aseptic purulent meningitis in two patients co-infected by HTLV-1 and Strongyloides stercoralis]
[Pathologies associated with HTLV-1 virus in Dakar (1992-1995)]
[Mycosis fungoides in a Gabonese patient infected with HTLV-I]
[HTLV-I and HTLV-II viruses: fifteen years after their description]
[HTLV1 and coinfections]
Antibody to human T-lymphotropic virus type I/II (HTLV-I/II) among male inmates entering Maryland prisons.
Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells.
Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4.
Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention.
Blood donor HTLV-1 antibody testing.
A new role for the HTLV-1 p8 protein: increasing intercellular conduits and viral cell-to-cell transmission
The HTLV-1 Virological Synapse.
Tax posttranslational modifications and interaction with calreticulin in MT-2 cells and human peripheral blood mononuclear cells of human T cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.
Profile of the MP Diagnostics HTLV Blot 2.4 test: a supplemental assay for the confirmation and differentiation of antibodies to HTLV-1 and HTLV-2.
The Duffy null genotype is associated with a lower level of CCL2, leukocytes and neutrophil count but not with the clinical outcome of HTLV-1 infection.
The Burden of Neglected HIV-2 and HTLV-1 Infections in Spain.
Human T-lymphotropic virus type I(HTLV-I) associated myelopathy in Nagasaki: clinical features and treatment of 21 cases.
HTLV-I: newest addition to blood donor screening.
Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical status
Inferring clonal structure in HTLV-1-infected individuals: towards bridging the gap between analysis and visualization.
BCL11B is frequently downregulated in HTLV-1-infected T-cells through Tax-mediated proteasomal degradation.
Testing for HTLV 1 and HTLV 2 among blood donors in Western Saudi Arabia: prevalence and cost considerations.
HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprises.
STR Profiling of HTLV-1-Infected Cell Lines.
HTLV-1 basic leucine zipper factor downregulates cyclin D1 expression via interactions with NF-κB.
HTLV-1 Tax activates HIV-1 transcription in latency models.
Performance of the Liaison® XL Murex recHTLV-I/II Immunoassay in the Detection of HTLV-1/2 Antibodies in Serum.
Infection of defective human T-lymphotropic virus type 1.
HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax.
Human T-cell lymphotropic virus type 1 and its oncogenesis.
Heat Shock Enhances the Expression of the Human T Cell Leukemia Virus Type-I (HTLV-I) Trans-Activator (Tax) Antigen in Human HTLV-I Infected Primary and Cultured T Cells.
Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study.
Immune suppression in HTLV-I carriers: a predictive sign of adult T-cell leukemia.
Disorders of the expression of the multichain IL-2 receptor in HTLV-I-associated adult T-cell leukemia.
HTLV-1 Associated Neurological Disorders.
The diversity of the structure and genomic integration sites of HTLV-1 provirus in MT-2 cell lines.
Human T-cell leukemia virus type 1 (HTLV-1) Tax1 oncoprotein but not HTLV-2 Tax2 induces the expression of OX40 ligand by interacting with p52/p100 and RelB.
A20 targets caspase-8 and FADD to protect HTLV-I-infected cells.
HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival.
Prevalence of Human T-lymphotropic virus type 1 (HTLV-1) Infection in Patients with Hematologic Disorders and Non-Hematologic Malignancies in a Tertiary Referral Hospital.
Truncated MTA-1: a pitfall in ELISA-based immunoassay of HTLV-1 infection
Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection.
Activation of macrophages/microglia with the calcium-binding proteins MRP14 and MRP8 is related to the lesional activities in the spinal cord of HTLV-I associated myelopathy.
Low HTLV-1 seroprevalence in endemic tropical spastic paraparesis in Ethiopia.
Detection of HTLV type I provirus by in situ polymerase chain reaction in mouthwash mononuclear cells of HAM/TSP patients and HTLV type I carriers.
Detection of proviral human T-cell lymphotrophic virus type I DNA in mouthwash samples of HAM/TSP patients and HTLV-I carriers.
Spastic paraparesis associated with human T-lymphotropic virus type I: a clinical, serological, and genomic study in Iranian-born Mashhadi Jews.
Niclosamide, an anti-helminthic molecule, downregulates the retroviral oncoprotein Tax and pro-survival Bcl-2 proteins in HTLV-1-transformed T lymphocytes.
SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness.
Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways.
Rate of positive autoimmune markers in Human T lymphotropic virus type 1 carriers: a case-control study from Iran.
Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients.
Infectivity of human T-lymphotropic virus type I to human nervous tissue cells in vitro.
Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.
An autopsy case of human T-lymphotropic virus type I-associated myelopathy.
Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lymphocytes are highly activated and adhesion to endothelial cells is increased.
Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.
Hypoxanthine-guanine phosphoribosyltransferase reporter gene mutation for analysis of in vivo clonal amplification in patients with HTLV type 1-associated Myelopathy/Tropical spastic paraparesis.
Serological and Molecular Methods to Study Epidemiological Aspects of Human T-Cell Lymphotropic Virus Type 1 Infection.
Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis.
Neopterin concentrations in serum and cerebrospinal fluid in HTLV-I infected individuals.
Developing novel treatments for HTLV-1-associated myelopathy (HAM) by investigating molecular pathomechanisms.
A Peruvian family with a high burden of HTLV-1-associated myelopathy/tropical spastic paraparesis.
Constitutive expression of IRF-5 in HTLV-1-infected T cells.
Effect of repetitive transcranial magnetic stimulation on reducing spasticity in patients suffering from HTLV-1-associated myelopathy.
Human T-lymphotropic virus type-I (HTLV-I)-associated myelopathy with bulbar palsy-type amyotrophic lateral sclerosis-like symptoms.
Immunological features of HTLV-I myelopathy in Rio de Janeiro, Brazil, and in vitro effects of cyclosporin A.
Detection and isolation of human T-cell leukemia/lymphoma virus type I (HTLV-I) from cultured lymphocytes of a Brazilian TSP/HAM patient.
Association between urinary symptoms and quality of life in HTLV-1 infected subjects without myelopathy.
HTLV-I/II as a common etiology of myelopathies in Bahia, Brazil.
Epidemiology of tropical spastic paraparesis in Columbia and associated HTLV-I infection.
Update on Neurological Manifestations of HTLV-1 Infection.
Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease.
Human T-lymphotropic virus 1 neurologic disease.
Spastic paraparesis of obscure origin. A case-control study of HTLV-I positive and negative patients from Rio de Janeiro, Brazil.
Syringohydromyelia or HTLV-I-associated myelopathy/tropical spastic paraparesis. A diagnostic challenge. Case report.
Tropical spastic paraparesis/HTLV-I-associated myelopathy in Brazil.
Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, Brazil.
Juvenile human T lymphotropic virus type 1-associated myelopathy.
HTLV-I-associated myelopathy/tropical spastic paraparesis in Brazil: a nationwide survey. HAM/TSP Brazilian Study Group.
Folliculitis decalvans and human T cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Progression of neurological disability in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Safety and efficacy of interferon-alpha in 167 patients with human T-cell lymphotropic virus type 1-associated myelopathy.
How does HTLV-I persist despite a strong cell-mediated immune response?
HTLV-I infection in the South West Indian Ocean islands, particularly in La Réunion and the Seychelles.
Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system.
Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis.
Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1-associated neurologic disease.
Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.
HTLV-1 tax-induced NF-kappaB activation is synergistically enhanced by 12-O-tetradecanoylphorbol-13-acetate: mechanism and implications for Tax oncogenicity.
Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
Is human T-lymphotropic virus type 1 infection associated with hearing loss?
Sequence and phylogenetic analysis of human T cell lymphotropic virus type 1 from Tumaco, Colombia.
Retroviral infections (HIV-1, HIV-2, and HTLV-I) in rural northwestern Tanzania. Clinical findings, epidemiology, and association with infections common in Africa.
Antibodies to HTLV-I p24 in African and Portuguese populations.
Human T-cell leukemia virus (HTLV-I) antibodies in Africa.
Analyses of HTLV-1 sequences suggest interaction between ORF-I mutations and HAM/TSP outcome.
Prevalence of human T-cell lymphotropic virus type 1 and 2 among patients with malignant hematological diseases in south Chile.
Inhibition of HIV type 1 replication by human T lymphotropic virus types 1 and 2 Tax proteins in vitro.
HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
Seroprevalence of HTLV-1 in chronic disease patients in Jamaica.
HTLV-1 and Adult T-Cell Leukemia/Lymphoma: A Review.
Nucleotide sequence analysis of human T-cell lymphotropic virus type I pX and LTR regions from patients with sicca syndrome.
Performance of HTLV-1 screening assays in Brazil.
Pearls & Oy-sters: "Not multiple sclerosis" and the changing face of HTLV-1: A case report of downbeat nystagmus.
Laboratory study of HIV-1 and HTLV-I/II coinfection.
In situ hybridization detection of HTLV-I RNA in peripheral blood mononuclear cells of TSP/HAM patients and their spouses.
Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes.
Human T-cell lymphotropic virus type-I antibodies in Falashas and other ethnic groups in Israel.
Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes.
Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-1 and HTLV-II.
The role of HTLV in HIV-1 neurologic disease.
cDNA sequencing confirms HTLV-I expression in adult T-cell leukemia/lymphoma and different sequence variations in vivo and in vitro.
Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruv
IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population.
Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru.
Prevalence and transmission of HTLV-I infection in Natal/KwaZulu.
Peripheral nerve lesions in HTLV-I associated myelopathy (HAM/TSP).
HLA profile and HTLV-I associated myelopathy (HAM/TSP) in Natal, South Africa
HTLV-I-associated myelopathy: clinicopathologic correlation with localization of provirus to spinal cord.
Myelopathy associated with human T cell lymphotropic virus type I (HTLV-I) in natal, South Africa. A clinical and investigative study in 24 patients.
Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase.
Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East Africa.
A cluster of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in Jujuy, Argentina.
Histopathological and immunohistochemical studies of infective dermatitis associated with HTLV-I.
Vertical transmission of HTLV-I/II: a review.
Norwegian scabies in Peru: the impact of human T cell lymphotropic virus type I infection.
A study of HTLV-I and its associated risk factors in Trinidad and Tobago.
Qualitative changes in the human T-cell leukemia/lymphotropic virus type I env gene sequence in the spastic versus nonspastic tropical paraparesis are not correlated with disease specificity.
Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy.
Effects of Danazol on Clinical Improvement of Patients with Human T-cell Lymphotropic Virus Type I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): A Placebo-Controlled Clinical Trial.
Activation of PKC-δ in HTLV-1-infected T cells.
HTLV-1 and blood transfusion.
Patterns of migration indicate sexual transmission of HTLV-I infection in non-pregnant women in Papua New Guinea.
Phenotypic study of peripheral blood leucocytes in HTLV-I-infected individuals from Minas Gerais, Brazil.
Proprioceptive neuromuscular facilitation in HTLV-I-associated myelopathy/tropical spastic paraparesis.
Direct infection of primary salivary gland epithelial cells by human T lymphotropic virus type I in patients with Sjögren's syndrome.
HTLV-I-induced T-cell activation.
Tax contributes apoptosis resistance to HTLV-1-infected T cells via suppression of Bid and Bim expression.
Interaction of HTLV-I Tax with the human proteasome: implications for NF-kappa B induction.
Detection of human T-cell lymphotropic virus type 1 in plasma samples.
HTLV-I positive adult T-cell leukaemia/lymphoma (ATLL) in Chile.
Muscular weakness represents the main limiting factor of walk, functional independence and quality of life of myelopathy patients associated to HTLV-1.
Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis.
HTLV-1 polymyositis.
Reexamination of the coding potential of the HTLV-1 pX region.
The use of botulinum toxin type A in the treatment of HTLV-1-associated overactive bladder refractory to conventional therapy.
Presence of HTLV-I Tax protein in cerebrospinal fluid from HAM/TSP patients.
Extracellular matrix protein expression in cerebrospinal fluid from patients with tropical spastic paraparesis associated with HTLV-I and Creutzfeldt-Jakob disease.
HTLV-I positive progressive spastic paraparesis (TSP) associated with a lymphoid disorder in three Chilean patients.
Progressive spastic paraparesis associated with human T-cell leukemia virus type I (HTLV-I).
Clinical and neuropathological study of six patients with spastic paraparesis associated with HTLV-I: an axomyelinic degeneration of the central nervous system.
Are lipid disorders involved in the predominance of human T-lymphotropic virus-1 infections in women?
Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
Lack of tax diversity for tropical spastic paraparesis/human T-cell lymphotropic virus type 1 (HTLV-I) associated myelopathy development in HTLV-I-infected subjects in São Paulo, Brazil.
Sensory dysfunction in HTLV-I-associated myelopathy/tropical spastic paraparesis. A comprehensive neurophysiological study.
Evoked potential abnormalities in progressive spastic paraparesis associated to HTLV-1.
Spinocerebellar syndrome in patients infected with human T-lymphotropic virus types I and II (HTLV-I/HTLV-II): report of 3 cases from Panama.
HTLV-I associated myelopathy in Brazil: a preliminary report.
Erectile dysfunction and HTLV-I infection: a silent problem.
Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-I carriers.
Urodynamic features of the voiding dysfunction in HTLV-1 infected individuals.
Pain in tropical spastic paraparesis/HTLV-I associated myelopathy patients.
Neuropathology of two Brazilian autopsied cases of tropical spastic paraparesis / HTLV-I associated myelopathy (TSP/HAM) of long evolution.
Keratoconjunctivitis sicca of human T cell lymphotropic virus type 1 (HTLV-1) infected individuals is associated with high levels of HTLV-1 proviral load.
HTLV-I-associated neurologic manifestations in four generations of a Brazilian family.
Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clo
Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy.
Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM.
Update: serologic testing for human T-lymphotropic virus type I--United States, 1989 and 1990.
Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines.
Insights on the pathogenicity of human T-lymphotropic/leukemia virus types I and II.
Intrathecal synthesis of IgG antibodies to HTLV-I supports an etiological role for HTLV-I in tropical spastic paraparesis.
Plasmatic proinflammatory chemokines levels are tricky markers to monitoring HTLV-1 carriers.
Role of the Fas/Fas ligand pathway in apoptotic cell death induced by the human T cell lymphotropic virus type I Tax transactivator.
Antibody reactivities to tumor-suppressor protein p53 and HTLV-I Tof, Rex and Tax in HTLV-I-infected people with differing clinical status.
CD160 expression defines a uniquely exhausted subset of T lymphocytes in HTLV-1 infection.
In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis.
HLA-G 3'-untranslated region polymorphisms are associated with HTLV-1 infection, proviral load and HTLV-associated myelopathy/tropical spastic paraparesis development.
HTLV-1 bZIP factor suppresses the centromere protein B (CENP-B)-mediated trimethylation of histone H3K9 through the abrogation of DNA-binding ability of CENP-B.
Tropical spastic paraparesis associated with HTLV-1 in Egypt.
Monitoring for HIV-1, HIV-2, HTLV-I sero-progression and sero-conversion in a population at risk in east Africa.
HTLV-1 related knowledge, attitude and behaviour patterns among mothers who participated in the Jamaica Breastfeeding Intervention Study (1996-2000).
Neurological morbidity among human T-lymphotropic-virus-type-1-infected individuals in a rural West African population.
Anterior horn cell degeneration in polymyositis associated with human T lymphotropic virus Type-1 in patients from Barbados.
CD4+ T-cell Count may not be a Useful Strategy to Monitor Antiretroviral Therapy Response in HTLV-1/HIV Co-infected Patients.
Analysis of the expression directed by two HTLV-I promoters in transgenic mice.
Experimental HTLV-I infection and associated myelopathy.
HTLV-negative and HTLV type I-positive tropical spastic paraparesis in northeastern Brazil.
Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene.
Bronchoalveolar lymphocytosis in patients with tropical spastic paraparesis associated with human T-cell lymphotropic virus type 1 (HTLV-1). Clinical, immunologic, and cytologic studies.
Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom.
Motor behavioral abnormalities and histopathological findings of Wistar rats inoculated with HTLV-1-infected MT2 cells.
Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment.
HTLV-I-associated lymphoma presenting as mycosis fungoides in an HTLV-I non-endemic area: a viro-molecular study.
Transient adult T-cell leukemia/lymphoma picture during varicella infection in an HTLV-1 carrier.
Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil.
High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis.
HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic response.
Human T-Lymphotropic Virus-1 Associated with Adult T-Cell Lymphoma/ Leukemia and Generalized Expansion of Palatal and Jaw Bones: A Rare Case Report.
Mimicry between HTLV-I and myelin basic protein: no response in HTLV-I-associated myelopathy patients.
HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil.
Comparative analysis of nucleotide sequences of the partial envelope gene (5' domain) among human T lymphotropic virus type I (HTLV-I) isolates.
Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM).
Paradoxical effects of a stress signal on pro- and anti-apoptotic machinery in HTLV-1 Tax expressing cells.
HTLV-1 infection and disease in Spain.
HTLV-I associated myelopathy/tropical spastic paraparesis in a 7-year-old boy associated with infective dermatitis.
HTLV-I infection and adult T-cell leukemia in Brazil: an overview.
Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
Diagnostic tool based on an HTLV-1-Tax expression system in eukaryotic cells using a poxvirus vector.
IL28B gene polymorphisms and Th1/Th2 cytokine levels might be associated with HTLV-associated arthropathy.
An HTLV-I/II vaccine: from animal models to clinical trials?
An HTLV-I vaccine: why, how, for whom?
Human retroviruses HTLV-I, HIV-1, and HIV-2 and neurological diseases in some equatorial areas of Africa.
Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries.
HTLV-1 seroprevalance in sarcoidosis. A clinical and laboratory study in northeast of Iran.
Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay.
Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: an isotype and subclass analysis.
HTLV-I infection associated with disease in aboriginal Indians from British Columbia: a serological and PCR analysis.
Nucleotide sequence analysis of an HTLV-I isolate from a Chilean patient with HAM/TSP.
HTLV-I infection among prostitutes and pregnant women in Kinshasa, Zaïre: how important is high-risk sexual behavior?
Prevalence of HTLV-I and HTLV-II infection in Gabon, Africa: comparison of the serological and PCR results.
Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases.
A case of human T lymphotropic virus type I-associated synovial swelling.
Absence of consistent association between human leukocyte antigen-I and -II alleles and human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis risk in an HTLV-1 French Afro-Caribbean population.
Increased expression of alpha 4 beta 1 and alpha 5 beta 1 integrins on HTLV-I-infected lymphocytes.
Extracellular human T-cell lymphotropic virus type I Tax protein induces cytokine production in adult human microglial cells.
Neurological manifestations in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis in the Amazon.
Impact of HTLV-I in quality of life and urogynecologic parameters of women with urinary incontinence.
Human T cell lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis in Sao Paulo, Brazil: association with blood transfusion.
Human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in São Paulo, Brazil.
Envelope sequence variation and phylogenetic relations of human T cell lymphotropic virus type 1 from endemic areas of Colombia.
Human T-cell lymphotropic virus type 1 myositis, peripheral neuropathy, and cerebral white matter lesions in the absence of spastic paraparesis.
C2H2-546: a zinc finger protein differentially expressed in HTLV-1 infected T cells.
Role of retrovirus HTLV-1 in African spastic paraplegia.
Seroepidemiology of human T-cell lymphotropic virus type I/II in Benin (West Africa).
HTLV-I alters the multidrug resistance associated protein 1 (ABCC1/MRP1) expression and activity in human T cells.
Human T-lymphotropic virus type 1 (HTLV-1) genetic typing in Kakeroma Island, an island at the crossroads of the ryukyuans and Wajin in Japan, providing further insights into the origin of the virus in Japan.
DNA sequence analysis of the gene encoding the HTLV-I p21e transmembrane protein reveals inter- and intraisolate genetic heterogeneity.
Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals.
Cell surface phenotype of in vitro proliferating lymphocytes in HTLV-I-associated myelopathy (HAM/TSP).
Sporadic carriers of human T-lymphotropic virus type I in northern Egypt.
Low prevalence of antibodies to HIV-1 and HTLV-I in Alexandria, Egypt.
Pain prevalence, characteristics and associated factors in human T-cell lymphotropic virus type 1 infected patients: a systematic review of the literature.
Serological cross-reactivities between the retroviruses HIV and HTLV-1 and the malaria parasite Plasmodium falciparum.
Limited T cell receptor usage by HTLV-I tax-specific, HLA class I restricted cytotoxic T lymphocytes from patients with HTLV-I associated neurological disease.
HTLV-I-associated myelopathy following allogeneic bone marrow transplantation.
Subtyping of human T cell lymphotropic virus type I from tropical spastic paraparesis/HTLV-associated myelopathy patients in Mozambique.
High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.
HTLV-I-associated myelopathy and polymyositis in a US native.
Falls in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Antibodies to cardiolipin and beta2-glycoprotein-1 in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Early sequential development of infective dermatitis, human T cell lymphotropic virus type 1-associated myelopathy, and adult T cell leukemia/lymphoma.
Testing the vestibular evoked myogenic potential (VEMP) to identify subclinical neurological alterations in different phases of human T-lymphotropic virus type 1 infection.
Vestibular-evoked myogenic potential (VEMP) to evaluate cervical myelopathy in human T-cell lymphotropic virus type I infection.
Th1/Th2 balance and HTLV-I proviral load in HAM/TSP patients treated with interferon-alpha.
HTLV-I associated myelopathy: clinical and epidemiological profile.
Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
Low prevalence of infection by HTLV-I in populations at risk for HIV in Djibouti.
Disability and determinants of gait performance in tropical spastic paraparesis/HTLV-I associated myelopathy (HAM/TSP).
Disability profile of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis using the Functional Independence Measure (FIM).
Adult T-cell leukemia-lymphoma in a patient with HTLV-I/II associated myelopathy.
Amplifications of multiple regions of the HTLV-I genome from DNA of an Italian spastic paraparesis patient but not from DNA of multiple sclerosis patients.
Transactivation of proenkephalin gene by HTLV-1 tax1 protein in glial cells: involvement of Fos/Jun complex at an AP-1 element in the proenkephalin gene promoter.
Failure to demonstrate human T cell lymphotropic virus type I in multiple sclerosis patients.
Antibody-dependent cell-mediated cytotoxicity (ADCC) in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Cellular immune surveillance against HTLV-I infected T lymphocytes in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Muscle weakness in extremities and diffuse centrilobular nodules in lungs. HTLV-1-associated bronchiolo-alveolar disorder.
Up-regulation of interleukin-12 receptor expression in peripheral blood mononuclear cells of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Relationship between the clinical efficacy of pentoxifylline treatment and elevation of serum T helper type 2 cytokine levels in patients with human T-lymphotropic virus type I-associated myelopathy.
A tax on luxury: HTLV-I infection of CD4+CD25+ Tregs.
Human T lymphotropic virus type I associated myelopathy and myasthenia gravis: a possible association?
HTLV-I production based on activation of integrin/ligand signaling in HTLV-I-infected T cell lines derived from HAM/TSP patients.
Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Involvement of p38 MAPK signaling pathway in IFN-gamma and HTLV-I expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Cognitive event-related potentials and brain magnetic resonance imaging in HTLV-1 associated myelopathy (HAM).
Peripheral nerve involvement in HTLV-I-associated myelopathy: report of a case.
Human T-cell lymphotropic virus type-I infection in the severe combined immunodeficiency mouse.
HTLV-I hu-SCID mouse in the study of HTLV-I neurotropism.
Occurrence of strongyloidiasis among patients with HTLV-1/2 seen at the outpatient clinic of the Núcleo de Medicina Tropical, Belém, State of Pará, Brazil.
Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease.
Human T cell lymphotropic virus type I (HTLV-I) p12I is dispensable for HTLV-I transmission and maintenance of infection in vivo.
Human T-cell lymphotropic virus type I (HTLV-I)-related clinical and laboratory findings for HTLV-I-infected blood donors.
Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers.
Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia.
Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis.
Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Human T-cell lymphotropic virus type-I (HTLV-I)-associated myelopathy/tropical spastic paraparesis with acute type of adult T-cell leukemia.
Human T-cell leukemia virus type-1 (HTLV-1) Tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells
Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells in HTLV-1-associated myelopathy (HAM-TSP).
Elevated levels of interleukin-12 and interferon-gamma in patients with human T lymphotropic virus type I-associated myelopathy.
HTLV-I-associated myelopathy associated with multi-organ inflammatory disease: a case report.
Heightened transmigrating activity of CD4-positive T cells through reconstituted basement membrane in patients with human T-lymphotropic virus type I-associated myelopathy.
Skeletal muscle involvement in tropical spastic paraparesis/HTLV-1-associated myelopathy.
Selectivity of human T lymphotropic virus type-1 (HTLV-1) and HTLV-2 infection among different populations in Brazil.
Correlation between polymorphisms at interleukin-6 but not at interleukin-10 promoter and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in Brazilian individuals.
Impact of depression on quality of life in people living with human T cell lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.
Epigallocatechin-3-gallate inhibits tax-dependent activation of nuclear factor kappa B and of matrix metalloproteinase 9 in human T-cell lymphotropic virus-1 positive leukemia cells.
HTLV-I associated adult T cell leukemia/lymphoma: report of two cases from an Amerindian population in coastal northwest British Columbia.
Prevalence of anxiety, depression and quality of life in HTLV-1 infected patients.
Cognitive impairment is frequent among symptomatic carriers of human T-cell lymphotropic virus type 1 (HTLV-1), regardless of their clinical status.
Transfusion transmission of human T-lymphotropic virus type I (HTLV-I) from an asymptomatic blood donor: conservation of LTR U3, env, and tax nucleotide sequences in a recipient with HTLV-I-associated myelopathy.
Long terminal repeat sequence analysis of HTLV type I molecular variants identified in four north African patients.
HTLV type 1 genetic types among native descendants in Argentina.
Type-I and type-III HTLV antibodies in hospitalized and out-patient Zairians.
Role of the HTLV-1 viral factors in the induction of apoptosis.
HTLV-I associated sicca syndrome in Guadeloupe: lack of relation with a peculiar encoding sequence of surface envelope glycoprotein.
Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection.
Sexual transmission of human T-lymphotropic virus type I (HTLV-I).
Cell surface phenotype and human T lymphotropic virus type 1 antigen expression in 12 T cell lines derived from peripheral blood and cerebrospinal fluid of West Indian, Guyanese and African patients with tropical spastic paraparesis.
Characterization of HTLV-I isolates and T lymphoid cell lines derived from French West Indian patients with tropical spastic paraparesis.
Intrathecal synthesis of antibodies to human T lymphotropic virus type I and the presence of IgG oligoclonal bands in the cerebrospinal fluid of patients with endemic tropical spastic paraparesis.
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.
Seroepidemiology of human T-cell lymphotropic virus 1 infection in hemodialysis patients: should we be concerned about it?
Regulation of the GATA3 promoter by human T-cell lymphotropic virus type I Tax protein.
Decreased GATA3 mRNA expression in human T-cell lymphotropic virus type 1 (HTLV-1) infection.
HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-/-γc-/- (RAG1-Hu) and BLT Mice.
T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neurological disease.
Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV-1 infected patients with tropical spastic paraparesis.
Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): possible involvement in neurodegenerative processes.
Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Characterization of cerebral white matter lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis in comparison with multiple sclerosis and collagen-vasculitis: a semiquantitative MRI study.
Allolymphocytotoxic antibodies in sera from HTLV-I-associated myelopathy/tropical spastic paraparesis patients--putative anti-HLA antibodies.
Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types.
Comparative analysis of HTLV-I promoter activities reveals no disease-linked pattern of expression.
Tissue expression pattern directed in transgenic mice by the LTR of an HTLV-I provirus isolated from a case of tropical spastic paraparesis.
Myelopathy and adult T-cell leukemia associated with HTLV-1 in a young patient with hearing loss as the initial manifestation of disease.
Dermatologic lesions in asymptomatic blood donors seropositive for human T cell lymphotropic virus type-1.
Simultaneous occurrence of HTLV-I associated myelopathy, uveitis and smouldering adult T cell leukaemia. GIPH (Interdisciplinary HTLV-I/II Research Group).
Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy.
Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.
High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Frequent HTLV-1 infection in the offspring of Peruvian women with HTLV-1-associated myelopathy/tropical spastic paraparesis or strongyloidiasis.
Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis.
Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru.
Tropical spastic paraparesis and HTLV-I infection: clinical and epidemiological study in Lima, Peru.
Human T-cell lymphotropic virus type 1 infection and tropical spastic paraparesis in Belgian expatriates.
Absence of Epstein-Barr virus activation in HTLV-I-associated tropical spastic paraparesis.
Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation.
Relation between human T-lymphotropic virus type I and neurologic diseases in Panama: 1985-1990.
Human T-cell lymphotropic virus type I and neurologic disease in Panama, 1985 and 1986.
Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Transient HTLV-I infection of a human glioma cell line following cell-free exposure.
Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice.
Molecular analysis of HTLV-I proviral integration and T cell receptor arrangement indicates that T cells in tropical spastic paraparesis are polyclonal.
Brain volume measurements in patients with human T-cell lymphotropic virus-1-associated tropical spastic paraparesis.
HTLV-I-associated myelopathy: oligoclonal immunoglobulin G bands contain anti-HTLV-I p24 antibody.
HTLV-1 infection and tropical spastic paraparesis in Esmeraldas Province of Ecuador.
Effects of human T-lymphotropic virus type II on human immunodeficiency virus type 1 phenotypic evolution.
Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.
Properties of HTLV-I transformed CD8+ T-cells in response to HIV-1 infection.
Polyarthritis in HTLV-1-infected patients. A review of 17 cases.
Clustering and clinical diversity of adult T-cell leukemia/lymphoma associated with HTLV-I in a remote black population of French Guiana.
Backward bifurcation in a model for HTLV-I infection of CD4+ T cells.
HTLV-1 associated myelopathy after renal transplantation.
Viral gene expression and pathogenesis in three emerging diseases: HIV and AIDS; HTLV-I and HAM/TSP; and HHV-8 and Kaposi's sarcoma.
HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation.
Muscle MRI findings of HTLV-1-associated myelopathy.
Resistance of CD4-positive T lymphocytes to etoposide-induced apoptosis mediated by upregulation of Bcl-xL expression in patients with HTLV-I-associated myelopathy.
High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells.
High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells.
Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.
MR imaging of the brain in myelopathy associated with human T-cell lymphotropic virus type I.
Clinical spectrum of HTLV-I in south Florida.
Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol.
Myelopathy among Brazilians coinfected with human T-cell lymphotropic virus type I and HIV.
Quantitative in situ PCR assay of HTLV-1 infected cells in peripheral blood lymphocytes of patients with ATL, HAM/TSP and asymptomatic carriers.
Limited sequence divergence of HTLV-I of Indian HAM/TSP patients from a prototype Japanese isolate.
The effect of rolipram on the production of cytokines in HTLV-I infected cell lines and peripheral blood mononuclear cells of patients with HTLV-I-associated myelopathy (HAM).
Micturitional disturbance in human T-lymphotropic virus type-1-associated myelopathy.
Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy.
Reduced Foxp3 expression with increased cytomegalovirus-specific CTL in HTLV-I-associated myelopathy.
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.
Serum antibodies to HTLV-I in Thai patients with chronic progressive myelopathy, multiple sclerosis, myopathy and in HIV-seropositive intravenous drug abusers.
Polymerase chain reaction (PCR) amplification demonstrates the absence of human T-cell lymphotrophic virus (HTLV)-I specific pol sequences in peripheral T-cell lymphomas.
Serological confirmation of human T-lymphotropic virus type I infection in healthy blood and plasma donors.
Transfusion-associated transmission of human T-lymphotropic virus types I and II: experience of a regional blood center.
Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals.
Immunohistochemical characteristics of polymyositis in patients with HTLV-I-associated myelopathy and HTLV-I carriers.
Factors associated with pain in individuals infected by human T-cell lymphotropic virus type 1 (HTLV-1).
Transcriptional activator Tax of HTLV-1 binds to the NF-kappa B precursor p105.
Proviral load determination of HTLV-1 and HTLV-2 in patients' peripheral blood mononuclear cells by real-time PCR.
Experience of human lymphotropic virus type I (HTLV-I) in an East London hospital.
High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy.
Interest of LQAS method in a survey of HTLV-I infection in Benin (West Africa).
Intrafamilial clustering and 4-year follow-up of asymptomatic human T-cell leukaemia virus type I (HTLV-I) infection in Benin (West Africa).
Human T cell lymphotropic virus type 1 in Zimbabwe.
MRI contributes to the differentiation between MS and HTLV-I associated myelopathy in British Columbian coastal natives.
Familial transmission of human T-lymphotropic virus type 1 (HTLV-1) in patients with adult T-cell leukemia/lymphoma or HTLV-1-associated myelopathy.
Alpha interferon restricts human T-lymphotropic virus type 1 and 2 de novo infection through PKR activation.
Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
Pathogenesis of chronic progressive myelopathy associated with human T-cell lymphotropic virus type I.
HTLV-I DNA sequences in CNS tissue of a patient with tropical spastic paraparesis and HTLV-I-associated myelopathy.
Characterization of T cells transmigrating through human endothelial cells in patients with HTLV-I-associated myelopathy.
Characterization of adherent T cells to human endothelial cells in patients with HTLV-I-associated myelopathy.
Increased adherence of T cells to human endothelial cells in patients with human T-cell lymphotropic virus type I-associated myelopathy.
Mechanism of inhibitory effect of dextran sulfate and heparin on human T-cell lymphotropic virus type I (HTLV-I)-induced syncytium formation in vitro: role of cell-to-cell contact.
Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.
Reflux of HTLV-I infected lymphocytes from the privileged compartment(s) to peripheral blood flow in patients with HTLV-I-associated myelopathy.
Anti-viral and immunomodulatory effects of interferon-alpha on cultured lymphocytes from patients with human T lymphotropic virus type I-associated myelopathy (HAM/TSP).
Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP): recent perspectives.
Lack of anti-Coxiella burnetii seropositivity in patients with HTLV-I-associated myelopathy.
An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP.
Activated T lymphocytes in cerebrospinal fluid of patients with HTLV-I-associated myelopathy (HAM/TSP).
Asymptomatic primary biliary cirrhosis in HTLV-I-associated myelopathy.
Selective matrix metalloproteinase inhibitor, N-biphenyl sulfonyl phenylalanine hydroxamic acid, inhibits the migration of CD4+ T lymphocytes in patients with HTLV-I-associated myelopathy.
Clinical manifestation of human T-cell lymphotropic virus type-I-associated myelopathy and vesicopathy.
Efficacy of donor screening for HTLV-I and the natural history of transfusion-transmitted infection.
Pathological changes in skeletal muscle in HTLV-I-associated myelopathy.
Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy.
HTLV-I associated myelopathy in the northern region of Brazil (Belém-Pará): serological and clinical features of three cases.
Transduction of dominant negative ATF-1 suppresses the pX gene expression in joint fibroblastic cells derived from HTLV-I transgenic rats.
Human T-lymphotropic virus type 1 infection is frequent in rural communities of the southern Andes of Peru.
Alopecia areata possibly induced by autoimmune reaction in a patient with human T-cell lymphotropic virus-1-associated myelopathy.
Widespread active inflammatory lesions in a case of HTLV-I-associated myelopathy lasting 29 years.
Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP).
Characterization of two human lymphoid cell lines producing human T-lymphotropic virus type I (HTLV-I) isolated from patients with HTLV-I-associated myelopathy or encephalopathy.
Neuropathology of HTLV-1-associated myelopathy (HAM/TSP): The 50th Anniversary of Japanese Society of Neuropathology.
Neuropathology of HTLV-1-associated myelopathy (HAM/TSP).
Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial.
Neuropathology of HTLV-I-associated myelopathy--a report of two autopsy cases.
Correlation of HTLV-1 Tax genetic diversity with HTLV-1 associated myelopathy/tropical spastic paraparesis progression and HTLV-1a genotypes in an HTLV-1 endemic region in Argentina.
HTLV-1a tax gene and long terminal repeat sequences from Argentinean strains reveal disagreement with tax restriction fragment length polymorphism subtyping.
Immunopathogenesis of HTLV-I associated neurologic disease: massive latent HTLV-I infection in bone marrow of HAM/TSP patients.
Cellular immune responses to HTLV-I: immunopathogenic role in HTLV-I-associated neurologic disease.
Human T lymphotropic virus, type-I myelopathy: an immunopathologically mediated chronic progressive disease of the central nervous system.
Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis.
HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurological disease.
Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis.
Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis.
HTLV-I-associated myelopathy/tropical spastic paraparesis in the United States.
Triple infection with HIV-1, HTLV-1 and Strongyloides stercoralis, rendering CD4+ T-cell counts a misleading entity.
The risk of tropical spastic paraparesis differs according to ethnic group among HTLV-I carriers in Inongo, Zaire.
The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.
IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease.
In vitro analysis of cell death of spinal oligodendrocytes in a rat model of HTLV-I infection.
Human T-lymphotropic virus type I-associated myelopathy. A case report.
Increased sialyl Lewis(x) antigen-positive cells mediated by HTLV-1 infection in peripheral blood CD4(+) T lymphocytes in patients with HTLV-1-associated myelopathy.
Vascular cell adhesion molecule-1-mediated matrix metalloproteinase-2 induction in peripheral blood T cells is up-regulated in patients with HTLV-I-associated myelopathy.
Anesthetic considerations in myelopathy associated with human T-cell lymphotropic virus type I (HTLV-I-associated myelopathy: HAM).
Cytotoxic T cell response and expression of the target antigen in HTLV-I infection.
Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells.
Human T lymphotropic virus-1 infection.
HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient.
The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.
Acute human T-lymphotropic virus type 1-associated myelopathy: a clinicopathologic study.
A rat model of human T lymphocyte virus type I (HTLV-I) infection: in situ detection of HTLV-I provirus DNA in microglia/macrophages in affected spinal cords of rats with HTLV-I-induced chronic progressive myeloneuropathy.
Distribution of human T cell lymphotropic virus type 1 (HTLV-1) subtypes in Brazil: genetic characterization of LTR and tax region.
The avidity and lytic efficiency of the CTL response to HTLV-1.
Human T-lymphotropic virus type I (HTLV-I)-specific CD8+ cells accumulate in the lungs of patients infected with HTLV-I with pulmonary involvement.
Predominant expression of Fas ligand mRNA in CD8+ T lymphocytes in patients with HTLV-1 associated myelopathy.
Graves' disease in HTLV-I carriers.
HTLV-I infection in patients with autoimmune thyroiditis (Hashimoto's thyroiditis).
HTLV-I-associated myelopathy (HAM) in Tokushima Prefecture--geographical and clinical studies in an area between endemic and non-endemic areas of HTLV-I infection.
HTLV-I-associated myelopathy (HAM/TSP) with Hashimoto's thyroiditis.
HTLV-I-associated myelopathy with adult T-cell leukemia.
Increased microvessel density in involved organs from patients with HTLV-I associated adult T cell leukemia lymphoma.
The incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type 1 carriers in Japan.
Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia.
Antibodies to human T-cell lymphotropic virus type I (HTLV-I) by particle agglutination (PA) test in Korean blood donors.
Sequence variations in LTR and env regions of HTLV-I do not discriminate between the virus from patients with HTLV-I-associated myelopathy and adult T-cell leukemia.
Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells
Induction of chronic inflammatory arthropathy and mesenchymal tumors in rats infected with HTLV-I.
Sequence heterogeneity of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I-associated myelopathy.
The presence of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Chronic progressive spinocerebellar syndrome associated with antibodies to human T-lymphotropic virus type I: clinico-virological and magnetic resonance imaging studies.
Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.
Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy.
Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy.
Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study.
Immunological studies of HTLV-I associated myelopathy.
Human CD4+ T lymphocytes recognize a highly conserved epitope of human T lymphotropic virus type 1 (HTLV-1) env gp21 restricted by HLA DRB1*0101.
Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.
Specificity of intrathecal IgG synthesis for HTLV-1 core and envelope proteins in HAM/TSP.
Differential diagnosis of HTLV-I-associated myelopathy and multiple sclerosis in Iranian patients.
The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy.
Increased osteopontin expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patient cells is associated with IL-17 expression.
Dendritic cells in HIV-1 and HTLV-1 infection.
Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (H
Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease.
Human T-cell lymphotropic virus type-I associated myelopathy complicated by optic neuritis.
Voiding dysfunction in patients with human T-lymphotropic-virus-type-1-associated myelopathy.
Human T-cell lymphotropic virus type 1-associated myelopathy, Sjögren syndrome, and lymphocytic pneumonitis.
HTLV-I and chronic nervous diseases: present status and a look into the future.
In vitro infection of human macrophages by human T-cell leukemia/lymphotropic virus type I (HTLV-I).
Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica.
Genetic stability of human T lymphotropic virus type I despite antiviral pressures by CTLs.
Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP).
Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM/TSP patient.
Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
An altered peptide ligand antagonizes antigen-specific T cells of patients with human T lymphotropic virus type I-associated neurological disease.
HTLV-I specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals.
Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy.
Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy.
Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells.
Evaluation of autonomic malfunction in HTLV-1 associated myelopathy (HAM).
In situ demonstration of the HTLV-I genome in the spinal cord of a patient with HTLV-I-associated myelopathy.
Granulocyte-macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy.
Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy.
Development of HTLV-I-associated myelopathy after blood transfusion in a patient with aplastic anemia and a recipient of a renal transplant.
Systemic interferon-alpha in the treatment of HTLV-I-associated myelopathy.
Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin.
Autopsy report of HTLV-I-associated myelopathy presenting with ALS-like manifestations.
Impairment of cell-mediated immune responses in HTLV-I-associated myelopathy.
HTLV-I associated myelopathy (HAM) after blood transfusion in a patient with CD2+ hairy cell leukemia.
HTLV-1-associated myelopathy/tropical spastic paraparesis-like rats by intravenous injection of HTLV-1-producing rabbit or human T-cell line into adult WKA rats.
Human T lymphotropic virus type I associated myelopathy with pulmonary and cutaneous lesions.
HTLV-I-associated infective dermatitis: past, present, and future.
HTLV-I, infective dermatitis, and tropical spastic paraparesis.
HLA DRB1*DQB1* haplotype in HTLV-I-associated familial infective dermatitis may predict development of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Tropical spastic paraparesis occurring in HTLV-1 associated infective dermatitis. Report of two cases.
Comparative biological responses of rabbits infected with human T-lymphotropic virus type I isolates from patients with lymphoproliferative and neurodegenerative disease.
Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy.
Isotypic and IgG subclass restriction of the humoral immune responses to human T-lymphotropic virus type-I.
The Changing Epidemiology of Human T-Cell Lymphotropic Virus Type 1 Infection in Peruvian Female Sex Workers, 1993-2010.
Human T-cell leukemia virus type I (HTLV-I) and blood transfusion.
A critical role for IL-17RB signaling in HTLV-1 tax-induced NF-κB activation and T-cell transformation.
Demographic factors associated with HTLV-1 infection in a Gabonese community.
Decreased survival of HTLV-I carriers in leprosy patients from the Democratic Republic of the Congo: a historical prospective study.
Differential serological diagnosis of HTLV-I and HTLV-II infection by external membrane protein peptide-based enzyme immunoassays.
T-cell lymphoma, tropical spastic paraparesis, and malignant fibrous histiocytoma in a patient with human T-cell lymphotropic virus, type 1.
Cross-reactive antibodies to target proteins are dependent upon oligomannose glycosylated epitopes in HTLV-1 associated neurological disease.
HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): A comparative study to identify factors that influence disease progression.
Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry.
Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.
Induction of HLA class II in HTLV-I infected neuronal cell lines.
Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization.
Peripheral neuropathy in HTLV-I infected individuals without tropical spastic paraparesis/HTLV-I-associated myelopathy.
Neurological manifestations in HTLV-I-infected blood donors.
Dermatological findings of human T lymphotropic virus type 1 (HTLV-I)-associated myelopathy/tropical spastic paraparesis.
Multiple sclerosis and HTLV-I associated myelopathy/tropical spastic paraparesis are two distinct clinical entities.
Clinical neurophysiological comparative study on HTLV-1 associated myelopathy/tropical spastic paraparesis.
Contralateral early blink reflex in patients with HTLV-I associated myelopathy/tropical spastic paraparesis.
HTLV-1 and myelopathy in Salvador (northeastern Brazil): a case control study.
Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry.
Localization of retrovirus in the central nervous system of a patient co-infected with HTLV-1 and HIV with HAM/TSP and HIV-associated dementia.
Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease.
Cellular and humoral immune responses associated with HTLV-I associated myelopathy/tropical spastic paraparesis.
HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system.
Geographic distribution of HTLV-I and identification of a new high-risk population.
The epidemiology of diseases associated with HTLV-I and HTLV-II.
Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients.
Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?
Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers.
Immunological abnormalities in HTLV-I-associated myelopathy: spontaneous release of interleukin-2 and interleukin-2 receptor by peripheral blood lymphocytes.
Ultrastructural pathology of human T-cell lymphotropic virus type I encephalomyelopathy in a white patient with adult T-cell leukemia/lymphoma.
HTLV-I-like viral particles in spinal cord cells in Jamaican tropical spastic paraparesis.
Urodynamic alterations in patients with HTLV-1 infection.
Schistosoma antigens downregulate CXCL9 production by PBMC of HTLV-1-infected individuals.
Schistosoma antigens downmodulate the in vitro inflammatory response in individuals infected with human T cell lymphotropic virus type 1.
Subacute progression of human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Subtyping of human T-lymphotropic virus type I by amplification of long terminal repeat sequences and restriction fragment length polymorphism analysis in carriers with multiple transfusions.
Chronic progressive myelopathy associated with HTLV-I: oligoclonal IgG and anti-HTLV-I IgG antibodies in cerebrospinal fluid and serum.
Oral health profile in patients infected with HTLV-1: clinical findings, proviral load, and molecular analysis from HTLV-1 in saliva.
Familial transmission and minimal sequence variability of human T-lymphotropic virus type I (HTLV-I) in Zaire.
The pyrimidine analog FNC inhibits cell proliferation and viral protein synthesis in HTLV‑1‑infected cells.
Design of new potent HTLV-1 protease inhibitors: in silico study
Primary brain T-cell lymphoma in an HTLV-1 serologically positive male.
Seroindeterminate HTLV-1 prevalence and characteristics in blood donors in Taiwan.
Intrafamilial transmission and risk assessment of HTLV-I among blood donors in southern Taiwan.
A novel therapeutic molecule against HTLV-1 infection targeting provirus.
Relationship between anti-Tax antibody responses and cocultivatable virus in HTLV-I-infected rabbits.
Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation.
Correlation between P19 presence and MHC class II expression in human fetal astroglial cells cocultured with HTLV-I donor cells.
In vitro virus propagation and high cellular responsiveness to the infected cells in patients with HTLV-I-associated myelopathy (HAM/TSP).
Human T-cell lymphotropic virus types I and II infections in a cohort of patients with neurological disorders in Belém, Pará, Brazil.
Antibody to human and simian retrovirus, HTLV-I, HTLV-II, HIV, STLV-III, and SRV-I not increased in patients with multiple sclerosis.
Association of CD40 ligand expression on HTLV-I-infected T cells and maturation of dendritic cells.
The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis.
An expression of anaplastic large cell lymphoma-associated antigens on HTLV-I-infected CD4+ T cells.
Microtubule proteins and their post-translational forms in the cerebrospinal fluid of patients with paraparesis associated with HTLV-I infection and in SH-SY5Y cells: an in vitro model of HTLV-I-induced disease.
Central nervous system activation of the indoleamine-2,3-dioxygenase pathway in human T cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad.
Expression of HTLV-1 Genes in T-Cells Using RNA Electroporation.
Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection.
Human leukocyte antigen class II alleles associated with human T-cell lymphotropic virus type I infection and adult T-cell leukemia/lymphoma in a Black population.
Viral-specific humoral immune responses following transfusion-related transmission of human T cell lymphotropic virus type-I infection.
Sequence analysis of human T cell lymphotropic virus type I (HTLV-I) Env genes amplified from central nervous system tissues of patients with HTLV-I-associated myelopathy or leukemia.
Induction of CC-chemokines with antiviral function in macrophages by the human T lymphotropic virus type 2 transactivating protein, Tax2
Activation of interleukin-2 receptor alpha expression by extracellular HTLV-I Tax1 protein: a potential role in HTLV-I pathogenesis.
Soluble HTLV-I Tax1 protein stimulates proliferation of human peripheral blood lymphocytes.
Polymerase chain reaction analysis for specific HTLV-1 sequences from cerebrospinal fluid and peripheral blood cells in Sardinian multiple sclerosis patients.
The combination of IκB kinase β inhibitor and everolimus modulates expression of interleukin-10 in human T-cell lymphotropic virus type-1-infected T cells.
A 15-year prospective longitudinal study of disease progression in patients with HTLV-1 associated myelopathy in the UK.
Human T-lymphotropic virus type I and II infections in First Nations alcohol and drug treatment centres in British Columbia, Canada, 1992-2000.
Transcytosis of HTLV-1 across a tight human epithelial barrier and infection of subepithelial dendritic cells.
Antibody against EBV in CSF from HIV-1 and HTLV-I infected patients.
Quality of life in patients with HTLV-I associated myelopathy/tropical spastic paraparesis.
Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease?
Frequency of p12K and p12R alleles of HTLV Type 1 in HAM/TSP patients and in asymptomatic HTLV type 1 carriers.
Cell-cell transmission allows human T-lymphotropic virus 1 to circumvent tetherin restriction.
A case report of progressive multifocal leukoencephalopathy in a human T-cell lymphotropic virus type 1-infected hemodialytic patient.
Increased levels of soluble vascular cell adhesion molecule-1 (VCAM-1) in the cerebrospinal fluid and sera of patients with multiple sclerosis and human T lymphotropic virus type-1-associated myelopathy.
Spontaneous T cell proliferation and release of soluble interleukin-2 receptors in patients with HTLV-I-associated myelopathy.
Plasmapheresis to treat human T lymphotropic virus type I-associated myelopathy.
Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy/tropical spastic paraparesis: double staining of immunohistochemistry and polymerase chain reaction in situ hybridization.
Dynamic acquisition of HTLV-1 tax protein by mononuclear phagocytes: Role in neurologic disease.
Inclusion body myositis associated with human T-lymphotropic virus-type I infection: eleven patients from an endemic area in Japan.
A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis.
HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years.
HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations.
A new HTLV type II subtype A isolate in an HIV type 1-infected prostitute from Cameroon, Central Africa.
Demographic, ethnic, and geographic differences between human T cell lymphotropic virus (HTLV) type I-seropositive carriers and persons with HTLV-I Gag-indeterminate Western blots in Central Africa.
Association between onychodystrophy and human T-lymphotropic virus type 1 infection.
Steroid-responsive myeloneuropathy in a man dually infected with HIV-1 and HTLV-I.
Immune responses to HTLV-I(ACH) during acute infection of pig-tailed macaques.
HTLV-I-associated myelopathy endemic in Texas-born residents and isolation of virus from CSF cells.
Isolation and characterization of HTLV-I from symptomatic family members with tropical spastic paraparesis (HTLV-I encephalomyeloneuropathy).
Tax secretion from peripheral blood mononuclear cells and Tax detection in plasma of patients with human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis and asymptomatic carriers.
HTLV-I associated myelopathy in Salvador (northeastern Brazil).
Antibody to heat shock protein 70 (HSP70) inhibits human T-cell lymphoptropic virus type I (HTLV-I) production by transformed rabbit T-cell lines.
HTLV-1 infection in a population-based cohort of older persons in Guinea-Bissau, West Africa: risk factors and impact on survival.
Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors.
Magnetic resonance imaging in HTLV-I associated myelopathy.
Danazol. A new perspective in the treatment of HTLV-1 associated myelopathy (preliminary report).
Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Tuberculous meningoencephalomyelitis and coinfection with HTLV-I + HTLV-II: case report.
HTLV-I associated myelopathy in Porto Alegre (Southern Brazil).
Failure to detect genomic material of HTLV-I or HTLV-II in mononuclear cells of Italian patients with multiple sclerosis and chronic progressive myelopathy.
Is myelopathy of unknown origin related with tropical spastic paraparesis and myelopathy associated with human T cell lymphotropic virus type I?
Low prevalence of human immunodeficiency virus-1 (HIV-1), HIV-2, and human T cell lymphotropic virus-1 infection in Somalia.
Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies).
A description of human T-lymphotropic virus type I-related chronic interstitial keratitis in 20 patients.
Sicca syndrome and HTLV-I-associated myelopathy/tropical spastic paraparesis.
Ocular manifestations in patients with HTLV-I associated infection--a clinical study of 93 cases.
Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.
Transmission of HTLV-I to rats via peripheral blood mononuclear cells and serum from a patient with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) with amyotrophic lateral sclerosis (ALS)-like features.
Neutralizing antibodies against HTLV-I in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients and asymptomatic carriers.
Transmission of human T-cell leukemia virus type I from a patient with HTLV-I associated myelopathy/tropical spastic paraparesis and an asymptomatic carrier to rabbits.
Activated T cells in HTLV-I-associated myelopathy: autologous mixed lymphocyte reaction.
Successful immunosuppressive therapy for HTLV-I associated myelopathy.
Increased human T lymphotropic virus type-1 (HTLV-1) proviral DNA in peripheral blood mononuclear cells and bronchoalveolar lavage cells from Japanese patients with HTLV-1-associated myelopathy.
Pathogenesis and prevention of HTLV-1-associated diseases.
Detection of Epstein-Barr virus and human T-cell lymphotropic virus type 1 in malignant nodal lymphoma, studied in Okinawa, a subtropical area in Japan.
Absence of HTLV-II co-infection in HTLV-I-associated myelopathy patients.
Autonomous proliferation of HTLV-CD4+ T cell clones derived from human T cell leukemia virus type I (HTLV-I)-associated myelopathy patients.
A high prevalence of human T-lymphotropic virus type I carriers in patients with antithyroid antibodies.
Postpartum exacerbation of HTLV-I associated myelopathy/tropical spastic paraparesis followed by an episode of painless thyroiditis.
A neuropathological study of paraparetic rats injected with HTLV-I-producing T cells.
HTLV-I uveitis.
Modulatory effects of curcumin on apoptosis and cytotoxicity-related molecules in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.
Measuring incidence of HTLV-1: the other human retrovirus.
High production of RANTES and MIP-1alpha in the tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells.
HTLV-1-associated myelopathy in a solid organ transplant recipient.
The epidemiology of myelopathy associated with human T-lymphotropic virus 1.
HTLV-1 and tropical spastic paraparesis. 1. Clinical features, pathology and epidemiology.
HTLV-I and cancers in tropical countries.
HTLV-I associated tropical spastic paraparesis. Cerebral spinal fluid evolutive aspects in 128 cases.
Evidence of preferential female prevalence of HTLV-I associated tropical spastic paraparesis in Bahia-Brazil.
HTLV-1 and polymyositis in Jamaica.
Prevention of mother-to-child transmission of human T-lymphotropic virus type-I.
Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells.
Prevalence of HTLV-1 antibodies in hemodialysis patients in Japan.
Study of lower limb somatosensory evoked potentials in 96 cases of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes.
HTLV type I Tax activation of the CXCR4 promoter by association with nuclear respiratory factor 1.
Human T-lymphotropic virus (HTLV I-II) infection among patients in an inner-city emergency department.
High level of HTLV-I specific protein expression in a patient with adult T-cell leukemia, chronic progressive myelopathy and Kaposi's sarcoma.
Epidemiology of human T-cell leukaemia/lymphoma virus type 1 (HTLV-1) infections in a subpopulation of Afro-Caribbean origin in England.
HTLV-I infections in French Guiana as monitored by western-blot, dot-blot and PCR techniques.
Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM/TSP patients and HTLV-I carriers.
Nucleotide sequence analysis of HTLV-I isolated from cerebrospinal fluid of a patient with TSP/HAM: comparison to other HTLV-I isolates.
IgG autoantibody response in HTLV-I-infected patients.
Short Communication: Failures in Detecting HTLV-1 and HTLV-2 in Patients Infected with HIV-1.
Seroepidemiological survey of HTLV-I infection among randomized populations of western central African countries.
Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II- and I-infected blood donors. Retrovirus Epidemiology Donor Study.
HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators.
Health effects of human T-lymphotropic virus type I (HTLV-I) in a Jamaican cohort.
Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I.
HTLV-I-associated leukemia: a model for chronic retroviral diseases.
Cerebrospinal fluid neopterin, but not osteopontin, is a valuable biomarker for the treatment response in patients with HTLV-I-associated myelopathy.
Pathogenesis and treatment of human T-cell lymphotropic virus Type I-associated myelopathy.
CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I.
Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP.
Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.
Differential effect of TGF-beta 1 on the in vitro activation of HTLV-I and the proliferative response of CD8+ T lymphocytes in patients with HTLV-I-associated myelopathy (HAM/TSP).
Heparin treatment in patients with human T-lymphotropic virus type I (HTLV-I)-associated myelopathy: a preliminary study.
Active production of anti-human T-lymphotropic virus type I (HTLV-I) IgM antibody in HTLV-I-associated myelopathy.
Presence of serum anti-human T-lymphotropic virus type I (HTLV-I) IgM antibodies means persistent active replication of HTLV-I in HTLV-I-associated myelopathy.
Epidemiology of HTLV-I in Gabon (Western Equatorial Africa).
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.
HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings.
HTLV-1 associated myelopathy in an HTLV-1 and HBV double carrier family: report of a case and the mode of vertical transmission of both viruses.
Relationship between Sjögren's syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients.
Increase of peripheral B lymphocytes committed to the production of monoreactive and high affinity antibodies to HTLV-1 in patients with HAM/TSP.
Elevated antibodies to synthetic peptides of HTLV-1 envelope transmembrane glycoproteins in patients with HAM/TSP.
Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy.
Pentosan polysulfate treatment ameliorates motor function with increased serum soluble vascular cell adhesion molecule-1 in HTLV-1-associated neurologic disease.
Spontaneous proliferation of and cytokine production by T cells adherent to human endothelial cells in patients with human T-lymphotropic virus type I-associated myelopathy.
The efficacy of interferon-alpha treatment in human T-lymphotropic virus type-I-associated myelopathy.
Comparative molecular analysis of HTLV-I proviral DNA in HTLV-I infected members of a family with a discordant HTLV-I-associated myelopathy in monozygotic twins.
Systemic diseases in patients with HTLV-1-associated uveitis.
Pigmentary retinal degeneration in patients with HTLV-I-associated myelopathy.
Noninfectious anterior uveitis in patients infected with human T-lymphotropic virus type I.
HTLV-I-associated myelopathy manifested after renal transplantation.
Amplification of HTLV-1-related sequences among patients with neurological disorders in highly endemic Nagasaki: lack of evidence for association of HTLV-1 with multiple sclerosis.
Post-mortem diagnosis of human T lymphotrophic virus type-1 (HTLV-1) associated myelopathy by detection of HTLV-1 DNA in the spinal cord of a patient with post-transfusional myelopathy.
Multiple clinical manifestation of HTLV1 infection in a single patient.
CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.
Plasma exchange for the treatment of human T-cell lymphotropic virus type 1 associated myelopathy.
Monocytes from HTLV-1-infected patients are unable to fully mature into dendritic cells.
Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.
FK506 and cyclosporin a regulate proliferation and proto-oncogene expression in HTLV-1-associated myelopathy/tropical-spastic-paraparesis-derived T cells.
Human T-lymphotropic virus type I DNA in spinal cord of tropical spastic paraparesis with concomitant human T-lymphotropic virus type I-negative Hodgkin's disease.
Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.
IL17A Polymorphism Is Not Associated with Human T-Lymphotropic Virus 1-Associated Myelopathy/Tropical Spastic Paraparesis.
Human T-cell lymphotropic virus type I in Iranian-born Mashhadi Jews: genetic and phylogenetic evidence for common source of infection.
Genetic and phylogenetic analyses of human T-cell lymphotropic virus type I variants from Melanesians with and without spastic myelopathy.
Sequence analysis of human T cell lymphotropic virus type I strains from southern India: gene amplification and direct sequencing from whole blood blotted onto filter paper.
Characteristics of Chronic Pain and Its Impact on Quality of Life of Patients With HTLV-1-associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Comparison of HTLV-I basal transcription and expression of CREB/ATF-1/CREM family members in peripheral blood mononuclear cells and Jurkat T cells.
Antibody to human T-lymphotropic virus type 1 in West-Indian-born UK residents with spastic paraparesis.
Design and synthesis of several small-size HTLV-I protease inhibitors with different hydrophilicity profiles.
Truncation and non-natural amino acid substitution studies on HTLV-I protease hexapeptidic inhibitors.
Upregulation of hsa-miR-125b in HTLV-1 asymptomatic carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis patients.
Establishment of HTLV-I-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particles.
Cerebrospinal fluid of HTLV-1 associated myelopathy patients induces axonal sproutings and Schwann cell proliferation in the rat sciatic nerve.
Evolution in a chronic RNA virus infection: selection on HTLV-I tax protein differs between healthy carriers and patients with tropical spastic paraparesis.
Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy.
Human T lymphotropic virus type I (HTLV-I)-specific T helper cell responses from HTLV-I seronegative patients with chronic myelopathy and MS in Japan.
Demonstration of human T lymphotropic virus type I (HTLV-I)-specific T cell responses from seronegative and polymerase chain reaction-negative persons exposed to HTLV-I.
Demonstration of human T-cell lymphotropic virus type I (HTLV-I) from an HTLV-I seronegative south Indian patient with chronic, progressive spastic paraparesis.
Sequence comparisons of HTLV-I from HAM/TSP patients and their asymptomatic spouses.
Analysis of the provirus genome integrated in T cell lines established from the cerebrospinal fluid of patients with human T lymphotropic virus type I-associated myelopathy (HAM).
A possible association between HLA and HTLV-I-associated myelopathy (HAM) in Japanese.
Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Increased mRNA expression of Th1-cytokine signaling molecules in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Increased Fas-mediated cytotoxicity of CD4-positive T cells in patients with human T-lymphotropic virus type I-associated myelopathy.
Increased production of inflammatory cytokines in cultured CD4+ cells from patients with HTLV-I-associated myelopathy.
Antiproliferative factor against the human glioblastoma cell line T98G identified in culture supernatants of CD4+ cells from patients with HTLV-I-associated myelopathy.
Depression of evoked electromyographic (EEMG) responses by propofol in a patient with human T-cell lymphotropic virus type I-associated myelopathy (HAM).
Dermatological findings in 3 generations of a family with a high prevalence of human T cell lymphotropic virus type 1 infection in Brazil.
Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease.
Novel complications with HTLV-1-associated myelopathy/tropical spastic paraparesis: interstitial cystitis and persistent prostatitis.
Neopterin in cerebrospinal fluid: a useful marker for diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and p
Modulation of glutathione intracellular levels alters the spontaneous proliferation of lymphocyte from HTLV-1 infected patients.
Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I/II) in Gabon: a prospective follow-up of 4 years.
Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis.
HTLV-1 in mouthwash cells from a TSP/HAM patient and asymptomatic carriers.
HTLV-I associated myelopathy: a case of viral-induced auto-immunity.
Demyelination and ethnicity: experience at the University of British Columbia Multiple Sclerosis Clinic with special reference to HTLV-I-associated myelopathy in British Columbian natives.
HTLV-I associated myelopathy: an endemic disease of Canadian aboriginals of the Northwest Pacific coast?
Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 Infection.
Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease.
Search for human T-cell leukemia virus type I (HTLV-I) proviral sequences by polymerase chain reaction in the central nervous system tissue of HTLV-I-associated myelopathy.
HTLV-I associated retinochoroidal degeneration.
Ocular manifestations in patients infected with human T-lymphotropic virus type I.
Interleukin-6 in cerebrospinal fluid of HTLV-I-associated myelopathy.
Circadian rhythms of blood pressure and heart rate in patients with human T-lymphotropic virus type-I-associated myelopathy.
Invasion of histiocytic sarcoma into the spinal cord of HTLV-1 tax transgenic mice with HTLV-1-associated myelopathy/tropical spastic paraparesis-like disease.
Detection of myelin basic protein in cerebrospinal fluid and serum from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Human T-lymphocyte virus type I (HTLV-I)-induced myeloneuropathy in rats: oligodendrocytes undergo apoptosis in the presence of HTLV-I.
HTLV-I induced myeloneuropathy in WKAH rats: apoptosis and local activation of the HTLV-I pX and TNF-alpha genes implicated in the pathogenesis.
Human T-lymphotropic virus type I associated myelopathy treated effectively with lymphocytapheresis using a leukocyte removal filter.
A carrier of human T-lymphotropic virus type I with periodic limb movements progressing to myelopathy.
Co-presentation of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis and adult-onset infective dermatitis associated with HTLV-1 infection.
Patterns of in vitro lymphoproliferative responses among HTLV-1-infected subjects: upregulation by HTLV-1 during HIV-1 co-infection.
Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.
Detection of HTLV-I antibodies and DNA in blood sample of a patient with myelopathy in Nigeria.
Evolution of HTLV-1 proviral load in patients from Salvador, Brazil.
Neuromyelitis optica associated with subacute human T-lymphotropic virus type 1 infection.
Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study.
HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression.
Risk Factors for Erectile Dysfunction in Men With HTLV-1.
Erectile insufficiency as first symptom of HTLV I/II associated myelopathy. Case report.
Infective dermatitis associated with the human T cell lymphotropic virus type I in Salvador, Bahia, Brazil.
Early Onset of HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) and Adult T-cell Leukemia/Lymphoma (ATL): Systematic Search and Review.
Recent studies on the epidemiology, clinical features and pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other diseases associated to HTLV.
HTLV-I associated myelopathy (HAM): review and recent studies.
Benign monoclonal T cell proliferation in HTLV-I infection.
Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion.
The history of discovery and clinico-epidemiology of HTLV-I-associated myelopathy(HAM).
A human T-cell lymphotropic virus type-I carrier with chronic renal failure, aplastic anemia, myelopathy, uveitis, Sjögren's syndrome and panniculitis.
Human T-cell lymphotropic virus type 1: is it time to screen organ donors and recipients?
Development of Graves' ophthalmopathy and uveitis after radioiodine therapy for Graves' disease in a patient with HTLV-I associated myelopathy (HAM).
Severe demyelinating myelopathy with low human T cell lymphotropic virus type 1 expression after transfusion in an immunosuppressed patient.
Limited sequence variation in human T-lymphotropic virus type 1 isolates from North American and African patients.
High risk of heterosexual transmission of human T-cell lymphotropic virus type 1 infection in Brazil.
A case of HTLV-I associated myelopathy(HAM) in Korea.
Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.
Type-I HTLV antibody in urban and rural Ghana, West Africa.
Absence of HTLV-1/2 infection and dermatological diseases in Manaus, State of Amazonas, Brazil.
A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitope.
The prevalence and clinical associations of HTLV-1 infection in a remote Indigenous community.
Human T-cell lymphotropic virus type I (HTLV-I) confirmed by PCR-Southern blot and sequencing analysis in a woman with tropical spastic paraparesis.
Changes in T cell phenotype and activated MAPKs are correlated to impaired cellular responses to antigens and glucocorticoids during HTLV-I infection.
Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1.
HTLV-I associated uveitis, myelopathy, rheumatoid arthritis and Sjögren's syndrome.
Physalin F, a seco-steroid from Physalis angulata L., has immunosuppressive activity in peripheral blood mononuclear cells from patients with HTLV1-associated myelopathy.
In vivo production of Rof and Tof proteins of HTLV type 1: evidence from cytotoxic T lymphocytes.
Functional comparison between HTLV-I envelopes originating from TSP/HAM or ATL cell lines.
IL-2-dependent HTLV-I-infected T cells escape from non-specific, MHC-unrestricted cellular cytotoxicity.
Complement-dependent cytotoxic antibodies to human T lymphotropic virus type I (HTLV-I)-infected cells in the sera of HTLV-I-infected individuals.
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis hypothesis. A shift of homologous peptides pairs, central nervous system (CNS)/HTLF-1, HTLV-1/thymus, thymus/CNS, in a thymus-like CNS environment, underlies the pathog
Adult T-cell leukemia/lymphoma and cluster of HTLV-I associated diseases in Brazilian settings.
Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Clinical and epidemiological aspects of HTLV-II infection in São Paulo, Brazil: presence of tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM) simile diagnosis in HIV-1-co-infected subjects.
Pathological and molecular biological features of a myelopathy associated with HTLV-1 infection.
HTLV-1 associated myelopathy in Canada.
Nucleoprotein Diet Ameliorates Arthritis Symptoms in Mice Transgenic for Human T-Cell Leukemia Virus Type I (HTLV-1)
Cardiovascular risk profile in patients with myelopathy associated with HTLV-1.
Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
Psychogenic movement disorder in human T-lymphotropic virus type 1 associated myelopathy.
Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
Parkinsonism in the course of HTLV-I-associated myelopathy.
Pathological and virological assessment of acute HTLV-I-associated myelopathy complicated with encephalopathy and systemic inflammation.
Diagnosis of HAM/TSP based on CSF proviral HTLV-I DNA and HTLV-I antibody index.
An inverse correlation of HTLV-I viral load in CSF and intrathecal synthesis of HTLV-I antibodies in TSP/HAM.
A soluble form of tumour necrosis factor receptor in cerebrospinal fluid and serum of HTLV-I-associated myelopathy and other neurological diseases.
HTLV-I associated myelopathy in patients from Brazil and Iran: neurological manifestations and cerebrospinal fluid findings.
The value of CSF analysis for the differential diagnosis of HTLV-I associated myelopathy and multiple sclerosis.
Altered expression of CXCR3 and CCR6 and their ligands in HTLV-1 carriers and HAM/TSP patients.
The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran.
Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection.
Association of a novel single nucleotide polymorphism in the human perforin gene with the outcome of HTLV-I infection in patients from northeast Iran (Mash-had).
Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
In vivo fluctuation of Tax, Foxp3, CTLA-4, and GITR mRNA expression in CD4(+)CD25(+) T cells of patients with human T-lymphotropic virus type 1-associated myelopathy.
Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
In vitro cytoskeleton changes of mouse neurons induced by purified HTLV-1, and PBMC from HAM/TSP patients and HTLV-1 carriers.
Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in seronegative tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM) patients.
Genetic characterization and phylogeny of human T-cell lymphotropic virus type I from Chile.
Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users.
No evidence for true HTLV-I or HIV-1 antibodies in Finnish Lapps.
Ocular lesions in HTLV-1 infected patients from Salvador, State of Bahia: the city with the highest prevalence of this infection in Brazil.
Presence of human T lymphotropic virus types I and II in Ghana, west Africa.
Human T-cell lymphotropic virus type I (HTLV-I) seroepidemiology and risk factors in metropolitan Panamá.
HTLV-I-associated myelopathy: are ferritin, S100beta protein, or guanine nucleotides CSF markers of disease?
Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long Terminal Repeat 5' Region from Patients with Tropical Spastic Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy and Asymptomatic Carriers.
Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2.
Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome.
Nucleotide sequences of human T-lymphotropic virus type I (HTLV-I) from a family cluster with tropical spastic paraparesis/HTLV-I-associated myelopathy.
Presence of human T lymphotropic virus type I in two patients with progressive myelopathy in Puerto Rico.
Prevalence of human T-cell lymphotropic virus I and II in Colombian blood donors, 2001-2014: Implications for transfusion safety.
Absence of antibody to HTLV I and III in sera of Canadian patients with multiple sclerosis and chronic myelopathy.
Design and development of a quantitative real time PCR assay for monitoring of HTLV-1 provirus in whole blood.
Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection.
The role of HTLV-I in tropical spastic paraparesis in Jamaica.
Tropical spastic paraparesis/HTLV-I associated myelopathy. Etiology and clinical spectrum.
Human T-lymphotropic virus type I: A retrovirus causing chronic myeloneuropathies in tropical and temperate climates.
Demographic characteristics of retroviral infections (HIV-1, HIV-2, and HTLV-I) among female professional sex workers in Lagos, Nigeria.
Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
Human T-lymphotropic virus type I antibodies in the serum of patients with tropical spastic paraparesis in the Seychelles.
Human T-lymphotropic virus type I-associated myelopathy in patients with the acquired immunodeficiency syndrome.
Interleukin-6 production in "normal" and HTLV-1 tax-expressing brain-specific endothelial cells.
Efficient transfer of HTLV-1 tax gene in various primary and immortalized cells using a flap lentiviral vector.
Tropical spastic paraparesis associated with human T lymphotropic virus type I in an east African naturalised in Sweden.
Elevated levels of iC3b and C4d, but not Bb, complement fragments from plasma of persons infected with human T cell leukemia virus (HTLV) with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease.
Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Prevalence of peripheral neuropathy in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Comparative studies on IL-6 production status in HTLV-1 chronically infected cell lines derived from different HTLV-1 associated pathologies.
Inflammatory lesions of peripheral nerve in a patient with human T-lymphotropic virus type I--associated myelopathy.
The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice.
Increased frequency of CD4+T cells expressing fractalkine receptor CX3CR1 in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), but its AIDS susceptible polymorphisms are not associated with the disease.
Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals.
Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals.
Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.
Increased levels of soluble Fas ligand in CSF of rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis patients.
Mutation rates in LTR of HTLV-1 in HAM/TSP patients and the carriers are similarly high to Tax/Rex-coding sequence.
Frequent mutation in pX region of HTLV-1 is observed in HAM/TSP patients, but is not specifically associated with the central nervous system lesions.
Nucleotide sequence analysis of HTLV-I isolate from a Korean patient with HAM/TSP.
In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: predominant expansion of CD8+ T cells.
Serum levels of apoptosis-related molecules in patients with multiple sclerosis and human T-lymphotropic virus Type I-associated myelopathy.
HTLV-I infection in the Free State region of South Africa: a sero-epidemiologic study.
Human T-lymphotropic virus type I tax polymorphisms in a transmission cohort: no association between sequence variation and disease manifestations.
Human parvovirus 4 prevalence among HTLV-1/2 infected individuals in Brazil.
Activation of LTRs from different human endogenous retrovirus (HERV) families by the HTLV-1 tax protein and T-cell activators.
Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1.
HIV-1, HIV-2, HTLV-I/II and STD among female prostitutes in Buenos Aires, Argentina.
HTLV-I, adult T-cell leukemia, and tropical spastic paraparesis.
An autopsy case of human T lymphotropic virus type I-associated myelopathy (HAM) with a duration of 28 years.
Acute myelopathy and cerebellar signs associated with uveitis with positive serum and cerebrospinal fluid antibodies to HTLV-I.
Induction of cytokines in glial cells by trans activator of human T-cell lymphotropic virus type I.
Osteoporosis in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
No proof of HTLV-I/II in intravenous drug abusers with a high rate of HIV-1 infection in central Thailand.
Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.
Cutaneous T-cell lymphoma, tropical spastic paraparesis, cerebral vasculitis, and protein S deficiency in a patient with HTLV-I.
Identification of human T-lymphotropic virus type I (HTLV-I) subtypes using restricted fragment length polymorphism in a cohort of asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from São Paulo, Braz
Molecular detection and isolation of human T-cell lymphotropic virus type I (HTLV-I) from patients with HAM/TSP in São Paulo, Brazil.
Human T-cell lymphotropic virus type I infects eccrine sweat gland epithelia.
Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis.
HTLV-1-associated myelopathy in China. A disease acquired overseas?
Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase.
Cutaneous and neurologic disease associated with HTLV-I infection.
Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
Activation and regulation of interferon regulatory factor 4 in HTLV type 1-infected T lymphocytes.
High-dose zidovudine induction in HTLV-I-associated myelopathy: safety and possible efficacy.
Human T lymphotropic virus type I-associated myelopathy. A report of 10 patients born in the United States.
Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-
Remarkable increase in CD26-positive T cells in patients with human T lymphotropic virus type I (HTLV-I) associated myelopathy.
Interferon-alpha treatment in HTLV-I-associated myelopathy. Studies of clinical and immunological aspects.
Anti-lymphocyte antibodies and circulating immune complexes in the sera of patients with myelopathy associated with human T lymphotropic virus type-I.
Relationship between the anti-HTLV-1 antibody level, the number of abnormal lymphocytes and the viral-genome dose in HTLV-1-infected individuals.
Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy.
Renal transplantation in patients with human T-cell lymphotropic virus type 1.
Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran.
Possible HLA association with susceptibility to HTLV-1 tropical spastic paraparesis in Israel in Iranian Jews as compared to HTLV 1-associated myelopathy in Japan.
Human T-lymphotropic virus type-1 (HTLV-1) in Israeli patients and their family relatives and its transmission to rats.
Human T-cell lymphotropic virus type 1 provirus and phylogenetic analysis in patients with mycosis fungoides and their family relatives.
Serum total antioxidant capacity status of HTLV-1 infected patients.
HTLV-1 associated adult T-cell leukemia/lymphoma in Israel: report of two patients of Romanian origin.
Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
Recent advances in the molecular biology of HTLV-1: trans-activation of viral and cellular genes.
Expression of the HTLV-1 genome and its association with a unique T-cell malignancy.
Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.
ALS syndrome in HTLV-I infection.
Spinal cord swelling in human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis: magnetic resonance indication for early anti-inflammatory treatment?
Antibody-dependent cell-mediated cytotoxicity: comparison between HTLV-I and HIV-1 assays.
Role of caspase 9 in activation of HTLV-1 LTR expression by DNA damaging agents.
HTLV-I: the forgotten retrovirus.
Human retroviruses: HTLV-I, II, and III and their association with leukemia and AIDS.
The origins of HIV-1 and HTLV-4/HIV-2.
Clinical and molecular parameters of HTLV-I infection.
[Rapidly progressive T-cell angiocentric lymphoma with CD56+ phenotype involving bilateral orbits and skin in a patient with anti-HTLV-I antibody]
Manifestations of human T-lymphotropic virus type I infection.
Infection with HTLV-I and HTLV-II: evolving concepts.
HTLV-I and human disease.
HTLV-I-associated T-cell leukemia/lymphoma in Israel.
Autoantibodies, human T lymphotropic virus type 1 and type 1 diabetes mellitus in Jamaicans.
Recurrent encephalopathy and seizures in a US native with HTLV-I-associated myelopathy/tropical spastic paraparesis: a clinicopathologic study.
HTLV-I-infected T cells evade the antiproliferative action of IFN-beta.
HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease.
HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking.
Immunogenetics of HTLV-I/II and associated diseases.
Epidemiology of HTLV-I infection in Spain. HTLV Spanish Study Group.
Seroprevalence study of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies in Lagos, Nigeria.
Human T-lymphotropic virus type I (HTLV-I)-specific antibodies and cell-free RNA in crevicular fluid-rich saliva from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy.
Association of Tuberculosis Status with Neurologic Disease and Immune Response in HTLV-1 Infection.
Impairment of the humoral and CD4(+) T cell responses in HTLV-1-infected individuals immunized with tetanus toxoid.
Tropical pyomyositis in a patient with systemic lupus erythematosus and HTLV 1/2 infection.
Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study.
HTLV-1 antibodies in serum and cerebrospinal fluid in tropical spastic paraparesis in Brazil.
Human T lymphotropic virus type 1 in a seronegative B chronic lymphocytic leukemia patient.
Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.
Proviral load and the balance of serum cytokines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
The family of human T-lymphotropic leukemia viruses: HTLV-I as the cause of adult T cell leukemia and HTLV-III as the cause of acquired immunodeficiency syndrome.
HTLV-I, the prototype human retrovirus: epidemiologic features.
Anatomical distribution of HTLV-I proviral sequence in an autopsy case of HTLV-I associated myelopathy: a polymerase chain reaction study.
Motor and somatosensory evoked potential findings in HTLV-I associated myelopathy.
Pulmonary involvement in patients with human T lymphotropic virus type 1-associated myelopathy: the presence of specific IgA antibody in bronchoalveolar lavage fluid.
Pulmonary involvement in patients with HTLV-I-associated myelopathy: increased soluble IL-2 receptors in bronchoalveolar lavage fluid.
Clinicopathologic characteristics of the lungs of patients with human T cell lymphotropic virus type 1-associated myelopathy.
Lymphocytic infiltrations in the lung of two autopsy cases with HTLV-I-associated myelopathy.
Age-dependent paraparesis in WKA rats: evaluation of MHC k-haplotype and HTLV-1 infection.
Transmission of lymphotropic retroviruses (HTLV-I and LAV/HTLV-III) by blood transfusion and blood products.
The association of antibodies against human T cell lymphotropic virus type I (HTLV-I) pX gene mutant products with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Differential patterns of interaction between HIV type 1 and HTLV type I in monocyte-derived macrophages cultured in vitro: implications for in vivo coinfection with HIV type 1 and HTLV type I.
Astrocytic alterations induced by HTLV type 1-infected T lymphocytes: a role for Tax-1 and tumor necrosis factor alpha.
HTLV-1 associated tropical spastic paraparesis in an African patient residing in Belgium.
Electron microscopic observation of a Brazilian HTLV-I isolated.
The Exceptional Oncogenicity of HTLV-1
Association between HLA Class I Alleles and Proviral Load in HTLV-I Associated Myelopathy/Tropical Spastic Paraperesis (HAM/TSP) Patients in Iranian Population.
Two Cases of Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis Caused by Living-Donor Renal Transplantation.
Human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis and systemic lupus erythematosus.
Human T-lymphotropic virus type 1-associated myelopathy and primary sclerosing cholangitis.
Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
A case report of HTLV-I associated myelopathy presenting with cerebellar ataxia and nystagmus.
Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients.
Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.
Adult T cell leukemia following HTLV-I-associated myelopathy/tropical spastic paraparesis: case reports and implication to the natural course of ATL.
Human T-cell lymphotropic virus types I and II infections in mother-child pairs in Nigeria.
Route of primary HTLV-1 infection regulates HTLV-1 distribution in reservoir organs of infected mice.
Hypometabolism of watershed areas of the brain in HTLV-1-associated myelopathy/tropical spastic paraparesis.
The proteins associated with human T-cell leukemia virus type-I (HTLV-I) and their functions.
The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
Low-back pain in HTLV-I-associated myelopathy/tropical spastic paraparesis: nociceptive or neuropathic?
Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome.
Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection.
Human T-Lymphotropic Virus Type-1-Associated Myelopathy/Tropical Spastic Paraparesis: The First Case Report in Southeast Asia.
HTLV-I associated myelopathy in a Seychellois immigrant.
HIV and HTLV-1 coinfection: the need to initiate antiretroviral therapy.
Clinical and neuroradiologic findings of congenital hydrocephalus in infant born to mother with HTLV-I-associated myelopathy.
Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Expression of metalloproteinase-2 (gelatinase A) in labial salivary glands of patients with Sjögren's syndrome with HTLV-I infection.
Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases.
Activation of HTLV-I long terminal repeat by stress-inducing agents and protection of HTLV-I-infected T-cells from apoptosis by the viral tax protein.
Human T lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in an HIV-positive patient coinfected with human T lymphotropic virus type 2 following initiation of antiretroviral therapy.
Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor.
HTLV-1-associated infective dermatitis demonstrates low frequency of FOXP3-positive T-regulatory lymphocytes.
Tropical spastic paraparesis/HTLV-I-associated myelopathy in Europe and in Africa: clinical and epidemiologic aspects.
Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1.
Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms.
Antiviral effect of raltegravir on HTLV-1 carriers.
HTLV-I Tax and Cytokeratin: Tax-Expressing Cells Show Morphological Changes in Keratin-Containing Cytoskeletal Networks.
Sexual practices and prevalence of HIV, HTLV-I/II, and Treponema pallidum among clandestine female sex workers in Lima, Peru.
Elevated serum levels of soluble E- and L-selectin in patients with human T-cell lymphotropic virus type I-associated myelopathy.
Pentoxifylline down-regulates adhesion molecule expression and inflammatory cytokine production in cultured peripheral blood mononuclear cells from patients with HTLV-I-associated myelopathy.
Soluble CD4 and CD8 in the peripheral blood of patients with multiple sclerosis and HTLV-1-associated myelopathy.
Autoantibodies to brain endothelial cells in the sera of patients with human T-lymphotropic virus type I associated myelopathy and other demyelinating disorders.
Leukemias associated with human T-cell lymphotropic virus type I in a non-endemic region.
Differential diagnosis of HTLV-I and HTLV-II infections by restriction enzyme analysis of 'nested' PCR products.
Human T cell leukemia virus type I (HTLV-I) and human diseases.
Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
Enlarged, multifocal upper limb neuropathy with HTLV-I associated myelopathy in a patient with chronic adult T-cell leukemia.
Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy.
Relapsing cervical cord lesions on MRI in patients with HTLV-I-associated myelopathy.
Chronic progressive cervical myelopathy with HTLV-I infection: Variant form of HAM/TSP?
Involvement of Fas/Fas ligand system in the spinal cords of HTLV-I-associated myelopathy.
Axonal damage revealed by accumulation of beta-amyloid precursor protein in HTLV-I-associated myelopathy.
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy.
Expression of adhesion molecules and monocyte chemoattractant protein -1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy.
Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: a possible mechanism to control viral infection in the central nervous system.
Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy.
Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy.
Evaluation of Line Immunoassay to Detect HTLV-1 Infection in an Endemic Area, Southwestern Japan; Comparison with Polymerase Chain Reaction and Western Blot.
Neuro-otologic abnormalities in myelopathy associated with human T-cell lymphotropic virus type 1.
Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
Cytotoxic and suppressor activities in patients with HTLV-I-associated myelopathy.
Prevalences of HTLV-1 infection and associated risk determinants in an urban population in Guinea-Bissau, West Africa.
HTLV-1 antibody class and subclass distribution in African TSP and control populations.
HTLV-1 infection is associated with a history of active tuberculosis among family members of HTLV-1-infected patients in Peru.
HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru.
Distinct roles of transforming growth factor-beta-activated kinase 1 (TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in human T cell lymphotropic virus 1-transformed T helper 17 cells producing interleukin-9.
HTLV-I-associated tropical spastic paraparesis in Martinique: a reappraisal.
Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases.
Association of HTLV-I with Arnold Chiari syndrome and syringomyelia.
Atrophy, focal spinal cord lesions and alterations of diffusion tensor imaging (DTI) parameters in asymptomatic virus carriers and patients suffering from human T-lymphotrophic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis
Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Molecular characterization of human T-lymphotropic virus, type 1 (HTLV-1) found in Kuwait: close similarity with HTLV-1 isolates originating from Mashhad, Iran.
HTLV-I/II prevalence in different geographic locations.
Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues.
Monocyte-driven activation-induced apoptotic cell death of human T-lymphotropic virus type I-infected T cells.
The promiscuous IL-2/IL-15 receptor: a target for immunotherapy of HTLV-I-associated disorders.
Effect of propolis and caffeic acid phenethyl ester (CAPE) on NFκB activation by HTLV-1 Tax.
Detection of HTLV-I in Peripheral Blood Lymphocytes from Patients with Chronic HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis and Asymptomatic Carriers by PCR-in situ Hybridization.
In situ PCR for the detection of HTLV-I in HAM/TSP patients.
Serum S100B levels in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells.
Inhibition of HTLV-1 transcription by cyclin dependent kinase inhibitors.
HTLV-1-associated myelopathy: first case reported in Taiwan.
Inhibition of human T-lymphotropic virus type I gene expression by the Streptomyces-derived substance EM2487.
Inhibition of the tax-dependent human T-lymphotropic virus type I replication in persistently infected cells by the fluoroquinolone derivative k-37.
71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1.
Stimulation of cyclin-dependent kinase activity and G1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein.
Linear antigenic regions of the structural proteins of human T-cell lymphotropic virus type I detected by enzyme-linked immunosorbent assays using synthetic peptides as antigens
Differential expression of Nur77 family members in human T-lymphotropic virus type 1-infected cells: transactivation of the TR3/nur77 gene by Tax protein.
Human and simian glial cells infected by human T-lymphotropic virus type I in culture.
HTLV-1-associated myelopathy/tropical spastic paraparesis accompanied with psoriasis.
Exaggerated messenger RNA expression of inflammatory cytokines in human T-cell lymphotropic virus type I-associated myelopathy.
Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level.
Analysis of functional conservation in the surface and transmembrane glycoprotein subunits of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.
HTLV-1-associated diseases.
HTLV-1 uveitis (HU).
Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene.
HTLV-1 and tropical spastic paraparesis. 2. The human T-cell lymphotropic virus type 1.
Chromosome studies in HTLV-I, -II, and HIV-1, -2 cell lines infected in vivo and in vitro.
Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.
Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure.
Human T cell lymphotropic virus type I (HTLV-I) among female prostitutes in Kinshasa, Zaire.
IgA antiphospholipid antibodies in HTLV-1-associated tropical spastic paraparesis.
In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes.
Smoking is a risk factor for development of adult T-cell leukemia/lymphoma in Japanese human T-cell leukemia virus type-1 carriers.
Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations.
Blocking vertical transmission of human T cell lymphotropic virus type 1 and 2 through breastfeeding interruption.
Flow cytometric differentiation of Asian and Western types of multiple sclerosis, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and hyperIgEaemic myelitis by analyses of memory CD4 positive T cell subsets and NK cell subsets.
Constitutively activated JNK is associated with HTLV-1 mediated tumorigenesis.
Inhibition of cellular proliferation in human T lyophotropic virus type I (HTLV-I)-infected T cells from patients with HAM by steroid hormones and cyclosporin A.
Increased susceptibility of human fetal astrocytes to human T-lymphotropic virus type I in culture.
DNA diagnosis of HTLV-I.
Increased serum levels of C-terminal parathyroid hormone-related protein in different diseases associated with HTLV-1 infection.
Human T-lymphotropic virus type I in Japan.
Elevated serum levels of soluble interleukin-2 receptors in HTLV-I--associated myelopathy.
Induction of the expression of gag protein in HTLV-I infected lymphocytes by anti-ICAM 1 antibody in vitro.
HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells that produces an inflammatory positive feedback loop via astrocytes in HAM/TSP.
Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).
Alteration of cytokine levels by fosfomycin and prednisolone in spontaneous proliferation of cultured lymphocytes from patients with HTLV-I-associated myelopathy (HAM/TSP).
Preferential recognition of synthetic peptides from HTLV-I gp21 envelope protein by HLA-DRB1 alleles associated with HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis).
Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virological and immunological study.
Voiding dysfunction: patients with human T-lymphotropic-virus-type-1-associated myelopathy.
Presence of the widespread subtype of HTLV-I in South Africa.
HTLV-I from Iranian Mashhadi Jews in Israel is phylogenetically related to that of Japan, India, and South America rather than to that of Africa and Melanesia.
Fulminant myelopathy following neurogenic proximal weakness associated with human T-cell lymphotropic virus type I infection.
Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy.
Human T-cell lymphotropic virus type I infection and disease in the Pacific basin.
Human T-lymphotropic virus type I infection in the Solomon Islands.
In vivo genomic footprinting of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeat enhancer sequences in HTLV-1-infected human T-cell lines with different levels of Tax I activity.
Establishment and characterization of an HTLV-I cell line from a Taiwanese patient with HTLV-I-associated myelopathy.
HTLV-I-associated myelopathy in a patient with adult T-cell leukemia.
HTLV-1 subgroups associated with the risk of HAM/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors.
HTLV-1 Tax: regulation of gene expression and disease.
Increased replication of HTLV-I in HTLV-I-associated myelopathy.
The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA.
Optic neuritis and human T-lymphotropic virus type 1-associated myelopathy: a case report.
Three cases of juvenile onset HTLV-I-associated myelopathy with pseudohypoparathyroidism.
A case of HTLV-I-associated myelopathy with IgA nephropathy and pseudohypoparathyroidism type 1.
Chronic progressive myeloneuropathy in WKAH rats induced by HTLV-I infection as an animal model for HAM/TSP in humans.
TNF-beta produced by human T lymphotropic virus type I-infected cells influences the proliferation of human endothelial cells and fibroblasts.
Natural killer (NK) cells in HTLV-I-associated myelopathy/tropical spastic paraparesis-decrease in NK cell subset populations and activity in HTLV-I seropositive individuals.
Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis
Incidence and clinical significances of human T-cell lymphotropic virus type I-associated myelopathy with T2 hyperintensity on spinal magnetic resonance images.
Description of a "trans-Saharan" strain of human T-lymphotropic virus type 1 in West Africa.
Synthesis and activity of tetrapeptidic HTLV-I protease inhibitors possessing different P3-cap moieties.
Locking the two ends of tetrapeptidic HTLV-I protease inhibitors inside the enzyme.
Quantitative assessment of spasticity in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Prevalence of human retroviral infection in Quillabamba and Cuzco, Peru: a new endemic area for human T cell lymphotropic virus type 1.
Association of HTLV Tax proteins with TAK1-binding protein 2 and RelA in calreticulin-containing cytoplasmic structures participates in Tax-mediated NF-κB activation.
Quantitation of HTLV-I proviral load by a real-time PCR assay using SYBR Green: comparison of two methods for DNA isolation.
HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics.
Outfoxing FoxO transcription factors: HTLV-1 Tax oncoprotein inactivates FoxO4 via the ubiquitin-proteasome pathway.
Human T-cell leukemia virus type 2 (HTLV-2) Tax protein transforms a rat fibroblast cell line but less efficiently than HTLV-1 Tax.
Elevated cyclic AMP levels in T lymphocytes transformed by human T-cell lymphotropic virus type 1.
Activation of the PI3K-Akt pathway by human T cell leukemia virus type 1 (HTLV-1) oncoprotein Tax increases Bcl3 expression, which is associated with enhanced growth of HTLV-1-infected T cells.
Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.
Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil.
Transformation of breast milk macrophages by HTLV-I: implications for HTLV-I transmission via breastfeeding.
Aurora A selective inhibitor MLN8237 suppresses the growth and survival of HTLV-1-infected T-cells in vitro.
Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.
Epidemiology of human immunodeficiency virus, viral hepatitis (B and C), treponema pallidum, and human T-cell lymphotropic I/II virus among men who have sex with men in Buenos Aires, Argentina.
MicroRNA miR-146a is induced by HTLV-1 tax and increases the growth of HTLV-1-infected T-cells.
Deguelin suppresses cell proliferation via the inhibition of survivin expression and STAT3 phosphorylation in HTLV-1-transformed T cells.
Identification of a novel motif responsible for the distinctive transforming activity of human T-cell leukemia virus (HTLV) type 1 Tax1 protein from HTLV-2 Tax2.
Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination.
Clonal proliferation of HTLV-1-infected cells is associated with spontaneous malignant tumor formation in mice.
Interaction of human immunodeficiency virus type 1, human T-cell leukemia/lymphoma virus type I (HTLV-I), and HTLV-II with in vitro-generated dendritic cells.
Involvement of TORC2, a CREB co-activator, in the in vivo-specific transcriptional control of HTLV-1.
CXCR7 is inducible by HTLV-1 Tax and promotes growth and survival of HTLV-1-infected T cells.
Propensity for HBZ-SP1 isoform of HTLV-I to inhibit c-Jun activity correlates with sequestration of c-Jun into nuclear bodies rather than inhibition of its DNA-binding activity.
Anticancer effects of phenoxazine derivatives revealed by inhibition of cell growth and viability, disregulation of cell cycle, and apoptosis induction in HTLV-1-positive leukemia cells.
The prolyl isomerase Pin1 stabilizes the human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein and promotes malignant transformation.
Decline in human T-cell lymphotropic virus-1 prevalence in urban areas of Bissau, Guinea-Bissau: exploring the association with HIV infections.
Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells.
Prevalence and risk factors for HIV, syphilis, hepatitis B, hepatitis C, and HTLV-I/II infection in low-income postpartum and pregnant women in Greater Metropolitan Vitória, Espírito Santo State, Brazil.
Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.
Overexpression of Aurora A by loss of CHFR gene expression increases the growth and survival of HTLV-1-infected T cells through enhanced NF-kappaB activity.
HTLV-2B Tax oncoprotein is modified by ubiquitination and sumoylation and displays intracellular localization similar to its homologue HTLV-1 Tax.
Higher HTLV-1c proviral loads are associated with blood stream infections in an Indigenous Australian population.
Ultrastructural study of the morphogenesis of human herpesvirus 6 type B in human T-lymphotropic virus type I-producing lymphoid cells.
Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein: a novel in vitro model of the growth of acute ATL cells.
Induction of galectin-1 expression by HTLV-I Tax and its impact on HTLV-I infectivity.
Human T-cell lymphotropic virus type 1 infection of CD34+ hematopoietic progenitor cells induces cell cycle arrest by modulation of p21(cip1/waf1) and survivin.
Seroprevalence of HIV-1, HBV, HTLV-1 and Treponema pallidum among pregnant women in a rural hospital in Southern Ethiopia.
Activation of the cyclin D2 and cdk6 genes through NF-kappaB is critical for cell-cycle progression induced by HTLV-I Tax.
Generation of HTLV-I-transformed T cell lines.
SR-related protein TAXREB803/SRL300 is an important cellular factor for the transactivational function of human T-cell lymphotropic virus type 1 Tax.
Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.
Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral Tax oncoprotein.
Human T Lymphotropic Virus Type 1 protein Tax reduces histone levels.
Triple synergism of human T-lymphotropic virus type 1-encoded tax, GATA-binding protein, and AP-1 is required for constitutive expression of the interleukin-5 gene in adult T-cell leukemia cells.
Epigallocatechin-3-gallate induces apoptosis and cell cycle arrest in HTLV-1-positive and -negative leukemia cells.
Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells.
HTLV-1-infected thymic epithelial cells convey the virus to CD4+ T lymphocytes.
HTLV-1 Tax upregulates early growth response protein 1 through nuclear factor-κB signaling.
HTLV-1 Tax-mediated TAK1 activation involves TAB2 adapter protein.
HTLV-1 Intrafamilial Transmission Among Japanese Immigrants in Brazil.
Celecoxib disrupts the canonical apoptotic network in HTLV-I cells through activation of Bax and inhibition of PKB/Akt.
Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells.
Human T-cell lymphotropic virus in patients infected with HIV-1: molecular epidemiology and risk factors for transmission in Piaui, Northeastern Brazil.
Dose-dependent dual effect of HTLV-1 tax oncoprotein on p53-dependent nucleotide excision repair in human T-cells.
The impact of HTLV-1 on the cellular genome.
Ku70 Senses HTLV-1 DNA and Modulates HTLV-1 Replication.
Cooperation of NF-kappaB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2-independent growth transformation of a T-cell line.
Telomere attrition induces a DNA double-strand break damage signal that reactivates p53 transcription in HTLV-I leukemic cells.
Targeting autophagic regulation of NFkappaB in HTLV-I transformed cells by geldanamycin: implications for therapeutic interventions.
A case of abdominal tuberculosis lymphadenitis extending into the gallbladder and duodenum in a human T-cell lymphotropic virus type 1 carrier.
Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB.
Detection of human T-cell leukemia virus type I (HTLV-I) provirus in an infected cell line and in peripheral mononuclear cells of blood donors by the nested double polymerase chain reaction method: comparison with HTLV-I antibody tests.
Expression and purification of recombinant HTLV-I/-II linear epitopes antigen and its application for screening of suspected patients.
Effects of Ascorbic Acid on Tax, NF- κB and MMP-9 in Human T-cell Lymphotropic virus type 1 positive malignant T-Lymphocytes.
Constitutive activation of TAK1 by HTLV-1 tax-dependent overexpression of TAB2 induces activation of JNK-ATF2 but not IKK-NF-kappaB.
Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
Characterization of cognitive performance and evaluation of quality of life among patients with HTLV-1.
[Duodenal Linphoma asociated to Strongyloides stercoralis infection. Two types of HTLV-1 infection].
Turning a blind eye: HTLV-1-associated uveitis in Indigenous adults from Central Australia.
A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax301-309-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients.
Adult T-cell leukemia-lymphoma in a pregnant woman diagnosed as a human T-cell lymphotropic virus type 1 carrier.
Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells.
Constitutive and induced activation of JAK/Stat pathway in leukemogenic and asymptomatic human T-cell lymphoptropic virus type 1 (HTLV-1) transformed rabbit cell lines.
Heptad repeats regulate protein phosphatase 2a recruitment to I-kappaB kinase gamma/NF-kappaB essential modulator and are targeted by human T-lymphotropic virus type 1 tax.
HTLV-I infection of WE17/10 CD4+ cell line leads to progressive alteration of Ca2+ influx that eventually results in loss of CD7 expression and activation of an antiapoptotic pathway involving AKT and BAD which paves the way for malignant transforma
Interactions between inflammatory gene polymorphisms and HTLV-I infection for total death, incidence of cancer, and atherosclerosis-related diseases among the Japanese population.
Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
Comparison of Western immunoblot antigens and interpretive criteria for detection of antibody to human T-lymphotropic virus types I and II.
Adult T-cell leukemia-lymphoma complicated by Takotsubo cardiomyopathy and HTLV-1-associated myelopathy after treatment with the anti-CCR4 antibody mogamulizumab.
Detection and differentiation of antibodies to human T-cell lymphotropic virus types I and II by the immunofluorescence method.
Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma.
Mechanistic aspects of apoptosis induction by l-lysine in both HTLV-1-positive and -negative cell lines.
Dengue fever and human T-cell lymphotropic virus type 1 infection.
Non-radioisotope detection of pol sequences of HTLV-1 proviral DNA: Standardisation and sensitivity analysis.
[Adult T-cell leukemia-lymphoma developed from an HTLV-1 carrier during treatment of B-cell lymphoma-associated hemophagocytic syndrome].
The HTLV-I p30 interferes with TLR4 signaling and modulates the release of pro- and anti-inflammatory cytokines from human macrophages.
Methods for Identifying and Examining HTLV-1 HBZ Post-translational Modifications.
A Luciferase Functional Quantitative Assay for Measuring NF-ĸB Promoter Transactivation Mediated by HTLV-1 and HTLV-2 Tax Proteins.
Quantitative Analysis of Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection Using Co-Culture with Jurkat LTR-Luciferase or Jurkat LTR-GFP Reporter Cells.
Analysis of NK Cell Function and Receptor Expression During HTLV-1 and HTLV-2 Infection.
Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1).
Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
Hepatitis B virus and human T-cell lymphotropic virus type 1 co-infection in the Northern Territory, Australia.
Effects of expressing human T-cell leukemia virus type 1 (HTLV-I) oncoprotein Tax on DOK1, DOK2 and DOK3 gene expression in mice.
[Diffuse interstitial lung disease revealing adult T-Cell leukemia/lymphoma (HTLV-1)].
HTLV-1 infection of human retinal pigment epithelial cells and inhibition of viral infection by an antibody to ICAM-1.
Deregulated activation of oncoprotein kinase Tpl2/Cot in HTLV-I-transformed T cells.
The tax protein from the primate T-cell lymphotropic virus type 3 is expressed in vivo and is functionally related to HTLV-1 Tax rather than HTLV-2 Tax.
CRM1, an RNA transporter, is a major species-specific restriction factor of human T cell leukemia virus type 1 (HTLV-1) in rat cells.
First description of HTLV-1/2 seroprevalence in HIV-infected inmates in Mozambique.
Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes.
Apoptosis induction by Epican Forte in HTLV-1 positive and negative malignant T-cells.
HIV-1-mediated syncytium formation promotes cell-to-cell transfer of Tax protein and HTLV-I gene expression.
Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon.
Synthesis, processing, and composition of the virion-associated HTLV-1 reverse transcriptase.
HTLV-1 Gag protein associates with CD82 tetraspanin microdomains at the plasma membrane.
Constitutive tyrosine and serine phosphorylation of STAT4 in T-cells transformed with HTLV-I.
Loss of interleukin-2-dependency in HTLV-I-infected T cells on gene silencing of thioredoxin-binding protein-2.
A novel mother-to-child human T-cell leukaemia virus type 1 (HTLV-1) transmission model for investigating the role of maternal anti-HTLV-1 antibodies using orally infected mother rats.
Persistent risk of adult T-cell leukemia/lymphoma after neonatal HTLV-1 infection through exchange transfusion.
Protective effect of the acyclic nucleoside phosphonate tenofovir toward human T-cell leukemia/lymphotropic virus type 1 infection of human peripheral blood mononuclear cells in vitro.
Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.
Pattern-reversal visual evoked potentials in patients with human T-lymphotropic virus type 1 uveitis.
HTLV-1 Tax impairs K63-linked ubiquitination of STING to evade host innate immunity.
Evaluation of INOS, ICAM-1, and VCAM-1 gene expression: A study of adult T cell leukemia malignancy associated with HTLV-1.
Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines.
Human T-lymphotropic virus type 1 and its ocular manifestations.
[Clinical characteristics and prognosis in 12 patients with adult T cell leukemia/lymphoma confirmed by HTLV-1 provirus gene detection].
Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells.
Human T-cell lymphotropic virus type I-transformed T-cells have a partial defect in ceramide synthesis in response to N-(4-hydroxyphenyl)retinamide
Rapidly fatal HTLV-1-associated T-cell leukemia/lymphoma in a patient with SLE.
Screening transplant donors for HTLV-1 and -2.
Proviral status of HTLV-1 integrated into the host genomic DNA of adult T-cell leukemia cells.
Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells.
Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 Tax expression.
A new sensitive and quantitative HTLV-I-mediated cell fusion assay in T cells.
Design of experimental synthetic peptide immunogens for prevention of HIV-1 and HTLV-I retroviral infections.
Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia.
Novel internal promoter/enhancer of HTLV-I for Tax expression.
Parathyroid hormone-related peptide in hypercalcemia associated with adult T cell leukemia/lymphoma: molecular and cellular mechanism of parathyroid hormone-related peptide overexpression in HTLV-I-infected T cells.
Preferential transcription of HTLV-I LTR in cell-free extracts of human T cells producing HTLV-I viral proteins.
Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection.
Distinct IkappaB kinase regulation in adult T cell leukemia and HTLV-I-transformed cells.
I-mfa domain proteins specifically interact with HTLV-1 Tax and repress its transactivating functions.
HTLV-1aA introduction into Brazil and its association with the trans-Atlantic slave trade.
Strongyloides hyperinfection following hematopoietic stem cell transplant in a patient with HTLV-1-associated T-cell leukemia.
[Enterococcal meningitis due to strongyloidiasis with HTLV-1 carrier].
Interaction of HTLV-1 Tax and methyl-CpG-binding domain 2 positively regulates the gene expression from the hypermethylated LTR.
HTLV-1 oncoprotein tax and cellular transcription factors.
HTLV-1-targeted immunotherapy.
How does HTLV-1 induce ATL?
The occurrence of systemic lupus erythematosus in an asymptomatic carrier of human T-cell lymphotropic virus type I.
Quantitative PCR for HTLV-1 provirus in adult T-cell leukemia/lymphoma using paraffin tumor sections.
Evidence of Sexual Transmission of Human T Cell Lymphotropic Virus Type 1 with ORF-I G29S Mutation Among Humans.
The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation.
Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma.
Activation of HTLV-I gene transcription by protein tyrosine phosphatase inhibitors.
First Report of Prevalence of HTLV-1 Among HIV-1/2-Infected Children in Mozambique.
[Recurrent strongyloidiasis as an indicator of HTLV-1 infection]
A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis.
Establishment of HTLV-I-infected cell lines from peripheral blood mononuclear cells of Brazilian patients.
Usefulness of a Nested-polymerase chain reaction for molecular diagnosis of human T-cell lymphotropic virus type I/II.
Relevance of CREB phosphorylation in the anti-apoptotic function of human T-lymphotropic virus type 1 tax protein in serum-deprived murine fibroblasts.
Enhanced tumorigenesis in HTLV-1 tax-transgenic mice deficient in interferon-gamma.
Genome-wide analyses of HTLV-1aD strains from Cape Verde, Africa.
Nucleotide sequence of the core (gag) gene from HTLV-1 isolate MT-2.
Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells.
[A case of psoriatic arthropathy complicated with HTLV-I carrier and secondary amyloidosis].
HTLV-I Tax protein inhibits apoptosis induction but not G1 arrest by pyrrolidinedithiocarbamate, an anti-oxidant, in adult T cell leukemia cells.
Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment.
KL-6 as an indicator for lymphocytic interstitial pneumonia (LIP) in a human T-lymphotrophic virus type 1 (HTLV-1) carrier.
Inhibition of apoptosis by human T-lymphotropic virus type-1 tax protein.
Uncommon presentation of Strongyloidiasis: chronic malabsorption, multiple small bowel strictures and appendicitis in HTLV-1 positive patient.
Human T-cell lymphotropic virus type I-infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism.
Targeting deoxyhypusine hydroxylase activity impairs cap-independent translation initiation driven by the 5'untranslated region of the HIV-1, HTLV-1, and MMTV mRNAs.
Structural and immunogenicity analysis of chimeric B-cell epitope constructs derived from the gp46 and gp21 subunits of the envelope glycoproteins of HTLV-1.
A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A*0201 transgenic mice: implications for HTLV-1 vaccine design.
Rapid isolation of viral integration site reveals frequent integration of HTLV-1 into expressed loci.
Tenth anniversary perspectives on AIDS. Host-HTLV type I interaction at the molecular level.
Quality of life and pain multidimensional aspects in individuals with HTLV-1.
HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication.
N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells.
Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs.
Novel enzyme-linked immunosorbent assay systems for the quantitative analysis of connective tissue growth factor (CTGF/Hcs24/CCN2): detection of HTLV-I tax-induced CTGF from a human carcinoma cell line.
HTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and Proliferation.
[HTLV-1 bZIP Factor (HBZ): Roles in HTLV-1 Oncogenesis].
[Dermatomiositis and evans syndrome associated with HTLV-1 infection].
Expression of butyrate response factor 1 in HTLV-1-transformed cells and its transactivation by tax protein.
New horizons in HTLV-I and HTLV-II diagnosis.
Expression of DOK1, 2, and 3 genes in HTLV-1-infected T cells.
Resveratrol induces downregulation in survivin expression and apoptosis in HTLV-1-infected cell lines: a prospective agent for adult T cell leukemia chemotherapy.
Enhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody
Binding of HTLV-1 virions to T cells occurs by a temperature and calcium-dependent process and is blocked by certain type 2 adenosine receptor antagonists.
Acute myelitis as presenting symptom of HIV-HTLV-1 co-infection.
Kikuchi disease (histiocytic necrotizing lymphadenitis) in association with HTLV1.
Binding of HTLV-1 tax oncoprotein to the precursor of interleukin-16, a T cell PDZ domain-containing protein.
Substituted quinolines induce inhibition of proliferation of HTLV-1 infected cells.
A conserved calcineurin-binding motif in human T lymphotropic virus type 1 p12I functions to modulate nuclear factor of activated T cell activation.
The HTLV-1 tax oncoprotein attenuates DNA damage induced G1 arrest and enhances apoptosis in p53 null cells.
A sulphated fucan from the Laminaria abyssalis inhibits the human T cell lymphotropic virus type 1-induced syncytium formation in HeLa cells.
Human T-lymphotropic virus type I tax activates I-kappa B kinase by inhibiting I-kappa B kinase-associated serine/threonine protein phosphatase 2A.
Detection of human T-lymphotropic virus type I (HTLV-I) infection during coculture of HTLV-I infected and uninfected cells using inverse long PCR.
The interaction of HTLV-1 Tax with HDAC1 negatively regulates the viral gene expression.
Genomic instability driven by the human T-cell leukemia virus type I (HTLV-I) oncoprotein, Tax.
Clustering of human T lymphotropic virus type I seropositive in Montserrat, West Indies: evidence for an environmental factor in transmission of the virus.
[HTLV-I negative adult T cell leukemia; a case report of acute type]
Lack of exposure to HTLV1 among Ethiopian immigrants of operation Solomon (1991) arriving to the Jerusalem area.
Persistence of HTLV-I in blood components after leukocyte depletion.
Overcoming the blockade at the upstream of caspase cascade in Fas-resistant HTLV-I-infected T cells by cycloheximide.
Comparison of CREB- and NF-kappaB-mediated transactivation by human T lymphotropic virus type II (HTLV-II) and type I (HTLV-I) tax proteins.
Immunization against HTLV-I with chitosan and tri-methylchitosan nanoparticles loaded with recombinant env23 and env13 antigens of envelope protein gp46.
Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.
Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice.
HCV/HTLV coinfection: Does HTLV-1 interfere in the natural history of HCV-related diseases?
Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
Human T-cell lymphotropic virus type 1-transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells.
A Case of Pneumonia Caused by Pneumocystis Jirovecii and Cryptococcus Neoformans in a Patient with HTLV-1 Associated Adult T- Cell Leukemia/Lymphoma: Occam's Razor Blunted.
HTLV type 1 Tax transduction in microglial cells and astrocytes by lentiviral vectors.
High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disorders
p53-independent induction of apoptosis by the HTLV-I tax protein following UV irradiation.
Inhibitory effect of extracts of Brazilian marine algae on human T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation in vitro.
Presentation of a new H-2D(k)-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin.
Thioredoxin-mediated redox control of human T cell lymphotropic virus type I (HTLV-I) gene expression.
Resistance to tumor necrosis factor-alpha-induced apoptosis in human T-lymphotropic virus type I-infected T cell lines.
Geographic-specific genotypes or topotypes of human T-cell lymphotropic virus type I as markers for early and recent migrations of human populations.
HTLV-I positive adult T-cell leukaemia-lymphoma: report of a typical case from Italy.
Defective human T-cell leukaemia virus type 1 (HTLV-1) genomes: no evidence in serologically indeterminate german blood donors but new type detected in established cell lines.
[HTLV-I associated interstitial pneumonia--a case report and bronchoalveolar lavage study].
Counseling and medical evaluation of HTLV-I- and HTLV-II-infected patients.
Seroprevalence of human T lymphotropic virus type I in Puerto Rico.
The role of human T cell lymphotropic virus type I tax in the development of cutaneous T cell lymphoma.
A historical study of human T lymphotropic virus type I transmission in Barbados.
Human T-cell leukemia virus type-I (HTLV-I) tax is not the only one factor to enhance human immunodeficiency virus type-I (HIV-1) infection in culture-supernatants.
Survival of patients with HTLV-I-associated lymph node lesions.
Efficacy of 3'-azido 3'deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells.
Functional changes in astrocytes by human T-lymphotropic virus type-1 T-lymphocytes.
Accelerated G(1) phase progression induced by the human T cell leukemia virus type I (HTLV-I) Tax oncoprotein.
Serological and virological evaluation of human T-lymphotropic virus type 1 infection in family groups from Tumaco, Colombia.
Induction of Tax i expression in MT-4 cells by 5-azacytidine leads to protein binding in the HTLV-1 LTR in vivo.
Expression of survivin in HTLV-I-infected T-cell lines and primary ATL cells.
The effect of ethnic differences on the pattern of HTLV-I-associated T-cell leukemia/lymphoma (HATL) in the United States.
Transient induction of IL-2 receptor in cultured T cell lines by HTLV-1 LTR-linked tax-1 gene.
Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies.
Phosphatidylglycerol participates in syncytium formation induced by HTLV type 1-bearing cells.
Progressive nemaline rod myopathy in a woman coinfected with HIV-1 and HTLV-2.
Differential budding efficiencies of human T-cell leukemia virus type I (HTLV-I) Gag and Gag-Pro polyproteins from insect and mammalian cells.
Plasma Soluble CD30 as a Possible Marker of Adult T-cell Leukemia in HTLV-1 Carriers: a Nested Case-Control Study.
Natural history of HTLV-I infection: relationship to leukemogenesis.
The MHC class I heavy chain is a common target of the small proteins encoded by the 3' end of HTLV type 1 and HTLV type 2.
Immunological aspects of rat models of HTLV type 1-infected T lymphoproliferative disease.
HTLV type 1 envelope glycoprotein gp46 evokes necrosis by binding to receptor complex.
Tax-dependent stimulation of G1 phase-specific cyclin-dependent kinases and increased expression of signal transduction genes characterize HTLV type 1-transformed T cells.
Inactivation of p53 by HTLV type 1 and HTLV type 2 Tax trans-activators.
Studies of the immortalizing activity of HTLV type 1 Tax, using an infectious molecular clone and transgenic mice.
HTLV type 1 Tax oncoprotein binds to DNA topoisomerase I and inhibits its catalytic activity.
Pleiotropic effects of HTLV type 1 Tax protein on cellular metabolism: mitotic checkpoint abrogation and NF-kappaB activation.
Suppression of DNA repair by HTLV type 1 Tax correlates with Tax trans-activation of proliferating cell nuclear antigen gene expression.
Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission.
Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell type-dependent.
Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals.
Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation.
RETINAL MANIFESTATIONS IN ADULT T-CELL LEUKEMIA/LYMPHOMA RELATED TO INFECTION BY THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1.
Long-term effects of HTLV-1 on brain astrocytes: sustained expression of Tax-1 associated with synthesis of inflammatory mediators.
The origin and evolution of human T-cell lymphotropic virus types I and II.
The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits.
Prevalence and phylogenetic analysis of HTLV-1 in a segregated population in Iran.
Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples.
The HTLV-I tax protein transcriptionally modulates OX40 antigen expression.
MHC-I expression in HTLV-1-positive and -negative cells.
Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP.
Synthesis and CD studies of an 88-residue peptide containing the main receptor binding site of HTLV-I SU-glycoprotein.
Deletion of the p16INK4A gene in ex vivo acute adult T cell lymphoma/leukemia cells and methylation of the p16INK4A promoter in HTLV type I-infected T cell lines.
HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300.
Differentiation of rat thymic myoid progenitor cell line established by coculture with human T-lymphotropic virus type-I producing human T cells.
Human T-cell Lymphotropic Virus Type-1 (HTLV-1)-associated Bronchioloalveolar Disorder Presenting with Mosaic Perfusion.
Unique morphological alterations of the HTLV-I transformed C8166 cells by infection with HIV-1.
The human T cell leukemia/lymphotropic virus type 1 Tax protein represses MyoD-dependent transcription by inhibiting MyoD-binding to the KIX domain of p300. A potential mechanism for Tax-mediated repression of the transcriptional activity of basic h
HTLV-1 tax oncoprotein represses the p53-mediated trans-activation function through coactivator CBP sequestration.
Somatic mutagenesis studies of NF-kappa B signaling in human T cells: evidence for an essential role of IKK gamma in NF-kappa B activation by T-cell costimulatory signals and HTLV-I Tax protein.
Is screening of Australian blood donors for HTLV-I necessary?
Accumulation of common T cell clonotypes in the salivary glands of patients with human T lymphotropic virus type I-associated and idiopathic Sjögren's syndrome.
Milk-borne transmission of HTLV-1.
Visualisation of phenotypically mixed HIV-1 and HTLV-I virus particles by electron microscopy.
Characteristics of human T-lymphotropic virus type-1 (HTLV-1)-infected cell line MT-2, which is not killed by a natural killer cell line NK-92 but is killed by lymphokine-activated killer cells.
HTLV-1-induced cell fusion is limited at two distinct steps in the fusion pathway after receptor binding.
Transcriptional activation of human TR3/nur77 gene expression by human T-lymphotropic virus type I Tax protein through two AP-1-like elements.
Constructing Chimeric Antigen for Precise Screening of HTLV-I Infection.
Comparisons of defective HTLV-I proviruses predict the mode of origin and coding potential of internally deleted genomes.
Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytes.
Molecular interactions between HTLV-1 Tax protein and the NF-kappa B/kappa B transcription complex.
Activation of NF-kappa B by the Tax protein of HTLV-1.
Tax protein of HTLV-1 inhibits CBP/p300-mediated transcription by interfering with recruitment of CBP/p300 onto DNA element of E-box or p53 binding site.
Apoptosis in placentas from human T-lymphotropic virus type I-seropositive pregnant women: a possible defense mechanism against transmission from mother to fetus.
Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I.
Differential response to genotoxic stress in immortalized or transformed human T-lymphotropic virus type I-infected T-cells.
Localization of HTLV-1 and HIV-1 proviral sequences in chromosomes of persistently infected cells.
Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.
Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms.
[HTLV-1-associated myelopathy(HAM)].
Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: clinical features and apoptosis by NOS inhibitor.
Hepatocyte growth inhibitory factor derived from HTLV-I(+) T-cell line is identical to IL-6.
HTLV-I in Australia and Oceania: long-term resident or recent immigrant?
Morphine effects on HTLV-I infection in the presence or absence of concurrent HIV-1 infection.
Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
Transformation of guinea pig leukocytes by coinfection with human T-cell lymphotropic virus types I and II.
Gene regulation mediated by interaction between HTLV-1 promoter elements and transcription factors Tax and CREB.
Monoclonal antibody profiling of cell surface proteins associated with the viral biofilms on HTLV-1 transformed cells.
Two types of HTLV-1 particles are released from MT-2 cells.
Binding of c-Rel to STAT5 target sequences in HTLV-I-transformed T cells.
FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides.
In vitro infection of CD4+ T lymphocytes with HTLV-I generates immortalized cell lines coexpressing lymphoid and myeloid cell markers.
Transgenic models of HTLV-I mediated disease and latency.
Stable human T-lymphotropic virus type I carrier rates for 7 years among a teenaged blood donor cohort of 1986 in Kumamoto, Japan.
The effect of the cellular stress response on human T-lymphotropic virus type I envelope protein expression.
Rapid syncytium formation between human T-cell leukaemia virus type-I (HTLV-I)-infected T-cells and human nervous system cells: a possible implication for tropical spastic paraparesis/HTLV-I associated myelopathy.
Clinical implication of the integration patterns of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma.
Examining the molecular genetics of HTLV-I with an infectious molecular clone of the virus and permissive cell culture systems.
Association between HTLV-1 Tax and I kappa B alpha is dependent on the I kappa B alpha phosphorylation state.
Quantification of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction.
Human T-lymphotropic retrovirus type-1 (HTLV-1) and its distribution in Asian populations.
Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells.
Estimation of the infectious viral load required for transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) and of the effectiveness of leukocyte reduction in preventing TT-HTLV-1.
Accumulation of human T lymphotropic virus type I-infected T cells in the salivary glands of patients with human T lymphotropic virus type I-associated Sjögren's syndrome.
High-Level Soluble Expression and One-step Purification of HTLV-I P19 Protein in Escherichia coli by Fusion Expression.
Regulation of the tumor marker Fascin by the viral oncoprotein Tax of human T-cell leukemia virus type 1 (HTLV-1) depends on promoter activation and on a promoter-independent mechanism.
Genomic organization of human B-ATF, a target for regulation by EBV and HTLV-1.
The role of human T-cell lymphotropic viruses (HTLV-I and II) in cutaneous T-cell lymphomas.
Role of kinases in HTLV-I transformation.
Human T lymphotropic virus type I in arthropathy and autoimmune disorders.
De novo reverse transcription of HTLV-1 following cell-to-cell transmission of infection.
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4.
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4.
Monoclonal antibodies define a cellular antigen involved in HTLV-I infection.
Persistent HTLV-I infection of breast luminal epithelial cells: a role in HTLV transmission?
[A survey of HTLV-1 carrier clinics in Japan].
No detection of HTLV-I proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T-cell lymphoma.
Persistence and differentiation of HTLV-I-transformed immature T-cells in HTLV-I carrier rabbits.
Up-regulation of iNOS mRNA expression and increased production of NO in human monoblast cell line, U937 transfected by HTLV-I tax gene.
Fatal pneumonia and viremia due to human parainfluenza virus type 1 in a patient with adult T-cell leukemia-lymphoma treated with mogamulizumab.
Resistance to herpes simplex virus type 1 and its latent infection of human T cell lymphotropic virus type I-transformed T cell lines of rabbits.
Transcriptional activation of the intercellular adhesion molecule 1 (CD54) gene by human T lymphotropic virus types I and II Tax is mediated through a palindromic response element.
Inducible knockout of the interleukin-2 receptor alpha chain: expression of the high-affinity IL-2 receptor is not required for the in vitro growth of HTLV-I-transformed cell lines.
Amyotrophic lateral sclerosis presentation of a human T-lymphotropic virus type-1 myelopathy--insight into pathogenesis.
Binding of the HTLV-I Tax1 transactivator to the inducible 21 bp enhancer is mediated by the cellular factor HEB1.
Cell-mediated HTLV-I infection of a cervix-derived epithelial cell line.
Herpes simplex virus type 2 infection, syphilis, and hepatitis B virus infection in Haitian women with human immunodeficiency virus type 1 and human T lymphotropic virus type I infections. The Johns Hopkins University (JHU)/Centre pour le Developpem
Role of the genetic background of rats in infection by HTLV-I and HTLV-II and in the development of associated diseases.
Activation of Bcl-2 expression in human endothelial cells chronically expressing the human T-cell lymphotropic virus type I.
Tax of the human T-lymphotropic virus type I transactivates promoter of the MDR-1 gene.
Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins.
Integration of proviral DNA into the PDGF beta-receptor gene in HTLV-I-infected T-cells results in a novel tyrosine kinase product with transforming activity.
Human T-cell lymphotropic virus type 1 can infect primary rat retinal glial cells and induce gene expression of inflammatory cytokines.
Signaling via the CD2 receptor enhances HTLV-1 replication in T lymphocytes.
Comparative Interactome of HIV-1 Tat and Human T Lymphotropic Virus Type-1 Tax and the Cellular Transcriptional Machinery.
Brief Report: Reduced Cell-Associated HTLV-2 DNA in Antiretroviral Treated HIV-1-HCV-Coinfected Patients Who Either Received Interferon-α/Ribavirin-Based Hepatitis C Therapy or Had Spontaneous HCV RNA Clearance.
The epidemiology of HTLV-I in Europe.
HTLV-I arthropathy and Sjögren syndrome.
Molecular biology of HTLV-I: recent progress.
The HTLV-I envelope glycoproteins: structure and functions.
Clonal expansion of infected cells: a way of life for HTLV-I.
Cell adhesion molecules in HTLV-I infection.
Molecular epidemiology of HTLV-I in the world.
HTLV-I transgenic models: an overview.
Transgenic mouse models for HTLV-I infection.
Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-I and HTLV-II.
Primary prevention of HTLV-I in Japan.
Multiple false-positive serologic tests for HIV, HTLV-1, and hepatitis C following influenza vaccination, 1991.
Increased expression of interleukin-2 receptor alpha on peripheral blood mononuclear cells in HTLV-I tax/rex mRNA-positive asymptomatic carriers.
AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro.
Repression of bax gene expression by the HTLV-1 Tax protein: implications for suppression of apoptosis in virally infected cells.
[Human T-Lymphotropic Virus Type I-Associated Myelopathy].
Lack of detectable human T-cell lymphotropic virus type I sequences in samples from multiple sclerosis patients.
Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax1.
Inhibition of syncytium formation by antisense oligonucleotide phosphorothioates complementary to tax mRNA of human T-cell leukemia virus type 1 (HTLV-1).
Antibodies directed against a variable and neutralizable region of the HTLV-I envelope surface glycoprotein.
Cytokine mediated growth inhibition of HTLV-I infected transformed human lymphocytes.
Chromosome changes associated with growth potential of HTLV-I infected human lymphocytes.
Expression of cell cycle-regulatory genes in HTLV-I-transformed T-cells and Tax1-immortalized T-cells.
HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16Ink4a and counteracts its inhibitory activity to CDK4.
HTLV-I Tax trans-activation and cell growth signaling.
[Intercellular transmission of HTLV-1: not all mechanisms have been revealed].
Status of soluble ST2 levels in serum of HTLV-1 infected individuals.
Dual infection of rabbits with human T cell lymphotropic virus types I and II.
Membrane tumor necrosis factor-alpha (TNF-alpha) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation--characterization of membrane TNF-alpha.
Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I).
HTLV-I virus in Europeans: the continuous spread. A meta-analysis.
HTLV-1 gene expression in adult T-cell leukemia cells elicits an NK cell response in vitro and correlates with cell rejection in SCID mice.
Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I Tax.
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro.
Prevention of human T cell lymphotropic virus type I infection in Japanese macaques by passive immunization.
HTLV-1 21 bp repeat sequences facilitate stable association between Tax and CREB to increase CREB binding affinity.
Development of a multiplex PCR assay for the simultaneous detection and discrimination of HIV-1, HIV-2, HTLV-I and HTLV-II.
Demonstration of antibodies to human T-cell lymphotropic virus-I tax in patients with the cutaneous T-cell lymphoma, mycosis fungoides, who are seronegative for antibodies to the structural proteins of the virus.
Rat primary T cells expressing HTLV-I tax gene transduced by a retroviral vector: in vitro and in vivo characterization.
The RU5 ('R') region from human leukaemia viruses (HTLV-1) contains an internal ribosome entry site (IRES)-like sequence.
Cytokine production by endothelial cells infected with human T cell lymphotropic virus type I.
Probing the conformation of the human T-lymphotropic virus I envelope protein complex with monoclonal antibodies.
p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells.
Failure to detect human T-lymphotropic virus type-I proviral DNA in cell lines and tissues from patients with cutaneous T-cell lymphoma.
HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users.
Constitutive cytokine release by simian T-cell lymphotrophic virus type I (STLV-I) and human T-cell lymphotrophic virus types I/II (HTLV-I/II) transformed cell lines.
Nucleo-cytoplasmic redistribution of the HTLV-I Rex protein: alterations by coexpression of the HTLV-I p21x protein.
Geographic and molecular epidemiology of primate T lymphotropic retroviruses: HTLV-I, HTLV-II, STLV-I, STLV-PP, and PTLV-L.
Genomic footprinting of HTLV type I and HIV type 1 in human T cell lines.
Selective cooperation of HTLV-1-encoded p40tax-1 with cellular oncoproteins in the induction of hematopoietic cell proliferation.
Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome.
Human T leukaemia virus type 1 (HTLV-1) specific T-helper cell response: clonal fluctuations and repertoire heterogeneity.
Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1.
Antibodies to HTLV-I in sera from patients with connective tissue diseases.
Molecular aspects of HTLV-I: relationship to neurological diseases.
The HTLV-1 Rex protein induces nuclear accumulation of unspliced viral RNA by avoiding intron excision and degradation.
Cis/trans-activation of the interleukin-9 receptor gene in an HTLV-I-transformed human lymphocytic cell.
Stimulation of the CD2 receptor pathway induces apoptosis in human T lymphotropic virus type I-infected cell lines.
HTLV-1 viral RNA is detected rarely in plasma of HTLV-1 infected subjects.
Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection.
HTLV-I and HTLV-II Tax: differences in induction of micronuclei in cells and transcriptional activation of viral LTRs.
Transfer of human T cell lymphotropic virus type I to human term trophoblast cells in vitro.
The genomic structure of a new simian T-lymphotropic virus, STLV-PH969, differs from that of human T-lymphotropic virus types I and II.
HTLV-1 p27rex stabilizes human interleukin-2 receptor alpha chain mRNA.
Mutations introduced along the HTLV-I envelope gene result in a non-functional protein: a basis for envelope conservation?
An antibody that binds domain 1 of CD4 inhibits replication of HIV-1, but not HTLV-I, in a CD4-positive/p56lck-negative HTLV-I-transformed cell line.
Clonal analysis suggests provirus expression in a subpopulation of human malignant trophoblast cells harbouring the human T cell lymphotropic virus type-I genome.
ATL and HTLV-I: in vivo cell growth of ATL cells.
Enhanced engraftment of HTLV-I-infected human T cells in severe combined immunodeficiency mice by anti-asialo GM-1 antibody treatment.
Expression of the interferon-gamma and interleukin-10 genes in rabbit HTLV-I-transformed T-cell lines.
Analysis of T cell receptor V beta expression in rabbit T lymphocytes induced to proliferate by an HTLV-I-transformed leukemogenic T cell line.
Synovial fluid T cells in HTLV-I positive RA.
In vitro infection of leukemic bone marrow with HTLV-I generates immortalized cell lines expressing T or myeloid cell phenotype.
Secretion of parathyroid hormone-like activity from human T-cell lymphotropic virus type I-infected lymphocytes.
Antimitotic and antiviral activities of Kelletinin A in HTLV-1 infected MT2 cells.
Analysis of a novel defective HTLV-I provirus and detection of a new HTLV-I-induced cellular transcript.
Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).
Constitutive overexpression of the L-selectin gene in fresh leukemic cells of adult T-cell leukemia that can be transactivated by human T-cell lymphotropic virus type 1 Tax.
Vertical transmission of human T-cell leukemia virus type I (HTLV-I): detection of proviral DNA in HTLV-I carrier gravida.
Regional localization of the putative cell surface receptor for HTLV-I to human chromosome 17q23.2-17q25.3.
HTLV-I activates complement leading to increased binding to complement receptor-positive cells.
Characterization of a HTLV-I-infected cell line derived from a patient with adult T-cell leukemia with stable co-expression of CD4 and CD8.
Preparation of a murine cell line which stably expresses human T lymphotropic virus type I (HTLV-I) env genome products.
Transformation of human leukocytes by co-cultivation with HTLV-1-associated myelopathy patients' leukocytes.
A survey of the human T-cell lymphotropic virus type I (HTLV-I) in south-western Colombia.
Differences in sensitivity to induction of apoptosis among rat fibroblast cells transformed by HTLV-I tax gene or cellular nuclear oncogenes.
Establishment of novel lymphoid cell lines dually infected with human T cell lymphotropic viruses types I and II.
Identification of two distinct elements in the long terminal repeat of HTLV-I responsible for maximum gene expression
Arthritis syndromes associated with human T cell lymphotropic virus type I infection.
Comparison of the response to T-cell activation by integrated HIV-1 and HTLV-1 LTR-lacZ vectors.
Transmission of HTLV-I and HIV among homosexual men in Trinidad.
A human chromosome 8 region with abnormalities in B cell, HTLV-I+ T cell and c-myc amplified tumours.
Increased reactivity to HTLV-I in inflammatory nervous system diseases.
HSP70 production and inhibition of cell proliferation in Molt-4 T-cells after cell-to-cell transmission of HTLV-I: effect of PGA1.
Enhanced human T-cell lymphotropic virus type I expression following induction of the cellular stress response.
Chronic myelopathies associated with human T-lymphotropic virus type I. A clinical, serologic, and immunovirologic study of ten patients in France.
Chronic hypertrophic cranial pachymeningitis associated with HTLV-I infection.
Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection.
The relationship between HTLV-I-infected cell lines and uveitis.
Tax protein of HTLV-1 destabilizes the complexes of NF-kappa B and I kappa B-alpha and induces nuclear translocation of NF-kappa B for transcriptional activation.
Recognition of human T-leukemia virus (HTLV-1) envelope by human CD4+ T-cell lines from HTLV-1 seronegative individuals: specificity and clonal heterogeneity.
Retroviral infection (HTLV-I) induces cytokine-regulated immunomodulation and cytotoxicity of medulloblastoma cells.
Oral infection of a common marmoset with human T-cell leukemia virus type-I (HTLV-I) by inoculating fresh human milk of HTLV-I carrier mothers.
HTLV-1 Tax enhances NF-kappa B2 expression and binds to the products p52 and p100, but does not suppress the inhibitory function of p100.
Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs.
Identification of transcriptional activation domain of TREB5, a CREB/ATF family protein that binds to HTLV-1 enhancer.
Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection.
A mathematical model of HTLV-I infection with two time delays.
Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines.
Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan.
Molecular phylogeny and dissemination of human T-cell lymphotropic virus type I viewed within the context of primate evolution and human migration.
Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors.
Cell-mediated transmission of human T cell lymphotropic virus type I to human malignant trophoblastic cells results in long-term persistent infection.
C3d and Epstein-Barr virus (CR2/CD21 ligands) stimulate cells of an HTLV-I line, MT-2.
Cell surface phenotypic changes induced in H9 T cells chronically infected with HTLV type I or HIV type 1 or coinfected with the two viruses.
Typing human T-cell lymphotropic virus (HTLV-I and HTLV-II) by nested polymerase chain reaction: application to clinical specimens.
Identification of HTLV-I- or HTLV-II-producing cells by cocultivation with BHK-21 cells stably transfected with a LTR-lacZ gene construct.
A rat model of HTLV-I infection: development of chronic progressive myeloneuropathy in seropositive WKAH rats and related apoptosis.
In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors.
Identification of MIP-1 alpha/LD78 as a monocyte chemoattractant released by the HTLV-I-transformed cell line MT4.
Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan.
Sequence analysis of the new human T cell leukemia/lymphoma virus type I isolate (HTLV-I) in Israel.
Expression and Purification of a Novel Computationally Designed Antigen for Simultaneously Detection of HTLV-1 and HBV Antibodies.
Performance of Liaison XL automated immunoassay platform for blood-borne infection screening on hepatitis B, hepatitis C, HIV 1/2, HTLV 1/2 and Treponema pallidum serological markers.
Characterization of an IL-2 dependent human T-cell leukemia-virus type-I (HTLV-I) infected cell-line - a system for studying HTLV-I mediated transformation.
Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription.
Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in general inhabitants in non-adult T-cell leukemia (ATL)-endemic Hokkaido, Japan.
Selective inhibition of human T-lymphotropic virus type I-transformed human T-cell growth by a tax-targeted conditionally cytotoxic recombinant retrovirus.
A single stem-loop structure within the HTLV-1 Rex response element is sufficient to mediate Rex activity in vivo.
A vaccine against HTLV-1 HBZ makes sense.
Transactivation of the human interleukin-6 gene by human T-lymphotropic virus type 1 Tax protein.
A truncated HTLV-I envelope protein, lacking the hydrophobic membrane anchor domain, is associated with cellular membranes and virions.
A new human endogenous DNA sequence homologous to HTLV-I pol.
A Severe Bite From a Nonhuman Primate Is a Major Risk Factor for HTLV-1 Infection in Hunters From Central Africa.
Regional specificity of HTLV-I proviral integration in the human genome.
Molecular characterization of HTLV-I infection in Israel.
Decrease of heat shock protein 27/28 with heat stress in HTLV-I-transformed cells.
Engraftment of HTLV-I-transformed human T-cell line into SCID mice with NK cell function.
Differential response of NF-kappa B1 p105 and NF-kappa B2 p100 to HTLV-I encoded Tax.
Effect of p40tax trans-activator of human T cell lymphotropic virus type I on expression of autoantigens.
High levels of CC-chemokine expression and downregulated levels of CCR5 during HIV-1/HTLV-1 and HIV-1/HTLV-2 coinfections.
Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.
Cross-neutralizing antibodies against cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands.
Tax protein of human T-lymphotropic virus type I triggers DNA damage.
Exposure of p19 matrix protein of human T-cell leukemia virus type I (HTLV-I) on the surface of MOLT-4#8 cells after virus adsorption.
Aberrant expression of the monocyte/macrophage phenotype in a human T cell line immortalized by HTLV-I and an adult T cell leukemia/lymphoma cell line.
Chromosome studies of H9/HTLV III B cells and blood lymphocytes infected with human immunodeficiency virus (HIV-1).
Human T-cell lymphotropic virus type I-associated facial nerve palsy in Trinidad and Tobago.
Production of interleukin-1 alpha and interleukin-2 by separate, phenotypically different leukaemia and human T cell lymphotropic virus-1-transformed T cell clones.
Editorial to the Research Topic "Comparative studies between HTLV-1 and HTLV-2 function and pathobiology".
Detection of HTLV-I pX gene by polymerase chain reaction using newly designed primers.
[Recurrent facial palsy revealing Human T-lymphotropic virus type 1 (HTLV-1) infection].
HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-kB with other transcription factor families.
Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I.
HTLV-I encoded Tax in association with NF-kappa B precursor p105 enhances nuclear localization of NF-kappa B p50 and p65 in transfected cells.
Bilateral uveitis in a rabbit experimentally infected with human T-lymphotropic virus type I.
Complete nucleotide sequence of HTLV-II isolate NRA: comparison of envelope sequence variation of HTLV-II isolates from U.S. blood donors and U.S. and Italian i.v. drug users.
HTLV-1 gene expression by defective proviruses in an infected T-cell line.
Synovial infiltration in human T lymphotropic virus type I-associated adult T cell leukemia/lymphoma.
Transcriptional activation of the interleukin-6 gene by HTLV-1 p40tax through an NF-kappa B-like binding site.
Generation of monoclonal antibodies to the rabbit interleukin-2 receptor alpha chain (CD25) and its distribution in HTLV-1-transformed rabbit T cells.
Leukemogenesis-associated antigen in HTLV-I-transformed rabbit cells.
Variation in HTLV-I sequences from rabbit cell lines with diverse in vivo effects.
Characterization of human T-lymphotropic virus type I- and II-infected T-cell lines: antigenic, phenotypic, and genotypic analysis.
Emergence of double-positive CD4/CD8 cells from adult peripheral blood mononuclear cells infected with human T cell leukemia virus type I (HTLV-I).
Glycosphingolipid compositions of human T-lymphotropic virus type I (HTLV-I) and human immunodeficiency virus (HIV)-infected cell lines.
Expression of complement receptor 2 (CR2) on HTLV-1-infected lymphocytes and transformed cell lines.
Detection of human T-cell lymphotropic virus type 1 infection by the polymerase chain reaction using dried blood specimens on filter papers.
The clinical relevance of HTLV type I and II in transfusion medicine.
A human T lymphotropic virus type I (HTLV-I) long terminal repeat-directed antisense c-myc construct with an Epstein-Barr virus replicon vector inhibits cell growth in a HTLV-I-transformed human T cell line.
Stimulation of HTLV-I expression by subtoxic dose of 3-methylcholanthrene.
Identification of a putative cellular receptor for HTLV-I by a monoclonal antibody, Mab 34-23.
In vitro thermal enhancement of human T-cell leukaemia/lymphoma virus type I (HTLV-I) in HTLV-I-transformed cells.
Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy.
Constitutive expression and production of tumor necrosis factor-beta in T-cell lines infected with HTLV-I and HTLV-II.
Molecular determinants of PDLIM2 in suppressing HTLV-I Tax-mediated tumorigenesis.
Induction of micronuclei by HTLV-I Tax: a cellular assay for function.
Multiple arginine residues within the basic domain of HTLV-I Rex are required for specific RNA binding and function.
The human T-cell lymphotropic viruses types I/II are not involved in T prolymphocytic leukemia and large granular lymphocytic leukemia.
Cell-type-specific transactivation of the parathyroid hormone-related protein gene promoter by the human T-cell leukemia virus type I (HTLV-I) tax and HTLV-II tax proteins.
Transcription of the gene for parathyroid hormone-related peptide from the human is activated through a cAMP-dependent pathway by prostaglandin E1 in HTLV-I-infected T cells.
Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells.
Over expression of insulin-like growth factor receptor type-I in T-cell lines infected with human T-lymphotropic virus types-I and -II.
Comparative study of human and rabbit cell infection with cell-free HTLV-I.
Human T-lymphotropic virus type I tax regulates the expression of the human lymphotoxin gene.
HTLV-1 Tax protein recruitment into IKKε and TBK1 kinase complexes enhances IFN-I expression.
Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B.
Association of mycoplasma with HIV-1 and HTLV-I in human T lymphocytes.
Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells.
Absence of HTLV-I and HTLV-II proviral genome in the brains of patients with multiple sclerosis and amyotrophic lateral sclerosis.
Characterization of the antibody response to three different versions of the HTLV-I envelope protein expressed by recombinant vaccinia viruses: induction of neutralizing antibody.
HTLV-I and HTLV-II tax trans-activate the human EGR-1 promoter through different cis-acting sequences.
Simultaneous expression of T-cell and myeloid cell phenotypes in eight newly established HTLV-I-positive T-cell lines.
A high proportion of early response genes are constitutively activated in T cells by HTLV-I.
Adult T-cell leukaemia-derived factor/thioredoxin expression on the HTLV-I transformed T-cell lines: heterogeneous expression in ALT-2 cells.
Inhibitory effects of human interferons on the immortalization of human, but not rabbit, T lymphocytes by human T-lymphotropic virus type-I (HTLV-I).
Human T-lymphotropic virus type I proviral loads in patients with adult T-cell leukemia-lymphoma: Comparison between cutaneous type and other subtypes.
Infection of the HTLV-I-harbouring T-lymphoblastoid line MT-2 by Epstein-Barr virus.
Evaluation of immunodominant epitopes of human T-lymphotropic virus type 1 (HTLV-I) using synthetic peptides.
Comparative anti-viral and anti-proliferative activity of PGA1 and PGJ2 against HTLV-I-infected MT-2 cells.
Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping.
Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective study.
Detection of amplified HTLV-I/-II viral sequences using time-resolved fluorometry.
Successful graft of HTLV-I-transformed human T-cells (MT-2) in severe combined immunodeficiency mice treated with anti-asialo GM-1 antibody.
Geographical subtypes demonstrated by RFLP following PCR in the LTR region of HTLV-I.
Human T-cell leukemia virus type I(HTLV-I) infection of T cells bearing T-cell receptor gamma delta: effects of HTLV-I infection on cytotoxicity.
An antigenic structure of the trans-activator protein encoded by human T-cell leukemia virus type-I (HTLV-I), as defined by a panel of monoclonal antibodies.
[Parasitic pneumonia and HTLV-1 infection].
Clinical indications of multiple integrations of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma.
Transactivation of the c-myc gene by HTLV-1 tax is mediated by NFkB.
Oligo-2',5'-adenylate synthetase activity in cells persistently infected with human T-lymphotropic virus type I (HTLV-I).
Parathyroid hormone-related protein binding to human T-cell lymphotropic virus type I-infected lymphocytes.
Inefficient transmission of HTLV-I to MOLT-4 cells by cell-free virus and cocultivation.
Constitutive expression of c-jun and jun-B in cell lines infected with human T-lymphotropic virus types I and II.
Alternatively spliced mRNA of the pX region of human T lymphotropic virus type I proviral genome.
NLRP3 polymorphism is associated with protection against human T-lymphotropic virus 1 infection.
Infection of rats with HTLV-1: a small-animal model for HTLV-1 carriers.
Transactivation of Krox-20 and Krox-24 promoters by the HTLV-1 Tax protein through common regulatory elements.
NF-kappa B activity in T cells stably expressing the Tax protein of human T cell lymphotropic virus type I.
Synergism between two distinct elements of the HTLV-I enhancer during activation by the trans-activator of HTLV-I.
ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity.
Comparison between strains of human T lymphotropic virus type I isolated from inhabitants of the Solomon Islands and Papua New Guinea.
A synthetic peptide elicits antibodies reactive with the external glycoprotein of human T cell lymphotropic virus type I.
Functional conversion from HIV-1 Rev to HTLV-1 Rex by mutation.
Accumulation of p60lck in HTLV-I-transformed T cell lines detected by an anti-lck monoclonal antibody, MOL 171.
[Cutaneous manifestations detected in human T cell lymphotropic virus type 1 infected Chilean blood donors].
High prevalence of human T cell lymphotropic virus type II infection in patients affected by human immunodeficiency virus type 1--associated predominantly sensory polyneuropathy.
Differential expression of two lck transcripts directed from the distinct promoters in HTLV-I+ and HTLV-I- T-cells.
Direct binding of complement component C1q to human immunodeficiency virus (HIV) and human T lymphotrophic virus-I (HTLV-I) coinfected cells.
Chemoattractant(s) in culture supernatants of HTLV-I-Infected T-cell lines.
Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence.
trans-activation of the HIV-1 LTR by the HIV-1 Tat and HTLV-I Tax proteins is mediated by different cis-acting sequences.
HTLV-1 Tax induces expression of various immediate early serum responsive genes.
Constitutive IL-2 expression in HTLV-I-infected leukaemic T cell lines.
Human T-cell lymphotropic virus-1-positive T-cell leukemia/lymphoma in a child. Report of a case and review of the literature.
Priming for in vitro and in vivo anti-human T lymphotropic virus type 1 cellular immunity by virus-related protein reconstituted into liposome.
Transcriptional block of HTLV-I LTR by sequence-specific methylation.
Verification of HTLV-I infection in the Solomon Islands by virus isolation and gene amplification.
Malignant and nonmalignant T cell lines from human T cell lymphotropic virus type I-negative patients with Sézary syndrome.
The nucleolar localisation signal of the HTLV-I protein p27rex is important for stabilisation of IL-2 receptor alpha subunit mRNA by p27rex.
Can HTLV-1 infection be a potential risk factor for atherosclerosis?
IL-6 production by human T lymphocytes. Expression in HTLV-1-infected but not in normal T cells.
Reciprocal activation of human T-lymphotropic viruses in HTLV-I-transformed cells superinfected with HIV-1.
A murine cell line producing HTLV-I pseudotype virions carrying a selectable marker gene.
Coexistence of fusion receptors for human T-cell leukemia virus type-I (HTLV-I) and human immunodeficiency virus type-1 (HIV-1) on MOLT-4 cells.
Sensitivity and specificity of human T-lymphotropic virus (HTLV) types I and II polymerase chain reaction and several serologic assays in screening a population with a high prevalence of HTLV-II.
Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes.
Expression of HTLV-I envelope protein fused to hydrophobic amino-terminal peptide of baculovirus polyhedrin in insect cells and its application for serological assays.
Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits.
HTLV-I sequences are not detected in peripheral blood genomic DNA or in brain cDNA of multiple sclerosis patients.
p24 protein of a human T-lymphotropic virus type-I (HTLV-I) producing cell line (TCL-Kan) reacts with some normal pregnant women's sera.
Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma?
Chromosome and gene rearrangements in immortalized human lymphocytes infected with human T-lymphotropic virus type I.
Molecular and Cellular Mechanism of Leukemogenesis of ATL: Emergent Evidence of a Significant Role for HBZ in HTLV-1-Induced Pathogenesis.
Human T-lymphotropic virus type I transcriptional regulation by methylation.
HTLV-1 Infection and Its Associated Diseases.
Ribosome-lamella complexes observed in an Epstein-Barr virus-producing B-cell line, infected with human T-lymphotropic virus type I.
Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I (HTLV-I).
Kinetics of HIV-1 replication and intracellular accumulation of particles in HTLV-I-transformed cells.
Recognition of human T cell leukemia virus type I (HTLV-I) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells.
Structure-function analyses of the HTLV-I Rex and HIV-1 Rev RNA response elements: insights into the mechanism of Rex and Rev action.
Transmission of HTLV-I to rabbits via semen and breast milk from seropositive healthy persons.
Expression of a zinc finger gene in HTLV-I- and HTLV-II-transformed cells.
mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1-transformed T cells.
HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene.
HTLV-1 bZIP factor HBZ promotes cell proliferation and genetic instability by activating OncomiRs.
Persistent infection of rabbits with HTLV-I: patterns of anti-viral antibody reactivity and detection of virus by gene amplification.
Efficacy of an HTLV-1 subunit vaccine in prevention of a STLV-1 infection in pig-tailed macaques.
Evaluation of a HTLV-1 subunit vaccine in prevention of experimental STLV-I infection in Macaca nemestrina.
Coexpression of the genes for platelet-derived growth factor and its receptor in human T-cell lines infected with HTLV-I.
Effects of nutrients on matrix metalloproteinases in human T-lymphotropic virus type 1 positive and negative malignant T-lymphocytes.
Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-I (HTLV-I).
Trans-activation of human globin genes by HTLV-I tax1.
Detection of human immunodeficiency virus (HIV) and human lymphotropic virus (HTLV) type I or II dual infections by polymerase chain reaction.
Functionally different HTLV I-infected T cell lines with the same phenotype derived from a patient with melanoma.
Chromatographic analysis of the aminoacyl-tRNAs which are required for translation of codons at and around the ribosomal frameshift sites of HIV, HTLV-1, and BLV.
[Adult T-cell leukemia and HTLV-I].
Characteristic regional prevalence of HTLV-I in Shimane Prefecture.
HTLV-I p30: a versatile protein modulating virus replication and pathogenesis.
The association of HTLV-1 infection, persistent intestinal infection with Strongyloides stercoralis and gastrointestinal lymphoma.
Evaluation of a new generation synthetic peptide combination assay for detection of antibodies to HIV-1, HIV-2, HTLV-I, and HTLV-II simultaneously.
Human T-cell lymphotropic virus type I infection in neonates.
Seronegative virus carriers in the infection of rabbits with human T lymphotropic virus type I.
Study of the Association between Human T-cell Lymphotropic Virus Type 1 Infection and Lichen Planus
Markers of HTLV-I-related virus in hamadryas baboon lymphoma.
Inability to detect human T cell lymphotropic virus type 2-specific antibodies in a patient coinfected with HIV-1, human T cell lymphotropic virus type 1, human T cell lymphotropic virus type 2, and hepatitis C virus.
Expansion of natural killer cells in peripheral blood in a Japanese elderly with human T-cell lymphotropic virus type 1-related skin lesions.
Regression of HTLV1 associated intracardiac lymphoma following chemotherapy.
PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo
[A study of sera positive and doubtful for antibodies to the human immunodeficiency virus for the presence of HTLV-I-specific antibodies].
HTLV-I antibodies associated with cutaneous T cell lymphoma in Denmark.
Absence of HTLV I from New Zealand.
Imaging Spinal Cord Atrophy in Progressive Myelopathies: HTLV-I Associated Neurologic Disease (HAM/TSP) and Multiple Sclerosis (MS).
HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia.
Retinal Nerve Fiber Layer Thickness in Human T-cell Lymphotropic Virus Type 1 Patients.
Viral Causes of Lymphoma: The History of Epstein-Barr Virus and Human T-Lymphotropic Virus 1
Glucose Metabolism and Oxygen Availability Govern Reactivation of the Latent Human Retrovirus HTLV-1.
Prosultiamine for treatment of lower urinary tract dysfunction accompanied by human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis.
Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells.
Prevalence of serum antibodies to human T lymphotropic virus-1 in an isolated tribe in the highlands of Irian Jaya, Indonesia.
HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT).
Transfusion-transmitted human T-lymphotropic virus Type I infection in a United States military emergency whole blood transfusion recipient in Afghanistan, 2010.
Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
Severe hypercalcaemia and lymphoma in an HTLV-1 positive Jamaican woman: a case report.
[HTLV-I negative T helper/inducer phenotype chronic lymphocytic leukemia associated with OKT3 epitope deficiency--a case report]
Defective provirus form of human T-cell leukemia virus type I in adult T-cell leukemia/lymphoma: clinicopathological features.
The second pX product p27 chi-III of HTLV-1 is required for gag gene expression.
Prevalence of HIV-1 and HIV-2/HTLV-IV infections in Luanda and Cabinda, Angola.
In vitro susceptibility of different human T-cell subpopulations and resistance of large granular lymphocytes to HTLV-I infection.
HTLV-I and HIV-1 infection in patients with lymphadenopathy syndrome detected during routine breast screening at a tumor prevention center.
HTLV-I carrier mothers with high-titer antibody are at high risk as a source of infection.
Deregulation of interleukin-2 receptor gene expression in HTLV-I-induced adult T-cell leukemia.
Degeneration of oxidative muscle fibers in HTLV-1 tax transgenic mice.
Immunohistochemical localization of HTLV-I p19- and p24-related antigens in synovial joints of patients with rheumatoid arthritis.
Failure to isolate human T cell lymphotropic virus type I and to detect variant-specific genomic sequences by polymerase chain reaction in Melanesians with indeterminate western immunoblot.
A comparison of HIV-1, HBV, and HTLV-I/II seroprevalence rates of injured patients admitted through California emergency departments.
Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells.
Antibody profile of early HTLV-I infection.
Myb protein binds to multiple sites in the human T cell lymphotropic virus type 1 long terminal repeat and transactivates LTR-mediated expression.
HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition.
Unstabilized DNA breaks in HTLV-1 Tax expressing cells correlate with functional targeting of Ku80, not PKcs, XRCC4, or H2AX.
[Measurement of antibodies to human T-lymphotropic virus type-1 (HTLV-1) in cerebro-spinal fluid in patients infected HTLV-1 by blood transfusion]
Mode of transmission of human T-cell leukemia virus type I (HTLV I) in a human promyelocytic leukemia HL60 cell.
Forefront studies on HTLV-1 oncogenesis.
Spontaneous neutrophil activation in HTLV-1 infected patients.
[Inclusion body myositis after interferon-alpha treatment in a patient with HCV and HTLV-1 infection].
Molecular insights on analogs of HIV PR inhibitors toward HTLV-1 PR through QM/MM interactions and molecular dynamics studies: comparative structure analysis of wild and mutant HTLV-1 PR.
Selective killing of human T cell lymphotropic virus type I-transformed cell lines by a damavaricin Fc derivative.
HTLV-1 infection: role of CTL efficiency.
Origin of HTLV-1 in hunters of nonhuman primates in Central Africa.
Characterization of overt and occult hepatitis B virus infection among HTLV-1 positive healthy carriers in the Northeast of Iran; AN HTLV-I endemic area.
Suppression of c-myc mRNA expression by steroid hormones in HTLV-I-infected T-cell line, KH-2.
The transcription elongation factor ELL2 is specifically upregulated in HTLV-1-infected T-cells and is dependent on the viral oncoprotein Tax.
Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP.
Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites.
Plant-derived diterpene esters enhance HTLV-I-induced colony formation of lymphocytes in co-culture.
Synthesis and antiviral activity of various 3'-azido analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1, HTLV-III/LAV).
Prevalence of human T-lymphotropic virus type 1 carriers among pregnant women in Hokkaido, Japan.
Acute human T-lymphotropic virus type I-associated myelitis: a rare case successfully treated with intravenous pulse methylprednisolone.
Development of T cell lymphoma in HTLV-1 bZIP factor and Tax double transgenic mice.
CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia/lymphoma.
Effect of prime-site sequence of retro-inverso-modified HTLV-1 protease inhibitor.
HBZ and its roles in HTLV-1 oncogenesis.
Transient increment of HTLV-2 proviral load in HIV-1-co-infected patients during treatment intensification with raltegravir.
HTLV-I infection: a dynamic struggle between viral persistence and host immunity.
Ophthalmic presentation of relapsed HTLV1- associated adult T-cell leukaemia lymphoma (ATLL) in a Trinidadian man.
Increased expression of HBZ and Foxp3 mRNA in bronchoalveolar lavage cells taken from human T-lymphotropic virus type 1-associated lung disorder patients.
HTLV-1-associated arthropathy treated with anti-TNF-alpha agent.
Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series.
Influence of human T-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis C virus infection.
Of mice, men, and HTLV-1.
Pilates exercises improve low back pain and quality of life in patients with HTLV-1 virus: a randomized crossover clinical trial.
Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
Lack of evidence for human T-lymphotropic virus type 1 and mouse mammary tumor-like virus involvement in the genesis of childhood acute lymphoblastic leukemia.
Effects of tDCS-induced motor cortex modulation on pain in HTLV-1: a blind randomized clinical trial.
An animal model of adult T-cell leukemia: humanized mice with HTLV-1-specific immunity.
Current status of HTLV-1 carrier in Japanese pregnant women.
Quantitative analysis of human T-lymphotropic virus type 1 (HTLV-1) gene expression using nucleo-cytoplasmic fractionation and splice junction-specific real-time RT-PCR (qRT-PCR).
Treatment with anti–tumor necrosis factor biologic agents in human T lymphotropic virus type I–positive patients with rheumatoid arthritis.
Resveratrol suppresses cell proliferation via inhibition of STAT3 phosphorylation and Mcl-1 and cIAP-2 expression in HTLV-1-infected T cells.
Phylogenetic analysis of human T cell lymphotropic virus type 1 isolated from Cuban individuals.
The HTLV-1 HBZ protein inhibits cyclin D1 expression through interacting with the cellular transcription factor CREB.
Relevance of molecular tests for HTLV-1 infection as confirmatory tests after the first sero-screening.
Bcl-3, induced by Tax and HTLV-1, inhibits NF-κB activation and promotes autophagy.
Mosaicism of HTLV-1 5' LTR CpG methylation in the absence of malignancy.
Characteristics of co-infections by HCV and HBV among Brazilian patients infected by HIV-1 and/or HTLV-1.
Delayed seroconversion and rapid onset of lymphoproliferative disease after transmission of human T-cell lymphotropic virus type 1 from a multiorgan donor.
Validation of a quantitative real-time PCR assay for HTLV-1 proviral load in peripheral blood mononuclear cells.
Expression of rhesus blood group antigens in HTLV-i infection in northeast Iran.
HTLV-I Tax regulates the cellular proliferation through the down-regulation of PIP3-phosphatase expressions via the NF-κB pathway
HTLV-1 cosmopolitan and HTLV-2 subtype b among pregnant women of non-endemic areas of Argentina.
The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors.
Correction: HTLV-1 bZIP Factor Enhances T-cell Proliferation by Impeding the Suppressive Signaling of Co-inhibitory Receptors.
HTLV-I-associated posttransplant lymphoproliferative disorder following virus transmission from recipient to donor cells.
Correction: Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells
Case for diagnosis. Infective dermatitis associated with HTLV-1: differential diagnosis of atopic dermatitis.
HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice.
Comment: seroprevalence of HTLV-1/2 among blood donors in the state of Maranhão, Brazil.
Histopathological and immunohistochemical assessment of acquired ichthyosis in patients with human T-cell lymphotropic virus type I-associated myelopathy.
Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
The tax protein-DNA interaction is essential for HTLV-I transactivation in vitro.
The mouse homologue of the HTLV-I tax responsive element binding protein TAXREB107 is a highly conserved gene which may regulate some basal cellular functions.
Inhibition of caspase cascade by HTLV-I tax through induction of NF-kappaB nuclear translocation.
Up-regulation of human T lymphotropic virus type 1 (HTLV-1) tax/rex mRNA in infected lung tissues.
In vitro infection of cell lines with HTLV-I and SIVmac results in altered intracellular free calcium concentration and increased membrane polarization.
Identification of an initiator-like element within the HTLV-I promoter.
Identification of HTLV-I 21 bp repeat-specific DNA-protein complexes.
Increased susceptibility of peripheral mononuclear cells of leukemic patients to HTLV-I infection in vitro.
EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I-associated adult T-cell leukemia/lymphoma.
Editorial Commentary: Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) and HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
[A case of polyneuropathy with B-CLL and HTLV-I associated myelopathy (HAM)]
Role of 7,8-dihydroneopterin in T-cell apoptosis and HTLV-1 transcription in vitro.
Safe blood? HTLV-1 infection is crippling.
A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40 chi HTLV-I.
Structural features of two T-cell-specific genes that suggest a potential role in HTLV-I-associated pathology.
Seroprevalence of HTLV-I and HTLV-II infection among immigrants in northern Italy.
Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I).
The low evolutionary rate of human T-cell lymphotropic virus type-1 confirmed by analysis of vertical transmission chains.
Nucleotide sequence analysis of isolates of human T-lymphotropic virus type 1 of diverse geographical origins.
Erratum to: 'Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia'.
Seroprevalence and risk factors associated with HTLV-I/II infection in injection drug users in northern New Jersey.
Ancient HTLV type 1 provirus DNA of Andean mummy.
Immunodominant B-cell clones responsive to an HIV-1 neutralization and cell fusion inhibition epitope in chimpanzee-to-chimpanzee passages of HTLV-IIIB and LAV-1.
Identification of HTLV-I gag protease and its sequential processing of the gag gene product.
HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells.
HIV, HTLV-1, and HBV infections in a cohort of Italian intravenous drug abusers: analysis of risk factors.
Isolation of HTLV-1 from an aggressive form of ATL in a Romanian patient not at risk of infection and with seronegative family members.
Comparative trends of seroprevalence and seroincidence rates of human T cell lymphotropic virus type I and human immunodeficiency virus 1 in pregnant women of various ethnic groups sharing the same environment in French Guiana.
Sero-epidemiologic and phylogenetic studies of HTLV-I infection in 2 countries of the Caspian Sea region.
Differential Tax expression in HTLV type I-infected asymptomatic carriers.
HTLV-I in Northeast Brazil: differences for male and female injecting drug users.
Human T-lymphotropic virus type I (HTLV-I) provirus-related DNA sequences in peripheral blood mononuclear cells of a patient, in the absence of a definite serological positivity.
The NK cell as a new player in the pathogenesis of HTLV-I associated neurologic disease
HTLV-I screening in Britain. Antenatal screening is important.
Human T-cell lymphotropic virus Type I association with Strongyloïdes stercoralis: a case control study among Caribbean blood donors from Guadeloupe (French West Indies)
Two distinct regions form a functional activation domain of the HTLV-1 trans-activator Tax1.
Dual effects of HTLV-1 bZIP factor in suppression of interferon regulatory factor 1.
[Cloning proviral DNA sequences of the human T-cell leukemia virus (HTLV-1) from the genome of cultured MT-4 cells]
The use of an HTLV-I-infected human T-cell line (ATH8) in an interleukin-2 bioassay.
A unique T-cell line derived from an HTLV-1-negative adult T-cell leukemia patient.
Rat lymphoid cell lines with HTLV-I production. III. Transmission of HTLV-I into rats and analysis of cell surface antigens associated with HTLV-I.
HTLV-1 HBZ positively regulates the mTOR signaling pathway via inhibition of GADD34 activity in the cytoplasm.
Human PKR transfected into murine cells stimulates expression of genes under control of the HIV1 or HTLV-I LTR.
Immortalization of human T lymphocytes by HTLV-I: phenotypic characteristics of target cells and kinetics of virus integration and expression.
A monoclonal antibody detecting a novel antigen expressed in the HTLV-I-infected cells.
HTLV-I screening in Britain.
Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
The tax mutation at nucleotide 7959 of human T-cell leukemia virus type 1 (HTLV-1) is not associated with tropical spastic paraparesis/HTLV-1-associated myelopathy but is linked to the cosmopolitan molecular genotype.
Human T cell lymphotropic virus type I and cutaneous T cell leukemia/lymphoma.
HTLV-I and HTLV-II in Africans.
Prevalence of markers for human immunodeficiency virus types 1 and 2, human T-lymphotropic virus type I, cytomegalovirus, and hepatitis B and C virus in multiply transfused thalassemia patients. The French Study Group On Thalassaemia.
Antibody to HIV-1, HTLV-I, and HCV in three populations of rural Haitians.
Antibody prevalence of parenterally transmitted viruses (HIV-1, HTLV-I, HBV, HCV) in Austrian intravenous drug users.
Suppression of skin reactivity to purified protein derivative by hepatitis C virus among HTLV-I carriers in Japan.
Presence of human immunodeficiency virus (HIV) and T-lymphotropic virus type I and II (HTLV-I/II) in a haemophiliac population in Belo Horizonte, Brazil, and correlation with additional serological results.
Human T-lymphotropic virus type 1 infection in a patient with arthritis in mozambique: molecular characterization of human T-lymphotropic virus type 1 isolate.
Markedly high seroprevalence of hepatitis B virus infection in comparison to hepatitis C virus and human T lymphotropic virus type-1 infections in selected Solomon Islands populations.
Influence of human T-cell lymphotropic virus type 1 (HTLV-1) Infection on laboratory parameters of patients with chronic hepatitis C virus.
A unique seroepidemiological pattern of HBV, HCV and HTLV-I in Nenets and Komi in northwestern Russia.
Prevalence of HTLV-1/2 infections in Spain: A cross-sectional hospital-based survey.
Sarcoidosis and HTLV-1 infection.
A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic score.
HTLV-I and HIV infection of the CNS in tropical areas.
Splenic lymphoproliferative disorders in human T lymphotropic virus type-I endemic area of japan: clinicopathological, immunohistochemical and genetic analysis of 27 cases.
Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance.
Antibody to the human T-lymphotropic virus type 1 (HTLV-1) envelope protein Gp46 in patients co-infected with HCV and HTLV-1.
The pleiotropic protein kinase CK2 phosphorylates HTLV-1 Tax protein in vitro, targeting its PDZ-binding motif.
Absence of HTLV-1/2 infection among HCV-infected patients with no HIV-1/2 infection in Spain.
Antibodies to HCV and HTLV-I in a group of HIV-seropositive STD patients.
A serosurvey of hepatitis B virus, hepatitis C virus, human T lymphotropic virus type-1 and syphilis in HIV-1-infected patients in Jamaica.
Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection.
HTLV-1, HIV-1, hepatitis B and hepatitis delta in the Pacific and South-East Asia: a serological survey.
Gender influence on the progression of HTLV-I associated myelopathy/tropical spastic paraparesis.
Human T lymphotropic virus type I (HTLV-1) associated myelopathy acquired through a liver transplant.
[Adult T-cell leukemia induced by HTLV-1: before and after HBZ].
[Case report of HTLV-1 associated myelopathy (HAM) manifested after renal transplantation].
Human T cell lymphotropic virus type I associated uveitis in a child.
[Acral crusted scabies in two HTLV1-infected patients].
Evaluation of retro-inverso modifications of HTLV-1 protease inhibitors containing a hydroxyethylamine isoster.
HTLV-1 virus detected in Nunavut.
Substitution of HIV Type 1 Nef with HTLV-1 p12.
HTLV-I infection in British and Jamaican relatives of British patients with tropical spastic paraparesis.
HTLV-I screening in Britain. Donors and recipients of organ transplants should also be screened.
HTLV-I screening in Britain. Blood supply in Britain should be made safer.
Aurora kinase inhibitor AZD1152 negatively affects the growth and survival of HTLV-1-infected T lymphocytes in vitro.
HTLV-I screening in Britain. Failure to screen may be a false economy.
HLA-DMB restricts human T-cell leukemia virus type-1 (HTLV-1) protein expression via regulation of ATG7 acetylation.
Phylogeny of primate T lymphotropic virus type 1 (PTLV-1) including various new Asian and African non-human primate strains.
Correction: Interferon-γ Promotes Inflammation and Development of T-Cell Lymphoma in HTLV-1 bZIP Factor Transgenic Mice.
Single-cell heterogeneity and cell-cycle-related viral gene bursts in the human leukaemia virus HTLV-1.
HTLV-I infection in French West Indies: a case-control study.
[Prevalence of human T-cell lymphotropic virus type I among Dutch blood donors]
Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.
[Tropical spastic paraparesis and mixed infection due to Treponema pallidum and HTLV-I]
Antibodies to human T lymphotropic virus type I in a population from the Philippines: evidence for cross-reactivity with Plasmodium falciparum.
Epstein-Barr virus-related Hodgkin's disease showing B cell lineage in an immunosuppressive patient seropositive for HTLV-I.
[A case of tropical spastic paraparesis associated with HTLV1 in the Niger Republic]
Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection.
Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden.
Neutralizing activity of human antibodies against the structural protein of human T-cell lymphotropic virus type I.
[Association between diffuse panbronchiolitis and HTLV-I infection]
Study of HTLV-I prevalence in patients with sexually transmitted diseases in Perm and Ekaterinburg, Russia.
Herpes simplex virus types 1 and 2, chlamydia, syphilis, and toxoplasma in pregnant Japanese women with HTLV-I.
Production of phagocytosis-inducing factor and expression of 4B4 antigen by cloned human T cells before and after transformation with HTLV-I.
[Autonomic functions in human T-lymphotropic virus type-I (HTLV-1) associated myelopathy].
Studies on the mechanisms of HTLV-I leukemogenesis.
Use of PCR amplification for diagnosis of HTLV-I infection after blood transfusion.
Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding.
Blood transfusion as a major risk factor for HTLV-I infection among hospitalized children in Gabon (Equatorial Africa).
[The immune response to human T-cell lymphotropic virus type 1]
HTLV-1 has reached Thailand via a heterosexual route.
Detection of human T lymphotrophic virus type I (HTLV-I) DNA and mRNA in individual cells by polymerase chain reaction (PCR) in situ hybridization (ISH) and reverse transcription (RT)-PCR ISH.
HIV-1, HIV-2 and HTLV-I in Spanish inmates.
HTLV-II in patients with HTLV-I-associated myelopathy.
Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1.
Direct binding of the N-terminus of HTLV-1 tax oncoprotein to cyclin-dependent kinase 4 is a dominant path to stimulate the kinase activity.
Frequent infection with human T-cell lymphotropic virus type I in patients with AIDS but not in carriers of human immunodeficiency virus type 1.
An immunoglobulin G antibody capture particle-adherence test (GACPAT) for antibody to HIV-1 and HTLV-I that allows economical large-scale screening.
[Absence of HIV 1/HTLV I "autochtonous" coinfection in the region of Nice].
Early antibody profile during HTLV-I seroconversion.
[Neurologic manifestations related to HTLV-1 viruses].
[Identification of HTLV-I markers in patients with hemoblastoses]
[Chronic rheumatoid arthritis model mice transgenic for the HTLV-I tax gene]
[Neurogenic bladder in HAM (HTLV-I associated myelopathy)]
[HTLV-I antibody screening of blood donors]
Antiviral activity of individual versus combined treatments with interferon alpha, beta and gamma on early infection with HTLV-I in vitro.
Prevention of transmission of human T-cell lymphotropic virus type-I by blood transfusion by screening of donors.
Myelopathy and coinfection with HIV and HTLV-I.
Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma.
HTLV-I infection in selected populations in Australia and the western Pacific region.
[The expression of the gag precursor of the T-cell leukemia type-I virus (HTLV-I) in Escherichia coli cells].
Evaluation of enzyme immunoassay using a recombinant envelope protein expressed in insect cells for serological confirmation of HTLV-I infection.
Lymphoma-type adult T-cell leukaemia-lymphoma with a bulky cutaneous tumour showing multiple human T-lymphotropic virus-1 DNA integration.
U3 sequences from HTLV-I and -II LTRs confer pX protein response to a murine leukemia virus LTR.
Quantitative analysis of AIDS-related virus-carrying cells by plaque-forming assay using an HTLV-I-positive MT-4 cell line.
Serum human T-lymphotropic virus 1 proviral load in patients on hemodialysis.
p21rex protein of HTLV-1.
Apoptosis in labial salivary glands from Sjögren's syndrome (SS) patients: comparison with human T lymphotropic virus-I (HTLV-I)-seronegative and -seropositive SS patients.
Seroprevalence of HTLV-I in Portugal and evidence of double retrovirus infection of a healthy donor.
Seroprevalence and risk factors for HTLV-I/II infection among female prostitutes in the United States.
Enzyme immunoassay with synthetic peptides to detect anti-HTLV-I antibodies.
[Immunological analysis of HTLV-I env-pX transgenic rat with various collagen vascular diseases].
Detection of the HTLV-I gene on cytologic smear slides.
HTLV-I/HTLV-II-a model for virus associated neurodegenerative diseases.
Clinical evolution of cutaneous T cell lymphoma in a patient with antibodies to human T-lymphotropic virus type I.
Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/II-seropositive blood donors of the French West Indies.
Congenital hydrocephalus due to intrauterine HTLV-I infection.
A seroepidemiological survey of HTLV-I/HTLV-II in selected Belgian populations.
Effects of exogenous interleukin-7 on CD8(+) T-cell survival and function in human T-cell lymphotropic virus type 1 infection.
One-step chromatographic purification procedure of a His-tag recombinant carboxyl half part of the HTLV-I surface envelope glycoprotein overexpressed in Escherichia coli as a secreted form.
Human T-cell lymphotropic virus, type I (HTLV-I) reported in British Columbia.
Anti-HIV-1 antibodies, anti-HTLV-I antibodies and neopterin levels in parenteral drug addicts in the Austrian Tyrol.
Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki.
Human T-cell leukemia virus type-I/II (HTLV-I/II) serologic testing: the importance of assaying for the full complement of viral antigens.
[Detection of HTLV-I gene expression by using the polymerase chain reaction].
Human T-cell lymphotropic virus type 1 infective dermatitis emerging in adulthood.
Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.
[Present status of HTLV-I infections in developing countries and the countermeasures].
[Uveo-papillitis associated with paraparesis caused by HTLV-1 virus].
The LAV/HTLV-III screening in Copenhagen. Epidemiological results from four clinics over the period 1 July 1984 to 1 April 1985.
[HTLV-I associated myelopathy (HAM) in Fukushima Prefecture]
Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers.
Non-Hodgkin lymphoma in Gabon and its relation to HTLV-I.
Alcohol and immune function in HIV-1 seronegative, HTLV-I/II seronegative and positive men on methadone.
Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki.
Does human T-cell lymphotropic virus type I and human immunodeficiency virus type 1 coinfection accelerate acquired immunodeficiency syndrome? The jury is still out.
Human T-cell lymphotropic virus types I and II infections in patients with leukaemia/lymphoma and in subjects with sexually transmitted diseases in Nigeria.
A case of classical mycosis fungoides associated with human T-cell lymphotropic virus type I.
[Smoldering adult T-cell leukemia--HTLV-I has also an etiologic role in the diseases other than ATL]
HLA-DP antigens and HTLV-1 antibody status among Japanese with multiple sclerosis: evidence for an increased frequency of HLA-DPw4.
Adult T-cell leukemia with anti-HTLV-I antibody but no HTLV-I DNA in tumor cells.
Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia.
Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases.
[HTLV-I infection and blood transfusion]
Prevalence of antibodies to HTLV-1 in South American Indians (Mapuches) from Chile.
CD30-positive anaplastic large cell lymphoma in a human T-cell lymphotropic virus-I endemic area.
[Cerebrospinal fluid analysis and the pathogenesis of central nervous system infection by HTLV-I]
[Recurring anguilluliasis and pleomorphic T lymphoma associated with anti-HTLV-I antibodies].
Spastic paraparesis and HTLV-I infection in Peru.
Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events.
CD30-positive lymphoma in human T-cell leukaemia virus type 1 carrier without monoclonal integration of HTLV-1.
The seroepidemiology of HTLV-I amongst genitourinary medicine (GUM) attendees in South East London.
Mononuclear cells from peripheral blood of adult donors and from cord blood are equally protected by alpha- and beta-interferons against infection with HTLV-I.
[Coexistence of HIV-1 and HTLV-1 infections in Marseilles].
Cell-line specific activation of SV40 transcriptional enhancer by p40tax of HTLV-1.
[Retrospective blood transfusion survey from blood donor with anti-HTLV-I/II antibodies].
Human T lymphotropic virus type 1 infection and gastric cancer development in Japan.
HTLV-I carrier with unusual brain MR imaging findings.
Human T-cell lymphotropic virus type-I tax gene induces interleukin-8 secretion by autocrine mechanism and has No effect on interleukin-16 in transfected Jurkat cells.
Dominance of HTLV type I-specific antibody responsiveness in Old World monkeys.
Associations among HTLV-I, HTLV-II, and HIV in injecting drug users in Salvador, Brazil.
Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I.
Microencapsulation of a synthetic peptide epitope for HTLV-1 in biodegradable poly(D,L-lactide-co-glycolide) microspheres using a novel encapsulation technique.
[Human T-lymphotropic virus type 1 uveitis in children].
Regulation of gene expression by HTLV-I Tax protein.
T-cell lymphoma in Singapore: pathology, clinical findings and association with HTLV-1 antibodies.
Pooling of samples for seroepidemiological surveillance of human T-cell lymphotropic virus types I and II.
Sera from patients with multiple sclerosis react with human cell T lymphotropic virus-I gag proteins but not env proteins--Western blotting analysis.
Low seroprevalence of HTLV-I and HTLV-II in patients with a sexually transmitted disease. Study Group for HTLV and STDs.
[Bronchopneumonopathy in HTLV-1 associated myelopathy (HAM) and non-HAM HTLV-1 carriers]
[Prevalence of HTLV-I/II infection in various population groups in Gran Canaria]
Random integration of HTLV-1 provirus: increasing chromosomal instability.
HTLV-I virological and histopathological analysis in two cases of anti-centromere-antibody-seropositive Sjögren's syndrome.
[HTLV-I seronegative idiopathic progressive spastic paraparesis: clinical and neurophysiological study of the sensory features].
HTLV-I and HTLV-II infection in Uruguay.
Performance of absolute CD4+ count in predicting co-infection with human T-lymphotropic virus type 1 in antiretroviral-naive HIV-infected patients.
[Human T lymphotropic virus type I].
Autocrine role of macrophage inflammatory protein-1 beta in human T-cell lymphotropic virus type-I tax-transfected Jurkat T-cells.
HTLV-I and HIV infection in drug addicts in Italy.
Passage of human T-cell leukemia virus type-1 during progression to cutaneous T-cell lymphoma results in myelopathic disease in an HTLV-1 infection model.
Presence of human T-cell lymphotropic virus types I and II and coinfection with human immunodeficiency virus in different groups at risk in Argentina.
Seroepidemiology of human T-lymphotropic retrovirus type I (HTLV-I) in residents of Niigata Prefecture, Japan. Comparative studies by indirect immunofluorescence microscopy and enzyme-linked immunosorbent assay.
HTLV-1 Tax protein cooperates with Ras in protecting cells from apoptosis.
HTLV-I-related retroviral markers in Hungarian patients with mycosis fungoides.
Acute T-cell leukemia/lymphoma mimicking Hodgkin's disease with secondary HTLV I seroconversion.
[Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis].
Seroindeterminate patterns and seroconversions to human T-lymphotropic virus type I positivity in blood donors from Martinique, French West Indies.
[Current status of HTLV1 infection. Human T cell Leukemia Virus type 1].
Inhibition by human T-lymphotropic virus (HTLV-I) of T-lymphocyte mitogenesis: failure of exogenous T-cell growth factor to restore responsiveness to lectin.
Absence of HTLV-I infection in patients with malignancy in the Yucatan peninsula.
[Localization of HTLV-I-associated antigens in adult T cell leukemia cells and HTLV-I-infected cell line cells].
[HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria]
Human T-cell leukemia/lymphoma virus (HTLV I) DNA: detection in Italy in a lymphoma and in a Kaposi sarcoma patient.
The presence of antibodies to purified p24gag protein of HTLV-I in sera of patients with systemic lupus erythematosus (SLE).
Prevalence ratio of HTLV-1 in nursing mothers from the state of Paraiba, Northeastern Brazil.
Comparison of signal-to-cutoff values in first, second, and third generation enzyme immunoassays for the diagnosis of HTLV-1/2 infection in "at-risk" individuals from São Paulo, Brazil.
Case study: Fatal strongyloidiasis associated with human T-cell lymphotropic virus type 1 infection.
Incidence of human T lymphotropic virus type I seroconversion after age 40 among Japanese residents in an area where the virus is endemic.
Lack of relation between human T-lymphotropic virus type I infection and systemic lupus erythematosus in Jamaica, West Indies.
Evaluation of a combined lysate/recombinant antigen anti-HTLV-I/II ELISA in high and low endemic areas of HTLV-I/II infection.
Analysis of HTLV-I in Hodgkin's Disease.
Possible environmental factors related with transmission of HTLV-I among children.
Trends in HTLV-1 prevalence and incidence of adult T-cell leukemia/lymphoma in Nagasaki, Japan.
N-Terminal domain of HTLV-I integrase. Complexation and conformational studies of the zinc finger.
[Detection of HTLV-1 proviral DNA with nested PCR].
Short-term complete remission of a patient with human T lymphotropic virus type-1 associated adult T-cell leukemia/lymphoma with pancytopenia by sequential high-dose methylprednisolone and cyclosporin A.
HTLV-I seroprevalence in patients with malignancy.
Follow-up of asymptomatic HTLV-I carriers among blood donors in Kyushu, Japan.
[A case of HTLV-1 associated myelopathy progressed in course over 30 years]
No evidence for HTLV-I infection in 24 cases of French and Portuguese mycosis fungoïdes and Sezary syndrome (as seen in France).
Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I.
Failure to detect HTLV type 1 DNA from HTLV type 1-seronegative patients with chronic progressive spastic paraparesis in Kagoshima.
Prevalence of HTLV-I and HTLV-II infections among HIV-1-infected asymptomatic individuals in São Paulo, Brazil.
Transmission of human T-lymphotropic virus type I by bilateral living-donor lobar lung transplantation.
Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1.
Adult T-cell leukemia/lymphoma with multiple integration of HTLV-1 provirus presenting as an isolated paranasal sinus tumor: a case report.
[Lymphomatoid granulomatosis with hypereosinophilia and HTLV1 infection]
HTLV-I myelopathy - atypical features.
[Serological diagnosis of HTLV-1/2: combination of screening assays to define the serological status in blood donors].
Viral interference with host mRNA surveillance, the nonsense-mediated mRNA decay (NMD) pathway, through a new function of HTLV-1 Rex: implications for retroviral replication.
[Seroprevalence rate of HTLV-I in pregnant women in Osaka Prefecture].
Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
First cases of human T lymphotropic virus type 1 (HTLV-1) infection observed in Slovakia.
Low frequency of human T-cell lymphotropic virus 1 antibodies in Iranian gastric cancer patients in comparison to controls.
Serum antibodies to HTLV-I in human demyelinating disease.
[Pathogenetic significance of HTLV-I infection and immune surveillance in HAM]
[Maternal-infant transmission of the HTLV-1 virus]
Evaluation of a new HTLV-I/II polymerase chain reaction.
[Expression of sequences homologous to HTLV-I pXIV gene in the labial salivary glands of Japanese patients with Sjögren's syndrome and pathogenesis].
Epidemiologic comparison of human T-lymphotropic virus type I-infected blood donors from endemic and nonendemic regions over a 3-year period.
[Central sensory and motor conduction in adrenoleukodystrophy (ALD), cerebrotendinous xanthomatosis (CTX), HTLV-1-associated myelopathy (HAM) and tabes dorsalis]
[Neurologic pathology and HTLV-I virus]
Prevalence of antibodies to human T-lymphotropic virus type 1 (HTLV-1) in an HIV-endemic region of Africa.
[Virological studies on HTLV-1 carrier pregnant women].
Predominance of HIV-1 serotype distinct from LAV-1/HTLV-IIIB.
Molecular detection of pre-ATL state among healthy HTLV-1 carriers in an endemic area of Japan.
Seroepidemiology of human T-cell lymphotropic virus type I/II in northeastern Brazil.
HTLV-I and -II in southwestern Greece.
[Malignant strongyloidiasis and the HTLV-I virus]
Human complement component C1q inhibits the infectivity of cell-free HTLV-I.
Immunologic assessment of a cluster of asymptomatic HTLV-I-infected individuals in New Orleans.
Long-term follow-up of immunomodulation in treatment of HTLV-I-associated myelopathy.
Low prevalence of human T-lymphotropic virus type I among patients with tuberculosis in Senegal.
Bullous adult T-cell lymphoma/leukemia and human T-cell lymphotropic virus-1 associated myelopathy in a 60-year-old man.
[Interaction between HTLV-1 transcription activator tax and Taxreb107].
Mutational analysis of the HTLV-I trans-activator, Tax.
Prevalence of human T-cell lymphotropic virus (HTLV-1/2) in individuals from public health centers in Mozambique.
Transmission of human T-lymphotropic virus type I by blood components from a donor lacking anti-p24: a case report. The Transfusion Safety Study Group.
Expression of the intestinal T-lymphocyte-associated-molecule recognized by the HML-1 antibody on mononuclear cells from HTLV-I-infected subjects.
HIV viral load and CD4+ lymphocyte counts in subjects coinfected with HTLV-I and HIV-1.
[Clinical manifestations of HTLV-I infection]
[Development of thymic tumor in HTLV-I transgenic rats under control of a lymphoid tissue specific promoter]
HTLV-I and blood safety: let the community decide.
[Transmission of HTLV-I infection from mothers to children].
Mother-to-child transmission of human T-cell leukemia virus type I (HTLV-I): a fifteen-year follow-up study in Okinawa, Japan.
[Serological evaluation of human T lymphotropic virus type-I infection in routine hospital samples, especially using serodia.HTLV-I]
HTLV-I-associated facial nerve palsy in Africans and people of African descent. Research Group in Tropical Neurology.
Activated T-lymphocytes with polyclonal gammopathy in patients with human T-lymphotropic virus type I--associated myelopathy.
Vertical transmission of HTLV-1 in HTLV-1 carrier rat.
Absence of human T-lymphotropic retrovirus type-1 (HTLV-1) in different populations of Mongolia.
Induction of MMP9 (92 kDa gelatinase) activity and expression of tissue inhibitor of metalloproteinase-2 mRNA (TIMP-2) in primitive neuroectodermal cells infected with retrovirus HTLV-I.
HTLV-1 sweet-talks its way into cells.
Cohort effect of HTLV-I seroprevalence in southern Japan.
Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
Infantile onset of HTLV-I-associated myelopathy (HAM/TSP)
[Type 1 human T lymphotropic virus (HTLV-I)]
HTLV-II and a new endemic area for HTLV-I in Brazil.
Molecular epidemiology of HTLV type I in Japan: evidence for two distinct ancestral lineages with a particular geographical distribution.
Distinct DNA targets for trans-activation by HTLV-1 tax and adenovirus E1A.
Strongyloidiasis presenting as duodenal obstruction in a patient infected with human T-cell lymphotropic virus type 1.
Immunologic response and proviral load in human T-lymphotropic virus type 1 infected individuals with erectile dysfunction.
Cohort effect on HTLV-I seroprevalence in southern Japan.
Successful 2-year therapy with systemic interferon-alpha for HTLV-I associated myelopathy.
HTLV-1 associated polymyositis in Jamaica.
Sequential change of virus markers in seroconverters with community-acquired infection of human T lymphotropic virus type I.
Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in adult T-cell leukemia (ATL) in non-ATL-endemic Hokkaido of Japan.
[HTLV-1 associated dermatomyositis].
[HTLV-I seroprevalence in blood donors]
Prototypical HTLV-I/II infection is rare in LGL leukemia.
Activation of the GM-CSF promoter by HTLV-I and -II tax proteins.
Activation of HTLV-I transcription in the presence of Tax is independent of the acetylation of CREB-2 (ATF-4).
Human T-cell lymphotropic virus type-1 associated t-cell leukemia/lymphoma masquerading as necrotizing retinal vasculitis.
[A case of HTLV-I associated polyradiculoneuropathy and cerebral white matter lesions with smouldering type adult T cell leukemia]
Serologial screening of human T cell lymphotropic virus I and II (HTLV I/II) in blood banks by immunoblotting and enzyme-immuno assays: to demand or to defeat?
HTLV-1 seroconversion in a 56-year-old Japanese woman undergoing chemotherapy for acute nonlymphocytic leukemia.
HTLV-1 and multiple sclerosis: the link is missing.
Immunological and virological status of a hemophiliac infected with human T cell lymphotropic virus type 1 and human immunodeficiency virus type 1, and results of therapy.
Phase I/II trial of thymosin fraction 5 and thymosin alpha one in HTLV-III seropositive subjects.
HTLV-I-positive T-cell lymphoma/leukaemia in an African resident in UK.
Fusion of mature dendritic cells and human T-lymphotropic virus type I infected T cells: its efficiency as an antigen-presenting cell.
Prognostic value of the histologic classification of peripheral T-cell lymphoma: a clinico-pathologic study of 71 HTLV-1 negative cases.
[Analysis of the pathogenesis of organ specific autoimmune diseases in transgenic rats carrying the env-pX gene of HTLV-I]
FDA approval of HTLV-I tests.
[A case of limbic encephalitis associated with breast cancer developed in an HTLV-1 carrier]
Seroepidemiology of HTLV-I infection in northeast Thailand: a four year surveillance.
No evidence of vertical transmission of HTLV-I and HTLV-II in children at high risk for HIV-1 infection from São Paulo, Brazil.
Perinatal infection of human T-lymphotropic virus type I, the etiologic virus of adult T-cell leukemia/lymphoma. DNA amplification of specific human T-lymphotropic virus type I sequences.
New insights in HTLV-I phylogeny by sequencing and analyzing the entire envelope gene.
Primary B cell lymphoma of the rectum in a patient coinfected with HIV-1 and HTLV-I.
Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule.
Is seroprevalence of HTLV-I/II among blood donors in India relevant?
An enzyme-linked immunosorbent assay for immune complex of HTLV-I.
[Cross-reactivity of HTLV-I and -II with sera from Japanese patients with hairy cell leukemia]
Laboratory test differences associated with HTLV-I and HTLV-II infection. Retrovirus Epidemiology Donor Study Investigators.
[Variants of the interaction of the human T-cell leukemia virus (HTLV-I) with the B-cells of lymphoblastoid lines].
[Current status and problems of anti-HTLV-1 drug development].
[Serological examination of the population of the Far East for the presence of antibodies to human T cell leukemia virus HTLV-1]
A comparative study of HIV-1 and HTLV-I protease structure and dynamics reveals a conserved residue interaction network.
SLE, thrombocytopenia, and HTLV-I.
Familial clustering of HTLV-I infection in southeastern Italy.
Tumours derived from HTLV-I tax transgenic mice are characterized by enhanced levels of apoptosis and oncogene expression.
[Short stature in a case of HTLV-I-associated myelopathy with juvenile onset]
[Primary polymyositis associated to HTLV-I]
[Immune response to HTLV-I infection].
Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologic studies.
Antibodies to HTLV-I p24 in sera of blood donors, elderly people and patients with hemopoietic diseases in France and in French West Indies.
[Multiple sclerosis viewed from the point of HTLV-I associated myelopathy]
Search for an HTLV-I-like retrovirus in patients with MS by enzymatic DNA amplification.
Hepatitis B and C viruses, human T-cell lymphotropic virus types I and II, and leukemias: a case-control study. The Italian Leukemia Study Group.
AIDS-related vacuolar myelopathy is not associated with coinfection by human T-lymphotropic virus type I.
[Quantitation of HTLV-I proviral load using real-time quantitative PCR with Taqman MGB probe].
Necrobiotic xanthogranuloma in a human T-lymphotropic virus type 1 carrier.
Experimental transmission of HTLV-I into C3H/HeJ mice.
[Klebsiella pneumoniae meningitis, Strongyloides stercoralis infection and HTLV-1]
Identification of the RT-RH/IN cleavage site of HTLV-I.
[T-lymphocytosis and increased levels of soluble IL-2 receptors in bronchoalveolar lavage fluid in cases of HTLV-I-associated myelopathy with pulmonary involvement]
Adult T-cell leukemia/lymphoma comprising non-floral leukemic cells in Taiwan, a country non-endemic for human T-cell leukemia virus type I.
Human herpesvirus 6 does not enhance human T cell lymphotropic virus type I (HTLV-I) expression in the HTLV-I-transformed cell line MT4.
[Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
Inhibitors of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced multinucleated cell formation and HTLV-I p19 antigen expression in HTLV-I-infected T-cell line KH-2Lo.
HTLV-I carrier status disclosed at diagnosis of cytomegalovirus gastric ulcer.
Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells.
Performance of IgG and IgG1 anti-HTLV-1 reactivity by an indirect immunofluorescence flow cytometric assay for the identification of persons infected with HTLV-1, asymptomatic carriers and patients with myelopathy.
Autoantibodies and immunoglobulins in atomic bomb survivors with human T-lymphotropic virus type I.
HTLV type 1 molecular study in Brazilian villages with African characteristics giving support to the post-Columbian introduction hypothesis.
[HTLV-I associated myelopathy with bilateral abductor vocal cord paralysis--case report]
[Mechanisms of viral leukemogenesis. II. T-cell leukemia associated with retroviruses HTLV-I and HTLV-II]
[Evidence of HTLV-I infection in different risk groups in Barcelona]
Genomic expressions of human T-lymphotropic virus (HTLV-I).
Seroprevalence of HTLV-I in Natal/KwaZulu.
Intrafamilial transmission of HTLV-I and its association with anti-Tax antibody in an endemic population in Japan.
An HTLV-I carrier who developed CD4+ T-CLL expressed the IL-2 receptor beta chain alone without expressing the alpha chain.
HTLV-1 associated myelopathy/tropical spastic paraparesis: how far have we come?
Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation.
HTLV-I--associated B-cell CLL: indirect role for retrovirus in leukemogenesis.
Association of HTLV1 infection and esophageal squamous cell carcinoma.
Prevalence of HTLV-I/II antibodies in HIV seropositive and HIV seronegative STD patients in Vellore region in southern India.
Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas.
An unclassified cerebral small cell tumor in a patient with human T-cell lymphotropic virus type 1-induced primary extranodal lymphoma.
[Current problems on the management of HTLV-1 asymptomatic carriers and ATL patients].
Serological survey and virus isolation of simian T-cell leukemia/T-lymphotropic virus type I (STLV-I) in non-human primates in their native countries.
Prevalence of HTLV type I infection in Iran: a serological and genetic study.
Human T-lymphotropic virus type I (HTLV-I) and adult T-cell leukemia (ATL) are endemic to southwestern Japan.
Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I.
Maintaining potent HTLV-I protease inhibition without the P3-cap moiety in small tetrapeptidic inhibitors.
Reduction of HTLV-I-infected cells in blood by leukocyte filtration.
[Expression of pX gene of HTLV-I and its possible involvement in ATL leukemogenesis]
Influence of cytokine and mannose binding protein gene polymorphisms on human T-cell leukemia virus type I (hTLV-I) provirus load in HTLV-I asymptomatic carriers.
HTLV-I in Argentina.
[Adult T-cell leukemia and non-malignant adenopathies associated with HTLV I virus. Apropos of 17 patients born in the Caribbean region and Africa].
Development and validation of a real-time PCR assay for a novel HTLV-1 tax sequence detection and proviral load quantitation.
Bronchiectasis is associated with human T-lymphotropic virus 1 infection in an Indigenous Australian population.
Seroprevalence of HTLV-I and HTLV-II.
Infection of human T-lymphotropic virus type I to astrocytes in vitro with induction of the class II major histocompatibility complex.
Prevalence of human T-cell lymphotropic virus type I infection among volunteer blood donors in Kuwait.
Significance of human T-lymphotropic virus type I indeterminant serological findings among healthy individuals.
In vitro modulation of lymphocyte proliferation by prednisolone and interferon-alpha in patients with HTLV-I-associated myelopathy (HAM).
Protection of mitochondrial perturbation by human T-lymphotropic virus type 1 tax through induction of Bcl-xL expression.
Human T-cell lymphotropic virus type 1-associated retinal vasculitis in children.
Management of coinfection with human immunodeficiency virus and human T-cell lymphotropic virus type I.
[Report of a case of strongyloidiasis with a coinfection by HTLV-1 and onychomycosis].
[Detection of HTLV-I virus in patients with myeloproliferative hemoblastoses]
[HTLV-1 in drug addicts in Andalucia]
Serum Antibodies to Cytoskeletal Systems in Patients with Adult T-Cell Leukemia and Healthy HTLV-1 Carriers.
Familial clusters in human T-cell lymphotropic virus type I-associated myelopathy.
Interleukin-2 receptor targeted therapy of ocular disease of HTLV-1-associated adult T-cell leukemia.
Study of the peptide length and amino acid specific substitution in the antigenic activity of the chimeric synthetic peptides, containing the p19 core and gp46 envelope proteins of the HTLV-I virus.
Antibody to the central region of human T-lymphotropic virus type 1 gp46 is associated with the progression of adult T-cell leukemia.
The first report of HTLV-I infection associated with blood transfusion in a thalassemic patient from Sicily, Italy.
Tracing the origin of Brazilian HTLV-1 as determined by analysis of host and viral genes.
A case of leukemia due to HTLV-1. A virus of regional significance.
Lack of evidence for a role of HTLV-I infection in the occurrence of subclinical HAM/TSP in the Miyazaki Cohort Study.
Seroprevalence of HTLV-I and HTLV-II in marrow transplant recipients.
Concomitant carriage of hepatitis B virus and human T-lymphotropic virus type I among blood donors in Kitakyushu, Japan.
Solid-phase synthesis of HTLV-1 protease inhibitors containing hydroxyethylamine dipeptide isostere.
Infection with human T cell lymphotropic virus 1 (HTLV-1).
Seropositivity for HTLV-1 among Italian prisoners.
[Viral particles identical to HTLV-I in lymphocyte cultures of an asymptomatic woman whose serum contained antibodies against HTLV-I and HTLV-III/LAV-I and LAV-II]
[Absence of HTLV-1 infection in drug addicts in Vizcaya]
HTLV-1 rex and HIV-1 rev act through similar mechanisms to relieve suppression of unspliced RNA expression.
The role of cytotoxic T lymphocytes in human T-cell lymphotropic virus type 1 infection.
Neurotoxic activity in HTLV-I carrier lymphocyte culture.
Alteration of T-cell functions by infection with HTLV-I or HTLV-II.
Expression of the HTLV-I tax transactivator in yeast: correlation between phenotypic alterations and tax function in higher eukaryotes.
Functional modifications of alloreactive T cell clones infected with HTLV-I.
Detection of human T-lymphotropic virus type-I DNA and mRNA in the lymph nodes; using polymerase chain reaction in situ hybridization (PCR/ISH) and reverse transcription (RT-PCR/ISH).
HTLV-1-negative pleomorphic T-cell lymphoma of the skin: the clinicopathological correlations and natural history of 15 patients.
[HTLV-1 infection in a prisoner: the first case in Spain]
[A case of strongyloidiasis hyperinfection during oral corticosteroid therapy associated with a nephrotic patient infected with HTLV-1].
Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1).
Long-term serologic follow-up of blood donors with biologic false reactivity on an anti-human T-cell lymphotropic virus Types I and II chemiluminescent immunoassay and implications for donor management.
Presence of HIV-1 reverse transcriptase inhibitory antibodies in the sera of some HTLV-1 carriers and absence of neutralizing antibodies against HIV-1 in the sera of HTLV-1 carriers.
Polyarthritis in human T lymphotropic virus type I-associated myelopathy.
Rapid progression to AIDS in dual HIV-1/HTLV-I infection.
Nasal-type natural killer cell lymphoma preceded by benign panniculitis arising in an asymptomatic HTLV-1 carrier.
Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation.
Serum antibodies to HTLV-I in autonomic failure with multiple system atrophy.
[Difference of antibody profile for human T-lymphotropic virus type-I (HTLV-I) among individuals]
[A case of human T lymphotropic virus type I-related lung disease in which Legionella pneumonia led to the diagnosis].
Atypical presentation of syphilis in an HTLV-I infected patient.
[Tropical spastic paraparesis and HTLV-I. The first case in Spain]
[Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II.
Serological characterization of human T-cell leukemia (lymphotropic) virus, type I (HTLV-I) small envelope protein.
Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel.
Kaposi sarcoma, Kaposi sarcoma-associated herpesvirus, and human T-cell lymphotropic virus type 1. What is the current evidence for causality?
[Prevalence of HIV-1, HIV-2 and HTLV-1 infections. Experience in a Parisian center for sexually transmitted diseases].
HTLV-I antibodies and lymphoproliferative disease of granular lymphocytes.
KIX-mediated assembly of the CBP-CREB-HTLV-1 tax coactivator-activator complex.
HTLV-1-associated inflammatory myopathies: low proviral load and moderate inflammation in 13 patients from West Indies and West Africa.
High proviral load of human T-lymphotropic virus type I in patients with myelodysplastic syndrome carrying HLA-A26.
Human T lymphotropic virus type I and II infections in healthy blood donors from Rio de Janeiro, Brazil.
[Gene expression in spinal cord of HTLV-I associated myelopathy sensitive and resistant rats].
The three human T-lymphotropic virus type I subtypes arose from three geographically distinct simian reservoirs.
HTLV-I infection of T and B cells of a patient with adult T-cell leukemia-lymphoma (ATLL) and transmission of HTLV-I from B cells to normal T cells.
[HTLV-I associated myelopathy]
HTLV-I and malignant hypereosinophilic syndrome.
[Diagnosis and treatment of HTLV-I associated myelopathy].
Myristoylation-dependent membrane targeting and release of the HTLV-I Gag precursor, Pr53gag, in yeast.
Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features.
Central-nervous-system lesions detected by magnetic resonance imaging in an HTLV-1 antibody positive symptomless individual.
Twenty-one base pair repeat elements influence the ability of a Gal4-Tax fusion protein to transactivate the HTLV-I long terminal repeat.
Sexual practices, drug use behaviors, and prevalence of HIV, syphilis, hepatitis B and C, and HTLV-1/2 in immigrant and non-immigrant female sex workers in Argentina.
[HTLV-I-associated myelopathy]
An HTLV-I carrier with Graves' disease followed by uveitis: isolation of HTLV-I from thyroid tissue.
Seroepidemiology of human T-cell lymphotropic virus type I infection in Taiwan.
[A multicenter clinico-epidemiological study of HTLV-I associated uveitis].
Infective dermatitis linked to HTLV-I.
Human T-cell lymphotropic virus-1-positive T-cell leukemia/lymphoma.
[An immunological study of human T-cell-leukemia virus type I (HTLV-I) infection (I)--Detection of low-titer anti-HTLV-I antibodies by HTLV-I associated membrane antigen (HTLV-MA) method].
HIV-1, HTLV-I and the interleukin-2 receptor: insights into transcriptional control.
Defective human T-lymphotropic virus type 1 provirus in asymptomatic carriers.
Chromosomal abnormalities in non-Hodgkin lymphoma with peripheral T-cell type: effect of HTLV-I infection.
Identification of clonally rearranged T-cell receptor beta chain genes in HTLV-I carriers as a potential instrument for early detection of neoplasia.
Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: a new association with intravenous drug abuse.
Seroincidence of human T-lymphotropic virus type I infection and characterization of seroconverters in Jamaican food handlers.
Absence of HTLV-1 infection in Southeast Asian refugees.
High rate of chromosomal abnormalities in HTLV-I-infected T-cell colonies derived from prodromal phase of adult T-cell leukemia: a study of IL-2-stimulated colony formation in methylcellulose.
A survey of HTLV-1 and HIVs in Ethiopian leprosy patients.
Functional and biochemical characterization of B-cell differentiation factor (BCDF) produced by an HTLV-I-transformed human T-cell clone and demonstration of specific binding of the factor to a BCDF responsive cell line.
[Tropical spastic paraparesis related with HTLV1 in Guadeloupe].
[HAM (HTLV-I associated myelopathy)].
The point mutation of tyrosine 759 of the IL-6 family cytokine receptor gp130 synergizes with HTLV-1 pX in promoting rheumatoid arthritis-like arthritis.
Misdiagnosis of HTLV-II infection using HTLV-I screening assays. HTLV-I/II Spanish Study Group.
Mechanism of transcriptional activation of viral and cellular genes by oncogenic protein of HTLV-1.
Characterization of a novel nuclear localization signal in the HTLV-I tax transactivator protein.
HTLV-1 intrafamilial transmission through three generations in an isolated Afro-Brazilian community.
A comparison of the performance of nine commercially available anti-HTLV-I screening assays.
New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types.
Primary extranodal lymphoma caused by HTLV-I.
[Pathogenesis of T-lymphocyte alveolitis associated with HTLV-I infection]
[The HTLV1 virus receptor is the transporter of glucose GLUT1: toward new diagnostic and therapeutic tools?].
Analysis of HTLV-I Env gene sequence from an Italian polytransfused patient: evidence for a Zairian HTLV-I in Sicily.
Long-term follow up study of vertical HTLV-I infection in children breast-fed by seropositive mothers.
[HTLV-I carriers in ATL/L-nonendemic area--with reference to blood transfusions].
[GLUT-1 is the receptor of retrovirus HTLV].
Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populations.
Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study.
Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants.
Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.
Antibodies to HTLV-I in populations of the southwestern Pacific.
Antibodies to Strongyloides stercoralis in healthy Jamaican carriers of HTLV-1.
Incidence of HTLV-I/II infection in seronegative high-risk individuals.
HTLV-1 and HTLV-2 infections in HIV-infected individuals from Santos, Brazil: seroprevalence and risk factors.
Effects of Nucleoside Analogs on Native and Site-Directed Mutants of HTLV Type 1 Reverse Transcriptase.
[Meningoradiculitis disclosing T-lymphocyte leukemia in HTLV-1 infection]
Differences in immune functions between human T-lymphotropic virus type I carriers and patients with adult T-cell leukemia/lymphoma.
Prevalence of HTLV-II in HIV-1-infected drug addicts in Marseille.
[Pathogenesis of pulmonary involvement in HTLV-I-associated myelopathy (HAM): studies on T-cell function]
Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants.
Lookback study of HTLV-1 and 2 seropositive donors and their recipients in Belo Horizonte, Brazil.
The human T-cell lymphotropic virus type-I dimerization initiation site forms a hairpin loop, unlike previously characterized retroviral dimerization motifs.
Human T lymphotropic virus type I and polymyositis and dermatomyositis in Japan.
HTLV-1/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: an 11-year follow-up.
HIV/HTLV-I coinfection and clinical grade at diagnosis.
Development of a microtiter plate fluorescent assay for inhibition studies on the HTLV-1 and HIV-1 proteinases.
HTLV-I associated primary CNS T-cell lymphoma.
Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I.
[T-cell lymphoma/leukemia secondary to HTLV-1 in adults. Report of a case]
Antibodies to HTLV-I among blood donors in Latvia, USSR.
Nucleotide sequence of the protease-coding region in an infectious DNA of simian retrovirus (STLV) of the HTLV-I family.
HTLV-I uveitis in a rabbit.
[An autopsy case of HTLV-I associated myelopathy (HAM)]
Human T lymphotropic virus type I infection in Papua New Guinea: high prevalence among the Hagahai confirmed by western analysis.
[Clinical and epidemiological survey of adult T cell leukemia in Kanagawa Prefecture and HTLV-I infection in hemodialyzed patients]
[Inhibitory effects of menogaril to the proliferation of HTLV-I infected T-cell lines and fresh tumor cells from adult T-cell leukemia patients]
High IgM antibody to human T-lymphotropic virus type I in systemic lupus erythematosus.
Antibodies in sera from Norwegian multiple sclerosis patients and the general population reacting with HTLV-1. A pilot study.
HTLV-I transmission from mother to fetus via placenta.
Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA.
Possibility of HTLV-I transmission from wife with ATL to husband.
Phylogenetic and molecular analysis of HTLV-1 isolates from a medium sized town in northern of Brazil: tracing a common origin of the virus from the most endemic city in the country.
HTLV-I infection among Nivkhi people in Sakhalin: comparative serologic and phylogenetic analyses for 9 years.
Adult T-cell leukaemia/lymphoma in Brazil and its relation to HTLV-I.
[HTLV-I infection in sailors who travel to sub-Saharan West Africa]
Community-based molecular epidemiology of HTLV type I in Taiwan and Kinmen: implication of the origin of the cosmopolitan subtype in northeast Asia.
HTLV-1 modifies the clinical and immunological response to schistosomiasis.
Sequence analysis of the first HTLV-I infection in Germany without relations to endemic areas.
Antibodies to ATLV/HTLV-1 in Africa.
No antibodies to HTLV-I and HIV in patients with dementia in Finland.
HTLV-I associated myelopathy: A new case in Spain.
Methylenetetrahydrofolate reductase genotype does not play a role in adult T-cell leukemia/lymphoma pathogenesis among human T-lymphotrophic virus type 1 carriers.
[Practical approach to the discovery of a positive HTLV-I/II serology in a blood donor]
Human T-cell lymphotropic virus type I-associated uveitis in an African American.
Sézary-like syndrome in a 10-year-old girl with serologic evidence of human T-cell lymphotropic virus type I infection.
Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease.
Surveillance for exposure to HTLV-I in Egyptian infants and children with various malignancies.
Analysis of factors of relevance to rapid clinical progression in HTLV-I-associated myelopathy.
Low risk of tropical spastic paraparesis/human T lymphotropic virus type 1-associated myelopathy development among persons aged >50 years.
Nodal T-cell lymphoma in an HTLV-I-endemic area: proviral HTLV-I DNA, histological classification and clinical evaluation.
Transfusion-transmitted human T-cell lymphotropic virus type I infection in Taiwan: a true risk and occasional coinfection with hepatitis C virus shown in a prospective study.
Prevalence of HTLV-I virus in blood donors and transfusion in Mali: Implications for blood safety.
Fine needle aspiration cytology of high grade T-cell lymphomas in human T-lymphotropic virus type 1 carriers.
HTLV-1 myeloneuropathy in the Solomon Islands.
Seroprevalence of anti-HTLV I/II and anti-HIV-1 antibodies in a sample population in the Marche Region, Italy.
HTLV-I/II infection in women with acute pelvic inflammatory disease.
Human T-lymphotropic virus type I among blood donors from Guadeloupe: donation, demographic, and biologic characteristics.
Double-stranded RNA as a not-self alarm signal: to evade, most viruses purine-load their RNAs, but some (HTLV-1, Epstein-Barr) pyrimidine-load.
Absence of human T cell lymphotrophic virus (HTLV) type I and II DNA in French anti-HTLV-I/II-negative intravenous drug users.
Transformation of different phenotypic types of human bone marrow T-lymphocytes by HTLV-1.
Re: "Human T-lymphotropic virus (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. II. Geographic and ecologic determinants".
Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug users.
Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathy.
Antigenic mixture of synthetic peptides for the immunodiagnosis of HTLV I/II infection.
Functional analysis of two long terminal repeats from the HTLV-I retrovirus.
[Epidemiology of HTLV-I carriers in Hirado Island and virological and immunological investigation of HTLV-I associated pulmonary disease]
Human T-lymphotropic virus type-1 related adult T-cell leukemia/lymphoma presenting as a parotid mass diagnosed by fine-needle aspiration biopsy.
HTLV-1-associated myelopathy/tropical spastic paraparesis.
Differential susceptibility of human mononuclear cells to infection with HTLV-I.
In vivo homodimerisation of HTLV-1 Gag and MA gives clues to the retroviral capsid and TM envelope protein arrangement.
Protective efficacy of multiepitope human leukocyte antigen-A*0201 restricted cytotoxic T-lymphocyte peptide construct against challenge with human T-cell lymphotropic virus type 1 Tax recombinant vaccinia virus.
[A virus called HTLV-1. Virological and molecular aspects].
Decreased eosinophil numbers in HTLV-I carriers.
Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis.
Identification of peptidomimetic HTLV-I protease inhibitors containing hydroxymethylcarbonyl (HMC) isostere as the transition-state mimic.
Congenital hydrocephalus due to intrauterine HTLV-I infection.
[HTLV-I-associated myelopathy].
Antibody responses to the env epitopes of human T-lymphotropic virus type I in rhesus macaques' naturally infected with simian T-lymphotropic virus type I.
[Urinary disturbance due to HTLV-1 associated myelopathy].
Human T-cell leukemia virus (HTLV-I) p24 antibody in New York City blood product recipients.
Immunoglobulin G antibodies binding to a synthetic peptide deduced from the nucleotide sequence of the env gene of HTLV I in patients with leukemia and rheumatoid arthritis, HLA sensitized persons and blood donors.
Frequent expression of interleukin-9 mRNA and infrequent involvement of interleukin-9 in proliferation of primary adult T-cell leukemia cells and HTLV-I infected T-cell lines.
The antiproliferative effect of prostaglandin A and J on HTLV-I transformed cells is associated with induction of a heat-shock protein.
Immunoglobulin classes of antibody for human T-lymphotropic virus type-I (HTLV-I) in healthy donors and HTLV-I-associated disorders.
Human T lymphotropic virus 1 and paracoccidioidomycosis: a probable association in Latin America.
Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from São Paulo, Brazil.
Shy-Drager syndrome and human T-lymphotropic virus type I infection.
HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein.
[Potentially treatable subacute forms of infection due to the HTLV-1]
Prevalence of human T-cell lymphotropic virus type I infection in Singapore: a preliminary report.
Transforming activity and the level of Tax protein: effect of one point mutation in HTLV-I tax gene.
International forum: Saudi Arabia. Donor screening for HTLV-I in Saudi Arabia: is it cost effective?
A novel single cell PCR assay: detection of human T lymphotropic virus type I DNA in lymphocytes of patients with adult T cell leukemia.
[Seroepidemiological analysis of the age specific prevalence of anti HTLV-I in Miyazaki Prefecture].
HTLV-I/II survey on hemodialysis patients in Buenos Aires.
Involvement of human T lymphotropic virus type I in human neoplasia.
Skin reactivity to aeroallergens is reduced in human T-lymphotropic virus type I-infected healthy blood-donors (asymptomatic carriers).
HTLV in Sweden: antibodies to HTLV I antigens in experimental monkeys and their caretakers.
Characterization of the spectrum of postthymic T-cell malignancies in Taiwan. A clinicopathologic study of HTLV-1-positive and HTLV-1-negative cases.
Highly attenuated HTLV type Ienv poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits.
HTLV1 related cutaneous T cell lymphoma.
T-cell receptor J beta 1/J beta 2 locus rearrangements in an HTLV-1-positive T-cell lymphoma with complex chromosomal aberrations.
HTLV-I in Australia.
Myelopathy in a patient dually infected with HIV-1 and HTLV-I.
Seroprevalence of HTLV-I/HTLV-II in blood donors in Buenos Aires (Argentina)
[Antibodies against HTLV I in T-lymphoproliferative diseases of the skin]
p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex.
Detection of HTLV-I genome in seronegative infants born to HTLV-I seropositive mothers by polymerase chain reaction.
Mycosis fungoides and Sezary syndrome are not associated with HTLV-I infection: an international study.
Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic.
Activation of NF-kappa B by the HTLV-I trans-activator protein Tax requires an additional factor present in lymphoid cells.
Vertical transmission of HTLV-I.
Milk-borne transmission of HTLV-I as a major route in the endemic cycle.
Nuclear localization of HTLV-I bZIP factor (HBZ) is mediated by three distinct motifs.
Human T-Lymphotropic Virus 1 (HTLV-1) Pathogenesis: A Systems Virology Study.
Human T-lymphotropic virus 1aA circulation and risk factors for sexually transmitted infections in an Amazon geographic area with lowest human development index (Marajó Island, Northern Brazil).
Infective dermatitis associated with human T-lymphotropic virus type 1 infection in Adelaide, South Australia.
Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients.
High prevalence of human T-lymphotropic virus type I infection in isolated populations of the Western Pacific region confirmed by Western immunoblot.
Acute progressive human T-lymphotropic virus type 1-associated myelopathy with Sjögren's syndrome: Cause or coincidence?
Successful treatment of ustekinumab in a psoriasis patient with human T-cell leukemia/lymphotropic virus type 1 infection.
Acute myelitis resembling human T-lymphotropic virus type 1-associated myelopathy presenting as high-signal-intensity long cord lesions on T2-weighted magnetic resonance images combined with lymphoma-type adult T-cell leukemia/lymphoma.
Isolated bladder dysfunction in human T lymphotropic virus type 1 infection: 10 years of follow-up.
Human T-cell lymphotropic virus-1 infection: three infected generations in the same family.
[The evidence for HTLV-1 infection in different risk groups in Barcelona]
Human T-lymphotropic virus 1, breastfeeding, and antiretroviral therapy.
Crusted scabies: a clinical marker of human T-lymphotropic virus type 1 infection in central Australia.
Chronic paraparesis associated with human T-lymphotropic virus type I beginning after dental extraction.
Human T-lymphotropic virus type 1 infective dermatitis in central Australia.
Clinical features of human T lymphotropic virus type 1-associated uveitis in Hokkaido, Japan.
Blastic plasmacytoid dendritic cell neoplasm in a human T-cell lymphotropic virus type I (HTLV-1) carrier: a coincidental association?
Screening for Human T-cell Lymphotrophic Virus type-I (HTLV-I) infection in high risk schizophrenic patients.
Human T cell lymphotropic virus type 1 infection among U.S. thalassemia patients.
Infective dermatitis associated with human T-cell lymphotropic virus type 1 in a child with bronchiectasis.
Antiretroviral therapy promotes an inflammatory-like pattern of human T-cell lymphotropic virus type 1 (HTLV-1) replication in human immunodeficiency virus type 1/HTLV-1 co-infected individuals.
Aggressive adult T cell leukemia/lymphoma: the tip of the iceberg of the hidden human T cell lymphotropic virus type 1 infection burden in nonendemic countries.
Human T cell leukemia virus type 2 (HTLV-2) Tax2 has a dominant activity over HTLV-1 Tax1 to immortalize human CD4+ T cells.
Insights into origins of Human T-cell Lymphotropic Virus Type 1 based on new strains from aboriginal people of Canada.
Infective dermatitis associated with human T-cell lymphotropic virus type 1: evaluation of 42 cases observed in Bahia, Brazil.
Discrepancy between human T-cell lymphotropic virus type I screening test and confirmatory tests in non-endemic areas.
[Should antibodies against HTLV-1 be analyzed in Spanish blood donations?]
Human T lymphotropic virus type 1 increases T lymphocyte migration by recruiting the cytoskeleton organizer CRMP2.
Maternal proviral load and vertical transmission of human T cell lymphotropic virus type 1 in Guinea-Bissau.
Advantage of higher-avidity CTL specific for Tax against human T-lymphotropic virus-1 infected cells and tumors.
Monoclonal large granular lymphocyte proliferation in SLE with HTLV-I seroreactivity.
Can thymic epithelial cells be infected by human T-lymphotropic virus type 1?
FAS-670A/G single nucleotide polymorphism may be associated with human T lymphotropic virus-1 infection and clinical evolution to TSP/HAM.
Neurological manifestations of coinfection with HIV and human T-lymphotropic virus type 1.
[Tropical spastic paraparesis in Martinique. High prevalence of anti-HTLV-I antibodies].
Proviral loads of human T-lymphotropic virus Type 1 in asymptomatic carriers with different infection routes.
Comparison of DNA sequences of the long terminal repeat of human T lymphotropic virus type I in Japanese and Brazilian Amazonian samples.
Risk of bronchioloalveolar carcinoma in patients with human T-cell lymphotropic virus type 1 (HTLV-I): case-control study results.
Markers of human T lymphotropic virus type I in patients with cancer of uterine cervix in Amazon, Brazil.
Increased levels of circulating endothelial progenitor cells in human T-cell lymphotropic virus type I carriers.
Pneumocystis jirovecii pneumonia and alveolar hemorrhage in a pregnant woman with human T cell lymphotropic virus type-1 infection.
Decline in prevalence and asymmetric distribution of human T cell lymphotropic virus 1 and 2 in blood donors, State of Minas Gerais, Brazil, 1993 to 2007.
Multiple retroviral infection by HTLV type 1, 2, 3 and simian foamy virus in a family of Pygmies from Cameroon.
Stable human T-cell lymphotropic virus type 1 (HTLV-1) subtype a/subgroup a endemicity in Amerindians from Northwest Argentina: a health problem to be resolved.
Molecular analysis of human T cell lymphotropic virus type 1 and 2 (HTLV-1/2) seroindeterminate blood donors from Northeast Iran: evidence of proviral tax, env, and gag sequences.
Seroprevalence of human T-cell lymphotropic virus type 1 and 2 in blood donors from the regional hospital of Valdivia, Chile.
Geographic distribution of human T-lymphotropic virus types 1 and 2 among mothers of newborns tested during neonatal screening, Minas Gerais, Brazil.
Association of human T lymphotropic virus type I with Sjogren syndrome.
Evaluation of the use of real-time PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors.
Human T-lymphotropic virus type I or II (HTLV-I/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): two case reports.
Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan.
Primary pulmonary T-cell lymphoma in a human T-lymphotropic virus type-1 carrier showing atypical shadow.
Multiple integrations of human T-lymphotropic virus type 1 proviruses in the engrafted cells from the asymptomatic carriers in NOD/SCID/gammacnull mice.
The p13 protein of human T cell leukemia virus type 1 (HTLV-1) modulates mitochondrial membrane potential and calcium uptake.
Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1.
Arsenic trioxide inhibits human t cell-lymphotropic virus-1-induced syncytiums by down-regulating gp46.
Influence of human T lymphotropic virus type I infection on the etiology of community-acquired pneumonia.
Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia/lymphoma suggests ineffective salvage of relapsed patients.
Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil.
Isolated bladder dysfunction in human T lymphotropic virus type 1 infection.
Higher rate of major depression among blood donor candidates infected with human t-cell lymphotropic virus type 1.
Best screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2 in South America.
Divergent strains of human T-lymphotropic virus type 1 (HTLV-1) within the Cosmopolitan subtype in Argentina.
Antibody response after vaccination with tetanus and diphtheria toxoids in human T-cell lymphotropic virus type 1 asymptomatic carriers.
Human T-cell lymphotropic virus type I infective dermatitis in a child with severe lymphocytic interstitial pneumonitis.
Cardiac involvement with human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: The NIH experience.
High prevalence of human T-lymphotropic virus type I carriers among patients with myelodysplastic syndrome refractory anemia with excess of blasts (RAEB), RAEB in transformation and acute promyelocytic leukemia.
Low prevalence of human T cell lymphotropic virus type 1 infection in patients with gastric cancer.
Comparison of four commercial screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2.
Retrospective study of the prevalence of human T-cell lymphotropic virus-type 1/2, HIV, and HBV in pregnant women in Argentina.
Mapping the molecular characteristics of Brazilian human T-cell lymphotropic virus type 1 Env (gp46) and Pol amino acid sequences for vaccine design.
Chorioretinitis with late pigmentary changes in a carrier of human T-lymphotropic virus 1.
Phylogeny of human T cell lymphotropic virus type 1 in Peru: a high degree of evolutionary relatedness with South African isolates.
Hematologic and biochemical changes associated with human T lymphotropic virus type 1 infection in Jamaica: a report from the population-based blood donors study.
Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus.
Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null) (NOG) mice.
Human T lymphotropic virus type 1 subtype C melanesian genetic variants of the Vanuatu Archipelago and Solomon Islands share a common ancestor.
Increased prevalence of human T cell lymphotropic virus type 1 in patients attending a Brazilian dermatology clinic.
Other important aspects of human T-lymphotropic virus 1-associated myelopathy.
Quinoline compounds decrease in vitro spontaneous proliferation of peripheral blood mononuclear cells (PBMC) from human T-cell lymphotropic virus (HTLV) type-1-infected patients.
Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.
Seroepidemiological prevalence of human T-cell lymphotropic virus type I (HTLV-I) among healthy blood donors in Eastern Saudi Arabia.
The nuclear import of the human T lymphotropic virus type I (HTLV-1) tax protein is carrier- and energy-independent.
Enzymatic amplification of HTLV-I viral sequences from peripheral blood mononuclear cells and infected tissues.
Prevalence of antibodies to human T-lymphotropic virus types I and II among Saudi Arabian blood donors.
Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.
Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
Tramadol, vecuronium, and thoracic epidural ropivacaine combined with sevoflurane anesthesia in a patient with human T-lymphotropic virus type 1-associated myelopathy.
Higher prevalence of fibromyalgia in patients infected with human T cell lymphotropic virus type I.
Haplotypes of IL6 and IL10 and susceptibility to human T lymphotropic virus type I infection among children.
Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection.
Natural history of viral markers in children infected with human T lymphotropic virus type I in Jamaica.
Human T-cell lymphotropic virus type-1 infection and risk of cancer: 15.4 year longitudinal study among atomic bomb survivors in Nagasaki, Japan.
Seroprevalence of human T-cell lymphotropic virus type I among pregnant women in Accra, Ghana.
Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004.
Human T-cell lymphotropic virus type I (HTLV-1) associated myelopathy and Sjögren's syndrome representing pulmonary nodular amyloidosis and multiple bullae: Report of an autopsy case.
Burkitt lymphoma of the uterus in a human T lymphotropic virus type-1 carrier.
Human T lymphotropic virus type I/II infection: prevalence and risk factors in individuals testing for HIV in counseling centers from Southern Brazil.
Nocturnal hypertension and autonomic dysfunction due to human T-lymphotropic virus type-1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Awareness of mother-to-child transmission of human T-cell lymphotropic virus (HTLV) type I through breastfeeding in a small group of HTLV-positive women in Maripasoula and Papaïchton, French Guiana.
Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
Localization of human T-cell lymphotropic virus-1 gag proviral sequences in dermato-immunological disorders with eosinophilia.
Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
Human leukocyte antigen concordance and the transmission risk via breast-feeding of human T cell lymphotropic virus type I.
Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS.
Increased risk of tuberculosis with human T-lymphotropic virus-1 infection: a case-control study.
Characterization of mannose-binding lectin gene polymorphism among human T-cell lymphotropic virus 1 and 2-infected asymptomatic subjects.
Markers of hepatitis viruses and human T-lymphotropic virus types I/II in patients who have undergone open-heart surgery: evidence of increased risk for exposure to HBV and HEV.
Molecular characterization of human T-cell lymphotropic virus coinfecting human immunodeficiency virus 1 infected patients in the Amazon region of Brazil.
Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1.
Clinicopathological and virological analyses of familial human T-lymphotropic virus type I--associated polyneuropathy.
Outcomes of early life exposure to human T cell lymphotropic virus type 1.
Analysis of HLA class I and class II gene polymorphisms in Japanese patients with human T-cell lymphotropic virus type 1-associated uveitis.
Prevalence and partial sequence analysis of human T cell lymphotropic virus type I in China.
Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse.
Seroprevalence and risk factors for human T cell lymphotropic virus type 1 and 2 infection in human immunodeficiency virus-infected patients attending AIDS referral center health units in Londrina and other communities in Paraná, Brazil.
Comments on the brief report "Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I".
Human T-cell lymphotropic virus antibody prevalence in HIV-1-infected individuals attending a sexual health clinic in South-East London.
Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain.
A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load.
Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
Low-dose bexarotene and low-dose interferon alfa-2b for adult T-cell leukemia/lymphoma associated with human T-lymphotropic virus 1.
Provirus load is lower in human T lymphotropic virus (HTLV)-II carriers than in HTLV-I carriers: a key difference in viral pathogenesis?
The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between seroconverters and long-term carriers.
Paradoxical coexistence of atopic asthma and Human T-Lymphotropic Virus Type I (HTLV-I) infection: a case report.
Coinfection with HIV and human T lymphotropic virus type 1: what is the real impact on HIV disease?
Dynamics of human T-cell lymphotropic virus I (HTLV-I) infection of CD4+ T-cells.
Sensitivity and specificity of a DNA polymerase chain reaction nonisotopic-based detection method for the confirmation of infection with human T-lymphotropic virus types I and II.
Human T-cell lymphotropic virus type 1 (HTLV-1) and lymphoid malignancies in Dominica: a seroprevalence study.
Recognition of adult T-cell leukemia/lymphoma cells by CD4+ helper T lymphocytes specific for human T-cell leukemia virus type I envelope protein.
Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers.
The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1.
Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I.
Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
High prevalence of human T-lymphotropic virus type 1 (HTLV-1) in immigrant male-to-female transsexual sex workers with HIV-1 infection.
Human T lymphotropic virus 1 and hepatitis C virus as risk factors for inflammatory dermatoses in HIV-positive patients.
Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.
Prevalence of human T-cell lymphotropic virus-I/II-indeterminate reactivities in a Greek blood bank population.
Activation of simian virus 40 promoter by HTLV-I Tax protein: role of NF-kappaB and CBP.
Epidemiologic study of the association between human T-cell lymphotropic virus type 1 and Strongyloides stercoralis infection in female blood donors (Guadeloupe, French West Indies).
Clinical similarities and differences between human T-cell lymphotropic virus type 1-associated bronchiolitis and diffuse panbronchiolitis.
Computational simulation of chronic persistent virus infection: factors determining differences in clinical outcome of HHV-6, HIV-1 and HTLV-1 infections including aplastic, hyperplastic and neoplastic responses.
False-positive selection identified by ML-based methods: examples from the Sig1 gene of the diatom Thalassiosira weissflogii and the tax gene of a human T-cell lymphotropic virus.
Soluble form of Fas and Fas ligand in serum and bronchoalveolar lavage fluid of individuals infected with human T-lymphotropic virus type 1.
Regulation of human T-cell leukemia virus type 1 (HTLV-1) budding by ubiquitin ligase Nedd4.
A decrease in mother-to-child transmission of human T lymphotropic virus type I (HTLV-I) in Okinawa, Japan.
Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-kappaB requires IkappaB kinase-1-mediated phosphorylation of RelA/p65.
Prediagnostic human T lymphotropic virus type I provirus loads were highest in Jamaican children who developed seborrheic dermatitis and severe anemia.
Human T-lymphotropic virus type-I infection, survival and cancer risk in southwestern Japan: a prospective cohort study.
High expression of p40(tax) and pro-inflammatory cytokines and chemokines in the lungs of human T-lymphotropic virus type 1-related bronchopulmonary disorders.
Quantification of Human T-lymphotropic virus type I (HTLV-I) provirus load in a rural West African population: no enhancement of human immunodeficiency virus type 2 pathogenesis, but HTLV-I provirus load relates to mortality.
Human leucocyte antigen and human T-cell lymphotropic virus type 1 associated diseases in Brazil.
Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma.
Western blot seroindeterminate individuals for human T-lymphotropic virus I/II (HTLV-I/II) in Fortaleza (Brazil): a serological and molecular diagnostic and epidemiological approach.
Influence of human T lymphotrophic virus type I on cryptogenic fibrosing alveolitis - HTLV-I associated fibrosing alveolitis: proposal of a new clinical entity.
A cohort study of health effects of human T-cell lymphotropic virus type I infection in Jamaican children.
Globin haplotypes of human T-cell lymphotropic virus type I-infected individuals in Salvador, Bahia, Brazil, suggest a post-Columbian African origin of this virus.
Spinal Magnetic Resonance Image alterations in human T-lymphotropic virus type I-associated myelopathy patients before and after immunomodulating treatments.
Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV-I) infection among ethnically and geographically diverse Peruvian women.
Human T-lymphotropic type-1 virus specific antibody detected in sera of HIV/AIDS patients in Ghana.
Guttate morphoea in human T-cell lymphoma/lymphotrophic virus type-1 (HTLV-1) infection.
CD4 cell count among HIV-infected patients with an AIDS-defining disease: higher count in patients coinfected than in those not coinfected with human T-cell lymphotropic virus type I.
Performance certification of gelatin particle agglutination assay for anti-HTLV-1 antibody: inconclusive positive results.
Lack of association of Human T-cell lymphotrophic virus type 1(HTLV-1) infection and rheumatoid arthritis in an endemic area.
Detection of anti-human T-lymphotropic virus type I antibody in whole blood by a novel counting immunoassay.
Feasibility of human T-lymphotropic virus type I screening using pooled sera.
Clinical and pathological features in T-cell gastric lymphoma associated with human T-cell leukemia virus type 1 (HTLV-1) in comparison with B-cell gastric lymphoma.
Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis.
A nested case-control study of risk factors for adult T-cell leukemia/lymphoma among human T-cell lymphotropic virus type-I carriers in Japan.
Molecular epidemiology of human T lymphotropic virus type 1 transmission in Okinawa, Japan.
Human T-cell lymphotropic virus type 1 tax inhibits transforming growth factor-beta signaling by blocking the association of Smad proteins with Smad-binding element.
Mycosis fungoides and serology for human T-cell lymphotropic virus, type 1.
IFN regulatory factor 4 participates in the human T cell lymphotropic virus type I-mediated activation of the IL-15 receptor alpha promoter.
Human T cell lymphotropic virus type 1-associated myelopathy in São Paulo, Brazil. Epidemiologic and clinical features of a university hospital cohort.
Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica.
Genetic evidence of transmission of human T cell lymphotropic virus type 1 between spouses.
Chronic sensory neuronopathy associated with human T-cell lymphotropic virus type I infection.
Prevalence of blood-borne viral infections (cytomegalovirus, human herpesvirus-6, human herpesvirus-7, human herpesvirus-8, human T-cell lymphotropic virus-I/II, human retrovirus-5) among blood donors in Latvia.
New corneal findings in human T-cell lymphotropic virus type 1 infection.
Spatial distribution of the Human T-Lymphotropic Virus types I and II (HTLV-I/II) infection among blood donors of Hemominas Foundation, Belo Horizonte, Minas Gerais State, Brazil, 1994-1996.
Molecular and phylogenetic analyses of 16 novel simian T cell leukemia virus type 1 from Africa: close relationship of STLV-1 from Allenopithecus nigroviridis to HTLV-1 subtype B strains.
Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors.
Malignancy: Human T-Cell Lymphotropic Virus Type I and Adult T-Cell Leukaemia/Lymphoma.
Human T-cell lymphotropic virus type 1 infection among pregnant women in northeastern Brazil.
Spinal anesthesia in human T lymphotropic virus type I-associated myelopathy.
Dating the origin of the African human T-cell lymphotropic virus type-i (HTLV-I) subtypes.
Clinical features of human T-lymphotropic virus type 1 uveitis: a long-term follow-up.
Sex-specific mortality from adult T-cell leukemia among carriers of human T-lymphotropic virus type I.
Human T-cell lymphotropic virus-1-associated renal disease in Jamaican children.
Allogeneic bone marrow transplantation-related transmission of human T lymphotropic virus type I (HTLV-I).
Elevated levels of soluble adhesion molecules in sera and BAL fluid of individuals infected with human T-cell lymphotropic virus type 1.
Pulmonary fibrosis in association with human T cell lymphotropic virus type 1 (HTLV-1) infection.
The influence of human T lymphotropic virus type I infection on the outcome of cardiovascular surgery.
Repression of tax-mediated human t-lymphotropic virus type 1 transcription by inducible cAMP early repressor (ICER) protein in peripheral blood mononuclear cells.
Human T-lymphotropic virus 1 adult T-cell lymphoma with Giardia and Strongyloides parasitism.
Decrease of human T-cell lymphotropic virus type I prevalence and low incidence among pregnant women from a high endemic ethnic group in French Guiana.
Detection of a major gene predisposing to human T lymphotropic virus type I infection in children among an endemic population of African origin.
Prevalence of HIV-1/2, HTLV-I/II, hepatitis B virus (HBV), hepatitis C virus (HCV), Treponema pallidum and Trypanosoma cruzi among prison inmates at Manhuaçu, Minas Gerais State, Brazil.
Human T cell lymphotropic virus type I-associated infective dermatitis in Jamaica: a case report of clinical and biologic correlates.
Nucleotide sequence analyses of partial envgp46 gene of human T-lymphotropic virus type I from inhabitants of Fujian Province in Southeast China.
Virus infection in patients with histiocytic necrotizing lymphadenitis in Taiwan. Detection of Epstein-Barr virus, type I human T-cell lymphotropic virus, and parvovirus B19.
Importance of immune deviation toward Th1 in the early immunopathogenesis of human T-lymphotropic virus type I-associated myelopathy.
The prevalence of human T-cell lymphotropic virus type I infection in patients with cutaneous malignancies.
Persistent human herpesvirus 8 viremia associated with coinfection with human T-cell lymphotropic virus type I and myelofibrosis.
Chemokine synthesis and cellular inflammatory changes in lungs of mice bearing p40tax of human T-lymphotropic virus type 1.
Laboratory abnormalities in former blood donors seropositive for human T-lymphotropic virus types 1 and 2: a prospective analysis.
Risk of transfusion-transmitted human T-cell lymphotropic virus-type I in Latin America.
A diffuse alveolar hemorrhage in a human T-lymphotropic virus type I carrier with acute cerebellar ataxia and interstitial pneumonitis: an autopsy case report.
Unusual CD4+CD8+ phenotype in a greek patient diagnosed with adult T-cell leukemia positive for human T-cell leukemia virus type I (HTLV-I).
A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan.
Elevated levels of beta-chemokines in bronchoalveolar lavage fluid (BALF) of individuals infected with human T lymphotropic virus type-1 (HTLV-1).
First seroepidemiological study and phylogenetic characterization of human T-cell lymphotropic virus type I and II infection among Amerindians in French Guiana.
The prevalence of antibodies to simian T-cell leukaemia/lymphotropic virus (STLV-I) in non-human primate colonies in Kenya.
First report of the presence of human T-cell lymphotropic virus I infection in Italian drug addicts.
Is human T-cell lymphotropic virus type I more clever than human immunodeficiency virus type 1?
Absence of human T-lymphotropic virus type I tax sequences in a population of normal blood donors in the Baltimore, MD/Washington, DC, area: results from a multicenter study.
Comparative evaluation of 14 immunoassays for detection of antibodies to the human T-lymphotropic virus types I and II using panels of sera from Sweden and West Africa.
Human T-cell lymphotropic virus type 1-associated neurologic disorder without spastic paraparesis.
Molecular epidemiology of human T-cell leukemia virus type I (HTLV-1) Brazil: the predominant HTLV-1s in South America differ from HTLV-ls of Japan and Africa, as well as those of Japanese immigrants and their relatives in Brazil.
Induction of lymphocytic inflammatory changes in lung interstitium by human T lymphotropic virus type I.
Persistent infection with human T lymphotropic virus type 1 after allogeneic bone marrow transplantation from a seronegative donor.
Polymorphism of the 5'-flanking region of the tumor necrosis factor (TNF)-alpha gene and susceptibility to human T-cell lymphotropic virus type I (HTLV-I) uveitis.
Human T lymphotropic virus type I (HTLV-I) infection in neurological patients in Salvador, Bahia, Brazil.
Evidence for the cofactor role of human T-cell lymphotropic virus type 1 in mycosis fungoides and Sézary syndrome.
Human T-cell lymphotropic virus type I and systemic lupus erythematosus.
Retraction: absence of human T-cell lymphotropic virus type I in cutaneous T-cell lymphoma.
High rate of human T lymphotropic virus type IIa infection in HIV type 1-infected intravenous drug abusers in Ireland.
Prevalence of antibody to human T cell lymphotropic virus types 1/2 among aboriginal groups inhabiting northern Argentina and the Amazon region of Peru.
Hypopigmented mycosis fungoides associated with human T cell lymphotropic virus type I tax in a pediatric patient.
Expression of murine HOXD9 during embryonic joint patterning and in human T lymphotropic virus type I tax transgenic mice with arthropathy resembling rheumatoid arthritis.
Geographical clustering of human T-cell lymphotropic virus type I in Guadeloupe, an endemic Caribbean area.
Human T-cell lymphotropic virus type 1 infection and ocular manifestations in São Paulo, Brazil.
Application of an in situ PCR hybridization method to detection of human T-lymphotropic virus type I-infected cells in the lung.
Identification of a novel bovine serum protein which is involved in human T-cell leukemia virus type I (HTLV-I)-induced syncytium formation.
Relationship between the human T-lymphotropic virus type 1 infection and clinical manifestations of tegumentary leishmaniasis in the Colombian Pacific Coast.
Risk factors for human T cell lymphotropic virus type I among injecting drug users in northeast Brazil: possibly greater efficiency of male to female transmission.
Multi-clonal expansion of unique human T-lymphotropic virus type-I-infected T cells with high growth potential in response to interleukin-2 in prodromal phase of adult T cell leukemia.
Persistent high HTLV-1 proviral load in a patient with complete remission of Adult T-cell leukemia/lymphoma (ATL).
Promotion of early osteoclastogenesis and B lymphopoiesis in the bone marrow of transgenic rats with the env-pX gene of human T-cell lymphotropic virus type I.
Low copy numbers of human T-cell lymphotropic virus type I (HTLV-I) tax-like DNA detected in the salivary gland of seronegative patients with Sjögren's syndrome in an HTLV-I endemic area.
Low prevalence of human T-cell lymphotropic virus type I infection among volunteer blood donors in Taiwan.
Evidence for a post-Columbian introduction of human T-cell lymphotropic virus [type I] [corrected] in Latin America.
Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis.
Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I.
Human Th1 and Th2 T-cell clones are equally susceptible to infection and immortalization by human T-lymphotropic virus type I.
Human T-lymphotropic virus type-I infection, antibody titers and cause-specific mortality among atomic-bomb survivors.
Eradication of human T-lymphotropic virus type 1 by allogeneic bone-marrow transplantation.
Search for human T-lymphotropic virus type I carriers among northeastern Chinese.
Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level.
Human T cell leukemia virus-I (HTLV-I) Tax-mediated apoptosis in activated T cells requires an enhanced intracellular prooxidant state.
Seroprevalence of human T-lymphotropic virus type I (HTLV-I) in Saudi Arabia.
Studies to address reports of human T-lymphotropic virus type I tax sequences in US blood donors.
Distinct domains in herpes simplex virus type 1 US11 protein mediate post-transcriptional transactivation of human T-lymphotropic virus type I envelope glycoprotein gene expression and specific binding to the Rex responsive element.
A possible case of human T-cell lymphotropic virus type I transmission through sexual assault.
Human T-lymphotropic virus types I and II in Africa in 1969.
Two new human T-lymphotropic virus type I phylogenetic subtypes in seroindeterminates, a Mbuti pygmy and a Gabonese, have closest relatives among African STLV-I strains.
Detection of Epstein-Barr virus and HTLV-I in T-cell lymphomas of skin in Taiwan.
Predictors of level of circulating abnormal lymphocytes among human T-lymphotropic virus type I carriers in Japan.
Multiple organ failure associated with extensive metastatic calcification in a patient with an intermediate state of human T lymphotropic virus type I (HTLV-I) infection: report of an autopsy case.
Oligoclonal proliferation of human T-cell leukaemia virus type 1 bearing T cells in adult T-cell leukaemia/lymphoma without deletion of the 3' provirus integration sites.
Epstein-Barr virus-associated Hodgkin's disease in HTLV-I seropositive patients: a report of two cases.
Sensitivity of two enzyme-linked immunosorbent assay tests in relation to western blot in detecting human T-cell lymphotropic virus types I and II infection among HIV-1 infected patients from São Paulo, Brazil.
Mapping of multiple RNA binding sites of human T-cell lymphotropic virus type I rex protein within 5'- and 3'-Rex response elements.
White cell reduction by filtration may significantly decrease human T-lymphotropic virus type 1 Tax sequences and Tax-encoded proteins in blood used for transfusion.
HTLV-I and HTLV-II virus expression increase with HIV-1 coinfection.
Identification of exposed epitopes on the envelope glycoproteins of human T-cell lymphotropic virus type I (HTLV-I)
Spontaneous proliferative response of peripheral blood mononuclear cells in vitro as an indicator of high response to human T-lymphotropic virus type 1 infection in an infant with interstitial pneumonia.
Primary gastric T-cell lymphoma with and without human T-lymphotropic virus type 1.
Detection of human T lymphotropic virus type I proviral DNA in patients with diffuse panbronchiolitis.
An association of human T-cell lymphotropic virus type I infection with vascular dementia.
Coinfection with human immunodeficiency virus and human T-cell lymphotropic virus type I: reciprocal activation with clinical and immunologic consequences.
Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study Group.
Human T lymphotropic virus-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T cells and its significance in leukemogenesis of adult T cell leukemia.
Fatal strongyloidiasis in an immunocompromised HTLV-I infected patient.
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures.
Immunogenicity and conformational properties of an N-linked glycosylated peptide epitope of human T-lymphotropic virus type 1 (HTLV-I).
Possible association between multiple sclerosis and the human T cell leukemia virus (HTLV)-related endogenous element, HRES-1.
Is crusted (Norwegian) scabies a marker of adult T cell leukemia/lymphoma in human T lymphotropic virus type I-seropositive patients?
Coinfection with human T lymphotropic virus type I and human immunodeficiency virus.
Human T cell lymphotropic virus type II and human immunodeficiency virus type 1 disease progression.
Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo.
Breast milk is not a significant source for early Epstein-Barr virus or human herpesvirus 6 infection in infants: a seroepidemiologic study in 2 endemic areas of human T-cell lymphotropic virus type I in Japan.
Tuberculosis and human T-cell lymphotropic virus type 1 infection.
Expression and immunogenicity in rats of recombinant adenovirus 5 DNA plasmids and vaccinia virus containing the HTLV-I env gene.
Use of a generic polymerase chain reaction assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serology.
Co-infection with GB virus C in an area of high endemicity for human T-lymphotropic virus type I in Japan.
Clonal integration and expression of human T-cell lymphotropic virus type I in carriers detected by polymerase chain reaction and inverse PCR.
Tenosynovial nodulosis in a patient infected with human T cell lymphotropic virus I.
Simian T cell leukemia virus type I from naturally infected feral monkeys from central and west Africa encodes a 91-amino acid p12 (ORF-I) protein as opposed to a 99-amino acid protein encoded by HTLV type I from humans.
Human T cell leukemia/lymphoma virus type I (HTLV-I) and Pneumocystis carinii associated with T cell proliferation and haemophagocytic syndrome.
Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan.
Absence of human T-lymphotropic virus type I in Japanese patients with cutaneous T-cell lymphoma.
Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study.
Interaction of human T-cell lymphotropic virus type I Tax, Ets1, and Sp1 in transactivation of the PTHrP P2 promoter.
Absence of human T-cell lymphotropic virus type I in cutaneous T-cell lymphoma.
Clinical and histologic spectrum of human T-cell lymphotropic virus type I-associated lymphoma involving the skin.
Molecular subtyping of human T-lymphotropic virus type I (HTLV-I) by a nested polymerase chain reaction-restriction fragment length polymorphism analysis of the envelope gene: two distinct lineages of HTLV-I in Taiwan.
Dried sera for confirming blood-borne virus infections (HCV, HTLV-I, HIV & HBsAg).
Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells.
Non-compressive myelopathy--is human T-cell lymphotropic virus type 1 (HTLV-1) the cause in Indian context?
Recurrent histiocytic necrotizing lymphadenitis (Kikuchi's disease) in an human T lymphotropic virus type I carrier.
Distribution of human leukocyte antigens in a population of black patients with human T-cell lymphotrophic virus type I-associated adult T-cell leukemia/lymphoma.
A case-control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-I) in Jamaica.
Serum dehydroepiandrosterone and DHEA-sulfate in patients with adult T-cell leukemia and human T-lymphotropic virus type I carriers.
Clinical associations with human T-cell lymphotropic virus type-I in Papua New Guinea.
Inhibition of HTLV-I induction and virus-induced syncytia formation by oligodeoxynucleotides.
High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies.
Activation of the HTLV-I long terminal repeat by the hepatitis B virus X protein.
Increased production of interferon gamma but not interleukin 4 in human T-lymphotropic virus type I carriers.
Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretions.
Infectious complications and immunodeficiency in patients with human T-cell lymphotropic virus I-associated adult T-cell leukemia/lymphoma.
Costimulatory effects of T cell proliferation during infection with human T lymphotropic virus types I and II are mediated through CD80 and CD86 ligands.
Presence of human T-cell lymphotropic virus types I and II infections in Honduras.
Human T-cell lymphotropic virus type I infection in Barbados: results of a 20-year follow-up study.
Evidence against a role for human T-cell lymphotrophic virus type I (HTLV-I) in the pathogenesis of American cutaneous T-cell lymphoma.
Immunodeficiency and elevated CD4 T lymphocyte counts in two patients coinfected with human immunodeficiency virus and human lymphotropic virus type I.
Human T-cell lymphotropic virus type I (HTLV-I) carrier with clinical manifestations characteristic of diffuse panbronchiolitis.
T-cell type primary spinal intramedullary lymphoma associated with human T-cell lymphotropic virus type I after a renal transplant: case report.
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users.
Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group.
Sequence variation and subtyping of human and simian T-cell lymphotropic virus type I strains from South Africa.
High expression of ganglioside alpha-2,8-sialyltransferase (GD3 synthase) gene in adult T-cell leukemia cells unrelated to the gene expression of human T-lymphotropic virus type I.
Development of human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma during immunosuppressive treatment following renal transplantation.
Human T lymphotropic virus 1-2 positive antibodies in potential organ donors in France.
Envelope gene sequences of human T-lymphotropic virus type 1 in Taiwan.
Polymyositis, arthritis, and uveitis in a macaque experimentally infected with human T lymphotropic virus type I.
Evaluation of morbidity among human T lymphotropic virus type 1 carriers in Miyazaki, Japan.
Sensitivity and specificity of four assays to detect human T-lymphotropic virus type I or type I/II antibodies.
Localization of human T-cell lymphotropic virus-1 tax proviral sequences in skin biopsies of patients with mycosis fungoides by in situ polymerase chain reaction.
Adult T-cell leukaemia/lymphoma with multiple integrations of human T-cell lymphotropic virus type I proviral DNA: differing clinical features are linked to varied proviral integration.
The prevalence of antibodies to human T-lymphotropic virus type I in different population groups in Papua New Guinea.
Identification of a type-specific protein that differentiates serologically between human T cell lymphotropic virus types I and II.
Human T lymphotropic virus I, myelopathy, polymyositis and synovitis.
Kaposi's sarcoma in a human immunodeficiency virus-negative patient with asymptomatic human T lymphotropic virus type I infection.
In vitro infection of epidermal Langerhans cells with human immunodeficiency virus type 1 (HTLV-IIIB isolate).
False-positive serologic tests for human T-cell lymphotropic virus type I among blood donors following influenza vaccination, 1992.
Human T-lymphotropic virus type I infections in western India.
Mother-to-child transmission of human T-lymphotropic virus type I (HTLV-I): an extended follow-up study on children between 18 and 22-24 years old in Okinawa, Japan.
Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years.
Primary T-cell lymphoma of the gastrointestinal tract associated with human T-cell lymphotropic virus type I. An analysis using in situ hybridization and polymerase chain reaction.
Human T-cell lymphotropic virus type I and II DNA amplification in seropositive and seronegative at-risk individuals.
Transfusion transmission of human T-lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look-back investigations.
Sibling adult T-cell leukemia/lymphoma and clustering of human T-cell lymphotropic virus type I infection in a Jamaican family.
Clinical course of human T-lymphotropic virus type I carriers with molecularly detectable monoclonal proliferation of T lymphocytes: defining a low- and high-risk population.
Impact of urinary incontinence on the quality of life (QoL) of women living with HTLV-1 in Salvador, Brazil.
Transfusion transmission of human T-lymphotropic virus types I and II: lessons to be learned from look-back investigations and implications for patient counseling.
A case of angiocentric immunoproliferative lesions (angiocentric lymphoma) associated with human T-cell lymphotropic virus type 1.
Interfamilial and intrafamilial genomic diversity and molecular phylogeny of human T-cell lymphotropic virus type I from Papua New Guinea and the Solomon Islands.
Pulmonary involvement in human T-cell lymphotropic virus type-I uveitis: T-lymphocytosis and high proviral DNA load in bronchoalveolar lavage fluid.
Clinical and immunologic features of human T-cell lymphotropic virus type I uveitis.
Guidelines for counseling human T-lymphotropic virus type I (HTLV-I)- and HTLV type II-infected persons.
Human T lymphotropic virus type I/II in Lake Lindu Valley, Central Sulawesi, Indonesia.
Human T-lymphotropic virus (HTLV) types I and II infection in sexual contacts and family members of blood donors who are seropositive for HTLV type I or II. American Red Cross HTLV-I/II Collaborative Study Group.
Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status.
Diseases among men living in human T-lymphotropic virus type I endemic areas in Japan.
Detection of human T lymphotropic virus type I proviral DNA in fresh cells from ascitic fluid in a patient with adult T-cell leukemia.
Prophylaxis against a Melanesian variant of human T-lymphotropic virus type I (HTLV-I) in rabbits using HTLV-I immune globulin from asymptomatically infected Japanese carriers.
Detection of human T-cell lymphotropic virus type-1 proviral DNA in the saliva of an adult T-cell leukaemia/lymphoma patient using the polymerase chain reaction.
Detection of human T lymphotropic virus type II/b in human immunodeficiency virus type 1-coinfected persons in southeastern Italy.
Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera.
Lymphocyte subset alterations associated with increased spontaneous lymphocyte proliferation in human T lymphotropic virus (HTLV) infection: distinctive patterns for HTLV-I versus HTLV-II infection.
Human T-lymphotropic virus type I (HTLV-I) DNA in an HTLV-I-endemic area (Miyazaki, Japan)
Type-specific immune response to human T cell lymphotropic virus (HTLV) type I and type II infections in Nigeria.
Production of granulocyte-macrophage colony stimulating factor by human T-lymphotropic virus type I-infected human glioma cells.
Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica.
Human T-lymphotropic virus type I uveitis.
Some epidemiological features of the human T-cell lymphotropic virus type I (HTLV-I) and ATL in Nigerians.
Spastic paraparesis in a patient carrying defective human T cell leukemia virus type I (HTLV-I) provirus sequences but lacking a humoral or cytotoxic T cell response to HTLV-I.
Detection of the pX gene of human T-lymphotropic virus type I in respiratory diseases with diffuse interstitial pulmonary shadows and lung cancer.
Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study.
Detection of human T-lymphotropic virus type-I/II env antibodies by immunoassays using recombinant fusion proteins.
Atypical human T-cell lymphotropic virus type-I-associated T-cell lymphoma in a low-prevalence Alaska Native population. Implications for disease surveillance.
Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy.
Human T-lymphotropic virus (HTLV) types I and II: seroprevalence among intravenous drug users in continental France. Retrovirus Study Group of the French Society of Blood Transfusion.
Effects of whole blood lysis and fixation on the infectivity of human T-lymphotropic virus type 1 (HTLV-I).
Virus production and spontaneous cell proliferation in HTLV-I-infected lymphocytes.
Mechanisms of human T-cell lymphotropic virus type I viral-associated myelopathy.
Clinical importance of extraordinary integration patterns of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma.
Human T-cell lymphotropic virus type I-associated retinal lymphoma. A clinicopathologic report.
Low prevalence of human T-lymphotrophic virus type I (HTLV-I) in HIV-positive patients in Kenya.
Human T-cell lymphotropic virus type I disease in Argentine intravenous drug users with human immunodeficiency virus type 1 infection.
Human T cell lymphotropic virus type I-induced T cell activation. Resistance to TGF-beta 1-induced suppression.
A human T-cell lymphotropic virus type I carrier with temporal arteritis terminating in acute myelogenous leukemia.
Transmission of human T cell lymphotropic virus (HTLV) type II by transfusion of HTLV-I-screened blood products.
Genotyping of human T cell lymphotropic virus type I using Australo-Melanesian topotype-specific oligonucleotide primer-based polymerase chain reaction: insights into viral evolution and dissemination.
Human T cell leukemia virus type 1 (HTLV-1) antibodies in healthy populations and renal transplanted patients in the north-east of Brazil.
Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. I. Cell differentiation determines sensitivity to prostaglandins and virus infection.
A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction.
Low prevalence of human T lymphotropic virus type I in !Kung San in Bushmanland, Namibia.
Results of 1-year screening of donors in The Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection.
Elevated anti-human T-cell lymphotropic virus type I antibody in serum of patients with retinal vasculitis and uveitis living in Izumo area.
Prevalence of human T cell lymphotropic virus (HTLV) types I and II and human immunodeficiency virus type 1 infections among persons with Hansen's disease in New York City.
Seroepidemiology of human T-lymphotropic virus type I infection among intravenous drug abusers in Taiwan.
Sexual transmission of simian T-lymphotropic virus type I: a model of human T-lymphotropic virus type I infection.
Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan.
Simultaneous confirmation and differentiation of human T-lymphotropic virus types I and II infection by modified western blot containing recombinant envelope glycoproteins.
Lack of correlation between human T-lymphotropic virus type I DNA integration and clinical course of adult T-cell leukemia/lymphoma.
HTLV-1 Tax1 represses the proapoptotic protein Bim, which is crucial for T-cell transformation.
Sequence and phylogenetic analyses of human T cell lymphotropic virus type 1 from a Brazilian woman with adult T cell leukemia: comparison with virus strains from South America and the Caribbean basin.
Human T-cell lymphotropic virus type I-associated adult T-cell leukemia. The Joseph Goldberger Clinical Investigator Lecture.
What is the pathogenesis of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis?
Sexual transmission of human T-lymphotropic virus type I among female prostitutes and among patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan.
Vaccination of rabbits with recombinant vaccinia virus carrying the envelope gene of human T-cell lymphotropic virus type I.
Correlation between viral DNA load and serum anti p19 antibody concentration in symptomless human T-lymphotropic virus type-I (HTLV-I)-infected individuals.
Polyclonal use of T-cell receptor alpha for human T-cell lymphotropic virus type 1-infected T cells.
Expression of human T-cell leukaemia virus type I and associated antigens, and interleukin-2 and receptor in lymph nodes of adult T-cell leukaemia/lymphoma.
Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia.
Cytokine-producing mammary carcinomas in transgenic rats carrying the pX gene of human T-lymphotropic virus type I.
Maternal proviral load and vertical transmission of Human T cell Lymphotropic Virus type 1 in Guinea-Bissau.
Human T-lymphotropic virus type I-associated uveitis in patients with Graves' disease treated with methylmercaptoimidazole.
Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece.
Dependency of antibody titer on provirus load in human T lymphotropic virus type I carriers: an interpretation for the minor population of seronegative carriers.
Isolation, characterization, and transmission of human T-lymphotropic virus types I and II in culture.
Uveitis associated with post-transfusional human T-lymphotropic virus type 1.
A novel magnetic particle agglutination in microtiter plates for rapid detection of human T-lymphotropic virus type I antibody.
Human T-cell lymphotropic virus type I and severe neoplasia of the cervix in Jamaica.
Hematopoietic progenitor cells from patients with adult T-cell leukemia-lymphoma are not infected with human T-cell leukemia virus type 1.
Mother-to-child transmission of human T-cell lymphotropic virus type I (HTLV-I) in Jamaica: association with antibodies to envelope glycoprotein (gp46) epitopes.
Discrimination of human T-lymphotropic virus type-I and type-II infections by synthetic peptides representing structural epitopes from the envelope glycoproteins.
HTLV-1-induced leukotriene B4 secretion promotes the recruitment of target cells.
Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in family members of adult T-cell leukemia (ATL) patients in non-ATL-endemic Hokkaido of Japan.
The relative distribution of T cell subsets is altered in Jamaican children infected with human T cell lymphotropic virus type I.
Transplant and organ donor-associated transmission of human T-lymphotropic virus types I and II.
Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein.
Primary pulmonary hypertension in association with human T-cell lymphotropic virus type I in a hemophiliac.
Anti-Human T-lymphotropic virus type-I antibodies in atomic-bomb survivors.
Spontaneous proliferation of memory (CD45RO+) and naive (CD45RO-) subsets of CD4 cells and CD8 cells in human T lymphotropic virus (HTLV) infection: distinctive patterns for HTLV-I versus HTLV-II.
Human T-lymphotropic virus type-I, and hepatitis A, B and C viruses in Nepal: a serological survey.
Higher expression levels of alternatively spliced pX mRNA in human T lymphotropic virus type I asymptomatic carriers positive for antibodies to p40tax protein.
Implications of human T-lymphotropic virus type-I and type-II testing in donors and patients.
Re: "Sexual transmission of human T-lymphotropic virus type I among female prostitutes and among patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan".
Soluble E-selectin in the serum and cerebrospinal fluid of patients with multiple sclerosis and human T-lymphotropic virus type 1-associated myelopathy.
Functional properties of antigen-specific T cells infected by human T-cell leukemia-lymphoma virus (HTLV-I).
Detection of pX proteins in human T-cell leukemia virus (HTLV)-infected cells by using antibody against peptide deduced from sequences of X-IV DNA of HTLV-I and Xc DNA of HTLV-II proviruses.
Tax-mediated re-routing of the HTLV-1 p13 protein to nuclear speckles.
The kinetics of HTLV-1 proviral load after allogeneic hematopoietic cell transplantation with reduced intensity conditioning regimen; a comparison with that from sibling donors and that from unrelated donors.
A transgenic Drosophila melanogaster model to study HTLV-I oncoprotein Tax-driven leukemogenesis in vivo.
Molecular characterization of HTLV-1 and HTLV-2 and routes of virus transmission in HIV-infected patients from the southeastern and southern Brazil.
Molecular epidemiology of HTLV-1 in Argentina.
Sera from patients with multiple sclerosis react with human T-cell lymphotropic virus-I GAG proteins: Western blotting and solid-phase radioimmunoassay analyses.
Human immunodeficiency virus and human T-lymphotropic virus type I infection among homosexual men in Kingston, Jamaica.
HTLV-I myelitis: isolation of virus, genomic analysis, and infection in neural cell cultures.
Human T lymphotropic virus type I antibody patterns: evidence of difference by age and risk group.
Infectious states of human T lymphotropic virus type I and hepatitis B virus among Japanese immigrants in the Republic of Bolivia.
Preparation of virus-free pyridoxylated hemoglobin from the blood of HBV or HTLV-I healthy carriers.
Bone marrow derived cells express human T-cell lymphotropic virus type I (HTLV-I)-related antigens in patients with multiple sclerosis.
Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells.
Human protein binding to DNA sequences surrounding the human T-cell lymphotropic virus type-I long terminal repeat polyadenylation site.
Direct activation of resting T lymphocytes by human T-lymphotropic virus type I.
Loss of interleukin-2 requirement for the generation of T colonies defines an early event of human T-lymphotropic virus type I infection.
Origin of HTLV-I virus in Japan.
Identification of a protease gene of human T-cell leukemia virus type I (HTLV-I) and its structural comparison.
Serological differences between human T-lymphotropic virus type-I (HTLV-I) and HTLV-III/LAV.
Quantitative evaluations of the effect of UV irradiation on the infectivity of HTLV-III (AIDS virus) with HTLV-I-carrying cell line, MT-4.
Studies in healthy human T-cell-leukemia lymphoma virus (HTLV-I) carriers from the Caribbean.
Portuguese role in spread of HTLV-I virus.
Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.
Detection of HTLV-I (human T-cell lymphotropic virus, type I) proviral DNA in leukemic cells from a French patient with Sezary syndrome.
AIDS virus and HTLV-I differ in codon choices.
Transmission of human T-cell leukemia virus (HTLV-I) by blood transfusion: demonstration of proviral DNA in recipients' blood lymphocytes.
Production of a monoclonal antibody to a membrane antigen of human T-cell leukaemia virus (HTLV1/ATLV)-infected cell lines from a systemic lupus erythematosus (SLE) patient: serological analyses for HTLV1 infections in SLE patients.
Antibodies to human T-cell leukemia virus (HTLV-1) in non human primates from Senegal.
Correlation between high susceptibility to AIDS virus and surface expression of OKT-4 antigen in HTLV-I-positive cell lines.
A glycoprotein antigen detected with new monoclonal antibodies on the surface of human lymphocytes infected with human T-cell leukemia virus type-I (HTLV-I).
Selective cytotoxicity of AIDS virus infection towards HTLV-I-transformed cell lines.
Presence of antibodies to the human T-cell leukemia virus HTLV I in German patients with symptoms of AIDS.
Human T-cell leukemia-lymphoma virus type 1 and adult T-cell leukemia-lymphoma in Okinawa.
Antibodies to human T-cell lymphotropic virus-I membrane antigens and inverted T4/T8 ratios in hemophiliacs.
Antibodies to adult T-cell leukemia virus (ATLV/HTLV-I) in AIDS patients and people at risk of AIDS in Germany.
Presence of antibodies to human lymphoma-leukemia virus (HTLV-I) in Germans with symptoms of the acquired immunodeficiency syndrome (AIDS).
Incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type I carriers in Saga, Japan.
Thrombotic thrombocytopenic purpura and human T-lymphotrophic virus, type 1 (HTLV-1)
Elevated serum antibody titers to Epstein-Barr virus in HTLV-I-associated myelopathy (HAM).
Seroprevalence of human T-cell lymphotropic virus type 1 among homosexual men in the United States.
Serum soluble interleukin-2 receptor levels in patients with adult T-cell leukemia and human T-cell leukemia/lymphoma virus type-I seropositive healthy carriers.
Immunocytochemical and ultrastructural characterization of human T-lymphotropic virus type I (HTLV-I)-producing rabbit lymphoid cell lines.
IL-2 production in human T lymphotropic virus I-infected leukemic T lymphocytes analyzed by in situ hybridization.
Human T lymphotropic virus I infection deregulates surface expression of the transferrin receptor.
Human T-cell lymphotropic virus I and adult T-cell leukemia: report of a cluster in North Carolina.
Isolation of human T-lymphotropic virus type I (HTLV-I) from a black South African with Kaposi's sarcoma.
Lymphoma-specific T- and B-cell responses suggest the involvement of HTLV-I in virus-non-productive lymphomas of a married couple.
Human T cell lines established from the cerebrospinal fluid of patients with human T lymphotropic virus type I-associated myelopathy (HAM).
Simultaneous infection with the human immunodeficiency virus and HTLV-1 in a patient with AIDS.
Spread of human T-cell leukemia virus (HTLV-I) in the Dutch homosexual community.
A lymphoproliferative disorder caused by human T-lymphotropic virus type I. Demonstration of a continuum between acute and chronic adult T-cell leukemia/lymphoma.
Human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma in an atypical host.
The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice.
Transmission of human T cell lymphotropic virus type I by blood transfusion before and after mass screening of sera from seropositive donors.
Spastic paraparesis and dual exposure to human T-lymphotropic virus type I and human T-lymphotropic virus type IV.
Effect of 1 alpha,25-dihydroxyvitamin D3 on proliferation of activated T-cells and established human lymphotropic virus type I-positive T-cell lines.
Evaluation of the safety of blood products with respect to human immunodeficiency virus infection by using an HTLV-I-infected cell line (SKT-1B).
Chromosome aberrations and clinical features of adult T cell leukemia-lymphoma not associated with human T cell leukemia virus type I.
Seroepidemiology of adult T-cell leukemia virus (HTLV-I/ATLV): origin of virus carriers in Japan.
Transmission of adult T-cell leukemia virus (HTLV-I) through blood transfusion and its prevention.
Significance of postnatal mother-to-child transmission of human T-lymphotropic virus type-I on the development of adult T-cell leukemia/lymphoma.
Occurrence of human T cell lymphotropic virus (type I) antibodies in cutaneous T cell lymphoma.
Significance of viral co-infections by HIV, HTLV-1, Epstein-Barr virus and cytomegalovirus for immunological conditions in Japanese hemophiliacs.
Human T-cell lymphotropic virus type I in Australian aborigines.
DNA blotting analysis of human retroviruses in cerebrospinal fluid of spastic paraparesis patients: the viruses are identical to human T-cell leukemia virus type-1 (HTLV-1).
Antibody to human T-cell lymphotropic virus type I in Australian aborigines.
Human T-lymphotropic virus type I-associated benign transient immature T-cell lymphocytosis.
Detection of antibodies to human T-lymphotropic virus type 1 (HTLV-1).
Purification of envelope glycoproteins of human T cell lymphotropic virus type I (HTLV-I) by affinity chromatography.
Tropical spastic paraparesis: lack of human T-lymphotropic virus type I antibodies in blood donors from Bogota, Colombia.
Superinduction of trans-activation accounts for augmented human immunodeficiency virus replication in HTLV-I-transformed cells.
Anti-human T-cell lymphotrophic virus type I antibody-positive adult T-cell leukemia/lymphoma with no monoclonal proviral DNA. A clinicopathologic and immunologic study.
Demonstration of clonal proliferation of T lymphocytes in early neoplastic disease. Studies with probes for the beta-chain of the T cell receptor and human T cell lymphotropic virus type I.
Human T-lymphotropic virus I-infected T cells constitutively express lymphotoxin in vitro.
Comparative analysis of gene expression patterns in the HTLV-1 infected T-cell clones.
Lack of virus transmission to offspring from a gorilla positive for HTLV-I-related antibodies and provirus.
Voiding dysfunction in patients with human T-lymphotropic virus type-1-associated myelopathy (HAM).
Adult-type T-cell lymphoma in an adolescent with human T-lymphotropic virus type 1 seropositivity.
Subacute meningoencephalitis associated with human T-lymphotrophic virus type I (HTLV-I). Report of a case.
An interaction map for HTLV-1 Tax and PDZ-containing proteins.
Electroencephalographic abnormalities in human T-cell lymphotropic virus type I-associated myelopathy.
Human T-lymphotropic virus type I-associated myelopathy presenting as spinocerebellar syndrome.
A cluster of human T-lymphotropic virus type-I carriers found in the southern district of Tokushima Prefecture.
Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus. One-year experience.
Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1).
Surface and cytoplasmic expression of CD2, CD13, and CD25 antigens in human T lymphotropic virus type I infected cell line. An immunoelectron microscopic study.
Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Prevalence of antibody to human T cell leukemia virus type 1 (HTLV-1) in populations of Ivory Coast, West Africa.
HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus.
Antibodies against p40tax gene product of human T-lymphotropic virus type-I (HTLV-I) under various conditions of HTLV-I infection.
Absence of human T-cell lymphotropic virus type I coinfection in human immunodeficiency virus-infected hemophilic men.
Rat cytotoxic T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens.
Identification and synthesis of the epitope for a human monoclonal antibody which can neutralize human T-cell leukemia/lymphotropic virus type I.
Functional alterations of herpes simplex virus-specific CD4+ multifunctional T cell clones following infection with human T lymphotropic virus type I.
The effects of tumor promoters on HTLV-1 expression in a low-virus producer and a non-virus producer cell line.
Species-dependent antigenicity of the 34-kDa glycoprotein found on the membrane of various primate lymphocytes transformed by human T-cell leukemia virus type-I (HTLV-I) and simian T-cell leukemia virus (STLV-I).
C-terminal region of human T cell lymphotropic virus type I (HTLVI) p19 core protein is immunogenic in humans and contains an HTLVI-specific epitope.
Seroprevalence of human T-lymphotropic virus type I (HTLV-I) in Costa Rica.
Human T-cell lymphotropic virus type I (HTLV-I) antibodies in pre-diagnostic serum of patients with familial adult T-cell leukemia/lymphoma (ATL).
The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax.
Study of seroconversion of antibody to human T-cell lymphotropic virus type-I in children of Okinawa, Japan.
Angiocentric T-cell lymphoma associated with human T-cell lymphotropic virus type I infection.
Sex ratio of human T-lymphotropic virus type I infection and blood transfusion.
Serum Gc, Hp and alpha 2HS phenotypes in human T-lymphotropic leukemia virus type I infection.
American blood donors seropositive for human T-lymphotropic virus types I/II exhibit normal lymphocyte subsets.
Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides.
Antibodies to human T lymphotropic virus type 1 in patients with leprosy in tropical areas.
Adult T-cell leukemia/lymphoma and horizontally transmitted human T-lymphotropic virus type I.
Antibody to human T-cell lymphotropic virus type I was not detected in clients attending an aboriginal health service in Melbourne.
Confirmatory tests for human T-cell leukemia virus type 1 (HTLV-1): western blot compared with RIPA on African sera.
Lack of viral latency of human T-cell lymphotropic virus type I.
Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
Multiple sclerosis, human T-lymphotropic virus type I, and human endogenous retrovirus sequences.
Detection and characterization of human T-cell lymphotropic virus type I (HTLV-I) associated T-cell neoplasms in an HTLV-I nonendemic region by polymerase chain reaction.
Comparison of radioimmunoprecipitation assay and western blot in the confirmation of sera repeatedly reactive for human T cell lymphotropic virus type I by ELISA.
Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. II. Geographic and ecologic determinants.
Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients.
Human T-lymphotropic virus type I screening in volunteer blood donors--United States, 1989.
Human T-cell lymphotropic virus type I infection and pregnancy: a case-control study and 12-month follow-up of 135 women and their infants.
DNA amplification of human T lymphotropic virus type I (HTLV-I) proviral DNA in breast milk of HTLV-I carriers.
Immunogenicity of human T cell leukemia virus type-I (HTLV-I) antigens for cytotoxic T lymphocytes in the rat system.
Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I. The Mother-to-Child Transmission Study Group.
Human T-lymphotropic virus type I genome in adult T-cell leukemia/lymphoma.
Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). The American Red Cross HTLV-I/II Collaborative Study Group.
Serologic distinction between human T-lymphotropic virus (HTLV) type I and HTLV type II.
Autonomous growth of human T-lymphotropic virus type I infected human lymphocytes treated with N-methyl-N'-nitro-N-nitrosoguanidine and ultraviolet rays.
Human T-lymphotropic virus type I: new risk for Chilean population.
Modified Western blot assay for confirmation and differentiation of human T cell lymphotropic virus types I and II.
Epidemic patterns of hepatitis type B virus (HBV) and human T lymphotropic virus type I (HTLV-I) in two ATL-endemic islands in Kyushu, Japan.
Detection of human T-cell lymphotropic virus type I-related antibodies in patients with lymphocytic interstitial pneumonia.
Human T-lymphotropic virus type I infection among blood donors in the Solomon Islands.
Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).
Differential antibody responsiveness to p19 gag results in serological discrimination between human T lymphotropic virus type I and type II.
Semiquantitative analysis of integrated genomes of human T-lymphotropic virus type I in asymptomatic virus carriers.
Constitutive production of interleukin-6 and tumor necrosis factor-alpha from spontaneously proliferating T cells in patients with human T-cell lymphotropic virus type-I/II.
Cohort study of hepatotropic virus and human T lymphotropic virus type-I infections in an area endemic for adult T cell leukemia.
Detection of antibodies to human T-lymphotropic viruses type I and III in Japanese hemophiliacs.
Transformation and cytopathogenic effect in an immune human T-cell clone infected by HTLV-I.
Uveitis associated with human T-cell lymphotropic virus type I.
Human T lymphotropic virus I, myelopathy, polymyositis and synovitis: an expanding rheumatic spectrum.
Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II.
Serologic differentiation of human T lymphotropic virus type I from type II infection by synthetic peptide immunoassays.
Comparison of enzyme-linked immunosorbent and indirect immunofluorescence assays for the detection of human T-cell lymphotropic virus type-I antibodies in sera from rural Haiti.
Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.
Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression.
Human lymphotropic retroviruses associated with mycosis fungoides: evidence that human T-cell lymphotropic virus type II (HTLV-II) as well as HTLV-I may play a role in the disease.
HTLV type I/II in British Columbia Amerindians: a seroprevalence study and sequence characterization of an HTLV type IIa isolate.
Prevalence of human T cell lymphotropic virus types 1 and 2 (HTLV-1/2) in selected Tijuana subpopulations.
Absence of human T-lymphotropic virus types I and II infection in an Ontario hemophilia population.
Coexistence of human T-lymphotropic virus types I and II among the Wayuu Indians from the Guajira Region of Colombia.
Lymphocyte subsets in muscle biopsies of human T-lymphotropic virus type I carriers with polymyositis.
The effects of breastfeeding and presence of antibody to p40tax protein of human T cell lymphotropic virus type-I on mother to child transmission.
Increase in T cells expressing the gamma/delta receptor and CD4+CD8+ double-positive T cells in primary immunodeficiency complicated by human T-cell lymphotropic virus type I infection.
HTLV-I in multiply transfused patients in Trinidad and Tobago.
Sexual transmission of human T-lymphotropic virus type I in Peruvian prostitutes.
Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes.
Characterization of a B-cell immunodominant epitope of human T-lymphotropic virus type 1 (HTLV-I) envelope gp46.
Prevalence of herpesvirus, human T-lymphotropic virus type 1, and treponemal infections in Southeast Asian refugees.
Prevalence of HTLV-I-associated T-cell lymphoma.
Human T-lymphotropic virus type I/II. Status of enzyme immunoassay and western blot testing in the United States in 1989 and 1990.
Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis.
Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies.
Humoral responses to the immunodominant gag and env epitopes of human T-lymphotropic virus type I among Melanesians.
Human sera from varicella-zoster virus (VZV) infections cross-react with human T cell leukaemia virus type 1 (HTLV-1): common epitopes in VZV gene 22 protein and HTLV-1 p19 gag protein.
The prevalence of antibody to HTLV-I/II in United States plasma donors and in United States and French hemophiliacs.
Anti-HTLV-III and anti-HTLV-I antibodies and T cell subsets in hemophiliacs living in HTLV-I endemic and nonendemic areas of Japan.
HIV-1, HIV-2, and HTLV-I infection in high-risk groups in Brazil.
HTLV-III and HTLV-I infection in populations at risk in the Veneto region of Italy.
Correction: Epidemiological Analysis of HTLV-1 and HTLV-2 Infection among Different Population in Central China.
HTLV-1 in solid-organ transplantation: current challenges and future management strategies.
Antagonistic effects of HTLV-1 Tax oncoprotein on BRCA1 expression and function.
Arsenic trioxyde in the treatment of HTLV1 associated ATLL.
Development of HTLV-1 associated myelopathy/tropical spastic paraparesis in a patient with simian T-lymphotropic virus type 1-like infection.
Incidence of tropical spastic parapesis/ HTLV-1 associated myelopathy/ (TSP/HAM) in patients followed in a Reference center in Salvador, Brasil.
Human T-cell lymphotropic virus type 1 infection among U.S. Thalassemia patients.
Antagonistic effect of the tumor suppressor Menin and the HBZ protein of HTLV-1 on telomerase activity.
Differential expression in genes involved in the NF-κβ pathway among asymptomatic HTLV-1 carriers and HAM/TSP patients in Peru.
HTLV-1 associated bronchiectasis among Indigenous Australians is associated with higher HTLV-1 proviral loads: Results of a prospective case-control study.
Functional comparison of the HTLV-1 and HTLV-2 antisense viral proteins: implications for pathogenesis.
Dynamics of dendritic cells and T cells in HTLV-1-associated neuroinflammatory disease: implications in immunomodulatory therapies and diagnostic tools.
Interaction of HTLV-1 Tax with minichromosome maintenance proteins accelerates the replication timing program.
Absence of association of IFNL3/IL28B rs 12979860 and IFNL4 ss 469415590 polymorphisms with the neurological status of HTLV-1 Afro-Caribbean subjects in Martinique.
HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse.
[Central nervous system leukemia mimicking rapidly progressive HTLV-1 associated myelopathy].
HTLV-1 infection and associated diseases in Peruvian twins probably exposed to HTLV-1 mother-to-child transmission.
Analysis of temporal expression of HTLV-2 reveals similarities and functional differences from HTLV-1.
Amendment on brain signal intensity on Magnetic Resonance Imaging of asymptomatic HTLV-1 seropositive and HTLV-1 associated myelopathy.
Molecular epidemiology of HTLV-I-associated non-Hodgkin's lymphomas in Jamaica.
Immunohistochemical and virological features of HTLV-1-associated myosites: a study of 13 patients from West Indies and Africa.
Distinct activities of HTLV-1 Tax1 from HTLV-2 Tax2 play key roles in pathogenesis.
IFN-α2b reduces released particles of Human T-lymphotropic Virus-I from HTLV-I transformed cell line.
HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter.
Comparative analysis of HTLV-1 and HTLV-2 post-translational modifications of Tax proteins in relation to their intracellular localization and activation of gene expression.
New HTLV-1 and HTLV-2 infections in rural population, in North of Gabon, Central Africa.
Tumor suppressor in lung cancer identifies latency infected cells in non malignant HTLV-1 infection.
Crossing of the intestinal barrier by HTLV-1 infected lymphocytes.
Effect of immunization on HTLV-I infection in rabbits.
An interferon signature is associated with HAM/TSP but not viral containment in HTLV-1 infection.
HLA-G 3142C/G polymorphism is related to development of symptoms in HTLV-1 infected individuals.
Differential miRNA expression profiles in Peruvian HTLV-1 carriers.
[A case of multiple sclerosis with high CSF antibody titer to HTLV-I]
[Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus]
Detection of HTLV-1 replication and CD4+ proliferation in the humanized BLT mouse model.
Modulation of spontaneous proliferation of T-lymphocytes from HTLV-1- infected individuals by quinoline compounds.
Eosinophil count in healthy HTLV-I carriers.
HTLV-I, HIV-1 and HIV-2 seroprevalences in Guadeloupe, French West Indies.
BNZ-gamma peptide, a potential therapeutic agent in HTLV-1 associated myelopathy.
Cytokines, chemokines and leukotrienes profile and signature analysis in HTLV-1 infection as an evidence of disease progression.
[Human immunodeficiency virus type 2 and human T-cell lymphotropic virus type 1 and type 2 infections in Spain: an update].
Hypothetical HTLV-I induction by ionizing radiation.
HTLV-1/2 prevalence in Brazilian blood donors: regional and demographic variation.
HTLV-1 HBZ activates mTOR signaling pathway via inhibition of GADD34.
Assessment of functional capacity and flexibility of patients infected with HTLV-1.
HTLV-I/II infection among immigrants to Spain.
Molecular epidemiology of HTLV-1 infection in the caribbean area as compared to West Africa : relationship with the slave trade.
[HTLV-I/II in Switzerland: apropos of 4 case reports]
Progression to AIDS in homosexual men co-infected with HIV and HTLV-I in Trinidad.
The contribution of monocytes/macrophages to HTLV-1 infection and persistence.
IL28B gene polymorphism SNP rs8099917 allele GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers.
HTLV-I antibody study in normal individuals and unselected hospital patients in Malaysia.
HTLV-I/II seroprevalence in The Gambia: a study of mother-child pairs.
Generation and ex vivo expansion of HTLV-1 specific CD8+ cytotoxic T-lymphocytes for adoptive immunotherapy.
Polymorphisms in HLA-C and KIR alleles are not associated with HAM/TSP risk in HTLV-1-infected subjects.
Detection of HTLV-I and HTLV-II infection in Africans using type-specific envelope peptides.
Antibodies to HTLV-I in Nigerian blood-donors, their relatives and patients with leukaemias, lymphomas and other diseases.
Spontaneous lymphocyte proliferation in HTLV-I/II infection reflects preferential activation of CD8 and CD16/56 cell subsets.
Host determinants of HTLV-1 integration site preference.
[Case of an HTLV-1 carrier complicated with chronic pulmonary histoplasmosis].
153 Molecular pathogenesis by HTLV-1 bZIP factor.
130 Reinhard Kurth Honorary Lecture HTLV-I and Adult T Cell Leukemia/Lymphoma (ATLL): Cellular and Molecular Basis of Transformation.
[Tropical spastic paraparesis and HTLV-I associated myelopathy in infancy. A case report and review of the literature]
[Spastic paraplegia and polymyositis associated with HTLV-1 in a Togolese patient]
HTLV-1 but not HTLV-2 found in pygmies from Central African Republic.
Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection.
Demographic and familial characteristics of HTLV-1 infection among an isolated, highly endemic population of African origin in French Guiana.
[Prevalence of infection due to HTLV-1 in remnant quilombos in Central Brazil].
[The significance of HTLV-1 and HIV-2 for transfusion medicine in Europe]
[Human retrovirus HTLV-1: descriptive and molecular epidemiology, origin, evolution, diagnosis and associated diseases].
[T-cell lymphoma-leukemia caused by HTLV-1 in adults: two lymphomatous forms]
[A virus called HTLV-1. Epidemiological aspects].
Tropical spastic paraparesis: HTLV-I antibodies in patients from the Seychelles.
Frequency and function of KIR+ CD8+ T cells in HTLV-1 infection.
Neurological disability in HTLV-1 infected individuals according to the initial clinical presentation: cohort study.
HTLV-I antibody studies in villagers in East Sepik Province, Papua New Guinea.
Konzo, an epidemic spastic paraparesis in Africa, is not associated with antibodies to HTLV-I, HIV, or HIV gag-encoded proteins.
Frequency of mental disturbances in HTLV-1 patients in the state of Bahia, Brazil.
Reduced Tim-3 expression on HTLV-I Tax-specific cytotoxic T lymphocytes in HTLV-I infection.
HTLV-I antibodies in Papua New Guinea.
P-glycoprotein expression in HTLV-III cells after treatment with HIV-1 protease inhibitors.
Susceptibility of HBZ and Tax expressing primary HTLV-1+ T cell clones to CTL lysis.
Identification and characterization of new Sp1 sites located in the R region of the Human T-lymphotropic virus 1 (HTLV-1) long terminal repeat.
HTLV-I/II infection in a high viral endemic area of Zaire, Central Africa: comparative evaluation of serology, PCR, and significance of indeterminate western blot pattern.
Non-spastic paraparesis associated with HTLV-I.
SQSTM1/p62 regulates HTLV-1 tax mediated NF-κB activation.
HTLV-1 affects the adipogenic differentiation of human mesenchymal stem cells.
Malignant transformation of thymoma in recipient rats by heterotopic thymus transplantation from HTLV-I transgenic rats.
Kinetics and intracellular compartmentalization of HTLV-1 gene expression.
Human leukocyte antigen (HLA) class I frequencies in human T-cell lymphotropic virus type 1 (HTLV-1)-infected patients from Salvador-Brazil.
Encephalomyelopathy associated with HTLV-I a primary disease or coexisting with multiple sclerosis?
[HTLV-I infection in Spain. Analysis of 24 cases identified until November, 1994. Spanish Group for the Study of HTLV-I/II)]
Neurological outcomes analysis of HTLV-1 seropositive patients of the Interdisciplinary Research HTLV Group (GIPH) cohort, Brazil.
Anti-HTLV-I in blood donors in Natal.
[Exophiala jeanselmei pheohyphomycosis in a Senegalese patient with HTLV-I infection and lymphoma]
Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.
Psychological distress in blood donors notified of HTLV-I/II infection. Retrovirus Epidemiology Donor Study.
Nation-wide epidemiological study in Japan on HTLV-1 associated myelopathy/tropical spastic paraparesis using HAM-net, a novel patient registration system.
[Epidemiology of HTLV-I].
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T-Cell Lymphotropic Virus Type 1.
Increased prevalence of HTLV-1 among HIV-2-infected women but not HIV-2-infected men in rural Guinea-Bissau.
Vestibulospinal tract dysfunction in HTLV-1-asymptomatic infection and in HAM/TSP.
An imported case of adult T cell leukemia in a HTLV-I-infected patient in Italy.
Do African and European ancestry and polymorphism of HLA class I play an important role in controlling HTLV-1 proviral load in admixed cohorts from Salvador, Brazil?
Regional differences in human retroviral infections HIV-1, HIV-2, and HTLV-I/II in rural Guinea (west Africa)
Functional analysis of Foxp3 and CTLA-4 expressing HTLV-1-infected cells in a rat model.
Detection of HTLV-1 gene on cytologic smear slides.
HTLV-1 proviral load as an indicative marker of HAM/TSP: a systematic review of studies of patients with HAM/TSP.
Severe and treatment resistant strongyloidiasis--indicator of HTLV-I infection.
Retinal manifestations in adult T-cell leukemia/lymphoma virus type 1 (HTLV-1).
Both orf-I isoforms, p12 and p8, are required for efficient HTLV-1 infection and persistence.
Exosomes derived from HTLV-1 infected cells contain the viral protein Tax.
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL.
[The association of HTLV-1 and tropical spastic paraparesis in an African woman].
The reverse genetics of HTLV-1 infected patients.
[Preliminary study of HTLV-I seroprevalence in Chilean Indian populations]
Changes in proviral load (PVL) among patients with rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) receiving empirical therapy.
[Sarcoidosis and leukemia/T-cell lymphoma associated with HTLV-1 virus infection in adults (apropos of a case)].
HTLV-I seropositivity in east Caprivi, SWA/Namibia.
Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients.
Development and validation of a Multiplex Real-Time PCR for HTLV-1/2 confirmatory diagnosis.
Cross-neutralizing antibodies against HIV-1 (HTLV-IIIB and HTLV-IIIRF) and HIV-2 (SBL-6669 and a new isolate SBL-K135).
Expression of alternatively spliced HTLV-1 mRNAs is influenced by mitosis and by a novel cis-acting regulatory sequence.
Association between HTLV-1 and HIV-2 infections in Bissau, Guinea-Bissau.
HTLV-1 associated myelopathy/tropical spastic paraparesis in Egypt.
Estimation of clonal diversity in HTLV-1 infection.
HTLV-1 proviral load in adult T-cell leukemia/lymphoma (ATLL) patients from non-endemic regions of Argentina.
HTLV-1 Tax-induced NF-κB activation is negatively regulated by Ubiquitin-specific peptidase 20 (USP20).
Successful use of ketamine for intractable burning pain of HTLV-1-associated myelopathy.
Ivermectin-responsive crusted scabies in HTLV1 carrier.
Absence of HTLV-I and HTLV-II infection in prostitutes in the area of Seville, Spain.
HIV and HTLV-I survey in Venda.
[Viral Tax protein expression in salivary glands of patients infected with human t-cell lymphotropic virus type I and Sicca Syndrome].
Seroprevalence of HTLV-I/II antibodies in blood donors and different groups at risk in Tunisia.
The antisense protein of HTLV-2 positively modulates HIV-1 replication.
Varying modulation of HTLV-1 LTR activity by BAF complexes.
[Immunohistochemistry of degenerative changes in the central nervous system in spastic paraparesis associated to human T lymphotropic virus type I (HTLV-I)].
[HTLV-II infection in Spain. Analysis of 113 cases identified until November, 1994. Spanish Group for the Study of HTLV/I/II]
Molecular study of HBZ and gp21 Human T cell lymphotropic virus type 1 proteins isolated from different clinical profile infected individuals.
HTLV-2b among HIV type 1-coinfected injecting drug users in Spain.
[Evidence of HTLV-1 infection in different groups at risk in Barcelona]
HTLV-1 epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional proliferative suppression of Tregs.
Epitope mapping of human monoclonal antibodies recognizing conformational epitopes within HTLV type 1 gp46, employing HTLV type 1/2 envelope chimeras.
HTLV-I in Burundi (east Africa): lack of reactivity to the HTLV-I immunodominant envelope epitope.
A novel tetramethylnaphthalene derivative synergistically inhibits HTLV-1-infected cell proliferation in combination with cepharanthine.
[HTLV-1 infection prevalence in recently arrived sub-Saharan immigrants].
Adult-onset infective dermatitis associated with HTLV-I. Clinical and immunopathological aspects of two cases.
Antibody to HTLV-I in a black South African with a neurological disorder resembling multiple sclerosis.
[HTLV-I-associated myelopathy: a systemic disease]
Antibodies anti HTLV-I/II in Sicilian residents, in drug addicts, and in African immigrants.
Comparison of clinical, immunological and virological markers in patients with HTLV-1 / HIV-1 co-infection with those with mono-infection.
HIV-1, HIV-2, HTLV-I/II and Treponema pallidum infections: incidence, prevalence, and HIV-2-associated mortality in an occupational cohort in Guinea-Bissau.
Major depression and generalized anxiety disorder among HTLV-I/II infected former blood donors.
High prevalence of HTLV-1 and 2 viruses in pregnant women in São Luis, state of Maranhão, Brazil.
[Natural history of HTLV-I infection]
Familial spread of HTLV-I in KwaZulu/Natal.
HTLV type I isolated from a Pygmy in Cameroon is related to but distinct from the known central African type.
[Intra-family transmission of human T-cell lymphotropic virus-1 (HTLV-1) in a cohort of HTLV-1-positive patients (Bénin)]
Cutaneous type of adult T cell leukemia/lymphoma in a French West Indian woman. Clonal rearrangement of T-cell receptor beta and gamma genes and monoclonal integration of HTLV-I proviral DNA in the skin infiltrate.
[Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires]
HTLV-I infection in western equatorial Africa.
HTLV-1 infection in Papua New Guinea: evidence for serologic false positivity.
JunD/HBZ enhances HBZ enhances HTLV-1 antisense transcription.
Activated leukocyte cell adhesion molecule (ALCAM) facilitates trafficking of HTLV-1 infected lymphocytes through the blood brain barrier.
HTLV-1 world distribution and estimation of the number of asymptomatic infected carriers.
No evidence of association between Atherosclerosis, risk factors for cardiovascular disease and human T-cell lymphotropic virus type 1(HTLV-1) infection.
HTLV-1/2 is rare among Eastern-European intravenous drug users (IDUs).
Importance of a Rapid and Accurate Diagnosis in Strongyloides Stercoralis and Human T-Lymphotropic Virus 1 Co-infection: A Case Report and Review of the Literature.
A novel medium-throughput biological assay system for HTLV-1 infectivity and drug discovery.
Recurrent Cystoisospora belli in a patient with HTLV-1 infection.
Human bone marrow mesenchymal stromal cells exhibit suppressive effects on lymphocytes derived from HTLV-1 infected individuals.
HTLV-1 infection interferes with immune responses to Mycobacterium tuberculosis antigens.
Sensitivity and specificity of spinal cord Magnetic Resonance Imaging in the diagnosis of HTLV-1 associated myelopathy.
Generation of direct antigen-sandwich enzyme-linked immune-sorbent assays (ELISA) for quantitation of HTLV-1 gp46, p24, Tax and related host cellular antigens OX40, OX40L and CD25.
Prevalence of Human T-lymphotropic virus type 1 and 2 among blood donors in Manaus, Amazonas State, Brazil.
The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis.
CADM1 Overexpression and CD7 Downregulation in Strongyloides stercoralis and HTLV-1 Coinfection as Possible Markers for Adult T-cell Leukemia/Lymphoma progression.
HTLV-1-infected HIS Rag2-/-γc-/- mice, a suitable model for in vivo investigating the effects of drugs in ATL treatment?
The roles of innate and acquired immune responses on HTLV-I infection.
Humanized anti CCR4 antibody KW0761 targets HTLV-1 infected CD4+ CCR4+ and CD8+CCR4+ T cells to treat HAM/TSP.
Deep sequencing analysis of Human T cell lymphotropic virus type 1 (HTLV-1) long terminal repeat (LTR) region of tropical spastic paraparesis (TSP)/HTLV-1 associated myelopathy (HAM) and asymptomatic carriers.
Deep sequencing of the TCRβ repertoire reveals T cell clonal expansion is associated with HTLV-1 proviral load in HAM/TSP patients.
First report of HTLV-1 truncated p12 protein in Brazil.
The structure and genomic integration site of the HTLV-1 provirus determine selective clonal expansion and transformation to adult T cell leukaemia/lymphoma.
Alternative splicing signatures discriminate ATL cells from untransformed CD4+ counterparts deriving from HTLV-1 infected individuals.
Seroprevalence of Human T-lymphotropic virus type-1 and -2 infections among first-time United States Blood Donors 2000-2009.
Analysis of Tax sequence and its nucleotide polymorphisms in HTLV-1 cases from Argentina.
Prevalence and influence of tuberculosis in the neurologic manifestations of the Human T cell lymphotropic virus type 1 (HTLV-1).
Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals.
Interference of HTLV-1 Tax Protein with Cell Polarity Regulators: Defining the Subcellular Localization of the Tax-DLG1 Interaction.
HTLV-I and –II seroprevalence among United States blood donors, 2000-2009.
Impairment of humoral and cellular immune response to tetanus toxoid in HTLV-1 infected individuals.
Monitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality.
Checkpoints modulation by the Human T-lymphotropic virus type 1 Tax protein.
A seroepidemiological study of HTLV-1 infection in Nepal.
Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
A seroepidemiological survey of HTLV-1 in the Philippines.
Human phospholipid scramblase 1 interacts with and regulates transactivation of HTLV-1 Tax.
Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
HTLV-1 Tax plugs and freezes UPF1 helicase leading to nonsense-mediated mRNA decay inhibition.
Human T-lymphotropic virus type 1 infection and solid organ transplantation.
How Does HTLV-1 Undergo Oncogene-Dependent Replication Despite a Strong Immune Response?
Sporadic on/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells.
Natural course of HTLV-1 proviral DNA levels in carriers during pregnancy.
Sensory neuronopathy heralding human T cell lymphotropic virus type I myelopathy.
Multiple spotty lesions of the spinal cord in a Chinese patient with human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis.
Confirmatory molecular method for HTLV-1/2 infection in high-risk pregnant women.
Algorithm for dry eye disease diagnosis in individuals infected with human T-cell lymphotropic virus type 1.
HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment.
Making the invisible visible: searching for human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in Brazilian patients with viral hepatitis B and C.
Just a Spoonful of Sugar, HTLV-1 Style.
Indolent, waxing and waning cutaneous presentation of HTLV-1-associated adult T-cell leukemia/lymphoma in an HIV-1-positive patient.
Interpretation of low reactivity in the Abbott Architect rHTLV I/II assay.
Progressive flaccid myelopathy associated with HTLV-I.
HTLV-I and neurological disease in South India.
Absence of antibody to HTLV-1 in sera of Asian Indian patients with systemic autoimmune rheumatic diseases.
Origins of HTLV-1 in South America.
Ancient HTLV-1.
Low prevalence of ectopic germinal centre formation in patients with HTLV-I-associated Sjogren's syndrome.
HIV type 1 protease inhibitors fail to inhibit HTLV-I Gag processing in infected cells.
Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10.
Lack of HTLV-I carriers in the Sami, an ethnic group living in the Arctic area in Norway.
Relationship between antibody-dependent cell-mediated cytotoxicity due to anti-HTLV-1 and negative signal of major histocompatibility complex class I antigens on adult T-cell leukemia cell lines.
Erratum to: Evaluation of INOS, ICAM-1, and VCAM-1 gene expression: A study of adult T cell leukemia malignancy associated with HTLV-1.
A case of diffuse panbronchiolitis (DPB) in a patient positive for HTLV-1.
Immunomodulatory effects of concurrent HTLV-I infection in strongyloidiasis.
HTLV-I/II seropositivity in populations at high risk for HIV-1 infection in Cordoba City, Argentina.
Phylogenetic relatedness of HTLV type I from Bellona, a Polynesian outlier within the Solomon Islands, to HTLV type I from Japan and far Eastern Asia.
Age and gender specific prevalence of HTLV-1.
HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation.
A multicentric seroepidemiological survey of HTLV-I/II in Italy.
Different HTLV-I neutralization patterns among sera of patients infected with cosmopolitan HTLV-I.
Deleted HTLV-1 provirus in cord-blood samples of babies born to HTLV-1-carrier mothers.
Sequence analysis of two HTLV type I infections imported to Germany.
Characterization of peripheral blood T-lymphocytes transduced with HTLV-I Tax mutants with different trans-activating phenotypes.
The tax gene sequences form two divergent monophyletic lineages corresponding to types I and II of simian and human T-cell leukemia/lymphotropic viruses.
[Genome epidemiology and tropical spastic paraparesis associated with human T-cell lymphotropic virus type 1].
Anti-HTLV-1 antibody positive cutaneous T-cell lymphoma.
Isolation of STLV-I from orangutan, a great ape species in Southeast Asia, and its relation to other HTLV-Is/STLV-Is.
Seroprevalence and molecular epidemiology of HTLV-1 isolates from HIV-1 co-infected women in Feira de Santana, Bahia, Brazil.
Sequence analysis of HTLV-1 provirus associated with adult T-cell leukemia/lymphoma in Hong Kong.
The close relationship between South African and Latin American HTLV type 1 strains corroborated in a molecular epidemiological study of the HTLV type 1 isolates from a blood donor cohort.
Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB).
Phylogenetic heterogeneity of new HTLV type 1 isolates from southern India in subgroup A.
LTR sequence and phylogenetic analyses of a newly discovered variant of HTLV-I isolated from the Hagahai of Papua New Guinea.
Syngeneic hematopoietic stem cell transplantation from HTLV-1 seropositive twin for adult T-cell leukemia-lymphoma.
Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides.
Magnetic resonance imaging in HTLV-1 antibody positive patients.
Amplification and molecular cloning of HTLV-I sequences from DNA of multiple sclerosis patients.
Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I.
Phylogenetic characterization of a new HTLV type 1 from the Ainu in Japan.
HTLV-1 carrier psoriasis patients treated by anti-IL-23/IL-17.
Myasthenia gravis associated with HTLV-I infection and atypical brain lesions.
Expression of the pX gene of HTLV-I: general splicing mechanism in the HTLV family.
HTLV-I myelopathy.
Acute disseminated encephalomyelitis following HTLV-I associated myelopathy.
Progressive multifocal leukoencephalopathy in an HTLV-I carrier.
Inclusion body myositis in HIV-1 and HTLV-1 infected patients.
HTLV-1 Associated Motor Neuron Disease Mimicking "Man-in-the-Barrel" Syndrome.
Integration sites of the HTLV-1 provirus in host human genome in the IDH patients with monoclonal integration.
[HTLV-I and transfusions]
Features of HTLV-1 transcriptional and chromatin remodeling dynamics emerge from ChIP-chip analysis.
Comparison of walking measures in patients with HTLV-1 Associated Myelopathy.
Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5.
Phylogenetic and similarity analysis of HTLV-1 isolates from HIV-coinfected patients from the South and Southeast regions of Brazil.
HTLV-1 Tax-activated NF-κB is involved in both cell growth and death.
Role of HTLV-1 p30 during infection of monocytes and dendritic cells.
Onabotulinumtoxin type A improves lower urinary tract symptoms and quality of life in patients with human T cell lymphotropic virus type 1 associated overactive bladder.
A novel neuropilin-1-binding sequence in the human T-cell lymphotropic virus type 1 envelope glycoprotein.
[Sweet hijacking by the Tax oncoprotein of the Human T-cell lymphotropic virus type 1].
Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.
Attenuated effectiveness of tumor necrosis factor inhibitors for anti-human T-lymphotropic virus type 1 antibody-positive rheumatoid arthritis.
Role of Integrin Signaling Activation on the Development of Human T-Cell Leukemia VIrus-1 (HTLV-1)-Associated Myelopathy/Tropical Spastic Paraparesis: Its Relationship to HTLV-1-infected CD4+ T Cell Transmigrating Activity into the Tissues.
Estimating rates of de novo infection and mitotic replication in HTLV-1 persistence: de novo infection continues after early infection.
Proteomic profiling of HTLV-1 infected T-cells for the identification of potential biomarkers and therapeutic targets for HTLV-1 associated myelopathy/ tropical spastic paraparesis and adult T-cell leukemia.
The clinical utility of HTLV-1 viral load measurement.
The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation.
Biomarker to predict treatment response in patients with HTLV-1 associated myelopathy/Tropical spastic paraparesis (HAM/TSP).
[Epidemiology, origin and genetic diversity of HTLV-1 retrovirus and STLV-1 simian affiliated retrovirus].
Role of dimerization and palmitoylation on the function of HTLV-1 p12 and p8.
Emerging virus coinfections of the CNS: HTLV I/II as a common denominator.
Patterns of spinal cord atrophy in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP).
Development of HTLV-1 Database for data management and datamining HTLV-1 sequences.
Histopathologic differences between human T-lymphotropic virus type 1 (HTLV-1)-positive and HTLV-1-negative polymyositis.
Induction of APOBEC3B cytidine deaminase gene in HTLV-1 infected T-cells of ATL model mouse.
Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma.
Instruction of feeding methods to Japanese pregnant women who cannot be confirmed as HTLV-1 carrier by western blot test.
Silencing of HTLV-1 gag and env genes by small interfering RNAs in HEK 293 cells.
Occurrence of HTLV-I antibodies in Danish patients with cutaneous T-cell lymphoma.
[Human T-cell leukemia (lymphoma) virus (HTLV-I) antibodies in Danish patients with cutaneous T-cell lymphoma]
HTLV-I and -II in intravenous drug users from Sweden and Denmark.
Epidemiological features of HTLV-I carriers and incidence of ATL in an ATL-endemic island: a report of the community-based co-operative study in Tsushima, Japan.
Mortality among inhabitants of an HTLV-I endemic area in Japan.
[Low incidence of non-Hodgkin lymphoma but high seroprevalence of HTLV-I in Curaçao]
Primary prevention of HTLV-1 in Japan.
Seroprevalence study of HIV-I, HIV-II and HTLV-I among patients at the Dermato-Venereology Clinic of the Lagos University Teaching Hospital.
Low prevalence of HCV, HIV, and HTLV-I/II infection markers in northwestern Greece: results of a 3-year prospective donor study (1995-1997).
Novel biomarker of HTLV-1-associated disease: specific appearance of antibody recognizing the receptor-binding site on HTLV-1 envelope protein.
HIV-1, HTLV-I, and HTLV-II in a semiurban population in East Gabon.
[HTLV-I/II seroprevalence in Gay men and female sex workers on Margarita Island, Venezuela].
[Estimated prevalence rate of HTLV-I uveitis in Chikugo].
[Seroprevalence of human T-cell lymphotropic virus type I in Curaçao and predictive variables for that infection]
Incidence of HIV and HTLV-1 infection among sexually transmitted disease clinic attenders in Jamaica.
The seroprevalence of HTLV-I in patients with ocular diseases, pregnant women and healthy volunteers in the Kanto district, central Japan.
Co-infection with HIV-1/HTLV-II and the risk of progression to AIDS and death. The Oslo HIV Cohort Study Group.
Association of HTLV-I with autoimmune thyroiditis in patients with adult T-cell leukaemia (ATL) and in HTLV-I carriers.
Prevalence of HIV-1, HIV-2 and HTLV antibody, in Fortaleza, Ceara, Brazil, 1993-1994.
Epidemiological features of HTLV-I and adult T cell leukemia.
Seroepidemiological study of retroviruses (HTLV-I/II, HIV-1, HIV-2) in the Department of Atacora, northern Benin.
High seroprevalence of anti-HTLV-I antibody in rheumatoid arthritis.
Donor-derived HTLV-1 associated myelopathy after transplantation: a call for targeted screening.
Low genetic diversity of the Human T-cell Lymphotropic Virus (HTLV-1) in an endemic area of the Brazilian Amazon basin.
Relationship of human cord blood mononuclear cell lines, established by the HTLV-I integration, to expression of T-cell phenotypes and the T-cell receptor gene rearrangement.
Effect of TPA and HTLV-1 Tax on BRCA1 and ERE controlled genes expression.
Stable and transient periodic oscillations in a mathematical model for CTL response to HTLV-I infection.
Multiplex real-time PCR for the detection and quantitation of HTLV-1 and HTLV-2 proviral load: addressing the issue of indeterminate HTLV results.
Decreasing trends in HTLV-1/2 but stable HIV-1 infection among replacement donors in Argentina.
The best algorithm to confirm the diagnosis of HTLV-1 and HTLV-2 in at-risk individuals from São Paulo, Brazil.
Confirming the presence of HTLV-1 infection and the absence of HTLV-2 in blood donors from Arequipa, Peru.
HTLV-1/2 among high-risk groups in Argentina: molecular diagnosis and prevalence of different sexual transmitted infections.
Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010).
Unpredicted HTLV-1 infection in female sex worker from Imbituba, Santa Catarina, Brazil.
Current human T-cell lymphotropic virus type 1 mother-to-child transmission prevention status in Kagoshima.
Why is the distribution of HTLV-I carriers geographically biased? An answer through a mathematical epidemic model.
Non-HTLV-I associated pleomorphic T-cell lymphoma of the brain mimicking post-vaccinal acute inflammatory demyelination.
Population dynamics of HTLV-I infection: a discrete-time mathematical epidemic model approach.
Induction of neutralizing antibodies against HTLV-I envelope proteins after combined genetic and protein immunizations in mice.
[A case of cryptococcal meningitis in an HTLV-1 carrier].
Comparative performances of an HTLV-I/II EIA and other serologic and PCR assays on samples from persons at risk for HTLV-II infection.
Evolutionary dynamics of HTLV-I.
Killer cell systems of cynomolgus monkeys experimentally infected with HTLV-1.
Efficiency of indirect immunofluorescence assay as a confirmatory test for the diagnosis of human retrovirus infection (HIV-1 and HTLV-I/II) in different at risk populations
[Drug addiction and HIV-1/HTLV-2 co-infection in Marseille].
Hematological indices in a cohort of HTLV-I/II and HIV-1 infected intravenous drug users in New York City.
The HTLV-1 oncoprotein Tax is modified by the ubiquitin related modifier 1 (Urm1).
Different molecular mechanisms of HTLV-1 and HIV LTR activation by TPA.
Seroepidemiology of HTLV-I/II in universal screening of blood donations in France.
HTLV-I and HTLV-II world-wide distribution: reanalysis of 4,832 immunoblot results.
Predictive B- and T-cell linear epitopes in structural proteins of HTLV-I, HTLV-II, and STLV-I.
Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses type I/II.
Prevalence of HTLV-I in Arctic regions.
Antigens related to three core proteins of HTLV-I (p24, p19 and p15) and their intracellular localizations, as defined by monoclonal antibodies.
Absence of antibodies to HTLV-1 in sera from Hungarian MS patients.
[High prevalence of antiHTLV-1 antibodies in the Boni, an ethnic group of African origin isolated in French Guiana since the 18th century]
Gene expression profiles in HTLV-I-immortalized T cells: deregulated expression of genes involved in apoptosis regulation.
Critical Role of the HTLV-1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly.
Soluble recombinant HTLV-1 surface glycoprotein competitively inhibits syncytia formation and viral infection of cells.
[Pulmonary strongyloidiasis complicated by E. coli meningitis in a HIV-1 and HTLV-1 positive patient].
Quantitating the Transfer of the HTLV-1 p8 Protein Between T-Cells by Flow Cytometry.
Ultrasensitive photoelectrochemical biosensor for the detection of HTLV-I DNA: A cascade signal amplification strategy integrating λ-exonuclease aided target recycling with hybridization chain reaction and enzyme catalysis.
Retrospective screening of microarray data to identify candidate IFN-inducible genes in a HTLV-1 transformed model.
HTLV-1: Regulating the Balance Between Proviral Latency and Reactivation.
Detection of human T lymphotropic virus type-I bZIP factor and tax in the salivary glands of Sjögren's syndrome patients.
PDZ domain-binding motif of Tax sustains T-cell proliferation in HTLV-1-infected humanized mice.
Nucleotide composition bias and CpG dinucleotide content in the genomes of HIV and HTLV 1/2.
[HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
The HTLV type I sequence from an asymptomatic German blood donor is related to sequences from South America.
Isolation and characterization of the tax protein of HTLV-I.
[Using epidemiology and bioinformatics for studying HTLV-1 infection-associated adult T-cell leukemia].
Geographic independence of HTLV-I and HTLV-II foci in the Andes highland, the Atlantic coast, and the Orinoco of Colombia.
HTLV-I, HIV-I, and hepatitis B and C viruses in Western Province, Papua New Guinea: a serological survey.
Prevalence of HTLV-I compared to HIV-1 and HIV-2 antibodies in different groups in the Ivory Coast (West Africa)
The discovery of HTLV-1 myelitis: 21 years later.
A seroepidemiological survey of HTLV-I/II carriers in the Puna Jujeña.
[Clonal expansion and genomic characterization of the human T-cell lymphotropic virus type I during the integration process in adult T-cell leukemia/lymphoma].
Modulation of apoptosis during HTLV-1-mediated immortalization process in vitro.
[The role of region pX in the life cycle of HTLV-I and in carcinogenesis]
[A case of HTLV-1 associated bronchiolo-alveolar disorder showing progressive air trapping].
Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.
Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease.
[The human T-cell leukemia virus type I (HTLV-I) tax protein induces apoptosis].
[Gene structure and transformation mechanism of HTLV-I].
Ablation of transplanted HTLV-I tax-transformed tumors in mice by antisense inhibition of NF-kappa B.
Detection of serum antibodies in Ethiopian baboons that cross-react with SIV, HTLV-I, and type D retroviral antigens.
[Regulatory mechanism of HTLV-1 replication and its association with abnormal cell growth].
[Transformation by the tax gene of HTLV-1].
[A case of adult T-cell leukemia with a defective HTLV-I proviral DNA, in which the single T-cell clone appeared to have progressed from chronic phase to crisis]
[The 1st case of adult T-cell leukemia (ATL) with expressed immune response to HTLV in the USSR]
[Oncogenic transformation by the tax gene of HTLV-I].
[Regulation of HTLV-1 gene expression and its relevance to proliferation of the infected cells]
Induction of leukemic infiltration by allogeneic transfer of HTLV-I-transformed T cells in rabbits.
Chromosome damage induced in cord blood T-lymphocytes infected in vitro by HTLV-I.
Mechanism of the gene expression of HTLV-I and its association with ATL.
Improvement of quality of life after splenectomy in an HTLV-I carrier with T-cell prolymphocytic leukemia.
Effect of HTLV-III on the macromolecular synthesis in HTLV-I carrying cell line, MT-4.
Functional relation between HTLV-II x and adenovirus E1A proteins in transcriptional activation.
Interactions between normal lymphoid cells and HTLV-I producer cells.
The lor gene and pathogenesis of HTLV-I, -II, and -III.
Augmented T cell growth factor receptor expression in HTLV-1-infected human leukemic T cells.
Evaluations of substrate specificity and inhibition at PR/p3 cleavage site of HTLV-1 protease.
Curcumin targets Akt cell survival signaling pathway in HTLV-I-infected T-cell lines.
HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP).
Activation of a cryptic splice site in the tax gene of HTLV-I by a single nucleotide change.
Ethical aspects of HTLV-I testing in Aboriginal people.
Phylogeny of human T-lymphotropic virus-1 subtypes in Guinea-Bissau.
Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1.
Identification of novel monocistronic HTLV-1 mRNAs encoding functional Rex isoforms.
HTLV-1 inserts an ectopic CTCF-binding site into the human genome.
[Transmission of ATLV (HTLV-I) through blood transfusion].
Effect of pulsed methylprednisolone on disease severity, viral load and inflammation in patients with human T-lymphotropic virus type 1 associated myelopathy.
[HTLV-1 bZIP Factor (HBZ) gene has a growth-promoting effect on adult T-cell leukemia cells].
[Polymyositis and HTLV-I infection: case report]
[HIV-/HTLV-I infection. Little danger through blood transfusion]
HTLV-1 Tax targets centrosomal Cep63 protein.
[Detection of HTLV-I/ATLV by using the culture of lymph node lymphocytes with adult T-cell leukemia/lymphoma].
[HTLV-I retroviral variant in Zaire in patient with chronic neuromyelopathy. Nucleotidic sequence of the envelope gene]
Screening for HTLV-1 in healthy blood donors in Trinidad and Tobago, West Indies.
The effect of chemotherapeutics on cell-to-cell transport of HTLV-1 and the p8 protein through membrane nanotubes.
Localization of HTLV-I tax proviral DNA in mononuclear cells.
[Clinical and biological epidemiology of onco-retroviral HTLV-I and II infections]
High seroprevalence of HTLV-I in the Seychelles.
Detection of HTLV-I and not HTLV-II infection in Guinea Bissau (west Africa)
Lack of HTLV-I antibodies in Africans.
HTLV-I associated myelopathy/tropical spastic paraparesis with pseudohypothyroidism.
[Clinical investigation of 15 patients with pulmonary cryptococcosis--clinical comparison of HTLV-I carriers and non-carriers].
Viruses in focus yet again just how dangerous is HTLV-1?
Autoimmune disease and HTLV-1 infection.
Adult T-cell leukaemia and HTLV-I-associated myelopathy in a family.
[A case of T-cell lymphoma showing multiple nodular shadows and an elevated titer of human T-lymphotropic virus type I (HTLV-I) antibody]
HTLV-I tax gene product activates transcription via pre-existing cellular factors and cAMP responsive element.
Nutritional status and behavioral factors of individuals with HTLV-1 and tropical spastic paraparesis (HAM / TSP).
[Prevalence of hepatitis B and C virus, HTLV-1 and HIV in type B lymphoproliferative syndromes in Gabon]
[Human T-lymphotropic virus type I (HTLV-I): risk of transmission with transfusion].
Proviral HTLV-I and HTLV-II in the Efe pygmies of northeastern Zaire.
Low HTLV-I/II seroprevalence in pregnant women in Congo and a geographic cluster of an HTLV-like indeterminate western blot pattern.
[Sjögren's syndrome and HTLV-I myelopathy]
[Spastic tropical paraplegia associated with HTLV-1 in Central African Republic].
[African histoplasmosis: clinical and therapeutic aspects, relation to AIDS. Apropos of 4 cases, including a case with HIV-1-HTLV-1 co-infection]
[Adult T-cell leukemia associated with HTLV-1 in a HIV-2 seropositive African]
[Epidemiological features of retroviral infection by HTLV-1 in central Africa]
[Leukemia/lymphoma T syndrome associated with HTLV 1 in a patient of Moroccan origin].
[Epidemiology of infections caused by HIV-1, HIV-2 and HTLV-1 in the republic of Chad]
A plasmid vector for cloning and expression of gene segments: expression of an HTLV-I envelope gene segment.
The clinical spectrum of HTLV-1 infection.
Seroprevalence of HIV, HTLV-I/II and other perinatally-transmitted pathogens in Salvador, Bahia.
HTLV-1 infected CD4+T cells of HAM/TSP patients are susceptible to tunicamycin-induced endoplasmic reticulum stress.
[Detection of HTLV-1 DNA in biopsies of Chilean patients with cutaneous T-cell lymphoma].
In vivo immunogenicity of Tax (11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine.
One year follow-up study of T-cell subsets and incidence of seropositivity for HTLV-I and HTLV-III antibodies in patients treated "on demand" or sporadically with clotting concentrates.
Time to eradicate HTLV-1: an open letter to WHO.
Expression of miR-34a in T-Cells Infected by Human T-Lymphotropic Virus 1.
The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 p30II and the retroviral oncoproteins Tax and HBZ and is highly expressed in an in vivo xenograft model of HTLV-1-induced lymphoma.
Risk factors associated with HTLV-1 vertical transmission in Brazil: longer breastfeeding, higher maternal proviral load and previous HTLV-1-infected offspring.
The HTLV-1 basic leucine zipper factor (HBZ) attenuates repair of double-stranded DNA breaks via non-homologous end joining (NHEJ).
HTLV-1, ATLL, refractory hypercalcaemia and HIV-1 co-infection.
[Infection by HTLV-1 in heroin addicts in Barcelona]
HTLV-1 burden dependent on hijacking monocytes chemotaxis.
Reduced efficacy of chemotherapy might accumulate concurrent HTLV-1 infection among strongyloidiasis patients in Okinawa, Japan.
Stability of the HTLV-1 glycoprotein 46 (gp46) gene in an endemic region of the Brazilian Amazon and the presence of a significant mutation (N93D) in symptomatic patients.
IFI16 regulates HTLV-1 replication through promoting HTLV-1 RTI-induced innate immune responses.
A NKG2D Thr72Ala polymorphism is not associated with HAM/TSP and proviral load values in Peruvian HTLV-1 infected patients with HAM/TSP and asymptomatic carriers.
Introduction to the study of adult T-cell leukemia and HTLV-I sero-positivity in Romania.
Hepatitis C viral load in HCV-monoinfected and HCV/HIV-1-, HCV/HTLV-1/-2-, and HCV/HIV/HTLV-1/-2-co-infected patients from São Paulo, Brazil.
HTLV-1 Alters T Cells for Viral Persistence and Transmission.
How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy.
HTLV-1 proviral load in cerebrospinal fluid may not be a good marker to differentiate asymptomatic carriers with high proviral load in blood from HAM/TSP patients.
Application of HTLV-1 tax transgenic mice for therapeutic intervention.
Specificity of an oligonucleotide primer pair and of a single-base substitution in the amplification and detection of env gene sequences of HTLV-I variants from Papua New Guinea and the Solomon Islands.
A case of HTLV-1 associated adult T-cell lymphoma presenting with cutaneous lesions and tropical spastic paresis.
Human T-Lymphotropic Virus type 1c subtype proviral loads, chronic lung disease and survival in a prospective cohort of Indigenous Australians.
Impaired TNF, IL-1β, and IL-17 production and increased susceptibility to Mycobacterium tuberculosis infection in HTLV-1 infected individuals.
[Improvement of human T-lymphotropic virus type 1 associated demyelinating neuropathy with corticosteroid therapy].
[Diagnostic performance of the indirect immunofluorescence test for the detection of antibodies against HTLV-1].
[Management of an HTLV-1 infected man in assisted reproductive technology].
DARC polymorphism that abrogates erythrocyte Duffy antigen expression influences MCP-1 plasma level in HTLV-1 infected individuals but are not associated with HAM/TSP.
HLA-G 14-bp insertion/deletion polymorphism is a risk factor for HTLV-1 infection.
In vitro basal T-cell proliferation and HTLV-1 proviral load among HTLV-1 subjects co-infected with Hepatitis C and/or HIV-1.
Flower cells in patients with infective dermatitis associated with HTLV-1.
[HTLV-I and HTLV-II virus]
[Human T-cell lymphotropic virus type I infection in patients with lymphoproliferative disorders at two sentinel sites in Cuba].
[Molecular characterization of HTLV-1/2 among blood donors in Belém, State of Pará: first description of HTLV-2b subtype in the Amazon region].
[Prevalence, risk factors and genetic characterization of human T-cell lymphotropic virus types 1 and 2 in patients infected with human immunodeficiency virus type 1 in the cities of Ribeirão Preto and São Paulo].
Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
The 10 C-terminal residues of HTLV-I protease are not necessary for enzymatic activity.
HTLV Tax repress nonsense mediated mRNA decay by inhibiting the ATPase activity of UPF1.
HLA class I alleles in HTLV-1-associated myelopathy and asymptomatic carriers from the Brazilian cohort GIPH.
CD8 malignant proliferation in association with human T cell lymphotropic Virus 1 infection: a case report.
Activation of the IκB kinase complex by HTLV-1 Tax requires cytosolic factors involved in Tax-induced polyubiquitination.
[Molecular characterization of HTLV-1 among patients with tropical spastic paraparesis/HTLV-1 associated myelopathy in Belém, Pará].
Hemopoietic stem cell transplantation from a donor with indeterminate HTLV-1 status.
Prevalence of infection by HTLV-I/II among pregnant women and high-risk groups in the Peloponnese peninsula, Greece.
[Cloning and transmembrane glycoprotein expression of the retrovirus HTLV-1 in mammals' cells].
Adult T-cell leukemia/lymphoma in a Caucasian patient after sexual transmission of HTLV-1.
Cutaneous T-cell lymphoma with HTLV-I infection: clinical overlap with adult T-cell leukemia/lymphoma.
[Expression of the gene for the gp46 surface glycoprotein from the human T-cell leukemia virus type I (HTLV-I) in bacteria]
Anti-HTLV-I IgG in urine detected by sensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) using a synthetic peptide, Cys-env gp46(188-224), as antigen.
A transgenic model of transactivation by the Tax protein of HTLV-I.
[Differential expression of recombinant hybrid proteins containing amino- and carboxy-terminal regions of the exterior large glycoprotein (gp46) of the human T-cell leukemia virus (HTLV-I) in Escherichia coli cells]
Risk of HTLV-I infection in Japanese women who are last in birth order.
No evidence of HTLV-I infection in patients with mycosis fungoides and Sezary syndrome.
Gastrointestinal parasitic infection in healthy Jamaican carriers of HTLV-I.
Differential precipitation and zinc chelate chromatography purification of biologically active HTLV-I Tax1 expressed in E. coli.
HTLV-I env protein acts as a major antigen in patients with HTLV-I-associated arthropathy.
HTLV-1 and HTLV-2 prevalence in the United States.
Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice.
Evaluation of HTLV-I removal by filtration of blood cell components in a routine setting.
A rapid hemi-nested PCR for HTLV-I detection.
Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count.
Prevalence of mycosis fungoides and its association with EBV and HTLV-1 in Pakistanian patients.
Cost-effectiveness analysis of introducing HTLV-1 testing in South Africa.
KIR genes and adult T-cell leukemia/lymphoma in patients infected with HTLV-1.
HTLV-1 Tax induces Th1 master regulator T-bet and thus IFN-γ in CD4+CCR4+ T-cells of virus-associated myelopathy patients.
Identification and characterization of novel NF-kB dependent genes involved in HTLV-I pathogenesis.
Consequences of the association between HTLV-1 and tuberculosis.
Identification of long-range chromatin interactions between HTLV-1 and the host genome.
HTLV-1 tax hijacks cellular ubiquitination machinery to assemble K63-linked polyubiquitin for canonical NF-κB activation.
MicroRNAs expression in CD4 T cells from HTLV-1 individuals.
Prevalence of HTLV-1/2 and HIV-1/2 in individuals attending Public Health Center in Mozambique. One HTLV-1 symptomatic case report.
Are seroindeterminate western blot patterns in human T-Cell lymphotropic virus type 1 (Htlv-1) infected individuals associated with low proviral load levels?
HTLV-1 subtype C infection in a socially disadvantaged Indigenous Australian population: epidemiological insights from a retrospective hospital-based cohort study.
Suppression of HTLV-1 transcription by SIRT1 deacetylase.
Role of protein arginine methyltransferase 5 over-expression in HTLV-1-driven cellular transformation and leukemia.
The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice.
IFNG +874A/T Polymorphism Among Asymptomatic HTLV-1-Infected Individuals Is Potentially Related to a Worse Prognosis.
Proteomic analysis of plasma extracellular vesicles reveals mitochondrial stress upon HTLV-1 infection.
Maternal transmission of HTLV-1 other than through breast milk: discrepancy between the polymerase chain reaction positivity of cord blood samples for HTLV-1 and the subsequent seropositivity of individuals.
A critical role for IL-17RB signaling in HTLV-1 tax-induced NF-κB activation and T-cell transformation.
Inflammation with HTLV-1-specific CTLs occurs in the spinal cord of HTLV-1 carriers and the brain of the patients with HAM/TSP.
Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody.
Subtype analysis of HTLV-1 in patients with HTLV-1 uveitis.
STAMBPL1 is a deubiquitinating enzyme that regulates HTLV-I Tax subcellular localization and NF-kB activation.
Tuberculosis (TB) incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.
Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-β Response in HTLV-1-Associated Neuroinflammation.
Chemiluminescence immunoassay to detect anti-HTLV-I antibodies.
Interfamilial transmission of HTLV-1 in the South of Bahia, Brazil.
Prevalence of HIV-1, HIV-2, and HTLV-I/II in Spanish seamen.
HTLV-I associated myelopathy, a new clinical entity.
Molecular and clinical analyses of HTLV-1 subgroups associated with the risk of developing HAM/TSP.
CD64 as a biomarker and therapeutic target in HAM/TSP and HTLV-1-associated Infective Dermatitis.
ATL-like overgrowth and clonal expansion of HTLV-1 infected CD25+ CD4+ T- lymphocyte in humanized-NOG mouse model.
Droplet Digital PCR for absolute quantification and determination of proviral load of HTLV-1 and 2.
ORFI genetic polymorphisms in geographically distinct HTLV-1 infections.
Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: retrospective study in Martinique.
HTLV-I uveitis: a distinct clinical entity caused by HTLV-I.
Role of myosin Va on HTLV-1 p8I protein's traffic to cell surface.
A maternal risk factor for mother-to-child HTLV-I transmission: viral antigen-producing capacities in culture of peripheral blood and breast milk cells.
Localization and sub-cellular shuttling of HTLV-1 Tax with the microRNA machinery.
Analysis of the association between the sex and disease courses of 132 consequent patients with HTLV-1-associated myelopathy/Tropic spastic paraparesis (HAM/TSP).
Complete prevention of HTLV-1 infection in humanized mice (hu-PBL SCID) by a neutralizing monoclonal antibody to envelope gp46.
HTLV-1 Tax Specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications.
Characteristics of HAM/TSP after kidney transplantation from HTLV-1 positive living donors.
CD3e expression in HTLV-1-infected individuals is associated with proviral load and Tax expression.
Cas-L associates with human T-lymphotropic virus type I Tax and regulates its transactivation of NF-κB: possible role of Cas-L in pathophysiology of rheumatoid arthritis.
Identification of HTLV-I sequence in cord blood mononuclear cells of neonates born to HTLV-I antigen/antibody-positive mothers by polymerase chain reaction.
Evidence of a predominance of sexual transmission of HTLV-1 in Salvador, the city with the highest prevalence in Brazil.
Immunological characteristics of Spanish IDUs infected with HTLV-2 and HIV-1.
Human T-cell lymphotropic virus type 1 (HTLV-1) infection among couples of a cohort followed up in São Paulo, Brazil.
Impact of dendritic cells and adjuvant on the in vivo immunogenicity of HTLV-1 Tax 11-19 epitope in hybrid HLA-A2.1/DTR transgenic mice.
Association between Human T-Cell Lymphotropic Virus Type 1 and 2 (HTLV 1/2) infection and tuberculosis: systematic review and meta-analysis.
Prevalence of HTLV-1 infection in northeast of Iran.
Effect of freeze-thawing breast milk on vertical HTLV-I transmission from seropositive mothers to children.
Highlights from the HTLV-1 symposium at the 2017 Australasian HIV and AIDS Conference held jointly with the 2017 Australasian Sexual Health Conference, November 2017, Canberra, Australia.
HTLV-1 bZIP factor perturbs immune response to the pathogens in vivo by inhibiting IFN-gamma production.
Envelope Is a Major Viral Determinant of the Distinct In Vitro Cellular Transformation Tropism of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2.
HTLV-1 bZIP factor-mediated dysfunction of regulatory T cells in vivo.
Antibody to HTLV-I in indigenous inhabitants of the Andes and Amazon regions in Colombia.
The human leukemia virus HTLV-1 alters the structure and transcription of host chromatin in cis.
Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy.
Early Juvenile HTLV-1-associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): Study of 25 Patients.
FOXP3-positive T-cell lymphomas in non-HTLV1 carriers include ALK-negative anaplastic large cell lymphoma: expanding the Spectrum of T-cell lymphomas with regulatory phenotype.
Recurrent Enterococcus faecalis meningitis in a patient presenting with Strongyloides hyperinfection syndrome during HTLV-1-induced T-cell lymphoma.
Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals.
[Acute liver failure as presentation of adult T-cell leukemia in an HTLV-1 patient].
Plasma and cerebrospinal fluid levels of cytokines as disease markers of neurologic manifestation in long-term HTLV-1 infected individuals.
NF-κB signaling mechanisms in HTLV-1-induced adult T-cell leukemia/lymphoma.
Can we reduce the incidence of adult T-cell leukaemia/lymphoma? Cost-effectiveness of human T-lymphotropic virus type 1 (HTLV-1) antenatal screening in the United Kingdom.
Phylogenetic analysis of HTLV-1 in Iranian blood donors, HIV-1 positive patients and patients with beta thalassemia.
Overrepresentation of patients from HTLV-1 endemic countries among T cell Non-Hodgkin lymphomas in the Netherlands: an indication of under-diagnosis of Adult T cell leukaemia/lymphoma.
Efficacy of mirabegron for overactive bladder with human T cell lymphotropic virus-1 associated myelopathy.
[Combined spinal-epidural anesthesia for a patient with HTLV-1 associated myelopathy].
HTLV-1-associated myelopathy/tropical spastic paraparesis and peripheral neuropathy following live-donor renal transplantation.
[HTLV-1 and skin diseases].
[Human T-lymphotropic virus I/II detection in Chilean patients from Sexually Transmitted Diseases clinics].
Knockdown of Bcl-3 inhibits cell growth and induces DNA damage in HTLV-1-infected cells.
[miRNA in HTLV-1 related disease].
Double integration band of HTLV-1 in a young patient with infective dermatitis who developed an acute form of adult T-cell leukemia/lymphoma.
[Epidemiology of adult T-cell leukemia and HTLV-1 infection--toward the eradication of HTLV-1 infectious diseases].
Devastating aquaporin-4 and HTLV-1-associated necrotizing encephalopathy.
[HTLV-1-associated myelopathy/tropical spastic paraparesis: a differential diagnosis in multiple sclerosis].
[The current and future approaches to the treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
A probable association between HTLV-1 and endemic mycosis in Latin America.
HTLV-I-infected breast milk macrophages inhibit monocyte differentiation to dendritic cells.
[Intermediate uveitis due to human T-cell lymphotropic virus type 1].
[HTLV-1 infection. An underdiagnosed entity in paediatrics?].
[A case of primary T-cell central nervous system lymphoma (T-PCNSL) relevant to HTLV-I].
[Anti-HTLV-1 task force by the Prime Minister of Japan and his cabinet: New government policy against HTLV-1/ATL].
Successful treatment of HTLV-1-related overlap syndrome using tacrolimus.
Inhibiting HDACs in a preclinical model of HTLV-1-induced adult T-cell lymphoma.
High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey.
[Combined infection with HTLV-1 and Strongyloides stercoralis].
Selective inhibition of HTLV-1-infected cell proliferation by a novel tetramethylnaphthalene derivative.
[Targeted screening for HTLV-1 in couples requesting medically assisted reproduction].
[Virological aspects of HTLV-1 infection and new therapeutical concepts].
Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patients.
[Rapid progressive HTLV-1-associated myelopathy with bronchoalveolar lesions and a long spinal cord lesion extending to almost the entire spinal cord].
Sensitivity analysis of retrovirus HTLV-1 transactivation.
The tumor marker Fascin is strongly induced by the Tax oncoprotein of HTLV-1 through NF-kappaB signals.
Retraction: Curcumin targets Akt cell survival signaling pathway in HTLV-I-infected T-cell lines.
Polymyositis in childhood as clinical manifestation associated with HTLV-1.
Sphincter abnormality in polytransfused patient due to paroxysmal nocturnal hemoglobinuria (PNH): initial manifestation of tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM).
[HTLV-1 associated myelopathy: clinical and epidemiological profile in a 10-year case series study].
Clinical and immunological features of patients with atopy and concomitant HTLV-1 infection.
SMYD3 interacts with HTLV-1 Tax and regulates subcellular localization of Tax.
[Human T lymphotropic virus type-1, HTLV-1 provirus DNA].
Clonal expansion of HTLV-1 positive CD8+ cells relies on cIAP-2 but not on c-FLIP expression.
[Decline in the prevalence of HTLV-1/2 among blood donors at the Regional Blood Center of the City of Uberaba, State of Minas Gerais, from 1995 to 2008].
HTLV-1 and HIV-1 "accessory" proteins: a misleading misnomer.
Evaluation of a new screening assay for HTLV-1 and -2 antibodies for large-scale use.
Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
Seroprevalence of HTLV-1 among kidney graft recipients: a single-center study.
[Magnetic resonance imaging (MRI) of human T lymphocyte virus type I (HTLV-I) associated polyradiculoneuropathy].
Atypical presentation of adult T-cell leukaemia/lymphoma due to HTLV-1: prurigo nodularis lasting twelve years followed by an acute micropapular eruption.
Onset of opportunistic infections in patients co-infected by HTLV-1 and HIV-1, with high CD4+ cells count.
[Seroprevalence of HTLV-1/2 in blood donors from Misiones Province].
Evaluation of a new third-generation ARCHITECT rHTLV-I/II assay for blood screening and diagnosis.
Association of human T lymphotropic virus 1 amplification of periodontitis severity with altered cytokine expression in response to a standard periodontopathogen infection.
Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses.
"Not multiple sclerosis" and the changing face of HTLV-1: a case report of downbeat nystagmus.
Cutaneous tumor lysis syndrome in a patient with HTLV-1 adult T-cell lymphoma/leukemia.
Intestinal strongyloidiasis as a presenting symptom of HTLV-1-associated adult T-cell leukemia/lymphoma.
Nonspecific interstitial pneumonia pattern as pulmonary involvement in human T-cell lymphotropic virus type 1 carriers.
A clinical survey of uveitis in HTLV-1 endemic region.
FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia.
Trends of incidence rate of adult T-cell leukemia/lymphoma in an HTLV-1 endemic area in Japan.
[Prenatal screening for Trypanosoma cruzi and human T lymphotropic virus types 1 and 2 in pregnant Latin American women].
[Prevalence of human T-cell lymphotropic virus (HTLV-1/2) infection among puerperae in Cuiabá, Mato Grosso, 2006].
[Human T-lymphotropic virus 1 (HTLV-1), strongyloidiasis and scabies. Infections and associations to considerate].
[Lower levels of regulatory T-cells in a patient with HTLV-I associated myelopathy]
Factors predisposing to HTLV-1 infection in residents of the greater Tokyo area.
[Influence of antisense RNA and sequences of viral transactivators traps on RNA synthesis of HTLV-1 virus]
[Recent progress in ATL and HTLV-1 research].
HTLV-I infection results in resistance toward salivary gland destruction of Sjögren's syndrome.
Increased prevalence of HTLV-1 in patients with pulmonary tuberculosis coinfected with HIV, but not in HIV-negative patients with tuberculosis.
[HTLV 1/2 infection: prenatal performance as a disease control strategy in State of Mato Grosso do Sul].
HTLV-I, Tax: fox hunting still allowed.
[Salivary and lacrymal gland disorders and HTLV-1 infection].
Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.
[Neurological symptoms and disability in HTLV-1 associated myelopathy].
Evaluation of a new, fully automated immunoassay for detection of HTLV-I and HTLV-II antibodies.
[Strongyloides stercoralis hyperinfection syndrome with acute meningoencephalitis associated to HTLV-1 and HTLV-2 virus co-infection].
HTLV-I and neurological disease: from tropical spastic paraparesis to HTLV-I-associated myelopathy: what next?
Adult T-cell lymphoma with HTLV-I and HTLV-II infection.
[Human T-lymphotropic virus (HTLV I/II) seroprevalence amongst blood-donors in a hospital Bogotá, Colombia,between 1999 and 2004].
Association between HTLV-1 infection and pulmonary tuberculosis: another challenge for National Tuberculosis Programs?
[Molecular biology of HTLV-1].
Unusual finding of HTLV-I infection among Amazonian Amerindians.
[Frequency of HIV-1, rubella, syphilis, toxoplasmosis, cytomegalovirus, simple herpes virus, hepatitis B, hepatitis C, Chagas disease and HTLV I/II infection in pregnant women of State of Mato Grosso do Sul].
[Sociodemographic, epidemiological and behavioral profile of women infected with HTLV-1 in Salvador, Bahia, an endemic area for HTLV].
[Evaluation of the performance of immunological parameters as indicators for clinical progression of chronic HTLV-1 infection].
The Tax protein of HTLV-1 promotes oncogenesis in not only immature T cells but also mature T cells.
[Exfoliative erythroderma and infective dermatitis in an infant infected with human T-lymphotropic virus type I (HTLV I)].
Molecular characterization of the Tax-containing HTLV-1 enhancer complex reveals a prominent role for CREB phosphorylation in Tax transactivation.
Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma.
HTLV-1 Non-Saudi blood donors at King Fahd General Hospital, Jeddah.
Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
[HTLV-1 and HTLV-2 proviral load: a simple method using quantitative real-time PCR].
[A human T-cell lymphotropic virus type 1 carrier presenting with Sjögren's syndrome and bronchopneumopathy].
IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection.
Reactive oxygen species mediate N-(4-hydroxyphenyl)retinamide-induced cell death in malignant T cells and are inhibited by the HTLV-I oncoprotein Tax.
High seroprevalence of anti-HTLV-I/II antibodies among solid organ donors necessitates confirmatory testing.
Postgenomic up-regulation of CCL3L1 expression in HTLV-2-infected persons curtails HIV-1 replication.
A major susceptibility locus for HTLV-1 infection in childhood maps to chromosome 6q27.
[Infections due to HIV-2 and HTLV-1/2 in Spain].
Successful treatment of HTLV-1-associated acute adult T-cell leukemia lymphoma by allogeneic bone marrow transplantation: a 12 year follow-up.
Pulmonary mycobacterium Simiae infection and HTLV1 infection: an incidental co-infection or a predisposing factor?
HTLV-1 and other viral sexually transmitted infections in antenatal and gynaecological patients in Ghana.
HTLV-1 p12I protein sequences from South America: truncated proteins and common genetic signatures.
[Chronic progressive cervical myelopathy with HTLV-I infection: variant form of HAM/TSP].
A role for regulatory T cells in cutaneous T-Cell lymphoma; induction of a CD4 + CD25 + Foxp3+ T-cell phenotype associated with HTLV-1 infection.
Solid-phase syntheses of olefin-containing inhibitors for HTLV-1 protease using the Horner-Emmons reaction.
[Natural history of human T-lymphotropic virus type 1 (HTLV-1) infection].
[Somatosensitive and motor evoked potentials in HTLV-I associated myelopathy].
[Uveitis associated with thyroïditis in HTLV-1 carriers].
[Diagnostic tests: Human T lymphotropic virus type-I, HTLV-I provirus DNA].
Prognosis of HTLV-I-positive renal transplant recipients.
A comparative evaluation of prevalence of HTLV-1 antibodies in blood donors in Delhi India by PAT and LIA method.
GITR overexpression on CD4+CD25+ HTLV-1 transformed cells: detection by massively parallel signature sequencing.
Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes.
High levels of cytoplasmic HTLV-1 Tax mutant proteins retain a Tax-NF-kappaB-CBP ternary complex in the cytoplasm.
HPRT mutations, TCR gene rearrangements, and HTLV-1 integration sites define in vivo T-cell clonal lineages.
[Dermatologic lesions in patients infected with the human T-cell lymphotropic virus type 1 (HTLV-1)].
High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: a South American health concern.
Natural course of HTLV-1 carriers with monoclonal proliferation of T lymphocytes ("pre-ATL") in a 20-year follow-up study.
[Serological survey of human T lymphotropic virus type I (HTLV-1) IgG antibody in south region of Xinjiang]
HTLV-1-related lymphoma in Hong Kong Chinese.
The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women.
[Motor neuron syndrome associated to the HTLV-1 retrovirus]
An epidemiological study of HBV, HCV and HTLV-I in Sherpas of Nepal.
[Evaluation of HTLV-1 virus expression by introducing human CRM1 gene into T cells of rats with a sustained HTLV-1 infection].
[Analysis of immune controlling CD4+CD25+ T cells in HTLV-1 transgenic rats].
Prevalence of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis B and C viruses among immigrant sex workers in Madrid, Spain.
"Honeycomb lung" in an HTLV-I carrier.
Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers.
Prevalence of HIV, HTLV-I and HTLV-II among female sex workers in Spain, 2000-2001.
[Soroprevalence of HTLV-I/II, HIV, siphylis and toxoplasmosis among pregnant women seen at Botucatu - São Paulo - Brazil: risk factors for HTLV-I/II infection].
Extensive genital warts associated with HTLV-I infection.
[HIV-2 and HTLV-I/II infections in Spain].
[HTLV1 infection and pregnancy]
Disseminated molluscum contagiosum and pulmonary cryptococcosis coexisting in an HTLV-1 seropositive patient.
[HTLV-1 infection and Alzheimer-type dementia]
Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.
[Malignant transformation of epithelial thymoma developed in HTLV-I pX transgenic rat by heterotopic transplantation and its molecular analysis].
HTLV-1 carriers with B-cell lymphoma of localized stage head and neck: prognosis, clinical and immunopathological features.
[A patient with HTLV I-associated myelopathy (HAM) complaining of burning pain on the bilateral feet: a case report].
Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines.
[A woman with Sezary syndrome developed HTLV-1-associated myeloneuropathy. The reported case supports the theory of etiological connection].
Multiplex PCR using real time DNA amplification for the rapid detection and quantitation of HTLV I or II.
Anti-HTLV-I/II Seroprevalence in Healthy Blood Donors in İzmir, Turkey.
Leukemia and myelopathy: the persistent mystery of pathogenesis by HTLV-I/II.
[HTLV-1, 2].
[HTLV-I-associated myelopathy (HAM)].
[A HTLV-I carrier initially treated for Pneumocystis carinii pneumonia].
Virology. Forced entry--or does HTLV-I have the key?
Dual infections with HIV-1, HIV-2 and HTLV-I are more common in older women than in men in Guinea-Bissau.
[HTLV I associated tropical spastic paraplegia. Two case reports diagnosed in Paraguay]
Unusually high incidence of positive HTLV I/II results among young female organ donors in the peripartum period.
Increased risk of developing peripheral neuropathy in patients coinfected with HIV-1 and HTLV-2.
Infection with retroviruses other than HIV-1 in Spain: a retrospective analysis for HIV-2, HTLV-I, and/or HTLV-II.
Non-HTLV-1-associated primary gastric T-cell lymphomas show cytotoxic activity: clinicopathological, immunohistochemical characteristics and TIA-1 expression in 31 cases.
Adult T-cell leukemia with cyclic neutropenia in a seronegative patient carrying only the tax gene of HTLV-I.
[HTLV-1: multistep leukemogenesis of adult T-cell leukemia].
HTLV-I and HTLV-II infections in volunteer blood donors and high-risk groups in Lebanon.
[Analysis of CD4+CD25+ T cells in transgenic rats carrying the env-pX gene of HTLV-I].
[Absence of HTLV-I/II virus circulation in blood donors from the provinces of Santa Fe and Santiago del Estero]
[STRONGYLOIDES STERCORALIS: CLINICAL SEVERE FORMS ASSOCIATED TO HTLV-1 INFECTION]
[The prevalence of serum IgG antibodies against HTLV viruses type I and II in sarcoidosis patients].
[Chronic hepatitis C with HTLV-I associated myelopathy (HAM) treated with interferon].
[Chronic activation of T-and B-cells in HTLV-1-associated myelopathy].
Telomerase activity of human peripheral blood mononuclear cells in the course of HTLV type 1 infection in vitro.
Genetic mutation and early onset of T-cell leukemia in pediatric patients infected at birth with HTLV-I.
HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia.
Adult T-cell leukemia/lymphoma associated with HTLV-1 infection in a Brazilian adolescent.
Immunofluorescence assay reactivity patterns of serum samples presenting indeterminate Western blot results for antibodies to HIV-1 and HTLV-I/II in Cordoba, Argentina.
[Program for continuing professional education in ophthalmology. A review of ocular manifestation in HTLV-I infection].
Immunological hyperresponsiveness in HTLV-I LTR-env-pX transgenic rats: a prototype animal model for collagen vascular and HTLV-I-related inflammatory diseases.
Co-infection with HTLV-1 is associated with a shorter survival time for HIV-1-infected patients in Bahia, Brazil.
[HTLV-I/II seroprevalence and risk factors associated with infection in a blood donor population in Córdoba, Argentina].
HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis.
Detection of HTLV-I proviral DNA in sarcoidosis.
Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-kappaB activation.
HTLV-1-associated bronchopneumonopathy (HAB): CT-pathological correlation.
[Spastic paraparesias by HTLV-1: early identification of a new case. Review of the Spanish casuistics]
Absence of HTLV-I infection in multi-transfused thalassemia patients in North India.
Role of HTLV-I infection in the pathogenesis of Sjögren's syndrome and rheumatoid arthritis.
Retrovirus infections in a sample of injecting drug users in Rio de Janeiro City, Brazil: prevalence of HIV-1 subtypes, and co-infection with HTLV-I/II.
Inflammatory myopathy on HTLV-I infection: case report.
[Analysis of infiltrating T cells in the affected autoimmune lesions of HTLV-I transgenic rats]
[A case of acute type adult T cell leukemia and human T-lymphotropic virus type I associated myelopathy who presented meningitis and polyradiculoneuropathy and improved with steroid treatment]
Declining trends in HTLV-I prevalence among blood donors in Japan.
A case of triple retroviral infection with HIV-1 (genotype C3), HIV-2 and HTLV-I.
HTLV-I-associated granulomatous T-cell lymphoma in a child.
Low prevalence of Helicobacter pylori in individuals with HTLV-I infection.
HTLV-I infection and the low prevalence of Helicobacter pylori infection in Japan.
[HTLV-I tax gene on the etiological identification of tropical spastic paraparesis. A clinical, serological and polymerase chain reaction (PCR) study in 72 patients]
[Tropical spastic paraparesis/HTLV-I associated myelopathy. Report of 2 cases diagnosed in Cuiabá, Mato Grosso, Brazil].
[Evaluation of commercial equipment used in blood banks in Córdoba for the detection of anti-HTLV-I/II antibodies]
Laboratory performance in HTLV-I/II analysis.
Risk Factors for HTLV-I Mother to Child Transmission: Influence of Genetic Markers.
Transmission of HTLV-I by kidney transplant.
Co-Infection by HTLV-I/II is Associated With Increased Viral Load in PBMC of HIV-1 Infected Patients in Bahia, Brazil.
[A case of HTLV-1 associated myelopathy (HAM) with pseudopseudohypoparathyroidism]
Coiled-coil motif as a structural basis for the interaction of HTLV type 1 Tax with cellular cofactors.
Basis of HTLV type 1 target site selection.
Kinase-inducible domain-like region of HTLV type 1 tax is important for NF-kappaB activation.
Psychobehavioral and immunological characteristics of HTLV-1 carriers and non-carriers with persistently low natural killer cell activity.
Concomitant presence of bladder cancer and neurogenic bladder in a patient with HTLV-1 carrier: a case report.
High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis.
Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.
Transactivation of fibronectin promoter by HTLV-I Tax through NF-kappaB pathway.
[HTLV-I and genetic polymorphisms other than HLA].
[Genetic diversity of HLA in HTLV-I infection].
Real-time polymerase chain reaction for quantification of HTLV-1 proviral load: application for analyzing aberrant integration of the proviral DNA in adult T-cell leukemia.
[Manifestation of primary biliary cirrhosis and Basedow's disease caused by exposure to carbon monoxide in a patient with HTLV-1 associated myelopathy]
Evidence for humoral and cellular reactivity against keratin and thyroglobulin in HTLV-I infected rabbits.
Incidence of HTLV-I in high-risk population in Delhi.
In vivo fluctuation of HTLV-I and HTLV-II proviral load in patients receiving antiretroviral drugs.
HIV-1 and an HTLV-II-associated cutaneous T-cell lymphoma.
Detection of the tax gene of HTLV-I in labial salivary glands from patients with Sjögren's syndrome and other diseases of the oral cavity.
[A case of HTLV-I associated myelopathy with abnormal patchy MRI lesions in the spinal cord]
No evidence of HTLV-I or HTLV-II infection among the Hmong people of northern Thailand or injecting drug users in Bangkok.
Molecular pathologic analysis of the tonsil in HTLV-I-infected individuals.
[A patient with marked immunodeficiency in an HTLV-I carrier: a case report]
HTLV-I/HTLV-II coinfection in an AIDS patient from São Paulo, Brazil.
HTLV-1 Tax protein sensitizes cells to apoptotic cell death induced by DNA damaging agents.
HTLV-1 unrelated adult T-cell leukemia/lymphoma with unique phenotype and karyotype.
[Adult T-cell leukemia-lymphoma due to HTLV 1. Two cases of the acute form at the Principal Hospital of Dakar]
HTLV-I associated infective dermatitis may be an indolent HTLV-I associated lymphoma.
Sequences flanking the cAMP responsive core of the HTLV-I tax response elements influence CREB protease sensitivity.
HTLV-1 tax oncoprotein binds to DNA topoisomerase I and inhibits its catalytic activity.
Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load.
[Chronological analyses of neuropathological and molecular biological changes in affected spinal cord of HTLV-I-infected rat (HAM rat disease)]
HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha.
[Prevalence of HTLV-1 virus infection in Togo (Kozah prefecture and the University Hospital Center of Lomé]
Prevalence study of neurologic manifestations in HTLV-I positive blood donors
Gender difference in skin reactivity to purified protein derivative among carriers of HTLV-I in Japan.
[Preparation of T-lymphoblastoid cell lines from patients with T-cell leukemia and asymptomatic carriers of HTLV-I: analysis of the viral genome status].
Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma.
[Rapidly progressive myelopathy due to human lymphotropic virus (HTLV-1)]
Important role of thiol compounds to protect oxidative stress on HTLV-I(+) T lymphocytes.
[Coinfection with HIV and HTLV-I infection and survival in AIDS stage. French Guiana Study. GECVIG (Clinical HIV Study Group in Guiana)].
HTLV-II-associated cutaneous T-cell lymphoma in a patient with HIV-1 infection.
HIV and HTLV-1 co-infection.
CBP: A target molecule of HTLV-1 Tax in synoviocyte activation.
Reply to Origins of HTLV-1 in South America.
[A case with HTLV-I associated myelopathy (HAM) accompanied by primary biliary cirrhosis (PBC) and autoimmune hepatitis (AIH)]
The stimulation of gene expression by the R region from HTLV-1 and BLV.
Expression, purification and biological properties of the carboxyl half part of the HTLV-I surface envelope glycoprotein.
Long-term non-progression of HIV-1 in a patient coinfected with HTLV-II.
Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production.
[Tropical spastic paraparesis and mixed infection due to Treponema pallidum and HTLV-1]
[Cerebellar syndrome and peripheral neuropathy as manifestations of infection by HTLV-1 human T-cell lymphotropic virus]
Seroprevalence of HTLV-I in Cheju Island, a Korean island adjacent to the endemic area of Japan.
Clinical significance of serum soluble IL-2R levels in patients with adult T cell leukaemia (ATL) and HTLV-1 carriers.
[A case of anti-GM1 antibody positive HTLV-I associated myelopathy (HAM) with polyneuropathy]
HTLV-I induced intestinal lymphoma.
[A case of HTLV-I associated myelopathy presenting with cerebellar signs as initial and principal manifestations]
[A study of clinical symptoms, muscle pathology, therapeutic response, and prognosis of myositis in patients with HTLV-1 associated myelopathy (HAM)].
[Tropical spastic myelopathy-paraparesis due to human lymphotropic virus 1 (HTLV-1)]
Clinical course of HTLV-I-associated uveitis.
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome.
Estimating the time of HTLV-I infection following mother-to-child transmission in a breast-feeding population in Jamaica.
Prospective study of HTLV-I infection in an initially asymptomatic cohort.
HTLV-I-associated infective dermatitis.
CD30-positive anaplastic large cell lymphoma with HTLV-I proviral integration: a unique histologic subgroup of adult T-cell leukemia/lymphoma.
HTLV-I-associated myelopathy: acute progression and atypical MR findings.
Characteristic distribution of HTLV type I and HTLV type II carriers among native ethnic groups in South America.
Sequence of the env gene of some KwaZulu-Natal, South African strains of HTLV type I.
[A case of encephalomyeloneuritis and HTLV-I infection]
Role of HTLV-1 co-infection in the AIDS epidemic in the Caribbean: a cause for concern.
[Subcortical dementia in HTLV-I tropical spastic paraparesis. Study of 43 cases]
First non-imported HTLV-1 positive adult T cell leukemia/lymphoma (ATLL) in Germany.
A rapid method for determination of the relative copy number of HTLV-I proviral genome in HTLV-I carriers and adult T-cell leukemia patients by polymerase chain reaction.
Low prevalence of HTLV-I/II infection among HIV-1-infected injecting drug users in Russia.
Rapid quantification of HTLV-I provirus load: detection of monoclonal proliferation of HTLV-I-infected cells among blood donors.
[HTLV-1 induced adult T-cell leukemia. The first case now documented in Sweden]
Comparison of four HTLV-I and HTLV-I + II ELISAs.
High prevalence of HTLV-I infection among the family members of a patient with adult T-cell leukemia/lymphoma from northeastern Japan.
[Anguilluliasis associated with HTLV-I infection].
Diversity of leukaemic cell morphology in ATL correlates with prognostic factors, aberrant immunophenotype and defective HTLV-1 genotype.
Sequences downstream of the RNA initiation site of the HTLV type I long terminal repeat are sufficient for trans-activation by human cytomegalovirus immediate-early proteins.
[Strongyloidiasis and HTLV-I infection]
Interferon-alpha treatment in a case of HTLV-I-associated myelopathy.
Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies).
Clonal expansion of gammadelta-T lymphocytes in an HTLV-I carrier, associated with chronic neutropenia and rheumatoid arthritis.
[Electroneuromyography and somatosensory evoked potentials in HTLV-I associated myelopathy]
HTLV-I and HTLV-II coexist among the Embera and Inga Amerindians of Colombia.
[Blood-borne viral infection in hemodialysis units: special reference to hepatitis B virus, hepatitis C virus and human T-lymphotropic virus type 1].
Failure to detect anti-HTLV-1 antibody in a patient with adult T-cell leukaemia/lymphoma.
HTLV-I infection among relatives of patients with adult T-cell leukemia/lymphoma in Brazil: analysis of infection transmission.
[Adult T-cell lymphoma associated with HTLV-1: a familial form]
Is human T-cell lymphotropic virus type I more clever than human immunodeficiency virus type 1?
HTLV-I infection in Spain. HTLV Spanish Study Group.
Ethnic cluster of HTLV-I infection in Israel among the Mashhadi Jewish population.
Rheumatologic manifestations of HIV-1 and HTLV-1 infections.
Altered cell-mediated immunity in asymptomatic Colombian natives with positive or indeterminate serology for HTLV-I.
[Presence of HTLV-I antibodies in patients with sexually transmitted diseases].
Serological evidence of HTLV-I and HTLV-II coinfections in HIV-1 positive patients in Belém, state of Pará, Brazil.
[HTLV-I-associated myelopathy/tropical spastic paraparesis: report of 2 cases diagnosed in Florianópolis, Santa Catarina, Brazil]
[HTLV-I-associated myelopathy, tropical spastic paraparesis: report of the first cases in Sergipe, Brazil]
Influence of immunosuppression in HTLV-1-positive renal transplant recipients.
[HTLV-I as a carcinogenic factor and instrument for studying the migratory history of ancient man].
Response to corticosteroid therapy in a patient with HTLV-I-associated motor neuron disease.
HTLV-1 associated adult T-cell leukemia in a Micronesian patient: the first reported case.
[Increased IL-2 and sIL-2R in sera of infants with HTLV-I infection from mother].
A recombinant protein based immunoassay for the combined detection of antibodies to HIV-1, HIV-2 and HTLV-I.
Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
Sézary syndrome in an HTLV-I-seronegative, genome-positive Japanese.
[A case of rapidly progressive HTLV-I-associated myelopathy (HAM)]
Adult T-cell leukemia with HTLV-I-associated myelopathy after complete remission of acute myelogenous leukemia.
Absence of HTLV-1 proviral sequences in patients with lymphomatoid papulosis.
Presence of HTLV-I and HTLV-II infection in Honduras.
[Association of B-cell lymphoma and T-cell lymphoma in HTLV1 infection]
High prevalence of false-negative anti-HTLV type I/II enzyme-linked immunosorbent assay results in HIV type 1-positive patients.
Clonal HTLV-I-infected CD4+ T-lymphocytes and non-clonal non-HTLV-I-infected giant cells in incipient ATLL with Hodgkin-like histologic features.
Prophylaxis of experimental HTLV-I infection in cynomolgus monkeys by passive immunization.
HTLV-I and -II infections in a nationwide survey of pregnant women in Guinea-Bissau, West Africa.
Primary gastric T-cell lymphoma with and without human T-lymphotropic virus type 1.
[Comparative analysis of the sequenced fragment of the Macaca arctoides STLV-1 env gene encoding the immunodominant region gp46 and the similar fragments in HTLV-1 (ATK) and STLV-1 from various primate species]
HTLV-I and HTLV-II infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil.
The activation domain of a hormone inducible HTLV-1 Rex protein determines colocalization with the nuclear pore.
HTLV-I-infected T cells activate autologous CD4+ T cells susceptible to HTLV-I infection in a costimulatory molecule-dependent fashion.
[Pathomechanism of HTLV-I associated arthropathy and the role of tax gene].
HTLV-I provirus in seronegative healthy blood donors.
Zidovudine treatment is not associated with HTLV-1 reverse transcriptase gene mutations in HTLV-I/HIV-1 co-infected patients.
[Infection with HTLV virus type I-II in patients with cervico-uterine cancer in the Yucatan peninsula, Mexico]
[A case of tabes dorsalis observed in an HTLV-1 carrier]
Establishment of HTLV-1 carrier mice by injection with HTLV-1-producing T cells.
HTLV-I pX transgenic rats: development of cytokine-producing mammary carcinomas and establishment of the pX mammary carcinoma cell lines.
Antigenic variability of an immunodominant region (239-261) of the surface glycoprotein of HTLV-I.
Transcriptional activation and self-association in yeast: protein-protein dimerization as a pleiotropic mechanism of HTLV-I Tax function.
Howard Temin Memorial Lectureship. Molecular biology of HTLV-1: deregulation of host cell gene expression and cell cycle.
Molecular analysis of HTLV-I and HTLV-II isolates from Italian blood donors, intravenous drug users and prisoners.
[A seroepidemiological survey: antibody to HTLV-1 in sera from various populations in Guangdong Province]
Epidemiological Characteristics of HTLV-I and II Co-Infection in Brazilian Subjects Infected by HIV-1.
Serologic survey for HTLV-I in Kanagawa Prefecture.
[Study of therapeutic effects of macrolide antibiotics on patients with anti-HTLV-1 antibody positive DPB (diffuse panbronchitis)].
Cyclospora cayetanensis in an asymptomatic patient infected with HIV and HTLV-1.
[New form of subcortical dementia: encephalopathy due to infection with human lymphotropic T virus (HTLV-1). Clinical case]
Is HTLV-1 status another antenatal screening test that we need?
Mouse monoclonal antibodies directed against the HTLV-I protease recognize epitopes internal to the dimer.
[Confirmation of the presence in Cuba of human T-cell lymphotropic virus type I using the polymerase chain reaction]
[Search for antibodies against human T-cell lymphotropic virus type I (HTLV-I) in blood donors and risk groups]
Constitutive expression of the HTLV-I pX and env regions in Jurkat T-cells induces differential activation of SRE, CRE and NF kappa B pathways.
HTLV-I seroprevalence in the Sultanate of Oman.
[Small hand muscle atrophy as an initial sign in HTLV-I associated myelopathy]
Suppressed induction of 2-5AS in cells with HTLV-I is not associated with the fluctuation of IFN-receptor, IFN-regulatory factors (IRF-1 and IRF-2) or STAT-1 alpha.
Lack of HTLV-II infection in newborns born from HIV-1 infected mothers in southern Italy.
Scabies in HTLV-I seropositive patients.
Detection of HTLV-I proviral DNA by fluorescence in situ hybridization.
Extensive latent retroviral infection in bone marrow of patients with HTLV-I-associated neurologic disease.
Presence of HIV-1 subtypes B and F and HTLV-I in HIV/HTLV coinfected individuals of Martinique.
HTLV-I in HIV seropositive Indian blood donors.
The difficulty of detecting HTLV-1 proviral sequences in patients with mycosis fungoides.
Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic mice.
[Prevalence of HTLV-I and HTLV-II infection in Puglia]
Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
HTLV-I and CTCL: the link is missing.
Enhancement of nucleocytoplasmic export of HTLV-1 Rex mRNA through cis and trans interactions of the mRNA with the complex of Rex protein and Rex-responsive element.
HTLV-I provirus in seronegative Chilean patients with tropical spastic paraparesis.
Adult T cell leukemia presenting as multiple submucosal tumors of the intestine: detection of HTLV-I DNA by polymerase chain reaction.
Recurrence of Kikuchi's disease with aseptic meningitis in HTLV-1 carrier.
HTLV-I-seronegative, genome-positive adult T-cell leukemia: report of a case.
The main HTLV-I-harboring cells in the muscles of viral carriers with polymyositis are not macrophages but CD4+ lymphocytes.
Downregulation of IL-10 secretion and enhanced antigen-presenting abilities following HTLV-I infection of T cells.
Expanding spectrum of HTLV-1-related diseases: implications in understanding the mechanisms of viral pathogenesis.
Successful treatment of HTLV-1-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation.
Absence of HTLV-1 tax in Sjögren's syndrome.
Prevalence of and risk factors for HTLV-I and HTLV-II infection among patients at a hospital in the south Bronx, New York.
Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.
HTLV-I/II seroprevalence in 55 Brazilian patients with idiopathic uveitis.
[Interaction of HTLV-1 Tax with cellular factors]
Evidence of HTLV-I in thyroid tissue in an HTLV-I carrier with Hashimoto's thyroiditis.
[Development of collagen vascular diseases and production of autoantibodies in HTLV-I env-pX transgenic rats]
Prevalence of and risk factors for HTLV-I and HTLV-II infection among patients at a hospital in the South Bronx, New York.
[Recurrent bilateral uveitis associated with HTLV 1 infection].
Transmission and population dynamics of HTLV-I infection.
[Pneumocystis carinii pneumonia in a HTLV-I carrier with monoclonal proliferation of HTLV-I infected lymphocyte]
[Analysis of HTLV-1 expression in vivo]
[In situ PCR detection of HTLV-1 provirus in spinal cord lesions with HAM/TSP]
Serological evidence of HTLV-I but not HTLV-II infection in ethnic groups of Northern and Eastern Siberia.
HTLV-I and HTLV-II infections in subjects at risk for HIV-I infection from southeastern Italy (Apulia region).
Human T-lymphotropic virus type I (HTLV-I)
Clinical significance of CD45RO expression on peripheral blood mononuclear cells in HTLV-I-infected individuals.
Patterns of HTLV-I infection among family members of patients with adult T-cell leukemia/lymphoma and HTLV-I associated myelopathy/tropical spastic paraparesis.
[HTLV-I infection in Spanish drug addicts]
HTLV-I associated uveitis: a report of two cases.
Expression of CD23, CD32, Mac-1 and other adhesion molecules in eosinophils in strongyloidiasis and HTLV-I-positive patients.
Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
[Higher expression levels of alternatively spliced pX mRNA in human T lymphotropic virus type I (HTLV-I) asymptomatic carriers positive for antibodies to p40tax protein]
In vitro effects of immunosuppressive agents on cytokine production by HTLV-I-infected T cell clones derived from the ocular fluid of patients with HTLV-I uveitis.
Reliability of a screening assay for the simultaneous detection of antibodies to HIV-1/2 and HTLV-I/II.
New strip immunoblot for the confirmation of HTLV-I/II infection.
Seroprevalence of HTLV-I/II in different groups at risk in northeast Mexico.
AILD-like dysplasia transformed in AILD-type T cell lymphoma in an HTLV-1 carrier: usefulness of interferon-alpha.
[Case of adult T-cell leukemia without antibodies for HTLV-I but with for pX gene region].
Clinical and histologic spectrum of human T-cell lymphotropic virus type I-associated lymphoma involving the skin.
Lack of evidence of HTLV-I/II infection in T CD8 malignant or reactive lymphoproliferative disorders in France: a serological and/or molecular study of 169 cases.
Functional inactivation of wild-type p53 protein correlates with loss of IL-2 dependence in HTLV-I transformed human T lymphocytes.
The 5' coding sequence of IL-2 receptor alpha chain mRNA mediates mRNA stabilization by HTLV-1 Rex.
Ethnic segregation of HTLV-I and HTLV-II carriers among South American native Indians.
Myasthenia gravis, acute transverse myelitis, and HTLV-I.
Preliminary survey of anti-HTLV-I in northeastern-Thais.
Myasthenia gravis associated with dual infection of HIV and HTLV-I.
[Identification of immunoreactive epitopes in proteins coded by gag, env, and pol genes of the type I human T-lymphotropic virus (HTLV-I) using synthetic peptides]
Long-term sequential changes of antibody to p40tax in HTLV-I carrier mothers and children.
[HTLV-I infection in primary Sjögren's syndrome--epidemiological, clinical and virological studies].
Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1.
[Distribution and phylogenetic analysis of HTLV-I isolates, persisting in the Russian Far East]
Re-evaluation of anti-HTLV-I Western blot assay using HTLV-I and HTLV-II serum panels.
Prevalence of HTLV-I-associated uveitis in the Kanto Plain, Japan.
Immunoblastic transformation of a Sezary syndrome in a black Caribbean patient without evidence of HTLV-I.
[Seroprevalence of HTLV-I in various ocular diseases in central Japan].
HTLV-1 associated pandysautonomia with adrenal dysfunction.
Detection of HTLV-I provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis.
Infection with hepatitis viruses (B and C) and human retroviruses (HTLV-1 and HIV) in Saudi children receiving cycled cancer chemotherapy.
Time to consider additional diagnostic criteria for HTLV-I-associated myelopathy?
HTLV-I-like sequence in MS.
[HTLV-I-associated neuropathy]
Risk factors for HTLV-I among heterosexual STD clinic attenders.
[HTLV-I associated myelopathy (HAM) with cerebellar atrophy presenting a down-beat nystagmus]
Pentoxifylline treatment in HTLV-I-associated myelopathy.
[A hemodialysis patient with HTLV-1-associated myelopathy (HAM)].
Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR.
Risk factors for maternal HTLV-I infection in French Guiana: high HTLV-I prevalence in the Noir Marron population.
[Discovery of HTLV-I associated myelopathy]
[Human lymphotropic virus type I (HTLV-I)]
T-cell malignancies in Brazil. Clinico-pathological and molecular studies of HTLV-I-positive and -negative cases.
Abnormal B-cell function in HTLV-I-tax transgenic mice.
Limited TCR V beta usage of infiltrating T cells in synovial tissues from patients with HTLV-I associated arthropathy.
Vertical transmission of HTLV-I from a seronegative mother using the PA method.
HTLV-I infection among Nivkhi people in Sakhalin.
HTLV-1 proviral DNA in oral aspirates of newborns born to seropositive mothers.
Antibodies to HTLV-I in Sjögren's syndrome.
Evaluation of HTLV-I/II infection in blood donors in Buenos Aires.
c-Jun, c-Fos and their family members activate the transcription mediated by three 21-bp repetitive sequences in the HTLV-I long terminal repeat.
[The role of the HTLV-I virus in transformation of T lymphocytes]
No relationship between HTLV-1 infection and filariasis--Serological study on patients with filariasis in Recife, Brazil.
HTLV-I-associated illnesses in Spain. HTLV Spanish Study Group.
[HTLV1 infection and sicca syndrome].
In situ polymerase chain reaction detection of HTLV-I provirus and expression of the p53 tumor suppressor gene in infiltrating cells in skeletal muscle from a patient with adult T cell leukemia.
Evaluation of anti-HTLV-1 antibody in primary glomerulonephritis.
HTLV-II does not adversely affect the natural history of HIV-1 infection in intravenous drug users.
[Cross reactivity and amino acid structural homology of immunodominant peptide fragments of structural viruses from the human retroviruses HTLV-I, HTLV-II, HIV-1, and HIV-2]
Absence of human retroviral antibodies in epidemic neuropathy in Cuba: report of the first two cases of HTLV-I-associated tropical spastic paraparesis observed in Cuba.
Monoclonal integration of HTLV-1 in pleural effusion cells in a seropositive patient with tuberculous pleuritis.
Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodies.
Evaluation of a combined HIV-1/2 and HTLV-I/II assay for screening blood donors.
HTLV-1 oncoprotein Tax deregulates transcription of cellular genes through multiple mechanisms.
Mantle cell lymphoma with the features of mucosa-associated lymphoid tissue (MALT) lymphoma in an HTLV-I-seropositive patient.
Is mycosis fungoides associated with HTLV-I?
[Isolation, sequencing and ultrastructure of HTLV-I and HTLV-II retroviruses. Presence of the HTLV-II subtype b among Spanish intravenous drug addicts]
HTLV-I-associated myelopathy in Venezuela.
Tax-induced HTLV-I LTR transcriptional activation is modulated by phosphorylation.
[HAM rat disease: an animal model of HTLV-I infection].
Effects of cyclopentenone prostaglandins on myeloid cells during early infection with HTLV-I. II. Regulation of synthesis of inducible p72 heat shock protein.
Suppression of HTLV-1-induced human leukemia cell infiltration by zidovudine.
HTLV type I and HTLV type II infection among Indians and natives from Argentina.
[Migrating radiculopathy--an unusual complication of systemic lupus erythematosus in an HTLV-1 carrier]
[Rat model of HTLV-I infection--ultrastructural study of HAM rat disease]
[Vasculitis and neurologic manifestations related to HTLV-1].
CD8-positive adult T-cell leukemia cells with an integrated defective HTLV-I genome show a paracrine growth to IL-2.
[HTLV-I associated myelopathy found in Japanese patients].
HTLV-I and infection control.
[Role of surgery in paraplegia associated with HTLV-1 infection and cervicarthritis on narrow canal].
Nondetection of HTLV-I/II and HIV-2 in Thailand, 1991-1992.
[Antibodies to human T-cell lymphotropic virus type 1 in the aqueous humor of HTLV-I associated uveitis].
[Quantitation of HTLV-I proviral copies of infected cells in pregnant HTLV-I carriers and its correlation with vertical infection].
[HTLV-1 associated myelopathies in the city of Salvador, Bahia].
Cutaneous disease resembling mycosis fungoides in HIV-infected patients whose skin and blood cells also harbor proviral HTLV type I.
[Anti HTLV-I antibody titers in seropositive infected individuals]
[HTLV-1 associated myelopathy (HAM) with severe orthostatic hypotension--a case report]
[A case of HTLV-1 carrier associated with pulmonary cryptococcosis and thymoma]
[Molecular epidemiology of HTLV-I and HTLV-II retroviruses]
Exposure to hepatitis B and C and to HTLV-1 and 2 among Israeli drug abusers in Jerusalem.
[Studies on neurogenic bladder due to human T-lymphotropic virus type-I associated myelopathy (HAM)].
[Detection of HTLV-1 provirus DNA in T-cell neoplasms]
Modified western blot with recombinant antigens for serological differentiation between HTLV-I and HTLV-II.
[Analysis of HAM rat disease developed in HTLV-I carrier rat as an animal model of HAM/TSP in human]
[HTLV-I]
Serum antibodies from MS patients do not recognize HTLV-I, HIV-1, HIV-2 and SIV.
Myelopathy in a patient dually infected with HIV-1 and HTLV-I.
[Double neoplastic localization and HTLV-1 infection in Martinique].
HTLV-I messenger RNA is expressed in vivo in adult T-cell leukemia/lymphoma patients: an in situ hybridization study.
[A family case of HAM and HTLV-I carrier including two sisters presenting with myositis]
Antiproliferative activity of cyclopentenone prostaglandins in early HTLV-1 infection is independent of IL-2 and is associated with HSP70 induction.
HTLV-I proviral DNA in umbilical cord blood of babies born to carrier mothers.
Do T cells cause HTLV-1-associated disease?: a taxing problem.
HTLV-1 in acquired adult myopathy.
The distribution of T-cell subsets among HTLV-I carriers in Japan.
[Detection of HTLV-I proviral DNA by PCR method from bronchoalveolar lavage cells of HTLV-I carriers]
[Pathological and molecular analyses of mammary tumors induced in HTLV-I pX transgenic rats]
Serological diagnosis of HTLV-I/II infections in France.
Interactions between HTLV-I Tax and NF-kappa B/Rel proteins in T cells.
Intervention of maternal transmission of HTLV-1 in Nagasaki, Japan.
Recognition by human sera of a variable region of the surface glycoprotein of HTLV-I.
[A case of bronchiectasis accompanied by ulcerative colitis (UC) and HTLV-1 associated myelopathy (HAM)]
A patient with anaplastic large cell lymphoma (Ki-1 lymphoma) showing clonal integration of HTLV-1 proviral DNA.
Unintegrated HTLV-I proviral DNA in cell lines and uncultured peripheral blood mononuclear cells from tropical spastic paraparesis (TSP/HAM) and adult T-cell leukemia (ATL) patients.
Induction of intercellular adhesion molecule-1 and adherence of HTLV-1-infected T-cells to cultured keratinocytes.
T-cell receptor J beta I/J beta II locus rearrangements concurring with a complex chromosomal aberration in an HTLV-1 positive T-cell lymphoma.
HTLV-I and clinical disease correlates in central Australian aborigines.
HTLV-I/II seroprevalence and coinfection with other pathogens in blood donors in Buenos Aires.
Association of HTLV-I antibody profile of asymptomatic carriers with proviral DNA levels of peripheral blood mononuclear cells.
Lymphomatous presentation of CD4+/CD8+ HTLV-1-related adult T-cell leukemia/lymphoma in an Iranian woman.
HTLV-I in Romania.
[Infection by human T-cell lymphotropic virus type I/II in polytransfused patients in the state of Yucatán, Mexico].
[HTLV-I and retinal antigen recognized by T cells].
Changes in hematologic parameters among Japanese HTLV-I carriers.
HTLV-I associated adult T-cell leukaemia/lymphoma in Hong Kong.
HTLV-I-associated myelopathy in a patient with chronic renal failure.
Absence of HTLV-1 related sequences in MS from high prevalence areas in western Norway.
[Mandibular tumor disclosing aggressive large B-cell lymphoma in a Mauritanian patient with HTLV-1 virus infection]
[Ophthalmologic manifestations in spinal cord diseases caused by HTLV-I virus. Clinical study of 30 cases]
Failure to detect serological evidence of HTLV-I/II infection among HIV patients in Cuba.
HTLV-I/II seropositivity among eligible blood donors from Minas Gerais State, Brasil.
HTLV-I seroprevalence in patients with undefined uveitis in central Japan.
HTLV-1 infection in a thalassemic patient from Apulia (southern Italy)
Multistep alterations of human lymphocytes infected with HTLV-I and then exposed to carcinogens.
Human T-lymphotropic virus type-I influence on hepatotropic virus infections and the subsequent development of hepatocellular carcinoma.
[Recurrent anguilluliasis in a Senegalese infected with human T leukemia virus 1 (HTLV1)]
HTLV-I associated cutaneous T-cell lymphoma--report of a case with atypical clinical presentation.
Successful treatment of a patient with adult T-cell leukemia by daily oral administration of low-dose etoposide. Decrease in the amount of HTLV-I proviral DNA revealed by the polymerase chain reaction method.
Role of HTLV-I in development of non-Hodgkin lymphoma in Jamaica and Trinidad and Tobago. The HTLV Lymphoma Study Group.
Transmission routes of HTLV-I: an analysis of 66 families.
[Mechanism of transcriptional activation by HTLV-1 Tax].
HTLV-I and Behçet's disease.
[Interstitial pneumonia in patients with human T-cell lymphotropic virus type-1 infection]
[HTLV-I and transfusions].
[Myelopathy associated with HTLV-1: clinical electrophysiologic study]
Lack of association between peripheral neuropathy and HTLV-I infection in west Africa. Epidemiological, serological and nerve biopsy study.
Disseminated herpes zoster with multifocal neurologic involvement in an HTLV-1 carrier.
[Vertical transmission human T-cell lymphotropic virus type-I (HTLV-I)--genetic diagnosis and assessment of the probable routes of HTLV-I infection].
HTLV-II/HIV-1 coinfection and risk for progression to AIDS among intravenous drug users.
Long cellular repeats flanking a defective HTLV-I provirus: implication for site-targeted integration.
Behçet's disease and Sjögren syndrome in a patient with HTLV-I-associated myelopathy.
HTLV-I antibody screening in donated blood and thalassemic patients.
[Retrovirus: diagnostic tests and their interpretation (II). HIV-2, HTLV-I, and HTLV-II infection]
Quantitation of HTLV-I provirus among seropositive blood donors: relation with antibody profile using synthetic peptides.
Presence of cross-reactive antibodies to HTLV-1 and absence of antigens in patients with multiple sclerosis.
HTLV-I sequence in lymphoproliferative disorders.
Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.
Possible association of HTLV-I infection and dementia.
Seroprevalence of parenterally transmitted viruses (HIV-1, HBV, HCV, and HTLV-I/II) in forensic autopsy cases.
HTLV-I maternal transmission in Martinique, using serology and polymerase chain reaction.
[Clonal change of HTLV-1 infected lymphocytes before onset of adult T-cell leukemia/lymphoma]
Prevalence of anti-HTLV-I antibodies in HIV-seropositive individuals in Guadalajara, Mexico.
HTLV-I/II infections in Spain. The HTLV-I/II Spanish Study Group.
HTLV-I seroprevalence in blood donors in Cuba.
HTLV-I among Northern Territory blood donors.
HTLV-I: is donor screening really necessary?
HTLV-I among Northern Territory aborigines.
[HTLV-I associated myelopathy presenting with profound atrophy of unilateral lower limb]
Neurological disorders related to HTLV-I and HTLV-II.
HTLV-I-associated myelopathy in south India.
[Uveitis in human T-lymphotropic virus type I (HTLV-I) carriers--3. A molecular biological study].
[Uveitis in human T-lymphotropic virus type I (HTLV-I) carriers--2. An analysis of clinical features].
[Uveitis in human T-lymphotropic virus type I (HTLV-I) carriers--1. A seroepidemiological study].
[Human T lymphotropic virus type I and ocular diseases].
[Prevalence of HTLV-I antibodies and possible risk factors in Chilean prostitutes].
A HTLV-I carrier who showed various symptoms and antibodies of autoimmune diseases.
HTLV-I and scabies in Australian aborigines.
Structural changes in the N-linked sugar chains of serum immunoglobulin G of HTLV-I transgenic mice.
Occurrence of primary biliary cirrhosis, CREST syndrome and Sjögren's syndrome in a patient with HTLV-I-associated myelopathy.
Seroepidemiological survey of HTLV-I infection in French Polynesia, Cook Islands and Fiji.
Polymerase chain reaction amplified HTLV-I, HIV-1 and HIV-2 DNA fragments in subjects with mixed retroviral infections.
Lack of evidence for HTLV-II infection in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in an endemic area.
[The combined immunoenzyme test: anti-HIV-1 and -2 and anti-HTLV-1 in the detection of donors with retrovirus infections]
Crusted (Norwegian) scabies as a pre-diagnostic indicator for HTLV-1 infection.
[A synthetic peptide-based immunoenzyme test system for the joint detection of human retrovirus (HTLV-1 and HIV-1) antibodies]
Absence of HTLV-I infection among seronegative subjects in an endemic area of Japan.
[Multicenter study of HTLV-I and HTLV-II infection in Spain. Spanish Group for the Study of HTLV-II/II Infection]
Discovery of HTLV-1.
The history of HTLV-I.
Strongyloides hyperinfection in patients coinfected with HTLV-I and S. stercoralis.
The transcriptionally active factors mediating the effect of the HTLV-I Tax transactivator on the IL-2R alpha kappa B enhancer include the product of the c-rel proto-oncogene.
[HTLV-I and ocular disease].
Production and characterization of a monoclonal antibody directed against HTLV-1 p19: use in a specific capture enzyme immunoassay.
HTLV-1 provirus and mycosis fungoides.
Fatal metastatic calcification in a patient with HTLV-1-associated lymphoma.
HTLV-1 revisited.
HTLV-I/II and multiple sclerosis in Buenos Aires.
HTLV-I associated and non-associated primary T-cell lymphoma of gastrointestinal tract.
[Intermittent high-dose vitamin C therapy in patients with HTLV-I-associated myelopathy]
Mixed connective tissue disease and Sjögren's syndrome, accompanied by HTLV-I infection.
Combined treatments with interferon (alpha,beta) plus PGA1 to control early infection with HTLV-I in primary cord blood-derived mononuclear cells.
Two color flow cytometric analysis of lymphocytes in HTLV-I carrier children.
Analysis of anti-Tax antibody of HTLV-I carriers in an endemic area in Japan.
HTLV-1 in multiply transfused patients in Trinidad and Tobago, West Indies.
Southernmost carriers of HTLV-I/II in the world.
HTLV-I/II infection is absent among risk groups from Mexico City.
Lack of dual infection with HIV-1 and HTLV-I.
[A case of HTLV-I associated myelopathy with flutter-like oscillation]
HTLV-I and HTLV-II infections in French blood donors.
HTLV-I and HTLV-II infections in Spain.
Dual infection of HIV-1 and HTLV-I in south India: a study on a patient with AIDS-related complex.
[Primitive Sjögren's syndrome in France and Ecuador. Possible involvement od HTLV 1]
[Paraplegia associated with HTLV 1 in Martinique. Study of 271 cases including 70 with neuromuscular involvement]
Markers of health status in an HTLV-I-positive cohort.
Prevalence of HTLV-I/II among blood bank donors in Argentina.
A sero-epidemiological study on mother-to-child transmission of HTLV-I in southern Kyushu, Japan.
Evaluation of anti-HTLV-1 in physical-checkup individuals and blood donors in Taiwan.
Health care worker exposure to HIV-1 and HTLV I-II in critically ill, resuscitated emergency department patients.
Transmission of retroviruses from seronegative donors by transfusion during cardiac surgery. A multicenter study of HIV-1 and HTLV-I/II infections.
Very low seroprevalence of HTLV-I in patients with gynecologic disorders in Thailand.
[Tropical spastic paraparesis and HTLV-1 infection in Spain]
Hashimoto's thyroiditis in HTLV-I carriers.
[What is the mode of transmission for HTLV-I infection in Central Africa?].
Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers?
[Comparison of different methods for anti-HTLV-I assay]
Differences in HTLV-I integration patterns between skin lesions and peripheral blood lymphocytes of HTLV-I seropositive patients with cutaneous lymphoproliferative disorders.
Chromosomal localization of HTLV-1 viral integration sites using in situ hybridization: detection of a novel IL2R fragment.
Coexistence of acute monoblastic leukemia and adult T-cell leukemia: possible association with HTLV-I infection in both cases?
[Therapeutic effect of lymphocytapheresis on patients with HTLV-I-associated myelopathy (HAM)]
HTLV-I-positive case of ATL in Georgia (formerly USSR)
High HTLV-I proviral DNA level associated with abnormal lymphocytes in peripheral blood from asymptomatic carriers.
[High incidence of vaginal candidiasis in HTLV-I carrier pregnant women].
[In vitro experiment of transmission of human T-lymphotropic virus type I (HTLV-I) to placental villous cells].
[Transmission of HTLV-I].
[Detection of antibodies against T-cell lymphotropic virus HTLV-I/II in Cuban patients with chronic renal failure undergoing hemodialysis]
Adult T-cell leukaemia/lymphoma associated with HTLV-I in Natal.
Seroprevalence and cofactors of HTLV-I infection in Tumaco, Colombia.
HTLV-I and uveitis.
Regulation of HTLV-I gene expression by tax and AP-2.
Transactivation of the murine c-myc gene by HTLV-1 tax is mediated by NFkB.
No detection of HTLV-I DNA in punch skin biopsies from patients with cutaneous T-cell lymphoma by the polymerase chain reaction.
Evaluation of an enzyme immunoassay for the combined detection of antibodies to HIV-1, HIV-2, HTLV-I and HTLV-II.
Prevalence of four blood-borne viruses (HBV, HCV, HTLV-I, HIV-1) among haemodialysis patients in Japan.
[Significance of anti-HTLV-I antibody in cerebrospinal fluid in diagnosis of HTLV-I associated myelopathy (HAM)]
Application of screening and confirmatory assays for anti-HTLV-I/II in U.K. populations.
Cryptococcal pleural effusion in an HTLV-I carrier with Waldenstroem's macroglobulinemia.
Incidence of anti-HTLV-1 antibody in liver disease.
Difficulty of in situ detection of HTLV-I proviral genome sequence.
[Etiopathogenesis and therapeutic trends in adult T-cell leukemia associated with HTLV-I retrovirus]
HTLV-I-positive and HTLV-I-negative peripheral T-cell lymphomas in Taiwan Chinese.
BEAM regimen and G-CSF in HTLV-I-associated T-cell lymphoma.
Excretion of HTLV-I in saliva.
Determinants of HTLV-1 seroprevalence in Miyazaki Prefecture, Japan: a cross-sectional study.
A low prevalence of HTLV-I/-II infection among eight population groups from Merida Yucatan, Mexico.
HTLV-1 associated myelopathy/tropical spastic paraparesis with adult T-cell leukemia.
Failure to detect HTLV-I by in situ hybridization in the biopsied muscles of viral carriers with polymyositis.
HTLV-I among U.S. Marines stationed in a hyperendemic area: evidence for female-to-male sexual transmission.
HIV-1 and HTLV-I/II coinfection in Baltimore.
Declining trends of HTLV-I prevalence among blood donors in Kumamoto, Japan.
Indeterminate HTLV serologic results in U.S. blood donors: are they due to HTLV-I or HTLV-II?
Use of immunoreactive synthetic HTLV-1 peptides in the search for antibody reactivity in multiple sclerosis.
HTLV-1 antibodies in hemodialysis patients.
Quantification of HTLV-1 proviral copy number in peripheral blood of symptomless carriers from the French West Indies.
Absence of HTLV-I DNA sequences in cutaneous T-cell lymphoma/mycosis fungoides.
A seroepidemiological survey of antibodies to HTLV-I/HTLV-II in selected population groups in Paraguay.
Immunoglobulin prophylaxis against HTLV-I in a rabbit model.
[HTLV-1 infection in polytransfused patients]
Overlapping polymyositis and ulcerative colitis: HTLV-1 infection as an alternative explanation.
Overt and latent HIV 1 and HTLV-I infection in cohorts of at high risk individuals in Argentina.
[Seropositivity of anti-HTLV-II antibodies in patients with HTLV-I-associated myelopathy and adult T-cell leukemia]
Comprehensive studies on HTLV-1/ATL in Japan.
Serological profiles for HBV, HDV, HIV-1 and HTLV-1 in Saudi patients with a malignancy.
Case of adult T-cell leukaemia in HTLV-I infected family in Georgia, USSR.
[Peripheral neuropathy in HTLV-I-associated myelopathy].
HTLV-I in French Polynesia: a serological survey in sexually exposed groups.
HTLV-1 antibody testing in a Saudi Arabian blood donor population.
Reply: Prevalence of anti-HTLV-1 antibodies in sera from 153 cases of non-Hodgkin's lymphoma.
Prevalence of anti-HTLV-1 antibodies in sera from 153 cases of non-Hodgkin's lymphoma.
Declining seroprevalence and transmission of HTLV-I in Japanese families who immigrated to Hawaii.
Detection of HTLV-I antigen in peripheral and cord blood lymphocytes from carrier mothers.
HTLV-1 Rex protein accumulates unspliced RNA in the nucleus as well as in cytoplasm.
Absence of association of HTLV-I infection with type 1 neurofibromatosis in the United States or Japan.
[A case of HTLV-1 associated myelopathy and adult T-cell leukemia, presenting unique muscle pathology including rimmed vacuole]
[Acute lymphocytic meningitis in a patient with Anguillula infestation and HTLV-1 virus infection].
Serological discrimination between HTLV-I and HTLV-II antibodies by ELISA using synthetic peptides as antigens.
HTLV-I p24 antigen in circulating immune complexes associated with acute T-lymphoblastic leukemia.
Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I.
Sensitivity of HTLV-I antibody assays for HTLV-II.
Lack of anti-HTLV-II seropositivity in HTLV-I-associated myelopathy and adult T-cell leukaemia.
HTLV-1 infection in patients with leukaemia in southern India.
Western blot criteria for HTLV-I.
[Retrovirus infection and arthropathy: novel mechanism of synovial proliferation caused by human T lymphotrophic virus type-1 (HTLV-1)]
[A case of HTLV-1 associated myelopathy with diffuse white matter lesion of the frontal lobe and continuous lesion of the pyramidal tract on cranial MRI]
[Human T-cell lymphotropic virus Type I (HTLV-I) as a cause of progressive myelopathy]
HTLV-1 associated myelopathy combined with chronic thyroiditis.
[A case of smoldering ATLL in high risk family and familial double infection of HTLV-1 and HBV].
[HTLV-I tax mediated activation of cellular genes in transgenic mice]
[Bladder involvement in HTLV-I associated myelopathy].
HTLV-I infection in high-risk groups in Vizcaya, northern Spain.
[The role of the polymerase chain reaction (PCR) in the diagnosis of infection by HTLV-I/II virus]
HTLV-I and acute pancreatitis.
A seroepidemiological survey of HTLV-I infection in Shanghai and Chongqing cities in China.
[HTLV-I associated myelopathy with Hashimoto's thyroiditis--a report of two cases]
[Bronchoalveolar lavage studies in a HTLV-1-positive case associated with interstitial pneumonia]
HIV-1 infection of CD4-negative cells via HTLV pseudovirons.
There are other human retroviruses too--a note on myelopathy associated with HTLV-I.
Evidence of HTLV-I infection in Singapore prostitutes.
Structural similarity of envelope glycoprotein of HTLV-I and C-terminal region of v-erbB and EGF receptor.
Functional heterogeneity of CBL-1 and HTLV-IIIB.
[Value of gene amplification (polymerase chain reaction) in identification of neurological manifestations associated with HTLV-I].
MS and HTLV-I.
The effect of zidovudine on chronic myelopathy associated with HTLV-1.
Serological discrimination of HTLV I and II infection in Melanesia.
[What is your diagnosis? HTLV-I myelopathy]
[HTLV-I transmission by blood transfusion]
[An epidemiologic study of anti-HTLV-I (antibody to human T cell lymphotropic virus type I) by category of disease in the Kushima district of Miyazaki prefecture].
Isolation of HTLV-I from muscle of a patient with polymyositis.
Ultrastructural localization of HTLV-I gag proteins p19 and p24 by single and double immunogold labeling.
Expression of growth-related genes and drug-resistance genes in HTLV-I-positive and HTLV-I-negative post-thymic T-cell malignancies.
Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone.
HTLV-I-associated leukemia/lymphoma in south Florida.
HTLV-I in neurological patients from some Indian Ocean islands.
Infection of inbred rabbits with cell-free HTLV-I.
HTLV-I coninfection in a HIV-1-infected Peruvian population.
High incidence of antibodies to HTLV-I tax in blood relatives of adult T cell leukemia patients.
Differential interference of alpha, beta or gamma interferons with HTLV-I integration and expression in vitro.
Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.
[Latent HTLV-I and HIV-1 infection in seronegative subjects with risky behavior in Argentina]
Detection of HTLV-1 gag related sequences in leucocyte DNA from patients with polyendocrinopathies (Basedow-Graves' disease and insulin-dependent diabetes).
Mother-to-child transmission of HTLV-1.
Seroprevalence of HTLV-I/II and HIV-1 infection among male intravenous drug abusers in Chicago.
Infiltration of the lower respiratory tract by helper/inducer T lymphocytes in HTLV-1-associated adult T-cell leukemia/lymphoma.
Lymphocyte immunophenotypes among anti-HTLV-I/II-positive blood donors and recipients. The Transfusion Safety Study Group.
HTLV-I and HIV-I antibody frequency in thalassemics and drug addicts in southeast Sicily.
Multiple sclerosis as a retroviral disease? Epidemiological considerations in relation to HTLV-I epidemiology.
[Understanding of HTLV-I through PCR work]
[HTLV-1 in a Mapuche population]
[Atypical lumbar and nerve-root pain associated with the HTLV-1 virus]
HIV-1, HIV-2 and HTLV-I seroprevalence surveys in continental Ecuador and Galapagos.
[Prevalence of retrovirus (HIV-1 and HTLV-I) infection in blood donors in the state of Yucután, Mexico]
[Two cases of HTLV-I associated myelopathy (HAM) after cardiac operation].
[A case of HTLV-I infection complicated with multiple arthropathy and Sjögren's syndrome].
Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection.
Risk of HTLV-1 transmission in renal transplantation among aborigines.
HTLV-I infection in Iraq.
HTLV-1 associated T-cell lymphoma in a patient with a 10-year history of non-epidermotropic T-cell skin infiltrates.
HTLV-I viral-associated myelopathy after blood transfusion in a multiple trauma patient.
Absence of HTLV-I DNA in blood from patients with multiple sclerosis.
[Epidemiology of HTLV-I infection in its hyperendemic foci (Japan, tropical Africa, Caribbean)]
Lepromatous leprosy and seropositivity for HTLV-I.
Suppression of signals required for activation of transcription factor NF-kappa B in cells constitutively expressing the HTLV-I Tax protein.
Familial spastic paraparesis syndrome associated with HTLV-I infection.
HTLV-I in Spain.
[Neurologic diseases associated with the HTLV-1 virus in Panama]
[Orofacial lymphomas in seropositive patients manifesting the type I human lymphotropic virus (HTLV-I)]
Kaposi's sarcoma and HTLV-I infection.
Demyelinating changes in sural nerve biopsy of patients with HTLV-I-associated myelopathy.
Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA.
Decreased serum levels of IgE and IgE-binding factors in individuals infected with HTLV-I.
HTLV-I associated myelopathy in an identical twin.
Primary T-cell lymphoma with myelopathy associated with HTLV-1.
[An autopsy case of HTLV-I associated myelopathy (HAM) with adult T-cell leukemia (ATL)]
Low prevalence of HTLV-I infection in drug addicts in Turin.
[Detection of HTLV-I genome in infants born to HTLV-I seropositive mothers by polymerase chain reaction].
HTLV-I-associated myelopathy, tropical spastic paraparesis, and Borrelia burgdorferi.
Indolent cutaneous prodrome of fatal HTLV-I infection.
Epidemiologic assessment of screening tests for antibody to human T lymphotropic virus type I (HTLV-I).
HTLV-1 associated myelopathy in Chile.
Prevalence of HTLV-I in Alaska Natives.
Transfusion-transmitted HTLV-I/II infection in patients undergoing open-heart surgery.
[Diagnosis of HTLV-I infection].
HIV-1 and HTLV-I infection in renal transplant recipients.
[Pulmonary involvement in HTLV-I-associated myelopathy].
[Pathology of HTLV-I infections]
Retrospective screening for HTLV I infections in 68 acute leukemic patients multiply transfused before 1985.
[Latent HTLV-I and HIV-1 infection in seronegative patients with risk behavior in Argentina]
Spontaneous lymphocyte proliferation in vitro characterizes both HTLV-I and HTLV-II infection.
HIV-1 and HTLV-1 infections among intravenous drug abusers in Belgrade, Yugoslavia.
Detection of preleukemic state of adult T-cell leukemia (pre-ATL) in HTLV-1 carriers.
[Absence of HIV-2 and HTLV-I infection in prostitutes].
[HTLV-I and malignant hemopathies in Barcelona]
Blood transfusion and HTLV-I-associated myelopathy.
HTLV-I infection is not endemic in Apulia (southern Italy)
[Antibodies against HTLV-1 in patients undergoing multiple transfusions]
Cross-activation of the Rex proteins of HTLV-I and BLV and of the Rev protein of HIV-1 and nonreciprocal interactions with their RNA responsive elements.
[A case of HTLV-1 associated myelopathy with pulmonary involvement]
HTLV-I and HIV-1-associated neurologic abnormalities; syphilis as a confounding factor.
No evidence of HTLV-1 infection in Japanese multiple sclerosis patients in polymerase chain reaction.
Anti-viral antibodies in HIV (HTLV-III) infection possess auto-antibody activity against a CH1 domain determinant in human IgG: possible immunological consequences.
Low-titer antibodies reactive with HTLV-I gag p19 in patients with chronic myeloneuropathy.
[Difficulties in research on antibodies to HTLV-I]
Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements.
Monoclonal antibodies to HTLV-III451 gp41: delineation of an immunoreactive conserved epitope in the transmembrane region of divergent isolates of HIV-1.
[HTLV-1 infection in Barcelona].
[Production of monoclonal antibodies to human T-cell lymphotropic virus type 1 (HTLV-1) and studies of their specificity].
Low prevalence in Apulia (southern Italy) of HTLV I infection in drug addicts during 1986-88.
Non-prevalence of HTLV-I infection among intravenous drug users in northern Spain
HIV-1, HIV-2 and HTLV-I infection in high-risk groups in Spain.
HTLV-I infection and the family physician.
[Oligoclonal IgG bands in patients with HTLV-I associated myelopathy--detection by agarose isoelectric focusing, transfer to cellulose nitrate and immunoperoxidase staining]
Increases in helper inducer T cells and activated T cells in HTLV-I-associated myelopathy.
Detection of high concentrations of HTLV-1 p24 and a novel gag precursor, p45, in serum immune complexes of a healthy seropositive individual.
HTLV-I infection in multitransfused patients with thalassemia.
[Significance of the confirmatory test of enzyme immunoassay and western blotting method in detection of anti-HTLV-1 in sera]
Anti HTLV-I antibodies and HLA phenotypes in the West Indies.
[Neurologic diseases associated with HTLV-I infections]
[HTLV-I--a prototype in a growing group of leukemogenic viruses]
Evidence for dual infection of rabbits with the human retroviruses HTLV-I and HIV-1.
HTLV-I antibodies in Papua New Guinea.
Central motor conduction time in patients with HTLV-1 associated myelopathy.
HTLV-1 infection in Brazil.
[Increased awareness of infections caused by the HTLV-1 virus]
Recent advances in medicine (1988). AIDS, HTLV 1, mycosis fungoides/Sezary syndrome, psoriasis, HPV, lupus, scleroderma, and cancer.
HTLV-I infection and arthropod vectors.
Anti-HTLV-I antibodies in the serum and CSF from amyotrophic lateral sclerosis patients: negative findings.
HTLV-1 seroprevalence in AIDS patients and in HIV-1 seropositive and seronegative subjects at risk for AIDS in northern Italy.
A polyclonal CD4+ and CD8+ lymphocytosis in a patient doubly infected with HTLV-I and HIV-1: a clinical and molecular analysis.
Transcriptional regulation alone does not explain the constitutive expression of the interleukin 2 receptor (Tac/L-chain) in HTLV-1 infected cells.
Chronic inflammatory arthropathy associated with HTLV-I.
[Magnetic resonance imaging findings of HTLV-I-associated myelopathy]
Antibody response to a synthetic peptide covering a LAV-1/HTLV-IIIB neutralization epitope and disease progression.
Prevalence of HTLV-I-associated myelopathy among HTLV-I carriers in Saga, Japan.
[HTLV-I associated encephalo-myelopathy resembling ALS with concurrence of acute promyelocytic leukemia in a member of the relatives]
[HTLV-I associated myelopathy (HAM) complicated with chronic polymyositis]
HTLV-I p27rex regulates gag and env protein expression.
[Prevalence of anti-HTLV-I antibodies in intravenous drug addicts in Argentina]
[Neuromuscular manifestations of HIV-1 and HTLV-I infections]
HTLV-1 in Switzerland: low prevalence of specific antibodies in HIV risk groups, high prevalence of cross-reactive antibodies in normal blood donors.
[Coilocytitoc CIN III in a patient with T-cell lymphoma and HTLV I positive]
Absence of antibodies to HTLV-I/II in French patients with hematological malignancies.
Concomitant infection of HTLV-I and HIV-1: prevalence of IgG and IgM antibodies in Washington, D.C. area.
[Pneumocystis carinii pneumonia in a HTLV-I carrier terminating with acute type of adult T-cell leukemia]
Expression of HTLV-I antigen in cultured peripheral blood mononuclear cells from patients with HTLV-I associated myelopathy.
Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein.
[HTLV-I demonstrated in chronic progressive myelopathy].
[An analysis of lymphocyte surface markers in HTLV-I-associated myelopathy (HAM)]
Clinical picture of HTLV-I associated myelopathy.
[HTLV-1 in France].
[Viral infections in medicine. 2. The history of discovery and clinico-epidemiology of HTLV-I-associated myelopathy (HAM)].
[Spinal myoclonus related to HTLV-I associated myelopathy (HAM)]
[Clinical, virological and immunological studies of human T-lymphotropic virus type-I-associated myelopathy (HAM)].
The role of the Food and Drug Administration in development and standardization of tests for HIV and HTLV-I.
The American Red Cross experience with HTLV-I.
Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy.
Adenosine deaminase isoenzymes and HIV/HTLV-1 infections.
HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor.
Differential effects on expression of IL-2 receptors (p55 and p70) by the HTLV-I pX DNA.
Serial transplantation of an HTLV-I-transformed hamster lymphoid cell line into hamsters.
Transmission of HTLV-1.
HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation.
Another retroviral disease of the nervous system: chronic progressive myelopathy due to HTLV-1.
[Prevalence of HTLV-1 virus in pregnant women in Black Africa, Martinique, and foreigners living in France]
[Concepts and future prospects in HTLV-I-associated myelopathy].
[Blood donation and HTLV-1 and HIV]
Altered subsets of peripheral blood lymphocytes in patients with HTLV-I associated myelopathy (HAM).
Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors.
[IgM anti-ATLA antibodies in HTLV-I healthy carriers and patients with adult T cell leukemia and HTLV-I associated myelopathy].
HTLV-I-induced lymphoma mimicking Hodgkin's disease. Diagnosis by polymerase chain reaction amplification of specific HTLV-I sequences in tumor DNA.
Absence of antibodies to HTLV-I and HIV in serum and cerebrospinal fluid of Italian patients with multiple sclerosis.
Strongyloides infection and bacterial meningitis in immunocompromised host, especially anti-HTLV-1 antibody positive patients.
HTLV-1 associated myelopathy (HAM).
HTLV-1 infection due to mother milk and blood transfusion.
Distribution of adult T-cell leukemia and HTLV-I carriers in Kochi prefecture, Japan.
Gene rearrangements of T cell receptor beta and gamma chains in HTLV-I infected primary neoplastic T cells.
Prevalence of HTLV-I and HIV infection among white parenteral drug abusers.
Expression, release, and characterization of soluble human T-lymphotropic virus-I (HTLV-I) antigens from an infected cell line.
Comparative diagnostic assay results for detecting antibody to HTLV-I in Japanese blood donor samples: higher positivity rates by particle agglutination assay [corrected]
[Prevalence and prognostic significance of anti-HTLV-I and anti-HIV-2 antibodies in patients with HIV infection in the Roman region]
[HTLV-I associated myelopathy with multiple spotty areas found in the cerebral white matter and brain stem by MRI]
HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma.
Familial occurrence of HTLV-I--associated myelopathy.
Serologic studies of MS patients, controls, and patients with other neurologic diseases: antibodies to HTLV-I, II, III.
HTLV-I-associated spastic paraparesis in an Italian woman.
Low concentrations of suramin can reduce in vitro infection of human cord blood lymphocytes with HTLV-I during long-term culture.
T-lymphocyte alveolitis in HTLV-I-associated myelopathy.
Familial cases of HTLV-I-associated myelopathy.
Dual surface makers and HTLV-I proviral DNA in a cutaneous tumour nodule in a case of adult T cell leukaemia/lymphoma.
Expression of HTLV-I in serum of HTLV-I-related subjects and the early detection of overt ATL in HTLV-I carriers.
Can HTLV-1 lead to immunological disease?
Absence of HTLV-1 infection in India--a preliminary report.
[Prevalence and immunological properties of antibodies reactive with human T lymphotropic virus type I (HTLV-I) in sera from multiple sclerosis patients]
Breaking the cycle of HTLV-I transmission via carrier mothers' milk.
Strongyloides stercoralis as candidate co-factor for HTLV-I-induced leukaemogenesis.
Transcription of IL-2 receptor gene is stimulated by ATL-derived factor produced by HTLV-I(+) T cell lines.
Clinical electrophysiologic studies of HTLV-I-associated myelopathy.
Infection with HTLV-I and HTLV-III in T8 lymphoproliferative disease.
Viruses detected in HTLV-I-associated myelopathy and adult T-cell leukaemia are identical on DNA blotting.
[Morphological studies on cells from adult T cell leukemia. II. Lobulated lymphocytes and HTLV-I infection]
Transmission of adult T-cell leukemia retrovirus (HTLV-I) from mother to child: comparison of bottle- with breast-fed babies.
HTLV-I antibody and cell-mediated immunity status in sickle cell anemia.
HTLV-I-associated lymphoma involving the entire alimentary tract and presenting with an acquired immune deficiency.
Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering.
Necropsy findings in HTLV-I associated myelopathy.
Stages in LAV/HTLV-III lymphadenitis. I. Histological and immunohistological classification.
Antibodies to HTLV-1 in saliva of seropositive individuals from Japan.
No association between antibodies to HTLV-1 and polymyositis, rheumatoid arthritis and SLE.
Incidence of antibody to HTLV-I is not increased in Japanese MS patients.
Quantitative analysis of cytotoxicity induced by HTLV-I carrying cells against a human lymphoblastoid cell line, Molt-4.
Expression of the HT462 antigen on fresh leukemic T cells and on cells of HTLV-I infected lines.
Synthesis of PDGF by cultured human T cells transformed with HTLV-I and II.
[Mechanism of tumorigenesis by the HTLV-I virus].
Prevention of HTLV-I transmission through the breast milk by a freeze-thawing process.
HTLV-I and tropical spastic paraparesis in Africa.
Healthy HTLV-I carriers in Japan: the haematological and immunological characteristics.
Transmission of HTLV-1 by blood transfusion in an ATL-non-endemic area.
[Follow-up of lymphocyte morphology and detection of human T-cell leukemia virus type-I (HTLV-I) proviral DNA in HTLV-I carriers]
Isolation of HTLV-I from cerebrospinal fluid of a patient with myelopathy.
The origin of Japanese HTLV-I.
Search for HTLV-I and LAV/HTLV-III antibodies in serum and CSF of multiple sclerosis patients.
HTLV-I, visna, and tropical spastic paraparesis.
HTLV-I and tropical spastic paraparesis.
Blood transfusion and HTLV-I associated myelopathy.
Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1.
HTLV 1 induced adult T cell leukaemia in New Zealand.
Evidence for HTLV-I associated with mycosis fungoides and B-cell chronic lymphocytic leukemia.
The human interleukin-2 receptor: role in normal T-cell growth and association with HTLV-I-induced T-cell leukemia.
LAV/HTLV-III and HTLV-I antibodies in hemodialysis patients.
[Malignant lymphoma, ORL localization, and the presence of anti-HTLV-I antibodies in Martinique]
The prevalence of HTLV-III and HTLV-I antibodies in serum of hemophiliacs.